Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140610_SFK040_01 C20140610_SFK040_01 TB562640.[MT7]-VQLLGK[MT7].2b3_1.heavy 473.32 / 485.32 65206.0 29.527700424194336 46 16 10 10 10 2.215928570498194 30.923645416006984 0.0 3 0.9699904403472237 7.106249490585174 65206.0 46.56822849251523 0.0 - - - - - - - 1342.0 130 2 FES feline sarcoma oncogene 3 1 C20140610_SFK040_01 C20140610_SFK040_01 TB562640.[MT7]-VQLLGK[MT7].2y4_1.heavy 473.32 / 574.404 59938.0 29.527700424194336 46 16 10 10 10 2.215928570498194 30.923645416006984 0.0 3 0.9699904403472237 7.106249490585174 59938.0 24.473497296607366 1.0 - - - - - - - 298.0 124 1 FES feline sarcoma oncogene 5 1 C20140610_SFK040_01 C20140610_SFK040_01 TB562640.[MT7]-VQLLGK[MT7].2y5_1.heavy 473.32 / 702.463 60037.0 29.527700424194336 46 16 10 10 10 2.215928570498194 30.923645416006984 0.0 3 0.9699904403472237 7.106249490585174 60037.0 29.733156940043607 0.0 - - - - - - - 364.6666666666667 120 3 FES feline sarcoma oncogene 7 1 C20140610_SFK040_01 C20140610_SFK040_01 TB562640.[MT7]-VQLLGK[MT7].2b4_1.heavy 473.32 / 598.404 25148.0 29.527700424194336 46 16 10 10 10 2.215928570498194 30.923645416006984 0.0 3 0.9699904403472237 7.106249490585174 25148.0 18.656426144200623 0.0 - - - - - - - 398.0 50 1 FES feline sarcoma oncogene 9 2 C20140610_SFK040_01 C20140610_SFK040_01 TB324619.[MT7]-EELVAAVEDVR.2b3_1.heavy 687.373 / 516.279 38707.0 36.56230163574219 50 20 10 10 10 25.283108663218997 3.95520983325427 0.0 3 0.9954497532793231 18.288583968036548 38707.0 21.582393599259106 0.0 - - - - - - - 127.0 77 1 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 11 2 C20140610_SFK040_01 C20140610_SFK040_01 TB324619.[MT7]-EELVAAVEDVR.2y8_1.heavy 687.373 / 858.468 22919.0 36.56230163574219 50 20 10 10 10 25.283108663218997 3.95520983325427 0.0 3 0.9954497532793231 18.288583968036548 22919.0 27.077972614584816 0.0 - - - - - - - 1218.5714285714287 45 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 13 2 C20140610_SFK040_01 C20140610_SFK040_01 TB324619.[MT7]-EELVAAVEDVR.2b4_1.heavy 687.373 / 615.347 23683.0 36.56230163574219 50 20 10 10 10 25.283108663218997 3.95520983325427 0.0 3 0.9954497532793231 18.288583968036548 23683.0 10.232888438968065 0.0 - - - - - - - 764.0 47 3 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 15 2 C20140610_SFK040_01 C20140610_SFK040_01 TB324619.[MT7]-EELVAAVEDVR.2y7_1.heavy 687.373 / 759.399 22537.0 36.56230163574219 50 20 10 10 10 25.283108663218997 3.95520983325427 0.0 3 0.9954497532793231 18.288583968036548 22537.0 19.252804261204382 0.0 - - - - - - - 745.7142857142857 45 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 17 3 C20140610_SFK040_01 C20140610_SFK040_01 TB324507.[MT7]-FLQEAR.2y4_1.heavy 454.26 / 503.257 56388.0 26.80602502822876 46 20 10 6 10 19.937998380727283 5.015548606758001 0.03569984436035156 3 0.9990696605378122 40.45833187137444 56388.0 21.864522621669234 0.0 - - - - - - - 1208.6 112 5 FES feline sarcoma oncogene 19 3 C20140610_SFK040_01 C20140610_SFK040_01 TB324507.[MT7]-FLQEAR.2b3_1.heavy 454.26 / 533.32 60080.0 26.80602502822876 46 20 10 6 10 19.937998380727283 5.015548606758001 0.03569984436035156 3 0.9990696605378122 40.45833187137444 60080.0 33.599287472011 0.0 - - - - - - - 2205.714285714286 120 7 FES feline sarcoma oncogene 21 3 C20140610_SFK040_01 C20140610_SFK040_01 TB324507.[MT7]-FLQEAR.2y5_1.heavy 454.26 / 616.341 163541.0 26.80602502822876 46 20 10 6 10 19.937998380727283 5.015548606758001 0.03569984436035156 3 0.9990696605378122 40.45833187137444 163541.0 281.23199757344656 0.0 - - - - - - - 252.0 327 2 FES feline sarcoma oncogene 23 3 C20140610_SFK040_01 C20140610_SFK040_01 TB324507.[MT7]-FLQEAR.2b4_1.heavy 454.26 / 662.363 99433.0 26.80602502822876 46 20 10 6 10 19.937998380727283 5.015548606758001 0.03569984436035156 3 0.9990696605378122 40.45833187137444 99433.0 105.83546877354355 0.0 - - - - - - - 1133.0 198 8 FES feline sarcoma oncogene 25 4 C20140610_SFK040_01 C20140610_SFK040_01 TB563784.[MT7]-TIVQLENEIY[MT7]QIK[MT7].4y4_1.heavy 506.55 / 839.523 4097.0 40.885799407958984 50 20 10 10 10 11.712538482123342 8.537858821350161 0.0 3 0.9923821318522341 14.13089138653804 4097.0 50.568132464712264 0.0 - - - - - - - 193.33333333333334 8 9 BCAS2 breast carcinoma amplified sequence 2 27 4 C20140610_SFK040_01 C20140610_SFK040_01 TB563784.[MT7]-TIVQLENEIY[MT7]QIK[MT7].4b4_1.heavy 506.55 / 586.368 49575.0 40.885799407958984 50 20 10 10 10 11.712538482123342 8.537858821350161 0.0 3 0.9923821318522341 14.13089138653804 49575.0 154.62748022358787 0.0 - - - - - - - 648.6666666666666 99 9 BCAS2 breast carcinoma amplified sequence 2 29 4 C20140610_SFK040_01 C20140610_SFK040_01 TB563784.[MT7]-TIVQLENEIY[MT7]QIK[MT7].4b5_1.heavy 506.55 / 699.452 11882.0 40.885799407958984 50 20 10 10 10 11.712538482123342 8.537858821350161 0.0 3 0.9923821318522341 14.13089138653804 11882.0 29.36689430894309 0.0 - - - - - - - 245.7 23 10 BCAS2 breast carcinoma amplified sequence 2 31 4 C20140610_SFK040_01 C20140610_SFK040_01 TB563784.[MT7]-TIVQLENEIY[MT7]QIK[MT7].4y3_1.heavy 506.55 / 532.357 18027.0 40.885799407958984 50 20 10 10 10 11.712538482123342 8.537858821350161 0.0 3 0.9923821318522341 14.13089138653804 18027.0 71.40690455476908 2.0 - - - - - - - 325.90909090909093 36 11 BCAS2 breast carcinoma amplified sequence 2 33 5 C20140610_SFK040_01 C20140610_SFK040_01 TB458575.[MT7]-TYSEQWQQLQQELTK[MT7].3y3_1.heavy 733.383 / 505.347 78267.0 41.13650131225586 47 17 10 10 10 2.1088800507178904 36.809021318164525 0.0 3 0.979273292971684 8.557447118906937 78267.0 84.93202153794739 0.0 - - - - - - - 878.1428571428571 156 7 FES feline sarcoma oncogene 35 5 C20140610_SFK040_01 C20140610_SFK040_01 TB458575.[MT7]-TYSEQWQQLQQELTK[MT7].3b4_1.heavy 733.383 / 625.295 61801.0 41.13650131225586 47 17 10 10 10 2.1088800507178904 36.809021318164525 0.0 3 0.979273292971684 8.557447118906937 61801.0 94.0880608974359 0.0 - - - - - - - 719.6666666666666 123 9 FES feline sarcoma oncogene 37 5 C20140610_SFK040_01 C20140610_SFK040_01 TB458575.[MT7]-TYSEQWQQLQQELTK[MT7].3b5_1.heavy 733.383 / 753.354 166962.0 41.13650131225586 47 17 10 10 10 2.1088800507178904 36.809021318164525 0.0 3 0.979273292971684 8.557447118906937 166962.0 273.7931155183385 0.0 - - - - - - - 784.0 333 7 FES feline sarcoma oncogene 39 5 C20140610_SFK040_01 C20140610_SFK040_01 TB458575.[MT7]-TYSEQWQQLQQELTK[MT7].3y5_1.heavy 733.383 / 762.448 55654.0 41.13650131225586 47 17 10 10 10 2.1088800507178904 36.809021318164525 0.0 3 0.979273292971684 8.557447118906937 55654.0 85.61333008856738 0.0 - - - - - - - 738.5454545454545 111 11 FES feline sarcoma oncogene 41 6 C20140610_SFK040_01 C20140610_SFK040_01 TB458578.[MT7]-LLEPLVTQVTTLVNTNSK[MT7].3b6_1.heavy 753.445 / 809.525 47478.0 49.34880065917969 45 15 10 10 10 2.4231727957305615 41.268208431603426 0.0 3 0.9538442122792578 5.722219787992056 47478.0 67.07336939847025 0.0 - - - - - - - 333.75 94 4 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 43 6 C20140610_SFK040_01 C20140610_SFK040_01 TB458578.[MT7]-LLEPLVTQVTTLVNTNSK[MT7].3b5_1.heavy 753.445 / 710.457 63874.0 49.34880065917969 45 15 10 10 10 2.4231727957305615 41.268208431603426 0.0 3 0.9538442122792578 5.722219787992056 63874.0 66.9627288338854 0.0 - - - - - - - 459.0 127 1 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 45 6 C20140610_SFK040_01 C20140610_SFK040_01 TB458578.[MT7]-LLEPLVTQVTTLVNTNSK[MT7].3b3_1.heavy 753.445 / 500.32 70466.0 49.34880065917969 45 15 10 10 10 2.4231727957305615 41.268208431603426 0.0 3 0.9538442122792578 5.722219787992056 70466.0 77.35898174704303 0.0 - - - - - - - 598.3333333333334 140 3 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 47 6 C20140610_SFK040_01 C20140610_SFK040_01 TB458578.[MT7]-LLEPLVTQVTTLVNTNSK[MT7].3y5_1.heavy 753.445 / 707.38 53569.0 49.34880065917969 45 15 10 10 10 2.4231727957305615 41.268208431603426 0.0 3 0.9538442122792578 5.722219787992056 53569.0 104.17632794254914 0.0 - - - - - - - 643.7142857142857 107 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 49 7 C20140610_SFK040_01 C20140610_SFK040_01 TB563371.[MT7]-TVLLLADQMISR.2y8_1.heavy 752.438 / 933.482 123242.0 47.059200286865234 44 14 10 10 10 1.5680978524432976 44.00171397719034 0.0 3 0.9393278355726279 4.984791362040745 123242.0 279.81995081967216 0.0 - - - - - - - 675.6363636363636 246 11 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 51 7 C20140610_SFK040_01 C20140610_SFK040_01 TB563371.[MT7]-TVLLLADQMISR.2y5_1.heavy 752.438 / 634.334 67555.0 47.059200286865234 44 14 10 10 10 1.5680978524432976 44.00171397719034 0.0 3 0.9393278355726279 4.984791362040745 67555.0 202.8042188758961 0.0 - - - - - - - 731.0909090909091 135 11 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 53 7 C20140610_SFK040_01 C20140610_SFK040_01 TB563371.[MT7]-TVLLLADQMISR.2y9_1.heavy 752.438 / 1046.57 100279.0 47.059200286865234 44 14 10 10 10 1.5680978524432976 44.00171397719034 0.0 3 0.9393278355726279 4.984791362040745 100279.0 109.49945930600575 0.0 - - - - - - - 499.0 200 1 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 55 7 C20140610_SFK040_01 C20140610_SFK040_01 TB563371.[MT7]-TVLLLADQMISR.2y10_1.heavy 752.438 / 1159.65 41765.0 47.059200286865234 44 14 10 10 10 1.5680978524432976 44.00171397719034 0.0 3 0.9393278355726279 4.984791362040745 41765.0 62.798372529498025 0.0 - - - - - - - 404.14285714285717 83 7 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 57 8 C20140610_SFK040_01 C20140610_SFK040_01 TB563078.[MT7]-SLQC[CAM]ENLK[MT7].3y3_1.heavy 427.235 / 518.342 33338.0 23.94029998779297 46 20 10 10 6 5.263469398273796 18.99887553878359 0.0 5 0.990353613946847 12.555393167758586 33338.0 21.403168885047535 0.0 - - - - - - - 1735.5714285714287 66 7 SPAG5 sperm associated antigen 5 59 8 C20140610_SFK040_01 C20140610_SFK040_01 TB563078.[MT7]-SLQC[CAM]ENLK[MT7].3b4_1.heavy 427.235 / 633.315 10454.0 23.94029998779297 46 20 10 10 6 5.263469398273796 18.99887553878359 0.0 5 0.990353613946847 12.555393167758586 10454.0 12.828776789395823 2.0 - - - - - - - 719.2727272727273 75 11 SPAG5 sperm associated antigen 5 61 8 C20140610_SFK040_01 C20140610_SFK040_01 TB563078.[MT7]-SLQC[CAM]ENLK[MT7].3b5_1.heavy 427.235 / 762.357 4309.0 23.94029998779297 46 20 10 10 6 5.263469398273796 18.99887553878359 0.0 5 0.990353613946847 12.555393167758586 4309.0 15.523391061004002 0.0 - - - - - - - 193.3684210526316 8 19 SPAG5 sperm associated antigen 5 63 8 C20140610_SFK040_01 C20140610_SFK040_01 TB563078.[MT7]-SLQC[CAM]ENLK[MT7].3b3_1.heavy 427.235 / 473.284 64204.0 23.94029998779297 46 20 10 10 6 5.263469398273796 18.99887553878359 0.0 5 0.990353613946847 12.555393167758586 64204.0 20.396138535411172 0.0 - - - - - - - 565.0 128 1 SPAG5 sperm associated antigen 5 65 9 C20140610_SFK040_01 C20140610_SFK040_01 TB563373.[MT7]-NLMNAVVQTVK[MT7].3b6_1.heavy 502.297 / 787.425 5221.0 38.117401123046875 44 17 9 10 8 2.595168206667859 38.53314777171916 0.0 4 0.9714388651928624 7.285100088075862 5221.0 18.57862546608733 0.0 - - - - - - - 305.1818181818182 10 11 CTNNA1;CTNNA3 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 3 67 9 C20140610_SFK040_01 C20140610_SFK040_01 TB563373.[MT7]-NLMNAVVQTVK[MT7].3b4_1.heavy 502.297 / 617.32 12556.0 38.117401123046875 44 17 9 10 8 2.595168206667859 38.53314777171916 0.0 4 0.9714388651928624 7.285100088075862 12556.0 14.141914722445698 0.0 - - - - - - - 746.25 25 8 CTNNA1;CTNNA3 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 3 69 9 C20140610_SFK040_01 C20140610_SFK040_01 TB563373.[MT7]-NLMNAVVQTVK[MT7].3b5_1.heavy 502.297 / 688.357 15043.0 38.117401123046875 44 17 9 10 8 2.595168206667859 38.53314777171916 0.0 4 0.9714388651928624 7.285100088075862 15043.0 30.79693866113409 1.0 - - - - - - - 799.4285714285714 34 7 CTNNA1;CTNNA3 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 3 71 9 C20140610_SFK040_01 C20140610_SFK040_01 TB563373.[MT7]-NLMNAVVQTVK[MT7].3y4_1.heavy 502.297 / 619.39 8205.0 38.117401123046875 44 17 9 10 8 2.595168206667859 38.53314777171916 0.0 4 0.9714388651928624 7.285100088075862 8205.0 16.3854602772576 0.0 - - - - - - - 372.9 16 10 CTNNA1;CTNNA3 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 3 73 10 C20140610_SFK040_01 C20140610_SFK040_01 TB563375.[MT7]-AQNLLEQFQK[MT7].3y3_1.heavy 502.955 / 566.342 152237.0 36.69380187988281 50 20 10 10 10 5.8283296727885565 17.157574401956424 0.0 3 0.9908088740893779 12.863075302733339 152237.0 165.4448991508848 0.0 - - - - - - - 748.1428571428571 304 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 75 10 C20140610_SFK040_01 C20140610_SFK040_01 TB563375.[MT7]-AQNLLEQFQK[MT7].3b4_1.heavy 502.955 / 571.332 269353.0 36.69380187988281 50 20 10 10 10 5.8283296727885565 17.157574401956424 0.0 3 0.9908088740893779 12.863075302733339 269353.0 364.9013340223817 0.0 - - - - - - - 709.6666666666666 538 9 RGL1 ral guanine nucleotide dissociation stimulator-like 1 77 10 C20140610_SFK040_01 C20140610_SFK040_01 TB563375.[MT7]-AQNLLEQFQK[MT7].3b5_1.heavy 502.955 / 684.416 67945.0 36.69380187988281 50 20 10 10 10 5.8283296727885565 17.157574401956424 0.0 3 0.9908088740893779 12.863075302733339 67945.0 254.74939947780678 0.0 - - - - - - - 255.36363636363637 135 11 RGL1 ral guanine nucleotide dissociation stimulator-like 1 79 10 C20140610_SFK040_01 C20140610_SFK040_01 TB563375.[MT7]-AQNLLEQFQK[MT7].3y5_1.heavy 502.955 / 823.443 29247.0 36.69380187988281 50 20 10 10 10 5.8283296727885565 17.157574401956424 0.0 3 0.9908088740893779 12.863075302733339 29247.0 88.81162279613756 0.0 - - - - - - - 239.375 58 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 81 11 C20140610_SFK040_01 C20140610_SFK040_01 TB563377.[MT7]-EFWPQEVWSR.2y4_1.heavy 754.376 / 547.299 8164.0 41.92840099334717 44 18 10 6 10 2.0361683533956807 36.56494135789909 0.037601470947265625 3 0.9885999556333454 11.547704251202239 8164.0 11.26230455674333 1.0 - - - - - - - 809.1428571428571 16 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 83 11 C20140610_SFK040_01 C20140610_SFK040_01 TB563377.[MT7]-EFWPQEVWSR.2y8_1.heavy 754.376 / 1087.53 24011.0 41.92840099334717 44 18 10 6 10 2.0361683533956807 36.56494135789909 0.037601470947265625 3 0.9885999556333454 11.547704251202239 24011.0 65.97466898148149 0.0 - - - - - - - 278.4 48 10 FDFT1 farnesyl-diphosphate farnesyltransferase 1 85 11 C20140610_SFK040_01 C20140610_SFK040_01 TB563377.[MT7]-EFWPQEVWSR.2y9_1.heavy 754.376 / 1234.6 12774.0 41.92840099334717 44 18 10 6 10 2.0361683533956807 36.56494135789909 0.037601470947265625 3 0.9885999556333454 11.547704251202239 12774.0 28.27578125 0.0 - - - - - - - 682.6666666666666 25 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 87 11 C20140610_SFK040_01 C20140610_SFK040_01 TB563377.[MT7]-EFWPQEVWSR.2y7_1.heavy 754.376 / 901.453 78661.0 41.92840099334717 44 18 10 6 10 2.0361683533956807 36.56494135789909 0.037601470947265625 3 0.9885999556333454 11.547704251202239 78661.0 175.3035176206244 0.0 - - - - - - - 732.0 157 8 FDFT1 farnesyl-diphosphate farnesyltransferase 1 89 12 C20140610_SFK040_01 C20140610_SFK040_01 TB563887.[MT7]-RQVLQEALQGLQVALC[CAM]SQAK[MT7].4y4_1.heavy 632.861 / 577.343 80485.0 46.41550064086914 47 17 10 10 10 6.81937828592956 14.664093383165184 0.0 3 0.9707693137857951 7.200775236872458 80485.0 109.08786811140341 0.0 - - - - - - - 428.5 160 2 FES feline sarcoma oncogene 91 12 C20140610_SFK040_01 C20140610_SFK040_01 TB563887.[MT7]-RQVLQEALQGLQVALC[CAM]SQAK[MT7].4y5_1.heavy 632.861 / 737.373 74373.0 46.41550064086914 47 17 10 10 10 6.81937828592956 14.664093383165184 0.0 3 0.9707693137857951 7.200775236872458 74373.0 163.95164652469023 0.0 - - - - - - - 693.7142857142857 148 7 FES feline sarcoma oncogene 93 12 C20140610_SFK040_01 C20140610_SFK040_01 TB563887.[MT7]-RQVLQEALQGLQVALC[CAM]SQAK[MT7].4b7_1.heavy 632.861 / 969.56 22506.0 46.41550064086914 47 17 10 10 10 6.81937828592956 14.664093383165184 0.0 3 0.9707693137857951 7.200775236872458 22506.0 171.09364372469634 0.0 - - - - - - - 195.08333333333334 45 12 FES feline sarcoma oncogene 95 12 C20140610_SFK040_01 C20140610_SFK040_01 TB563887.[MT7]-RQVLQEALQGLQVALC[CAM]SQAK[MT7].4b10_2.heavy 632.861 / 634.366 153772.0 46.41550064086914 47 17 10 10 10 6.81937828592956 14.664093383165184 0.0 3 0.9707693137857951 7.200775236872458 153772.0 195.53020347945784 0.0 - - - - - - - 285.5 307 4 FES feline sarcoma oncogene 97 13 C20140610_SFK040_01 C20140610_SFK040_01 TB563076.[MT7]-DTVENLTAK[MT7].3y3_1.heavy 426.91 / 463.3 158364.0 25.705349445343018 40 14 10 6 10 2.3539141546183657 37.4980740903888 0.03339958190917969 3 0.9447736492835035 5.227209878989527 158364.0 80.22123413926664 0.0 - - - - - - - 927.0 316 1 SPAG5 sperm associated antigen 5 99 13 C20140610_SFK040_01 C20140610_SFK040_01 TB563076.[MT7]-DTVENLTAK[MT7].3b4_1.heavy 426.91 / 589.295 68910.0 25.705349445343018 40 14 10 6 10 2.3539141546183657 37.4980740903888 0.03339958190917969 3 0.9447736492835035 5.227209878989527 68910.0 50.917727803738316 0.0 - - - - - - - 1385.857142857143 137 7 SPAG5 sperm associated antigen 5 101 13 C20140610_SFK040_01 C20140610_SFK040_01 TB563076.[MT7]-DTVENLTAK[MT7].3b5_1.heavy 426.91 / 703.338 63988.0 25.705349445343018 40 14 10 6 10 2.3539141546183657 37.4980740903888 0.03339958190917969 3 0.9447736492835035 5.227209878989527 63988.0 71.97645958968315 0.0 - - - - - - - 343.6363636363636 127 11 SPAG5 sperm associated antigen 5 103 13 C20140610_SFK040_01 C20140610_SFK040_01 TB563076.[MT7]-DTVENLTAK[MT7].3b3_1.heavy 426.91 / 460.252 72048.0 25.705349445343018 40 14 10 6 10 2.3539141546183657 37.4980740903888 0.03339958190917969 3 0.9447736492835035 5.227209878989527 72048.0 39.51141984301241 0.0 - - - - - - - 1312.6 144 5 SPAG5 sperm associated antigen 5 105 14 C20140610_SFK040_01 C20140610_SFK040_01 TB563786.[MT7]-DAAEIVLEAFC[CAM]AHASQR.3y7_1.heavy 678.006 / 829.373 71586.0 45.83660125732422 47 17 10 10 10 3.3042461388055497 24.581154233259383 0.0 3 0.9786093222081466 8.42311806908813 71586.0 130.70119605980668 0.0 - - - - - - - 298.0 143 7 SPAG5 sperm associated antigen 5 107 14 C20140610_SFK040_01 C20140610_SFK040_01 TB563786.[MT7]-DAAEIVLEAFC[CAM]AHASQR.3b6_1.heavy 678.006 / 743.406 128374.0 45.83660125732422 47 17 10 10 10 3.3042461388055497 24.581154233259383 0.0 3 0.9786093222081466 8.42311806908813 128374.0 108.94561614879355 0.0 - - - - - - - 316.0 256 1 SPAG5 sperm associated antigen 5 109 14 C20140610_SFK040_01 C20140610_SFK040_01 TB563786.[MT7]-DAAEIVLEAFC[CAM]AHASQR.3b4_1.heavy 678.006 / 531.253 178711.0 45.83660125732422 47 17 10 10 10 3.3042461388055497 24.581154233259383 0.0 3 0.9786093222081466 8.42311806908813 178711.0 90.13693574816531 0.0 - - - - - - - 1309.7142857142858 357 7 SPAG5 sperm associated antigen 5 111 14 C20140610_SFK040_01 C20140610_SFK040_01 TB563786.[MT7]-DAAEIVLEAFC[CAM]AHASQR.3b5_1.heavy 678.006 / 644.337 194774.0 45.83660125732422 47 17 10 10 10 3.3042461388055497 24.581154233259383 0.0 3 0.9786093222081466 8.42311806908813 194774.0 141.8301948845088 0.0 - - - - - - - 126.0 389 1 SPAG5 sperm associated antigen 5 113 15 C20140610_SFK040_01 C20140610_SFK040_01 TB562748.[MT7]-IWEVLK[MT7].2b3_1.heavy 538.341 / 573.315 92201.0 39.42340087890625 50 20 10 10 10 11.663704422975155 8.57360546646056 0.0 3 0.9979716930738083 27.39820423605202 92201.0 105.89201102349139 0.0 - - - - - - - 1275.857142857143 184 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 115 15 C20140610_SFK040_01 C20140610_SFK040_01 TB562748.[MT7]-IWEVLK[MT7].2y4_1.heavy 538.341 / 632.41 79288.0 39.42340087890625 50 20 10 10 10 11.663704422975155 8.57360546646056 0.0 3 0.9979716930738083 27.39820423605202 79288.0 80.61232771583485 0.0 - - - - - - - 784.3333333333334 158 6 RGL1 ral guanine nucleotide dissociation stimulator-like 1 117 15 C20140610_SFK040_01 C20140610_SFK040_01 TB562748.[MT7]-IWEVLK[MT7].2y5_1.heavy 538.341 / 818.489 195264.0 39.42340087890625 50 20 10 10 10 11.663704422975155 8.57360546646056 0.0 3 0.9979716930738083 27.39820423605202 195264.0 502.5975036518889 0.0 - - - - - - - 350.0 390 10 RGL1 ral guanine nucleotide dissociation stimulator-like 1 119 15 C20140610_SFK040_01 C20140610_SFK040_01 TB562748.[MT7]-IWEVLK[MT7].2y3_1.heavy 538.341 / 503.367 105718.0 39.42340087890625 50 20 10 10 10 11.663704422975155 8.57360546646056 0.0 3 0.9979716930738083 27.39820423605202 105718.0 62.13770362203081 0.0 - - - - - - - 241.0 211 1 RGL1 ral guanine nucleotide dissociation stimulator-like 1 121 16 C20140610_SFK040_01 C20140610_SFK040_01 TB563476.[MT7]-IQPEAEYQGFLR.3y6_1.heavy 532.283 / 783.415 40470.0 36.82780075073242 47 17 10 10 10 4.053500844130725 24.670033101089693 0.0 3 0.9744229612309224 7.7002921658503 40470.0 75.28687989556136 0.0 - - - - - - - 271.25 80 8 FES feline sarcoma oncogene 123 16 C20140610_SFK040_01 C20140610_SFK040_01 TB563476.[MT7]-IQPEAEYQGFLR.3b6_1.heavy 532.283 / 812.427 44300.0 36.82780075073242 47 17 10 10 10 4.053500844130725 24.670033101089693 0.0 3 0.9744229612309224 7.7002921658503 44300.0 81.72715575183975 0.0 - - - - - - - 255.25 88 4 FES feline sarcoma oncogene 125 16 C20140610_SFK040_01 C20140610_SFK040_01 TB563476.[MT7]-IQPEAEYQGFLR.3b4_1.heavy 532.283 / 612.347 47874.0 36.82780075073242 47 17 10 10 10 4.053500844130725 24.670033101089693 0.0 3 0.9744229612309224 7.7002921658503 47874.0 65.04404733212827 0.0 - - - - - - - 1221.7142857142858 95 7 FES feline sarcoma oncogene 127 16 C20140610_SFK040_01 C20140610_SFK040_01 TB563476.[MT7]-IQPEAEYQGFLR.3y5_1.heavy 532.283 / 620.352 84387.0 36.82780075073242 47 17 10 10 10 4.053500844130725 24.670033101089693 0.0 3 0.9744229612309224 7.7002921658503 84387.0 25.256149310826398 0.0 - - - - - - - 319.0 168 2 FES feline sarcoma oncogene 129 17 C20140610_SFK040_01 C20140610_SFK040_01 TB563470.[MT7]-LQAQQELLQTK[MT7].3b6_1.heavy 529.982 / 842.449 185980.0 30.496000289916992 47 17 10 10 10 2.6771517243988945 29.881422804663195 0.0 3 0.9752117126047614 7.822361552127813 185980.0 279.0060197211918 0.0 - - - - - - - 236.16666666666666 371 6 FES feline sarcoma oncogene 131 17 C20140610_SFK040_01 C20140610_SFK040_01 TB563470.[MT7]-LQAQQELLQTK[MT7].3b4_1.heavy 529.982 / 585.348 188160.0 30.496000289916992 47 17 10 10 10 2.6771517243988945 29.881422804663195 0.0 3 0.9752117126047614 7.822361552127813 188160.0 94.25833620492187 0.0 - - - - - - - 817.5 376 2 FES feline sarcoma oncogene 133 17 C20140610_SFK040_01 C20140610_SFK040_01 TB563470.[MT7]-LQAQQELLQTK[MT7].3b5_1.heavy 529.982 / 713.406 116251.0 30.496000289916992 47 17 10 10 10 2.6771517243988945 29.881422804663195 0.0 3 0.9752117126047614 7.822361552127813 116251.0 61.73275279513898 0.0 - - - - - - - 726.6666666666666 232 3 FES feline sarcoma oncogene 135 17 C20140610_SFK040_01 C20140610_SFK040_01 TB563470.[MT7]-LQAQQELLQTK[MT7].3y4_1.heavy 529.982 / 633.405 187942.0 30.496000289916992 47 17 10 10 10 2.6771517243988945 29.881422804663195 0.0 3 0.9752117126047614 7.822361552127813 187942.0 213.18433636233232 0.0 - - - - - - - 327.0 375 4 FES feline sarcoma oncogene 137 18 C20140610_SFK040_01 C20140610_SFK040_01 TB562642.[MT7]-VLEATK[MT7].2b3_1.heavy 474.802 / 486.304 17657.0 22.49489974975586 46 20 10 10 6 8.306008431177547 12.039477304723004 0.0 5 0.9960960515576756 19.745536720630728 17657.0 17.705328435509564 1.0 - - - - - - - 767.6666666666666 37 6 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 139 18 C20140610_SFK040_01 C20140610_SFK040_01 TB562642.[MT7]-VLEATK[MT7].2y4_1.heavy 474.802 / 592.342 30707.0 22.49489974975586 46 20 10 10 6 8.306008431177547 12.039477304723004 0.0 5 0.9960960515576756 19.745536720630728 30707.0 39.45174328072312 1.0 - - - - - - - 759.8888888888889 65 9 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 141 18 C20140610_SFK040_01 C20140610_SFK040_01 TB562642.[MT7]-VLEATK[MT7].2y5_1.heavy 474.802 / 705.426 56668.0 22.49489974975586 46 20 10 10 6 8.306008431177547 12.039477304723004 0.0 5 0.9960960515576756 19.745536720630728 56668.0 152.46027777777778 1.0 - - - - - - - 697.75 113 8 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 143 18 C20140610_SFK040_01 C20140610_SFK040_01 TB562642.[MT7]-VLEATK[MT7].2b4_1.heavy 474.802 / 557.341 10329.0 22.49489974975586 46 20 10 10 6 8.306008431177547 12.039477304723004 0.0 5 0.9960960515576756 19.745536720630728 10329.0 13.357096349138503 1.0 - - - - - - - 1264.0 23 9 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 145 19 C20140610_SFK040_01 C20140610_SFK040_01 TB563472.[MT7]-EAAAALVEEETRR.3y6_1.heavy 530.285 / 819.396 42149.0 29.390199661254883 46 16 10 10 10 2.3756708797186197 34.208495250310804 0.0 3 0.9694171469812205 7.038988926211511 42149.0 59.406085363031714 0.0 - - - - - - - 282.0 84 9 BCAS2 breast carcinoma amplified sequence 2 147 19 C20140610_SFK040_01 C20140610_SFK040_01 TB563472.[MT7]-EAAAALVEEETRR.3b6_1.heavy 530.285 / 671.385 191231.0 29.390199661254883 46 16 10 10 10 2.3756708797186197 34.208495250310804 0.0 3 0.9694171469812205 7.038988926211511 191231.0 167.91598320427596 0.0 - - - - - - - 1284.5 382 6 BCAS2 breast carcinoma amplified sequence 2 149 19 C20140610_SFK040_01 C20140610_SFK040_01 TB563472.[MT7]-EAAAALVEEETRR.3b5_1.heavy 530.285 / 558.3 478564.0 29.390199661254883 46 16 10 10 10 2.3756708797186197 34.208495250310804 0.0 3 0.9694171469812205 7.038988926211511 478564.0 228.88309170388226 0.0 - - - - - - - 732.0 957 2 BCAS2 breast carcinoma amplified sequence 2 151 19 C20140610_SFK040_01 C20140610_SFK040_01 TB563472.[MT7]-EAAAALVEEETRR.3y12_2.heavy 530.285 / 658.352 270747.0 29.390199661254883 46 16 10 10 10 2.3756708797186197 34.208495250310804 0.0 3 0.9694171469812205 7.038988926211511 270747.0 225.36785266166197 0.0 - - - - - - - 1784.142857142857 541 7 BCAS2 breast carcinoma amplified sequence 2 153 20 C20140610_SFK040_01 C20140610_SFK040_01 TB562651.[MT7]-TADGWK[MT7].2b3_1.heavy 483.268 / 432.221 117136.0 22.49489974975586 44 14 10 10 10 2.414650485860986 41.41386117185537 0.0 3 0.9487863427187725 5.4299813475032686 117136.0 55.6100202020202 0.0 - - - - - - - 1216.0 234 4 FBXO32 F-box protein 32 155 20 C20140610_SFK040_01 C20140610_SFK040_01 TB562651.[MT7]-TADGWK[MT7].2y4_1.heavy 483.268 / 649.343 28694.0 22.49489974975586 44 14 10 10 10 2.414650485860986 41.41386117185537 0.0 3 0.9487863427187725 5.4299813475032686 28694.0 31.266125971759482 0.0 - - - - - - - 764.3333333333334 57 9 FBXO32 F-box protein 32 157 20 C20140610_SFK040_01 C20140610_SFK040_01 TB562651.[MT7]-TADGWK[MT7].2y5_1.heavy 483.268 / 720.38 44256.0 22.49489974975586 44 14 10 10 10 2.414650485860986 41.41386117185537 0.0 3 0.9487863427187725 5.4299813475032686 44256.0 118.03382975539569 0.0 - - - - - - - 708.7 88 10 FBXO32 F-box protein 32 159 20 C20140610_SFK040_01 C20140610_SFK040_01 TB562651.[MT7]-TADGWK[MT7].2y3_1.heavy 483.268 / 534.316 139855.0 22.49489974975586 44 14 10 10 10 2.414650485860986 41.41386117185537 0.0 3 0.9487863427187725 5.4299813475032686 139855.0 125.80566559222223 0.0 - - - - - - - 486.0 279 1 FBXO32 F-box protein 32 161 21 C20140610_SFK040_01 C20140610_SFK040_01 TB324708.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].3y6_1.heavy 838.807 / 873.553 67897.0 47.66270065307617 48 18 10 10 10 6.960601510785566 14.36657447564673 0.0 3 0.9898757648031796 12.255024014208882 67897.0 141.10641264737404 0.0 - - - - - - - 795.75 135 12 POSTN periostin, osteoblast specific factor 163 21 C20140610_SFK040_01 C20140610_SFK040_01 TB324708.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].3y3_1.heavy 838.807 / 518.342 121467.0 47.66270065307617 48 18 10 10 10 6.960601510785566 14.36657447564673 0.0 3 0.9898757648031796 12.255024014208882 121467.0 154.92456167410063 0.0 - - - - - - - 845.1 242 10 POSTN periostin, osteoblast specific factor 165 21 C20140610_SFK040_01 C20140610_SFK040_01 TB324708.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].3b3_1.heavy 838.807 / 534.341 171361.0 47.66270065307617 48 18 10 10 10 6.960601510785566 14.36657447564673 0.0 3 0.9898757648031796 12.255024014208882 171361.0 139.1972837787717 0.0 - - - - - - - 700.0 342 4 POSTN periostin, osteoblast specific factor 167 21 C20140610_SFK040_01 C20140610_SFK040_01 TB324708.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].3y5_1.heavy 838.807 / 760.469 72013.0 47.66270065307617 48 18 10 10 10 6.960601510785566 14.36657447564673 0.0 3 0.9898757648031796 12.255024014208882 72013.0 62.06472797092103 0.0 - - - - - - - 623.9090909090909 144 11 POSTN periostin, osteoblast specific factor 169 22 C20140610_SFK040_01 C20140610_SFK040_01 TB563772.[MT7]-GGRLPC[CAM]PELC[CAM]PDAVFR.3y7_1.heavy 663.337 / 864.403 27592.0 36.455650329589844 40 15 10 5 10 2.1152076925141867 40.26631638034466 0.04270172119140625 3 0.9589841538885326 6.072825880402312 27592.0 47.67410309994737 0.0 - - - - - - - 191.75 55 4 FES feline sarcoma oncogene 171 22 C20140610_SFK040_01 C20140610_SFK040_01 TB563772.[MT7]-GGRLPC[CAM]PELC[CAM]PDAVFR.3y6_1.heavy 663.337 / 704.373 66809.0 36.455650329589844 40 15 10 5 10 2.1152076925141867 40.26631638034466 0.04270172119140625 3 0.9589841538885326 6.072825880402312 66809.0 94.57871957295374 0.0 - - - - - - - 255.0 133 2 FES feline sarcoma oncogene 173 22 C20140610_SFK040_01 C20140610_SFK040_01 TB563772.[MT7]-GGRLPC[CAM]PELC[CAM]PDAVFR.3b8_1.heavy 663.337 / 1011.52 24143.0 36.455650329589844 40 15 10 5 10 2.1152076925141867 40.26631638034466 0.04270172119140625 3 0.9589841538885326 6.072825880402312 24143.0 45.86958651882112 0.0 - - - - - - - 718.375 48 8 FES feline sarcoma oncogene 175 22 C20140610_SFK040_01 C20140610_SFK040_01 TB563772.[MT7]-GGRLPC[CAM]PELC[CAM]PDAVFR.3b8_2.heavy 663.337 / 506.262 72941.0 36.455650329589844 40 15 10 5 10 2.1152076925141867 40.26631638034466 0.04270172119140625 3 0.9589841538885326 6.072825880402312 72941.0 57.70363411619283 0.0 - - - - - - - 638.5 145 2 FES feline sarcoma oncogene 177 23 C20140610_SFK040_01 C20140610_SFK040_01 TB458581.[MT7]-ELISLLHLSLLHLEEDK[MT7].4y4_1.heavy 573.337 / 664.327 17894.0 49.84659957885742 41 11 10 10 10 0.8690411744869999 66.03418319436425 0.0 3 0.8622158540348791 3.285830812021296 17894.0 -3.301476014760148 0.0 - - - - - - - 169.375 35 16 SPAG5 sperm associated antigen 5 179 23 C20140610_SFK040_01 C20140610_SFK040_01 TB458581.[MT7]-ELISLLHLSLLHLEEDK[MT7].4b4_1.heavy 573.337 / 587.352 6868.0 49.84659957885742 41 11 10 10 10 0.8690411744869999 66.03418319436425 0.0 3 0.8622158540348791 3.285830812021296 6868.0 45.46116637658422 2.0 - - - - - - - 166.625 19 16 SPAG5 sperm associated antigen 5 181 23 C20140610_SFK040_01 C20140610_SFK040_01 TB458581.[MT7]-ELISLLHLSLLHLEEDK[MT7].4y3_1.heavy 573.337 / 535.284 11613.0 49.84659957885742 41 11 10 10 10 0.8690411744869999 66.03418319436425 0.0 3 0.8622158540348791 3.285830812021296 11613.0 30.27550267087109 0.0 - - - - - - - 266.7 23 10 SPAG5 sperm associated antigen 5 183 23 C20140610_SFK040_01 C20140610_SFK040_01 TB458581.[MT7]-ELISLLHLSLLHLEEDK[MT7].4b3_1.heavy 573.337 / 500.32 7637.0 49.84659957885742 41 11 10 10 10 0.8690411744869999 66.03418319436425 0.0 3 0.8622158540348791 3.285830812021296 7637.0 13.444430754015267 0.0 - - - - - - - 271.2142857142857 15 14 SPAG5 sperm associated antigen 5 185 24 C20140610_SFK040_01 C20140610_SFK040_01 TB563770.[MT7]-K[MT7]GNLVYIIDFGLAK[MT7].4y4_1.heavy 496.556 / 532.357 25882.0 44.12480163574219 31 5 10 6 10 0.5804712642820758 87.56631373641932 0.035400390625 3 0.6727746224744934 2.095626557434541 25882.0 46.41970313286066 0.0 - - - - - - - 1194.0 51 10 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 187 24 C20140610_SFK040_01 C20140610_SFK040_01 TB563770.[MT7]-K[MT7]GNLVYIIDFGLAK[MT7].4b4_1.heavy 496.556 / 701.455 6006.0 44.12480163574219 31 5 10 6 10 0.5804712642820758 87.56631373641932 0.035400390625 3 0.6727746224744934 2.095626557434541 6006.0 5.612977099236641 1.0 - - - - - - - 198.85714285714286 12 14 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 189 24 C20140610_SFK040_01 C20140610_SFK040_01 TB563770.[MT7]-K[MT7]GNLVYIIDFGLAK[MT7].4b5_1.heavy 496.556 / 800.523 7293.0 44.12480163574219 31 5 10 6 10 0.5804712642820758 87.56631373641932 0.035400390625 3 0.6727746224744934 2.095626557434541 7293.0 9.35 0.0 - - - - - - - 206.33333333333334 14 9 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 191 24 C20140610_SFK040_01 C20140610_SFK040_01 TB563770.[MT7]-K[MT7]GNLVYIIDFGLAK[MT7].4b3_1.heavy 496.556 / 588.371 4004.0 44.12480163574219 31 5 10 6 10 0.5804712642820758 87.56631373641932 0.035400390625 3 0.6727746224744934 2.095626557434541 4004.0 10.061333333333334 1.0 - - - - - - - 607.25 8 8 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 193 25 C20140610_SFK040_01 C20140610_SFK040_01 TB458493.[MT7]-RYELPAPSSGQK[MT7].4y4_1.heavy 405.979 / 563.327 18979.0 24.38446617126465 36 11 10 7 8 0.6233517225888952 90.15208809962085 0.028598785400390625 4 0.8651943191511975 3.322800208273308 18979.0 7.271437684828235 2.0 - - - - - - - 281.0 37 2 BCAS2 breast carcinoma amplified sequence 2 195 25 C20140610_SFK040_01 C20140610_SFK040_01 TB458493.[MT7]-RYELPAPSSGQK[MT7].4b4_1.heavy 405.979 / 706.4 31421.0 24.38446617126465 36 11 10 7 8 0.6233517225888952 90.15208809962085 0.028598785400390625 4 0.8651943191511975 3.322800208273308 31421.0 7.092314468155763 1.0 - - - - - - - 246.125 62 8 BCAS2 breast carcinoma amplified sequence 2 197 25 C20140610_SFK040_01 C20140610_SFK040_01 TB458493.[MT7]-RYELPAPSSGQK[MT7].4b6_1.heavy 405.979 / 874.49 N/A 24.38446617126465 36 11 10 7 8 0.6233517225888952 90.15208809962085 0.028598785400390625 4 0.8651943191511975 3.322800208273308 0.0 0.0 5.0 - - - - - - - 0.0 0 0 BCAS2 breast carcinoma amplified sequence 2 199 25 C20140610_SFK040_01 C20140610_SFK040_01 TB458493.[MT7]-RYELPAPSSGQK[MT7].4b3_1.heavy 405.979 / 593.316 12934.0 24.38446617126465 36 11 10 7 8 0.6233517225888952 90.15208809962085 0.028598785400390625 4 0.8651943191511975 3.322800208273308 12934.0 0.12560293912517753 1.0 - - - - - - - 671.7777777777778 29 9 BCAS2 breast carcinoma amplified sequence 2 201 26 C20140610_SFK040_01 C20140610_SFK040_01 TB562750.[MT7]-IIAEAFK[MT7].2y4_1.heavy 540.339 / 638.363 23534.0 34.560001373291016 50 20 10 10 10 13.66670727314153 7.317051430268416 0.0 3 0.9980350281526101 27.836399655604147 23534.0 9.935157849614054 0.0 - - - - - - - 1750.2857142857142 47 7 DFNB31 deafness, autosomal recessive 31 203 26 C20140610_SFK040_01 C20140610_SFK040_01 TB562750.[MT7]-IIAEAFK[MT7].2y5_1.heavy 540.339 / 709.4 56044.0 34.560001373291016 50 20 10 10 10 13.66670727314153 7.317051430268416 0.0 3 0.9980350281526101 27.836399655604147 56044.0 61.527975909667475 0.0 - - - - - - - 363.75 112 4 DFNB31 deafness, autosomal recessive 31 205 26 C20140610_SFK040_01 C20140610_SFK040_01 TB562750.[MT7]-IIAEAFK[MT7].2y3_1.heavy 540.339 / 509.32 43671.0 34.560001373291016 50 20 10 10 10 13.66670727314153 7.317051430268416 0.0 3 0.9980350281526101 27.836399655604147 43671.0 42.14819771554136 0.0 - - - - - - - 1767.7142857142858 87 7 DFNB31 deafness, autosomal recessive 31 207 26 C20140610_SFK040_01 C20140610_SFK040_01 TB562750.[MT7]-IIAEAFK[MT7].2y6_1.heavy 540.339 / 822.484 64535.0 34.560001373291016 50 20 10 10 10 13.66670727314153 7.317051430268416 0.0 3 0.9980350281526101 27.836399655604147 64535.0 28.81818494091784 0.0 - - - - - - - 121.0 129 1 DFNB31 deafness, autosomal recessive 31 209 27 C20140610_SFK040_01 C20140610_SFK040_01 TB563088.[MT7]-FLIYAQDK[MT7].3y3_1.heavy 429.251 / 534.3 54583.0 35.39350128173828 50 20 10 10 10 2.3882619316276994 30.984180570610647 0.0 3 0.9930418306151768 14.786409345694326 54583.0 83.8322390469422 0.0 - - - - - - - 855.6 109 10 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 211 27 C20140610_SFK040_01 C20140610_SFK040_01 TB563088.[MT7]-FLIYAQDK[MT7].3b4_1.heavy 429.251 / 681.409 35603.0 35.39350128173828 50 20 10 10 10 2.3882619316276994 30.984180570610647 0.0 3 0.9930418306151768 14.786409345694326 35603.0 181.84327956989245 0.0 - - - - - - - 272.8 71 10 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 213 27 C20140610_SFK040_01 C20140610_SFK040_01 TB563088.[MT7]-FLIYAQDK[MT7].3y4_1.heavy 429.251 / 605.338 31882.0 35.39350128173828 50 20 10 10 10 2.3882619316276994 30.984180570610647 0.0 3 0.9930418306151768 14.786409345694326 31882.0 79.705 0.0 - - - - - - - 325.5 63 8 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 215 27 C20140610_SFK040_01 C20140610_SFK040_01 TB563088.[MT7]-FLIYAQDK[MT7].3b3_1.heavy 429.251 / 518.346 214364.0 35.39350128173828 50 20 10 10 10 2.3882619316276994 30.984180570610647 0.0 3 0.9930418306151768 14.786409345694326 214364.0 117.3971491181398 0.0 - - - - - - - 372.0 428 2 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 217 28 C20140610_SFK040_01 C20140610_SFK040_01 TB563387.[MT7]-GDGPIC[CAM]LVLAPTR.2y8_1.heavy 756.92 / 929.524 15460.0 39.50920104980469 50 20 10 10 10 10.073948486779175 9.92659433699088 0.0 3 0.9934806248620673 15.276475124927137 15460.0 24.65406241592682 0.0 - - - - - - - 722.75 30 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 219 28 C20140610_SFK040_01 C20140610_SFK040_01 TB563387.[MT7]-GDGPIC[CAM]LVLAPTR.2b6_1.heavy 756.92 / 744.347 8379.0 39.50920104980469 50 20 10 10 10 10.073948486779175 9.92659433699088 0.0 3 0.9934806248620673 15.276475124927137 8379.0 21.357164276401562 0.0 - - - - - - - 1180.0 16 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 221 28 C20140610_SFK040_01 C20140610_SFK040_01 TB563387.[MT7]-GDGPIC[CAM]LVLAPTR.2b5_1.heavy 756.92 / 584.316 10621.0 39.50920104980469 50 20 10 10 10 10.073948486779175 9.92659433699088 0.0 3 0.9934806248620673 15.276475124927137 10621.0 8.700819209039548 0.0 - - - - - - - 324.5 21 4 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 223 28 C20140610_SFK040_01 C20140610_SFK040_01 TB563387.[MT7]-GDGPIC[CAM]LVLAPTR.2y11_1.heavy 756.92 / 1196.68 19001.0 39.50920104980469 50 20 10 10 10 10.073948486779175 9.92659433699088 0.0 3 0.9934806248620673 15.276475124927137 19001.0 9.005110754020555 1.0 - - - - - - - 280.25 38 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 225 29 C20140610_SFK040_01 C20140610_SFK040_01 TB563385.[MT7]-ATISQFNTLTK[MT7].3b4_1.heavy 504.627 / 517.31 50966.0 32.21440124511719 50 20 10 10 10 6.712082654814199 14.89850544797383 0.0 3 0.9935625460068901 15.373474999952185 50966.0 23.883301565475936 1.0 - - - - - - - 761.5 144 2 RGL1 ral guanine nucleotide dissociation stimulator-like 1 227 29 C20140610_SFK040_01 C20140610_SFK040_01 TB563385.[MT7]-ATISQFNTLTK[MT7].3b5_1.heavy 504.627 / 645.369 88224.0 32.21440124511719 50 20 10 10 10 6.712082654814199 14.89850544797383 0.0 3 0.9935625460068901 15.373474999952185 88224.0 87.77086935795937 0.0 - - - - - - - 1188.4285714285713 176 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 229 29 C20140610_SFK040_01 C20140610_SFK040_01 TB563385.[MT7]-ATISQFNTLTK[MT7].3b3_1.heavy 504.627 / 430.278 106502.0 32.21440124511719 50 20 10 10 10 6.712082654814199 14.89850544797383 0.0 3 0.9935625460068901 15.373474999952185 106502.0 52.93149709642151 0.0 - - - - - - - 937.0 213 1 RGL1 ral guanine nucleotide dissociation stimulator-like 1 231 29 C20140610_SFK040_01 C20140610_SFK040_01 TB563385.[MT7]-ATISQFNTLTK[MT7].3y4_1.heavy 504.627 / 606.394 60105.0 32.21440124511719 50 20 10 10 10 6.712082654814199 14.89850544797383 0.0 3 0.9935625460068901 15.373474999952185 60105.0 57.82356586556337 0.0 - - - - - - - 1188.2857142857142 120 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 233 30 C20140610_SFK040_01 C20140610_SFK040_01 TB562659.[MT7]-QIISTIR.2b3_1.heavy 487.809 / 499.336 33805.0 27.87529945373535 50 20 10 10 10 8.124144702554592 12.308988042588108 0.0 3 0.9951203474012056 17.660018696951564 33805.0 28.289898562975488 1.0 - - - - - - - 507.0 67 1 FDFT1 farnesyl-diphosphate farnesyltransferase 1 235 30 C20140610_SFK040_01 C20140610_SFK040_01 TB562659.[MT7]-QIISTIR.2y5_1.heavy 487.809 / 589.367 86202.0 27.87529945373535 50 20 10 10 10 8.124144702554592 12.308988042588108 0.0 3 0.9951203474012056 17.660018696951564 86202.0 85.07971955256883 0.0 - - - - - - - 1753.5 172 8 FDFT1 farnesyl-diphosphate farnesyltransferase 1 237 30 C20140610_SFK040_01 C20140610_SFK040_01 TB562659.[MT7]-QIISTIR.2b4_1.heavy 487.809 / 586.368 12677.0 27.87529945373535 50 20 10 10 10 8.124144702554592 12.308988042588108 0.0 3 0.9951203474012056 17.660018696951564 12677.0 8.386677984358169 1.0 - - - - - - - 1785.25 38 8 FDFT1 farnesyl-diphosphate farnesyltransferase 1 239 30 C20140610_SFK040_01 C20140610_SFK040_01 TB562659.[MT7]-QIISTIR.2y6_1.heavy 487.809 / 702.451 122542.0 27.87529945373535 50 20 10 10 10 8.124144702554592 12.308988042588108 0.0 3 0.9951203474012056 17.660018696951564 122542.0 196.10396566380533 0.0 - - - - - - - 713.7777777777778 245 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 241 31 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 1814370.0 29.958499908447266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1814370.0 3010.3797312178085 0.0 - - - - - - - 1244.0 3628 7 243 31 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 676527.0 29.958499908447266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 676527.0 532.7474436829219 0.0 - - - - - - - 210.0 1353 1 245 31 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 726217.0 29.958499908447266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 726217.0 450.71704508819096 0.0 - - - - - - - 1311.5 1452 4 247 32 C20140610_SFK040_01 C20140610_SFK040_01 TB563482.[MT7]-IIDGVPVEITEK[MT7].3y3_1.heavy 534.318 / 521.305 218632.0 37.23889923095703 46 16 10 10 10 1.703444661415707 42.8681254773363 0.0 3 0.9617503837406381 6.290058981686919 218632.0 222.19632731015344 0.0 - - - - - - - 815.5 437 2 POSTN periostin, osteoblast specific factor 249 32 C20140610_SFK040_01 C20140610_SFK040_01 TB563482.[MT7]-IIDGVPVEITEK[MT7].3b4_1.heavy 534.318 / 543.326 120291.0 37.23889923095703 46 16 10 10 10 1.703444661415707 42.8681254773363 0.0 3 0.9617503837406381 6.290058981686919 120291.0 58.55897688062978 0.0 - - - - - - - 1254.0 240 1 POSTN periostin, osteoblast specific factor 251 32 C20140610_SFK040_01 C20140610_SFK040_01 TB563482.[MT7]-IIDGVPVEITEK[MT7].3b5_1.heavy 534.318 / 642.394 215872.0 37.23889923095703 46 16 10 10 10 1.703444661415707 42.8681254773363 0.0 3 0.9617503837406381 6.290058981686919 215872.0 30.005112284498196 1.0 - - - - - - - 878.0 446 1 POSTN periostin, osteoblast specific factor 253 32 C20140610_SFK040_01 C20140610_SFK040_01 TB563482.[MT7]-IIDGVPVEITEK[MT7].3y5_1.heavy 534.318 / 763.432 61714.0 37.23889923095703 46 16 10 10 10 1.703444661415707 42.8681254773363 0.0 3 0.9617503837406381 6.290058981686919 61714.0 137.0548038383485 0.0 - - - - - - - 282.25 123 4 POSTN periostin, osteoblast specific factor 255 33 C20140610_SFK040_01 C20140610_SFK040_01 TB458593.[MT7]-FLEAGIYEVPIIITDSGNPPK[MT7].3b8_1.heavy 854.475 / 1067.55 12325.0 48.55002498626709 37 13 10 6 8 0.9696017212690902 60.64984736457275 0.034099578857421875 4 0.9032262875587345 3.934752875685291 12325.0 10.765071430278947 0.0 - - - - - - - 724.0 24 8 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 257 33 C20140610_SFK040_01 C20140610_SFK040_01 TB458593.[MT7]-FLEAGIYEVPIIITDSGNPPK[MT7].3b6_1.heavy 854.475 / 775.447 7877.0 48.55002498626709 37 13 10 6 8 0.9696017212690902 60.64984736457275 0.034099578857421875 4 0.9032262875587345 3.934752875685291 7877.0 10.067907531177354 1.0 - - - - - - - 652.1538461538462 16 13 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 259 33 C20140610_SFK040_01 C20140610_SFK040_01 TB458593.[MT7]-FLEAGIYEVPIIITDSGNPPK[MT7].3b7_1.heavy 854.475 / 938.51 4587.0 48.55002498626709 37 13 10 6 8 0.9696017212690902 60.64984736457275 0.034099578857421875 4 0.9032262875587345 3.934752875685291 4587.0 10.719140765155725 0.0 - - - - - - - 304.5 9 14 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 261 33 C20140610_SFK040_01 C20140610_SFK040_01 TB458593.[MT7]-FLEAGIYEVPIIITDSGNPPK[MT7].3b5_1.heavy 854.475 / 662.363 8989.0 48.55002498626709 37 13 10 6 8 0.9696017212690902 60.64984736457275 0.034099578857421875 4 0.9032262875587345 3.934752875685291 8989.0 10.682677143523804 1.0 - - - - - - - 715.5555555555555 17 9 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 263 34 C20140610_SFK040_01 C20140610_SFK040_01 TB458594.[MT7]-ELLTQPGDWTLFVPTNDAFK[MT7].3y3_1.heavy 860.791 / 509.32 30225.0 49.13434886932373 44 17 10 7 10 3.660963430510623 27.315214122762278 0.026599884033203125 3 0.9749736886439319 7.784917797256747 30225.0 18.957047373674698 0.0 - - - - - - - 715.7142857142857 60 7 POSTN periostin, osteoblast specific factor 265 34 C20140610_SFK040_01 C20140610_SFK040_01 TB458594.[MT7]-ELLTQPGDWTLFVPTNDAFK[MT7].3b5_1.heavy 860.791 / 729.426 61419.0 49.13434886932373 44 17 10 7 10 3.660963430510623 27.315214122762278 0.026599884033203125 3 0.9749736886439319 7.784917797256747 61419.0 51.10551214580294 0.0 - - - - - - - 862.3333333333334 122 3 POSTN periostin, osteoblast specific factor 267 34 C20140610_SFK040_01 C20140610_SFK040_01 TB458594.[MT7]-ELLTQPGDWTLFVPTNDAFK[MT7].3b3_1.heavy 860.791 / 500.32 24285.0 49.13434886932373 44 17 10 7 10 3.660963430510623 27.315214122762278 0.026599884033203125 3 0.9749736886439319 7.784917797256747 24285.0 23.529802159028858 0.0 - - - - - - - 1228.4 48 10 POSTN periostin, osteoblast specific factor 269 34 C20140610_SFK040_01 C20140610_SFK040_01 TB458594.[MT7]-ELLTQPGDWTLFVPTNDAFK[MT7].3b8_1.heavy 860.791 / 998.528 26467.0 49.13434886932373 44 17 10 7 10 3.660963430510623 27.315214122762278 0.026599884033203125 3 0.9749736886439319 7.784917797256747 26467.0 22.04659049971695 0.0 - - - - - - - 732.5 52 8 POSTN periostin, osteoblast specific factor 271 35 C20140610_SFK040_01 C20140610_SFK040_01 TB458388.[MT7]-LLPALQSTITR.3y6_1.heavy 452.949 / 705.389 55661.0 39.91749954223633 45 20 10 5 10 11.135756311598856 8.980081568042337 0.044403076171875 3 0.994577653746479 16.752217761201457 55661.0 96.2458538503795 1.0 - - - - - - - 272.85714285714283 126 7 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 273 35 C20140610_SFK040_01 C20140610_SFK040_01 TB458388.[MT7]-LLPALQSTITR.3y5_1.heavy 452.949 / 577.33 167322.0 39.91749954223633 45 20 10 5 10 11.135756311598856 8.980081568042337 0.044403076171875 3 0.994577653746479 16.752217761201457 167322.0 370.05895105839716 0.0 - - - - - - - 281.0 334 2 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 275 35 C20140610_SFK040_01 C20140610_SFK040_01 TB458388.[MT7]-LLPALQSTITR.3b4_1.heavy 452.949 / 539.367 246372.0 39.91749954223633 45 20 10 5 10 11.135756311598856 8.980081568042337 0.044403076171875 3 0.994577653746479 16.752217761201457 246372.0 181.48251846262673 1.0 - - - - - - - 262.3333333333333 492 3 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 277 35 C20140610_SFK040_01 C20140610_SFK040_01 TB458388.[MT7]-LLPALQSTITR.3y4_1.heavy 452.949 / 490.298 57236.0 39.91749954223633 45 20 10 5 10 11.135756311598856 8.980081568042337 0.044403076171875 3 0.994577653746479 16.752217761201457 57236.0 91.61461600646726 0.0 - - - - - - - 253.0 114 4 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 279 36 C20140610_SFK040_01 C20140610_SFK040_01 TB563762.[MT7]-LREMESNWVSLVSK[MT7].3b8_1.heavy 656.027 / 1190.57 9266.0 40.63159942626953 45 15 10 10 10 2.590803217071967 29.803049909178636 0.0 3 0.951418334599269 5.576376244326643 9266.0 27.841502347417844 0.0 - - - - - - - 286.9230769230769 18 13 BCAS2 breast carcinoma amplified sequence 2 281 36 C20140610_SFK040_01 C20140610_SFK040_01 TB563762.[MT7]-LREMESNWVSLVSK[MT7].3y5_1.heavy 656.027 / 677.431 65078.0 40.63159942626953 45 15 10 10 10 2.590803217071967 29.803049909178636 0.0 3 0.951418334599269 5.576376244326643 65078.0 175.9899460870076 0.0 - - - - - - - 671.3 130 10 BCAS2 breast carcinoma amplified sequence 2 283 36 C20140610_SFK040_01 C20140610_SFK040_01 TB563762.[MT7]-LREMESNWVSLVSK[MT7].3b7_1.heavy 656.027 / 1004.5 53468.0 40.63159942626953 45 15 10 10 10 2.590803217071967 29.803049909178636 0.0 3 0.951418334599269 5.576376244326643 53468.0 87.48701904358565 0.0 - - - - - - - 765.0909090909091 106 11 BCAS2 breast carcinoma amplified sequence 2 285 36 C20140610_SFK040_01 C20140610_SFK040_01 TB563762.[MT7]-LREMESNWVSLVSK[MT7].3b7_2.heavy 656.027 / 502.751 25989.0 40.63159942626953 45 15 10 10 10 2.590803217071967 29.803049909178636 0.0 3 0.951418334599269 5.576376244326643 25989.0 80.4205485868346 0.0 - - - - - - - 308.9 51 10 BCAS2 breast carcinoma amplified sequence 2 287 37 C20140610_SFK040_01 C20140610_SFK040_01 TB458590.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].4y5_1.heavy 629.357 / 760.469 29575.0 47.66270065307617 48 18 10 10 10 6.11488136287123 16.35354703808108 0.0 3 0.9894633329154334 12.012369071176316 29575.0 49.1918993408718 0.0 - - - - - - - 772.7142857142857 59 7 POSTN periostin, osteoblast specific factor 289 37 C20140610_SFK040_01 C20140610_SFK040_01 TB458590.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].4y3_1.heavy 629.357 / 518.342 93827.0 47.66270065307617 48 18 10 10 10 6.11488136287123 16.35354703808108 0.0 3 0.9894633329154334 12.012369071176316 93827.0 165.67696034742005 0.0 - - - - - - - 801.3333333333334 187 9 POSTN periostin, osteoblast specific factor 291 37 C20140610_SFK040_01 C20140610_SFK040_01 TB458590.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].4b6_1.heavy 629.357 / 817.458 28442.0 47.66270065307617 48 18 10 10 10 6.11488136287123 16.35354703808108 0.0 3 0.9894633329154334 12.012369071176316 28442.0 112.5460863683841 0.0 - - - - - - - 324.0 56 14 POSTN periostin, osteoblast specific factor 293 37 C20140610_SFK040_01 C20140610_SFK040_01 TB458590.[MT7]-LLYPADTPVGNDQLLEILNK[MT7].4b3_1.heavy 629.357 / 534.341 124227.0 47.66270065307617 48 18 10 10 10 6.11488136287123 16.35354703808108 0.0 3 0.9894633329154334 12.012369071176316 124227.0 219.0538648438187 0.0 - - - - - - - 1248.111111111111 248 9 POSTN periostin, osteoblast specific factor 295 38 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 1598780.0 16.17889976501465 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1598780.0 7059.792604396095 0.0 - - - - - - - 853.8571428571429 3197 7 297 38 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 2293460.0 16.17889976501465 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2293460.0 11378.77098426057 0.0 - - - - - - - 808.2727272727273 4586 11 299 38 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 1265360.0 16.17889976501465 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1265360.0 1893.0306569954275 0.0 - - - - - - - 790.4444444444445 2530 9 301 39 C20140610_SFK040_01 C20140610_SFK040_01 TB458382.[MT7]-DWVLNEFK[MT7].3y3_1.heavy 446.915 / 567.326 25108.0 40.2140998840332 50 20 10 10 10 7.82108952717589 12.785942374464662 0.0 3 0.9987814198778956 35.350146118339985 25108.0 25.494799160351516 0.0 - - - - - - - 336.45454545454544 50 11 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 303 39 C20140610_SFK040_01 C20140610_SFK040_01 TB458382.[MT7]-DWVLNEFK[MT7].3b4_1.heavy 446.915 / 658.368 22215.0 40.2140998840332 50 20 10 10 10 7.82108952717589 12.785942374464662 0.0 3 0.9987814198778956 35.350146118339985 22215.0 71.7479274611399 0.0 - - - - - - - 289.25 44 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 305 39 C20140610_SFK040_01 C20140610_SFK040_01 TB458382.[MT7]-DWVLNEFK[MT7].3y4_1.heavy 446.915 / 681.369 22331.0 40.2140998840332 50 20 10 10 10 7.82108952717589 12.785942374464662 0.0 3 0.9987814198778956 35.350146118339985 22331.0 140.4208895043477 0.0 - - - - - - - 241.0 44 12 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 307 39 C20140610_SFK040_01 C20140610_SFK040_01 TB458382.[MT7]-DWVLNEFK[MT7].3b3_1.heavy 446.915 / 545.284 105870.0 40.2140998840332 50 20 10 10 10 7.82108952717589 12.785942374464662 0.0 3 0.9987814198778956 35.350146118339985 105870.0 117.44987829808787 0.0 - - - - - - - 370.4 211 5 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 309 40 C20140610_SFK040_01 C20140610_SFK040_01 TB563356.[MT7]-LRADNTLVAVK[MT7].3b6_1.heavy 496.643 / 815.449 35858.0 28.081074714660645 38 12 10 6 10 2.382794713227943 41.96752638607764 0.039501190185546875 3 0.8831697337289159 3.5748914720365637 35858.0 52.96783843962632 0.0 - - - - - - - 223.9090909090909 71 11 FES feline sarcoma oncogene 311 40 C20140610_SFK040_01 C20140610_SFK040_01 TB563356.[MT7]-LRADNTLVAVK[MT7].3b4_1.heavy 496.643 / 600.359 20829.0 28.081074714660645 38 12 10 6 10 2.382794713227943 41.96752638607764 0.039501190185546875 3 0.8831697337289159 3.5748914720365637 20829.0 18.063555647326037 0.0 - - - - - - - 1807.7142857142858 41 7 FES feline sarcoma oncogene 313 40 C20140610_SFK040_01 C20140610_SFK040_01 TB563356.[MT7]-LRADNTLVAVK[MT7].3b5_1.heavy 496.643 / 714.401 18105.0 28.081074714660645 38 12 10 6 10 2.382794713227943 41.96752638607764 0.039501190185546875 3 0.8831697337289159 3.5748914720365637 18105.0 22.12091722916206 1.0 - - - - - - - 799.8 36 10 FES feline sarcoma oncogene 315 40 C20140610_SFK040_01 C20140610_SFK040_01 TB563356.[MT7]-LRADNTLVAVK[MT7].3y4_1.heavy 496.643 / 560.389 115219.0 28.081074714660645 38 12 10 6 10 2.382794713227943 41.96752638607764 0.039501190185546875 3 0.8831697337289159 3.5748914720365637 115219.0 86.16947365205704 0.0 - - - - - - - 879.0 230 1 FES feline sarcoma oncogene 317 41 C20140610_SFK040_01 C20140610_SFK040_01 TB562766.[MT7]-STFAGSPER.2y8_1.heavy 548.281 / 864.421 12286.0 20.36722469329834 43 17 10 6 10 2.6917902340603344 29.804131158460113 0.035099029541015625 3 0.9777730372576642 8.262559314836418 12286.0 63.706805991801104 0.0 - - - - - - - 241.5 24 16 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 319 41 C20140610_SFK040_01 C20140610_SFK040_01 TB562766.[MT7]-STFAGSPER.2y5_1.heavy 548.281 / 545.268 12403.0 20.36722469329834 43 17 10 6 10 2.6917902340603344 29.804131158460113 0.035099029541015625 3 0.9777730372576642 8.262559314836418 12403.0 25.677625830959165 0.0 - - - - - - - 687.6666666666666 24 12 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 321 41 C20140610_SFK040_01 C20140610_SFK040_01 TB562766.[MT7]-STFAGSPER.2y6_1.heavy 548.281 / 616.305 11292.0 20.36722469329834 43 17 10 6 10 2.6917902340603344 29.804131158460113 0.035099029541015625 3 0.9777730372576642 8.262559314836418 11292.0 62.666699076000995 0.0 - - - - - - - 265.53333333333336 22 15 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 323 41 C20140610_SFK040_01 C20140610_SFK040_01 TB562766.[MT7]-STFAGSPER.2y7_1.heavy 548.281 / 763.373 7664.0 20.36722469329834 43 17 10 6 10 2.6917902340603344 29.804131158460113 0.035099029541015625 3 0.9777730372576642 8.262559314836418 7664.0 21.135150017806268 0.0 - - - - - - - 263.5 15 20 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 325 42 C20140610_SFK040_01 C20140610_SFK040_01 TB563191.[MT7]-TQYFHQEK[MT7].3y3_1.heavy 456.91 / 548.316 61685.0 20.988900184631348 41 15 10 6 10 1.5742946100233173 50.09744674676489 0.036800384521484375 3 0.9506680626156552 5.533456894203669 61685.0 85.00435029233228 0.0 - - - - - - - 1251.2222222222222 123 9 FBXO32 F-box protein 32 327 42 C20140610_SFK040_01 C20140610_SFK040_01 TB563191.[MT7]-TQYFHQEK[MT7].3b4_1.heavy 456.91 / 684.347 40934.0 20.988900184631348 41 15 10 6 10 1.5742946100233173 50.09744674676489 0.036800384521484375 3 0.9506680626156552 5.533456894203669 40934.0 98.12514186191328 0.0 - - - - - - - 750.1428571428571 81 7 FBXO32 F-box protein 32 329 42 C20140610_SFK040_01 C20140610_SFK040_01 TB563191.[MT7]-TQYFHQEK[MT7].3b3_1.heavy 456.91 / 537.279 102176.0 20.988900184631348 41 15 10 6 10 1.5742946100233173 50.09744674676489 0.036800384521484375 3 0.9506680626156552 5.533456894203669 102176.0 118.63596352583585 0.0 - - - - - - - 253.5 204 2 FBXO32 F-box protein 32 331 42 C20140610_SFK040_01 C20140610_SFK040_01 TB563191.[MT7]-TQYFHQEK[MT7].3y5_1.heavy 456.91 / 832.443 3859.0 20.988900184631348 41 15 10 6 10 1.5742946100233173 50.09744674676489 0.036800384521484375 3 0.9506680626156552 5.533456894203669 3859.0 6.6928081995088515 0.0 - - - - - - - 207.33333333333334 7 18 FBXO32 F-box protein 32 333 43 C20140610_SFK040_01 C20140610_SFK040_01 TB562628.[MT7]-EMAAAAAR.2b4_1.heavy 467.748 / 547.267 16398.0 18.280799865722656 38 18 2 10 8 9.439322828075037 10.593980290892649 0.0 4 0.988942259850874 11.725413657430622 16398.0 12.516840734607198 1.0 - - - - - - - 693.1428571428571 49 14 FES feline sarcoma oncogene 335 43 C20140610_SFK040_01 C20140610_SFK040_01 TB562628.[MT7]-EMAAAAAR.2y6_1.heavy 467.748 / 530.305 21686.0 18.280799865722656 38 18 2 10 8 9.439322828075037 10.593980290892649 0.0 4 0.988942259850874 11.725413657430622 21686.0 22.502243830439426 0.0 - - - - - - - 1261.1818181818182 43 11 FES feline sarcoma oncogene 337 43 C20140610_SFK040_01 C20140610_SFK040_01 TB562628.[MT7]-EMAAAAAR.2b5_1.heavy 467.748 / 618.304 16641.0 18.280799865722656 38 18 2 10 8 9.439322828075037 10.593980290892649 0.0 4 0.988942259850874 11.725413657430622 16641.0 34.243913800709066 0.0 - - - - - - - 735.0769230769231 33 13 FES feline sarcoma oncogene 339 43 C20140610_SFK040_01 C20140610_SFK040_01 TB562628.[MT7]-EMAAAAAR.2y7_1.heavy 467.748 / 661.345 47884.0 18.280799865722656 38 18 2 10 8 9.439322828075037 10.593980290892649 0.0 4 0.988942259850874 11.725413657430622 47884.0 9.36072537468032 2.0 - - - - - - - 388.5 250 2 FES feline sarcoma oncogene 341 44 C20140610_SFK040_01 C20140610_SFK040_01 TB563354.[MT7]-DLEIEQWHK[MT7].3b6_1.heavy 495.936 / 872.448 4658.0 31.121400833129883 50 20 10 10 10 4.312470229310603 23.188565875847477 0.0 3 0.9921685873688025 13.936652778920987 4658.0 23.429879879879877 0.0 - - - - - - - 241.58823529411765 9 17 ANKRD12 ankyrin repeat domain 12 343 44 C20140610_SFK040_01 C20140610_SFK040_01 TB563354.[MT7]-DLEIEQWHK[MT7].3b4_1.heavy 495.936 / 615.347 17635.0 31.121400833129883 50 20 10 10 10 4.312470229310603 23.188565875847477 0.0 3 0.9921685873688025 13.936652778920987 17635.0 9.278632841341146 0.0 - - - - - - - 762.375 35 8 ANKRD12 ankyrin repeat domain 12 345 44 C20140610_SFK040_01 C20140610_SFK040_01 TB563354.[MT7]-DLEIEQWHK[MT7].3b5_1.heavy 495.936 / 744.39 7764.0 31.121400833129883 50 20 10 10 10 4.312470229310603 23.188565875847477 0.0 3 0.9921685873688025 13.936652778920987 7764.0 15.641243183089202 0.0 - - - - - - - 731.9 15 10 ANKRD12 ankyrin repeat domain 12 347 44 C20140610_SFK040_01 C20140610_SFK040_01 TB563354.[MT7]-DLEIEQWHK[MT7].3b3_1.heavy 495.936 / 502.263 38375.0 31.121400833129883 50 20 10 10 10 4.312470229310603 23.188565875847477 0.0 3 0.9921685873688025 13.936652778920987 38375.0 25.504262747603036 0.0 - - - - - - - 1275.5 76 2 ANKRD12 ankyrin repeat domain 12 349 45 C20140610_SFK040_01 C20140610_SFK040_01 TB562762.[MT7]-DVAIEEK[MT7].2y4_1.heavy 546.313 / 662.384 33399.0 22.74329948425293 50 20 10 10 10 5.410531770071632 18.482471640431022 0.0 3 0.9926269428995075 14.363866823195217 33399.0 77.66566063012263 0.0 - - - - - - - 704.3 66 10 SPAG5 sperm associated antigen 5 351 45 C20140610_SFK040_01 C20140610_SFK040_01 TB562762.[MT7]-DVAIEEK[MT7].2y5_1.heavy 546.313 / 733.421 30052.0 22.74329948425293 50 20 10 10 10 5.410531770071632 18.482471640431022 0.0 3 0.9926269428995075 14.363866823195217 30052.0 89.31318475968956 0.0 - - - - - - - 292.8 60 5 SPAG5 sperm associated antigen 5 353 45 C20140610_SFK040_01 C20140610_SFK040_01 TB562762.[MT7]-DVAIEEK[MT7].2y3_1.heavy 546.313 / 549.3 33748.0 22.74329948425293 50 20 10 10 10 5.410531770071632 18.482471640431022 0.0 3 0.9926269428995075 14.363866823195217 33748.0 51.747273723670716 0.0 - - - - - - - 816.8571428571429 67 7 SPAG5 sperm associated antigen 5 355 45 C20140610_SFK040_01 C20140610_SFK040_01 TB562762.[MT7]-DVAIEEK[MT7].2y6_1.heavy 546.313 / 832.49 22452.0 22.74329948425293 50 20 10 10 10 5.410531770071632 18.482471640431022 0.0 3 0.9926269428995075 14.363866823195217 22452.0 75.55420603997074 0.0 - - - - - - - 325.3333333333333 44 12 SPAG5 sperm associated antigen 5 357 46 C20140610_SFK040_01 C20140610_SFK040_01 TB563350.[MT7]-QNQEFSFGNLR.2y8_1.heavy 742.374 / 969.479 7974.0 35.39350128173828 47 17 10 10 10 2.621342276662515 30.283491266965754 0.0 3 0.9735995650227232 7.578734734788451 7974.0 4.724935834791694 0.0 - - - - - - - 320.2857142857143 15 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 359 46 C20140610_SFK040_01 C20140610_SFK040_01 TB563350.[MT7]-QNQEFSFGNLR.2b4_1.heavy 742.374 / 644.312 7476.0 35.39350128173828 47 17 10 10 10 2.621342276662515 30.283491266965754 0.0 3 0.9735995650227232 7.578734734788451 7476.0 6.9392172909453365 0.0 - - - - - - - 734.0 14 9 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 361 46 C20140610_SFK040_01 C20140610_SFK040_01 TB563350.[MT7]-QNQEFSFGNLR.2y10_1.heavy 742.374 / 1211.58 9844.0 35.39350128173828 47 17 10 10 10 2.621342276662515 30.283491266965754 0.0 3 0.9735995650227232 7.578734734788451 9844.0 12.949328628168182 0.0 - - - - - - - 803.2222222222222 19 9 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 363 46 C20140610_SFK040_01 C20140610_SFK040_01 TB563350.[MT7]-QNQEFSFGNLR.2y7_1.heavy 742.374 / 840.436 7850.0 35.39350128173828 47 17 10 10 10 2.621342276662515 30.283491266965754 0.0 3 0.9735995650227232 7.578734734788451 7850.0 19.963721105156413 0.0 - - - - - - - 783.2857142857143 15 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 365 47 C20140610_SFK040_01 C20140610_SFK040_01 TB563627.[MT7]-SLFGSIGEIESC[CAM]K[MT7].3y3_1.heavy 572.302 / 538.278 61766.0 40.63159942626953 48 18 10 10 10 4.122732418641936 24.255758037515534 0.0 3 0.986169716374659 10.482020816718993 61766.0 47.689744281356354 0.0 - - - - - - - 430.0 123 2 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 367 47 C20140610_SFK040_01 C20140610_SFK040_01 TB563627.[MT7]-SLFGSIGEIESC[CAM]K[MT7].3b5_1.heavy 572.302 / 636.347 28788.0 40.63159942626953 48 18 10 10 10 4.122732418641936 24.255758037515534 0.0 3 0.986169716374659 10.482020816718993 28788.0 41.4575791433892 0.0 - - - - - - - 787.6666666666666 57 12 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 369 47 C20140610_SFK040_01 C20140610_SFK040_01 TB563627.[MT7]-SLFGSIGEIESC[CAM]K[MT7].3y4_1.heavy 572.302 / 667.32 45438.0 40.63159942626953 48 18 10 10 10 4.122732418641936 24.255758037515534 0.0 3 0.986169716374659 10.482020816718993 45438.0 32.259972235618086 1.0 - - - - - - - 353.14285714285717 106 7 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 371 47 C20140610_SFK040_01 C20140610_SFK040_01 TB563627.[MT7]-SLFGSIGEIESC[CAM]K[MT7].3b8_1.heavy 572.302 / 935.495 23739.0 40.63159942626953 48 18 10 10 10 4.122732418641936 24.255758037515534 0.0 3 0.986169716374659 10.482020816718993 23739.0 70.11388852799791 0.0 - - - - - - - 201.25 47 8 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 373 48 C20140610_SFK040_01 C20140610_SFK040_01 TB562620.[MT7]-TPAVIQR.2y4_1.heavy 464.788 / 515.33 11058.0 21.935199737548828 48 20 10 10 8 4.640899936777954 15.160018259532512 0.0 4 0.9995060458991495 55.526614329138056 11058.0 11.693303684060787 0.0 - - - - - - - 449.5 22 2 RGL1 ral guanine nucleotide dissociation stimulator-like 1 375 48 C20140610_SFK040_01 C20140610_SFK040_01 TB562620.[MT7]-TPAVIQR.2y5_1.heavy 464.788 / 586.367 14998.0 21.935199737548828 48 20 10 10 8 4.640899936777954 15.160018259532512 0.0 4 0.9995060458991495 55.526614329138056 14998.0 21.622867925339882 1.0 - - - - - - - 774.2 32 5 RGL1 ral guanine nucleotide dissociation stimulator-like 1 377 48 C20140610_SFK040_01 C20140610_SFK040_01 TB562620.[MT7]-TPAVIQR.2b4_1.heavy 464.788 / 513.315 15758.0 21.935199737548828 48 20 10 10 8 4.640899936777954 15.160018259532512 0.0 4 0.9995060458991495 55.526614329138056 15758.0 19.731127503834774 0.0 - - - - - - - 1192.25 31 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 379 48 C20140610_SFK040_01 C20140610_SFK040_01 TB562620.[MT7]-TPAVIQR.2y6_1.heavy 464.788 / 683.42 177696.0 21.935199737548828 48 20 10 10 8 4.640899936777954 15.160018259532512 0.0 4 0.9995060458991495 55.526614329138056 177696.0 207.72343959572362 1.0 - - - - - - - 414.8333333333333 362 6 RGL1 ral guanine nucleotide dissociation stimulator-like 1 381 49 C20140610_SFK040_01 C20140610_SFK040_01 TB563199.[MT7]-APILIATDVASR.2y8_1.heavy 685.91 / 832.452 65337.0 36.9182014465332 42 12 10 10 10 1.3808395809655063 57.659161448144694 0.0 3 0.885327963777716 3.609053949430716 65337.0 81.56075917052283 0.0 - - - - - - - 255.0 130 2 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 383 49 C20140610_SFK040_01 C20140610_SFK040_01 TB563199.[MT7]-APILIATDVASR.2b4_1.heavy 685.91 / 539.367 61134.0 36.9182014465332 42 12 10 10 10 1.3808395809655063 57.659161448144694 0.0 3 0.885327963777716 3.609053949430716 61134.0 53.0329355753088 0.0 - - - - - - - 764.0 122 1 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 385 49 C20140610_SFK040_01 C20140610_SFK040_01 TB563199.[MT7]-APILIATDVASR.2y9_1.heavy 685.91 / 945.536 57950.0 36.9182014465332 42 12 10 10 10 1.3808395809655063 57.659161448144694 0.0 3 0.885327963777716 3.609053949430716 57950.0 79.24144642754402 0.0 - - - - - - - 339.6666666666667 115 3 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 387 49 C20140610_SFK040_01 C20140610_SFK040_01 TB563199.[MT7]-APILIATDVASR.2y11_1.heavy 685.91 / 1155.67 122904.0 36.9182014465332 42 12 10 10 10 1.3808395809655063 57.659161448144694 0.0 3 0.885327963777716 3.609053949430716 122904.0 265.92457399103137 0.0 - - - - - - - 778.4444444444445 245 9 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 389 50 C20140610_SFK040_01 C20140610_SFK040_01 TB563498.[MT7]-ISTGGGETEETLK[MT7].3b6_1.heavy 537.289 / 617.338 51750.0 25.211349487304688 43 17 10 6 10 3.746009330732481 22.033403970511593 0.034900665283203125 3 0.9726332374613922 7.443123320419486 51750.0 50.61231565218075 0.0 - - - - - - - 1697.5 103 8 POSTN periostin, osteoblast specific factor 391 50 C20140610_SFK040_01 C20140610_SFK040_01 TB563498.[MT7]-ISTGGGETEETLK[MT7].3y3_1.heavy 537.289 / 505.347 92278.0 25.211349487304688 43 17 10 6 10 3.746009330732481 22.033403970511593 0.034900665283203125 3 0.9726332374613922 7.443123320419486 92278.0 44.2131699325961 0.0 - - - - - - - 1692.0 184 3 POSTN periostin, osteoblast specific factor 393 50 C20140610_SFK040_01 C20140610_SFK040_01 TB563498.[MT7]-ISTGGGETEETLK[MT7].3y4_1.heavy 537.289 / 634.389 58112.0 25.211349487304688 43 17 10 6 10 3.746009330732481 22.033403970511593 0.034900665283203125 3 0.9726332374613922 7.443123320419486 58112.0 95.68834880269789 0.0 - - - - - - - 1661.75 116 8 POSTN periostin, osteoblast specific factor 395 50 C20140610_SFK040_01 C20140610_SFK040_01 TB563498.[MT7]-ISTGGGETEETLK[MT7].3b7_1.heavy 537.289 / 746.38 57039.0 25.211349487304688 43 17 10 6 10 3.746009330732481 22.033403970511593 0.034900665283203125 3 0.9726332374613922 7.443123320419486 57039.0 49.207507700679415 0.0 - - - - - - - 687.875 114 8 POSTN periostin, osteoblast specific factor 397 51 C20140610_SFK040_01 C20140610_SFK040_01 TB562772.[MT7]-QVAAELLDREEAR.3y11_2.heavy 548.633 / 636.831 31127.0 30.87310028076172 46 16 10 10 10 3.1593634306594187 24.494874998110646 0.0 3 0.9636190298126136 6.450593716953354 31127.0 39.27318457300275 0.0 - - - - - - - 858.0 62 10 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 399 51 C20140610_SFK040_01 C20140610_SFK040_01 TB562772.[MT7]-QVAAELLDREEAR.3b4_1.heavy 548.633 / 514.311 25628.0 30.87310028076172 46 16 10 10 10 3.1593634306594187 24.494874998110646 0.0 3 0.9636190298126136 6.450593716953354 25628.0 13.011479826839826 0.0 - - - - - - - 1430.0 51 1 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 401 51 C20140610_SFK040_01 C20140610_SFK040_01 TB562772.[MT7]-QVAAELLDREEAR.3b5_1.heavy 548.633 / 643.353 65554.0 30.87310028076172 46 16 10 10 10 3.1593634306594187 24.494874998110646 0.0 3 0.9636190298126136 6.450593716953354 65554.0 60.763065953654184 0.0 - - - - - - - 440.0 131 1 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 403 51 C20140610_SFK040_01 C20140610_SFK040_01 TB562772.[MT7]-QVAAELLDREEAR.3y12_2.heavy 548.633 / 686.365 67644.0 30.87310028076172 46 16 10 10 10 3.1593634306594187 24.494874998110646 0.0 3 0.9636190298126136 6.450593716953354 67644.0 48.14851562060231 0.0 - - - - - - - 1210.0 135 4 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 405 52 C20140610_SFK040_01 C20140610_SFK040_01 TB562770.[MT7]-RFLDEK[MT7].2y4_1.heavy 548.324 / 648.369 2496.0 23.032232920328777 40 16 10 6 8 2.4660164396026527 34.38099301889666 0.034999847412109375 4 0.9640749120295744 6.491642999115216 2496.0 1.3085190039318482 2.0 - - - - - - - 693.625 4 8 FBXO32 F-box protein 32 407 52 C20140610_SFK040_01 C20140610_SFK040_01 TB562770.[MT7]-RFLDEK[MT7].2y5_1.heavy 548.324 / 795.437 5478.0 23.032232920328777 40 16 10 6 8 2.4660164396026527 34.38099301889666 0.034999847412109375 4 0.9640749120295744 6.491642999115216 5478.0 12.734389429377963 0.0 - - - - - - - 287.84615384615387 10 13 FBXO32 F-box protein 32 409 52 C20140610_SFK040_01 C20140610_SFK040_01 TB562770.[MT7]-RFLDEK[MT7].2b4_1.heavy 548.324 / 676.39 N/A 23.032232920328777 40 16 10 6 8 2.4660164396026527 34.38099301889666 0.034999847412109375 4 0.9640749120295744 6.491642999115216 31340.0 24.265753424657532 0.0 - - - - - - - 716.6666666666666 62 3 FBXO32 F-box protein 32 411 52 C20140610_SFK040_01 C20140610_SFK040_01 TB562770.[MT7]-RFLDEK[MT7].2y3_1.heavy 548.324 / 535.284 2357.0 23.032232920328777 40 16 10 6 8 2.4660164396026527 34.38099301889666 0.034999847412109375 4 0.9640749120295744 6.491642999115216 2357.0 0.7649837720879913 7.0 - - - - - - - 1216.4545454545455 5 11 FBXO32 F-box protein 32 413 53 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 2631630.0 18.92099952697754 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2631630.0 4763.415500399193 0.0 - - - - - - - 785.8 5263 10 415 53 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 1452390.0 18.92099952697754 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1452390.0 4031.0300875106204 0.0 - - - - - - - 206.6 2904 15 417 53 C20140610_SFK040_01 C20140610_SFK040_01 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 1832430.0 18.92099952697754 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1832430.0 7356.979563347841 0.0 - - - - - - - 695.1428571428571 3664 7 419 54 C20140610_SFK040_01 C20140610_SFK040_01 TB563898.[MT7]-EEEAGGFIANLEPVSLADREVISR.4b7_1.heavy 687.11 / 864.386 28518.0 42.67314910888672 37 11 10 6 10 0.8813174330490152 69.9316838874355 0.035797119140625 3 0.8539550101372225 3.189231099367198 28518.0 41.489016786570744 0.0 - - - - - - - 655.1428571428571 57 14 EXOSC2 exosome component 2 421 54 C20140610_SFK040_01 C20140610_SFK040_01 TB563898.[MT7]-EEEAGGFIANLEPVSLADREVISR.4y12_2.heavy 687.11 / 671.378 44361.0 42.67314910888672 37 11 10 6 10 0.8813174330490152 69.9316838874355 0.035797119140625 3 0.8539550101372225 3.189231099367198 44361.0 59.03997489499206 0.0 - - - - - - - 1223.0833333333333 88 12 EXOSC2 exosome component 2 423 54 C20140610_SFK040_01 C20140610_SFK040_01 TB563898.[MT7]-EEEAGGFIANLEPVSLADREVISR.4b3_1.heavy 687.11 / 532.237 8172.0 42.67314910888672 37 11 10 6 10 0.8813174330490152 69.9316838874355 0.035797119140625 3 0.8539550101372225 3.189231099367198 8172.0 10.911583658523053 0.0 - - - - - - - 396.25 16 4 EXOSC2 exosome component 2 425 54 C20140610_SFK040_01 C20140610_SFK040_01 TB563898.[MT7]-EEEAGGFIANLEPVSLADREVISR.4b6_1.heavy 687.11 / 717.317 31436.0 42.67314910888672 37 11 10 6 10 0.8813174330490152 69.9316838874355 0.035797119140625 3 0.8539550101372225 3.189231099367198 31436.0 37.70120789039191 0.0 - - - - - - - 768.8888888888889 62 9 EXOSC2 exosome component 2 427 55 C20140610_SFK040_01 C20140610_SFK040_01 TB563896.[MT7]-AISPDSPISQSWAEITSQTEGLSR.3b6_1.heavy 902.123 / 715.374 33204.0 45.84617614746094 37 14 10 3 10 2.314865188867809 35.44643226055362 0.07630157470703125 3 0.9455331989078425 5.263870922297428 33204.0 35.30822771213748 1.0 - - - - - - - 283.57142857142856 66 14 FES feline sarcoma oncogene 429 55 C20140610_SFK040_01 C20140610_SFK040_01 TB563896.[MT7]-AISPDSPISQSWAEITSQTEGLSR.3b5_1.heavy 902.123 / 628.342 16198.0 45.84617614746094 37 14 10 3 10 2.314865188867809 35.44643226055362 0.07630157470703125 3 0.9455331989078425 5.263870922297428 16198.0 9.33342007434944 1.0 - - - - - - - 706.25 42 8 FES feline sarcoma oncogene 431 55 C20140610_SFK040_01 C20140610_SFK040_01 TB563896.[MT7]-AISPDSPISQSWAEITSQTEGLSR.3y8_1.heavy 902.123 / 877.437 35066.0 45.84617614746094 37 14 10 3 10 2.314865188867809 35.44643226055362 0.07630157470703125 3 0.9455331989078425 5.263870922297428 35066.0 106.2205154111779 0.0 - - - - - - - 234.71428571428572 70 14 FES feline sarcoma oncogene 433 55 C20140610_SFK040_01 C20140610_SFK040_01 TB563896.[MT7]-AISPDSPISQSWAEITSQTEGLSR.3y9_1.heavy 902.123 / 978.485 67090.0 45.84617614746094 37 14 10 3 10 2.314865188867809 35.44643226055362 0.07630157470703125 3 0.9455331989078425 5.263870922297428 67090.0 218.04187272332882 0.0 - - - - - - - 331.0 134 12 FES feline sarcoma oncogene 435 56 C20140610_SFK040_01 C20140610_SFK040_01 TB562639.[MT7]-TWAAVPR.2b3_1.heavy 472.775 / 503.273 42844.0 28.031700134277344 50 20 10 10 10 6.474474747297115 15.445268365861926 0.0 3 0.990186522453954 12.447871627941263 42844.0 28.244211679568927 0.0 - - - - - - - 1314.6 85 5 RGL1 ral guanine nucleotide dissociation stimulator-like 1 437 56 C20140610_SFK040_01 C20140610_SFK040_01 TB562639.[MT7]-TWAAVPR.2y5_1.heavy 472.775 / 513.314 91065.0 28.031700134277344 50 20 10 10 10 6.474474747297115 15.445268365861926 0.0 3 0.990186522453954 12.447871627941263 91065.0 41.18035202372829 0.0 - - - - - - - 881.6666666666666 182 3 RGL1 ral guanine nucleotide dissociation stimulator-like 1 439 56 C20140610_SFK040_01 C20140610_SFK040_01 TB562639.[MT7]-TWAAVPR.2b4_1.heavy 472.775 / 574.311 64181.0 28.031700134277344 50 20 10 10 10 6.474474747297115 15.445268365861926 0.0 3 0.990186522453954 12.447871627941263 64181.0 57.399846001160526 0.0 - - - - - - - 789.5 128 4 RGL1 ral guanine nucleotide dissociation stimulator-like 1 441 56 C20140610_SFK040_01 C20140610_SFK040_01 TB562639.[MT7]-TWAAVPR.2y6_1.heavy 472.775 / 699.394 128788.0 28.031700134277344 50 20 10 10 10 6.474474747297115 15.445268365861926 0.0 3 0.990186522453954 12.447871627941263 128788.0 157.37784920237362 0.0 - - - - - - - 814.7272727272727 257 11 RGL1 ral guanine nucleotide dissociation stimulator-like 1 443 57 C20140610_SFK040_01 C20140610_SFK040_01 TB563363.[MT7]-IITTGELAPQETTITEIK[MT7].3b6_1.heavy 749.429 / 759.437 557151.0 37.943199157714844 48 18 10 10 10 3.9012904460139777 25.632544252677185 0.0 3 0.9870816993355299 10.846535337944784 557151.0 403.2754286746854 0.0 - - - - - - - 497.0 1114 1 AK5 adenylate kinase 5 445 57 C20140610_SFK040_01 C20140610_SFK040_01 TB563363.[MT7]-IITTGELAPQETTITEIK[MT7].3y4_1.heavy 749.429 / 634.389 346164.0 37.943199157714844 48 18 10 10 10 3.9012904460139777 25.632544252677185 0.0 3 0.9870816993355299 10.846535337944784 346164.0 215.60906535167766 0.0 - - - - - - - 745.0 692 1 AK5 adenylate kinase 5 447 57 C20140610_SFK040_01 C20140610_SFK040_01 TB563363.[MT7]-IITTGELAPQETTITEIK[MT7].3b8_1.heavy 749.429 / 943.558 290663.0 37.943199157714844 48 18 10 10 10 3.9012904460139777 25.632544252677185 0.0 3 0.9870816993355299 10.846535337944784 290663.0 172.06809176677382 0.0 - - - - - - - 434.5 581 2 AK5 adenylate kinase 5 449 57 C20140610_SFK040_01 C20140610_SFK040_01 TB563363.[MT7]-IITTGELAPQETTITEIK[MT7].3b7_1.heavy 749.429 / 872.521 264217.0 37.943199157714844 48 18 10 10 10 3.9012904460139777 25.632544252677185 0.0 3 0.9870816993355299 10.846535337944784 264217.0 236.4378606617728 0.0 - - - - - - - 322.8 528 5 AK5 adenylate kinase 5 451 58 C20140610_SFK040_01 C20140610_SFK040_01 TB563618.[MT7]-FYGDDPQSSPNLGR.3y7_1.heavy 566.273 / 730.384 147127.0 28.538299560546875 50 20 10 10 10 3.807265800992337 20.68960342918217 0.0 3 0.9901772367396063 12.44197692538385 147127.0 89.50567176317983 0.0 - - - - - - - 718.5 294 2 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 453 58 C20140610_SFK040_01 C20140610_SFK040_01 TB563618.[MT7]-FYGDDPQSSPNLGR.3b4_1.heavy 566.273 / 627.289 86049.0 28.538299560546875 50 20 10 10 10 3.807265800992337 20.68960342918217 0.0 3 0.9901772367396063 12.44197692538385 86049.0 98.98551594595264 0.0 - - - - - - - 90.0 172 2 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 455 58 C20140610_SFK040_01 C20140610_SFK040_01 TB563618.[MT7]-FYGDDPQSSPNLGR.3b5_1.heavy 566.273 / 742.316 297578.0 28.538299560546875 50 20 10 10 10 3.807265800992337 20.68960342918217 0.0 3 0.9901772367396063 12.44197692538385 297578.0 132.35760499922344 0.0 - - - - - - - 224.5 595 2 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 457 58 C20140610_SFK040_01 C20140610_SFK040_01 TB563618.[MT7]-FYGDDPQSSPNLGR.3y5_1.heavy 566.273 / 556.32 192846.0 28.538299560546875 50 20 10 10 10 3.807265800992337 20.68960342918217 0.0 3 0.9901772367396063 12.44197692538385 192846.0 117.95962273946938 0.0 - - - - - - - 1324.5 385 4 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 459 59 C20140610_SFK040_01 C20140610_SFK040_01 TB562776.[MT7]-TVSSSSLK[MT7].2y4_1.heavy 548.826 / 578.363 9332.0 20.87070083618164 50 20 10 10 10 5.877977883386593 17.012653328049794 0.0 3 0.9915590706317513 13.423361166357813 9332.0 10.042774692473618 0.0 - - - - - - - 677.8181818181819 18 11 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 461 59 C20140610_SFK040_01 C20140610_SFK040_01 TB562776.[MT7]-TVSSSSLK[MT7].2y5_1.heavy 548.826 / 665.395 10209.0 20.87070083618164 50 20 10 10 10 5.877977883386593 17.012653328049794 0.0 3 0.9915590706317513 13.423361166357813 10209.0 13.261486375191552 0.0 - - - - - - - 769.4285714285714 20 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 463 59 C20140610_SFK040_01 C20140610_SFK040_01 TB562776.[MT7]-TVSSSSLK[MT7].2y6_1.heavy 548.826 / 752.427 21670.0 20.87070083618164 50 20 10 10 10 5.877977883386593 17.012653328049794 0.0 3 0.9915590706317513 13.423361166357813 21670.0 113.59589235127478 0.0 - - - - - - - 158.86666666666667 43 15 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 465 59 C20140610_SFK040_01 C20140610_SFK040_01 TB562776.[MT7]-TVSSSSLK[MT7].2y7_1.heavy 548.826 / 851.495 15846.0 20.87070083618164 50 20 10 10 10 5.877977883386593 17.012653328049794 0.0 3 0.9915590706317513 13.423361166357813 15846.0 22.123438991994828 0.0 - - - - - - - 193.25 31 12 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 467 60 C20140610_SFK040_01 C20140610_SFK040_01 TB563614.[MT7]-YGFQYISVGELLR.2b3_1.heavy 844.96 / 512.263 17175.0 47.41189956665039 47 17 10 10 10 2.5469595413501995 31.316278530795444 0.0 3 0.9711528961911224 7.248726000153056 17175.0 73.24015567765568 0.0 - - - - - - - 293.6470588235294 34 17 AK5 adenylate kinase 5 469 60 C20140610_SFK040_01 C20140610_SFK040_01 TB563614.[MT7]-YGFQYISVGELLR.2y9_1.heavy 844.96 / 1049.6 25242.0 47.41189956665039 47 17 10 10 10 2.5469595413501995 31.316278530795444 0.0 3 0.9711528961911224 7.248726000153056 25242.0 42.63972283650302 0.0 - - - - - - - 705.6666666666666 50 9 AK5 adenylate kinase 5 471 60 C20140610_SFK040_01 C20140610_SFK040_01 TB563614.[MT7]-YGFQYISVGELLR.2b4_1.heavy 844.96 / 640.321 19673.0 47.41189956665039 47 17 10 10 10 2.5469595413501995 31.316278530795444 0.0 3 0.9711528961911224 7.248726000153056 19673.0 28.512807488040913 0.0 - - - - - - - 723.4 39 10 AK5 adenylate kinase 5 473 60 C20140610_SFK040_01 C20140610_SFK040_01 TB563614.[MT7]-YGFQYISVGELLR.2y7_1.heavy 844.96 / 773.452 13948.0 47.41189956665039 47 17 10 10 10 2.5469595413501995 31.316278530795444 0.0 3 0.9711528961911224 7.248726000153056 13948.0 50.136273008749 0.0 - - - - - - - 274.44444444444446 27 18 AK5 adenylate kinase 5 475 61 C20140610_SFK040_01 C20140610_SFK040_01 TB563756.[MT7]-LASTIADNQEQDLEK[MT7].3y3_1.heavy 655.012 / 533.341 31329.0 30.329200744628906 47 17 10 10 10 6.365467099729005 15.709766217196734 0.0 3 0.974963131007068 7.783269326876298 31329.0 12.541751051632977 0.0 - - - - - - - 1296.0 62 2 SPAG5 sperm associated antigen 5 477 61 C20140610_SFK040_01 C20140610_SFK040_01 TB563756.[MT7]-LASTIADNQEQDLEK[MT7].3b5_1.heavy 655.012 / 630.394 27764.0 30.329200744628906 47 17 10 10 10 6.365467099729005 15.709766217196734 0.0 3 0.974963131007068 7.783269326876298 27764.0 13.771791508138723 0.0 - - - - - - - 756.0 55 1 SPAG5 sperm associated antigen 5 479 61 C20140610_SFK040_01 C20140610_SFK040_01 TB563756.[MT7]-LASTIADNQEQDLEK[MT7].3y4_1.heavy 655.012 / 648.369 37811.0 30.329200744628906 47 17 10 10 10 6.365467099729005 15.709766217196734 0.0 3 0.974963131007068 7.783269326876298 37811.0 26.686561699853804 0.0 - - - - - - - 1188.0 75 3 SPAG5 sperm associated antigen 5 481 61 C20140610_SFK040_01 C20140610_SFK040_01 TB563756.[MT7]-LASTIADNQEQDLEK[MT7].3b7_1.heavy 655.012 / 816.458 15340.0 30.329200744628906 47 17 10 10 10 6.365467099729005 15.709766217196734 0.0 3 0.974963131007068 7.783269326876298 15340.0 4.3503155794901 1.0 - - - - - - - 252.0 31 3 SPAG5 sperm associated antigen 5 483 62 C20140610_SFK040_01 C20140610_SFK040_01 TB563754.[MT7]-YGFQYISVGELLRK[MT7].3y6_1.heavy 654.375 / 859.548 22819.0 43.42250061035156 46 16 10 10 10 3.1212396444031114 32.038552431985224 0.0 3 0.9678852327956924 6.86816632970671 22819.0 34.02048331149652 0.0 - - - - - - - 825.1111111111111 45 9 AK5 adenylate kinase 5 485 62 C20140610_SFK040_01 C20140610_SFK040_01 TB563754.[MT7]-YGFQYISVGELLRK[MT7].3b4_1.heavy 654.375 / 640.321 23967.0 43.42250061035156 46 16 10 10 10 3.1212396444031114 32.038552431985224 0.0 3 0.9678852327956924 6.86816632970671 23967.0 32.56824082186833 0.0 - - - - - - - 740.3333333333334 47 12 AK5 adenylate kinase 5 487 62 C20140610_SFK040_01 C20140610_SFK040_01 TB563754.[MT7]-YGFQYISVGELLRK[MT7].3b5_1.heavy 654.375 / 803.385 17076.0 43.42250061035156 46 16 10 10 10 3.1212396444031114 32.038552431985224 0.0 3 0.9678852327956924 6.86816632970671 17076.0 27.613799162081193 0.0 - - - - - - - 698.75 34 8 AK5 adenylate kinase 5 489 62 C20140610_SFK040_01 C20140610_SFK040_01 TB563754.[MT7]-YGFQYISVGELLRK[MT7].3y8_1.heavy 654.375 / 1045.65 49313.0 43.42250061035156 46 16 10 10 10 3.1212396444031114 32.038552431985224 0.0 3 0.9678852327956924 6.86816632970671 49313.0 79.56255966516656 0.0 - - - - - - - 680.6666666666666 98 9 AK5 adenylate kinase 5 491 63 C20140610_SFK040_01 C20140610_SFK040_01 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 1792380.0 38.2495002746582 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1792380.0 2962.7960623029157 0.0 - - - - - - - 366.5 3584 2 493 63 C20140610_SFK040_01 C20140610_SFK040_01 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 717259.0 38.2495002746582 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 717259.0 684.889547718381 1.0 - - - - - - - 680.5 1672 2 495 63 C20140610_SFK040_01 C20140610_SFK040_01 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 1379360.0 38.2495002746582 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1379360.0 377.6660979688838 0.0 - - - - - - - 524.0 2758 1 497 64 C20140610_SFK040_01 C20140610_SFK040_01 TB563229.[MT7]-ELQWPDEGIR.2b3_1.heavy 693.86 / 515.295 35301.0 35.88610076904297 50 20 10 10 10 9.732978536302172 10.27434712067009 0.0 3 0.9934170250525697 15.202420281486555 35301.0 29.287093618376513 0.0 - - - - - - - 567.0 70 2 PCNX pecanex homolog (Drosophila) 499 64 C20140610_SFK040_01 C20140610_SFK040_01 TB563229.[MT7]-ELQWPDEGIR.2y9_1.heavy 693.86 / 1113.57 16768.0 35.88610076904297 50 20 10 10 10 9.732978536302172 10.27434712067009 0.0 3 0.9934170250525697 15.202420281486555 16768.0 0.0934879338598053 2.0 - - - - - - - 252.0 48 2 PCNX pecanex homolog (Drosophila) 501 64 C20140610_SFK040_01 C20140610_SFK040_01 TB563229.[MT7]-ELQWPDEGIR.2y6_1.heavy 693.86 / 686.347 34544.0 35.88610076904297 50 20 10 10 10 9.732978536302172 10.27434712067009 0.0 3 0.9934170250525697 15.202420281486555 34544.0 0.5473283171308957 1.0 - - - - - - - 126.0 69 1 PCNX pecanex homolog (Drosophila) 503 64 C20140610_SFK040_01 C20140610_SFK040_01 TB563229.[MT7]-ELQWPDEGIR.2y7_1.heavy 693.86 / 872.426 24458.0 35.88610076904297 50 20 10 10 10 9.732978536302172 10.27434712067009 0.0 3 0.9934170250525697 15.202420281486555 24458.0 13.98735526569134 1.0 - - - - - - - 252.0 48 2 PCNX pecanex homolog (Drosophila) 505 65 C20140610_SFK040_01 C20140610_SFK040_01 TB563223.[MT7]-LIDFLEC[CAM]GK[MT7].3y3_1.heavy 461.591 / 508.267 146656.0 43.03645133972168 39 13 10 6 10 1.1700153994458626 51.07761500015412 0.03620147705078125 3 0.9231155094453783 4.422016745513921 146656.0 243.68723323520624 0.0 - - - - - - - 281.6 293 10 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 507 65 C20140610_SFK040_01 C20140610_SFK040_01 TB563223.[MT7]-LIDFLEC[CAM]GK[MT7].3b4_1.heavy 461.591 / 633.373 91682.0 43.03645133972168 39 13 10 6 10 1.1700153994458626 51.07761500015412 0.03620147705078125 3 0.9231155094453783 4.422016745513921 91682.0 287.33997060303807 0.0 - - - - - - - 227.55555555555554 183 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 509 65 C20140610_SFK040_01 C20140610_SFK040_01 TB563223.[MT7]-LIDFLEC[CAM]GK[MT7].3y4_1.heavy 461.591 / 637.31 49682.0 43.03645133972168 39 13 10 6 10 1.1700153994458626 51.07761500015412 0.03620147705078125 3 0.9231155094453783 4.422016745513921 49682.0 239.82909250585482 0.0 - - - - - - - 209.45454545454547 99 11 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 511 65 C20140610_SFK040_01 C20140610_SFK040_01 TB563223.[MT7]-LIDFLEC[CAM]GK[MT7].3b3_1.heavy 461.591 / 486.304 124205.0 43.03645133972168 39 13 10 6 10 1.1700153994458626 51.07761500015412 0.03620147705078125 3 0.9231155094453783 4.422016745513921 124205.0 239.89785660392153 0.0 - - - - - - - 664.0 248 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 513 66 C20140610_SFK040_01 C20140610_SFK040_01 TB562602.[MT7]-AGPLSGK[MT7].2y4_1.heavy 459.287 / 548.352 17890.0 22.191499710083008 42 12 10 10 10 4.1692275062899125 23.985258623842142 0.0 3 0.883915481145382 3.586588839272539 17890.0 5.960193743250811 0.0 - - - - - - - 295.0 35 2 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 515 66 C20140610_SFK040_01 C20140610_SFK040_01 TB562602.[MT7]-AGPLSGK[MT7].2y5_1.heavy 459.287 / 645.405 4260.0 22.191499710083008 42 12 10 10 10 4.1692275062899125 23.985258623842142 0.0 3 0.883915481145382 3.586588839272539 4260.0 3.7155676657584014 5.0 - - - - - - - 1759.857142857143 25 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 517 66 C20140610_SFK040_01 C20140610_SFK040_01 TB562602.[MT7]-AGPLSGK[MT7].2b6_1.heavy 459.287 / 627.358 7209.0 22.191499710083008 42 12 10 10 10 4.1692275062899125 23.985258623842142 0.0 3 0.883915481145382 3.586588839272539 7209.0 8.005778475039527 0.0 - - - - - - - 816.0 14 11 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 519 66 C20140610_SFK040_01 C20140610_SFK040_01 TB562602.[MT7]-AGPLSGK[MT7].2y6_1.heavy 459.287 / 702.427 31194.0 22.191499710083008 42 12 10 10 10 4.1692275062899125 23.985258623842142 0.0 3 0.883915481145382 3.586588839272539 31194.0 28.50409840516685 0.0 - - - - - - - 1286.25 62 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 521 67 C20140610_SFK040_01 C20140610_SFK040_01 TB562705.[MT7]-YAFDFAR.2b3_1.heavy 517.265 / 526.278 10669.0 35.927101135253906 48 18 10 10 10 8.634368220980177 11.58162328044054 0.0 3 0.9859909118971828 10.414756571680806 10669.0 7.621099601593626 2.0 - - - - - - - 609.8571428571429 21 7 DCUN1D4;DCUN1D5 DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae);DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) 523 67 C20140610_SFK040_01 C20140610_SFK040_01 TB562705.[MT7]-YAFDFAR.2y5_1.heavy 517.265 / 655.32 23849.0 35.927101135253906 48 18 10 10 10 8.634368220980177 11.58162328044054 0.0 3 0.9859909118971828 10.414756571680806 23849.0 42.690732485177016 0.0 - - - - - - - 655.5555555555555 47 9 DCUN1D4;DCUN1D5 DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae);DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) 525 67 C20140610_SFK040_01 C20140610_SFK040_01 TB562705.[MT7]-YAFDFAR.2b4_1.heavy 517.265 / 641.305 101295.0 35.927101135253906 48 18 10 10 10 8.634368220980177 11.58162328044054 0.0 3 0.9859909118971828 10.414756571680806 101295.0 181.88221079348443 0.0 - - - - - - - 645.7142857142857 202 7 DCUN1D4;DCUN1D5 DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae);DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) 527 67 C20140610_SFK040_01 C20140610_SFK040_01 TB562705.[MT7]-YAFDFAR.2y6_1.heavy 517.265 / 726.357 75438.0 35.927101135253906 48 18 10 10 10 8.634368220980177 11.58162328044054 0.0 3 0.9859909118971828 10.414756571680806 75438.0 177.4933889185526 0.0 - - - - - - - 201.2 150 5 DCUN1D4;DCUN1D5 DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae);DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) 529 68 C20140610_SFK040_01 C20140610_SFK040_01 TB562932.[MT7]-FDHLVLRR.3b4_1.heavy 400.576 / 657.348 8851.0 28.110700607299805 40 20 4 10 6 7.229209500687829 13.832771064455308 0.0 6 0.9968618150686775 22.024672702514298 8851.0 32.430143555242715 1.0 - - - - - - - 271.2307692307692 17 13 DFNB31 deafness, autosomal recessive 31 531 68 C20140610_SFK040_01 C20140610_SFK040_01 TB562932.[MT7]-FDHLVLRR.3y4_1.heavy 400.576 / 543.372 22429.0 28.110700607299805 40 20 4 10 6 7.229209500687829 13.832771064455308 0.0 6 0.9968618150686775 22.024672702514298 22429.0 12.404653481403138 2.0 - - - - - - - 387.0 53 2 DFNB31 deafness, autosomal recessive 31 533 68 C20140610_SFK040_01 C20140610_SFK040_01 TB562932.[MT7]-FDHLVLRR.3b3_1.heavy 400.576 / 544.264 56117.0 28.110700607299805 40 20 4 10 6 7.229209500687829 13.832771064455308 0.0 6 0.9968618150686775 22.024672702514298 56117.0 44.969366926119044 0.0 - - - - - - - 699.7142857142857 112 7 DFNB31 deafness, autosomal recessive 31 535 68 C20140610_SFK040_01 C20140610_SFK040_01 TB562932.[MT7]-FDHLVLRR.3b7_2.heavy 400.576 / 513.304 15383.0 28.110700607299805 40 20 4 10 6 7.229209500687829 13.832771064455308 0.0 6 0.9968618150686775 22.024672702514298 15383.0 8.72390094089489 2.0 - - - - - - - 797.7142857142857 189 7 DFNB31 deafness, autosomal recessive 31 537 69 C20140610_SFK040_01 C20140610_SFK040_01 TB562603.[MT7]-LADGEK[MT7].2y4_1.heavy 460.768 / 592.306 52499.0 18.638599395751953 50 20 10 10 10 11.956876160292255 8.363388451917842 0.0 3 0.9959473081522496 19.37955486817396 52499.0 42.20818569532168 0.0 - - - - - - - 878.2 104 5 ARHGEF19;SPG11 Rho guanine nucleotide exchange factor (GEF) 19;spastic paraplegia 11 (autosomal recessive) 539 69 C20140610_SFK040_01 C20140610_SFK040_01 TB562603.[MT7]-LADGEK[MT7].2y5_1.heavy 460.768 / 663.343 138550.0 18.638599395751953 50 20 10 10 10 11.956876160292255 8.363388451917842 0.0 3 0.9959473081522496 19.37955486817396 138550.0 103.78689898289996 0.0 - - - - - - - 789.0 277 1 ARHGEF19;SPG11 Rho guanine nucleotide exchange factor (GEF) 19;spastic paraplegia 11 (autosomal recessive) 541 69 C20140610_SFK040_01 C20140610_SFK040_01 TB562603.[MT7]-LADGEK[MT7].2y3_1.heavy 460.768 / 477.279 184092.0 18.638599395751953 50 20 10 10 10 11.956876160292255 8.363388451917842 0.0 3 0.9959473081522496 19.37955486817396 184092.0 89.00609665619709 0.0 - - - - - - - 1233.5 368 2 ARHGEF19;SPG11 Rho guanine nucleotide exchange factor (GEF) 19;spastic paraplegia 11 (autosomal recessive) 543 69 C20140610_SFK040_01 C20140610_SFK040_01 TB562603.[MT7]-LADGEK[MT7].2b5_1.heavy 460.768 / 630.321 21414.0 18.638599395751953 50 20 10 10 10 11.956876160292255 8.363388451917842 0.0 3 0.9959473081522496 19.37955486817396 21414.0 6.973853676418752 0.0 - - - - - - - 863.25 42 4 ARHGEF19;SPG11 Rho guanine nucleotide exchange factor (GEF) 19;spastic paraplegia 11 (autosomal recessive) 545 70 C20140610_SFK040_01 C20140610_SFK040_01 TB562930.[MT7]-QQHGEANK[MT7].3y3_1.heavy 400.551 / 476.295 1590.0 12.239899635314941 42 12 10 10 10 0.8354818779556268 73.4384480914339 0.0 3 0.8819455943236886 3.555929458861073 1590.0 6.013883326658657 1.0 - - - - - - - 143.12 3 25 BCAS2 breast carcinoma amplified sequence 2 547 70 C20140610_SFK040_01 C20140610_SFK040_01 TB562930.[MT7]-QQHGEANK[MT7].3b3_2.heavy 400.551 / 269.646 1704.0 12.239899635314941 42 12 10 10 10 0.8354818779556268 73.4384480914339 0.0 3 0.8819455943236886 3.555929458861073 1704.0 4.7469036697247695 0.0 - - - - - - - 125.75 3 28 BCAS2 breast carcinoma amplified sequence 2 549 70 C20140610_SFK040_01 C20140610_SFK040_01 TB562930.[MT7]-QQHGEANK[MT7].3y4_1.heavy 400.551 / 605.338 170.0 12.239899635314941 42 12 10 10 10 0.8354818779556268 73.4384480914339 0.0 3 0.8819455943236886 3.555929458861073 170.0 2.3720930232558137 5.0 - - - - - - - 0.0 0 0 BCAS2 breast carcinoma amplified sequence 2 551 70 C20140610_SFK040_01 C20140610_SFK040_01 TB562930.[MT7]-QQHGEANK[MT7].3y5_1.heavy 400.551 / 662.359 582.0 12.239899635314941 42 12 10 10 10 0.8354818779556268 73.4384480914339 0.0 3 0.8819455943236886 3.555929458861073 582.0 8.786805040770941 0.0 - - - - - - - 0.0 1 0 BCAS2 breast carcinoma amplified sequence 2 553 71 C20140610_SFK040_01 C20140610_SFK040_01 TB458261.[MT7]-LLELIAK[MT7].2y4_1.heavy 544.37 / 588.42 44229.0 41.414398193359375 50 20 10 10 10 6.3276082944359135 15.80375954812713 0.0 3 0.9944732726122967 16.593122764527312 44229.0 76.44725932781921 0.0 - - - - - - - 746.2 88 10 FBXO32 F-box protein 32 555 71 C20140610_SFK040_01 C20140610_SFK040_01 TB458261.[MT7]-LLELIAK[MT7].2b3_1.heavy 544.37 / 500.32 65882.0 41.414398193359375 50 20 10 10 10 6.3276082944359135 15.80375954812713 0.0 3 0.9944732726122967 16.593122764527312 65882.0 79.14622789015517 0.0 - - - - - - - 415.0 131 4 FBXO32 F-box protein 32 557 71 C20140610_SFK040_01 C20140610_SFK040_01 TB458261.[MT7]-LLELIAK[MT7].2b4_1.heavy 544.37 / 613.404 49020.0 41.414398193359375 50 20 10 10 10 6.3276082944359135 15.80375954812713 0.0 3 0.9944732726122967 16.593122764527312 49020.0 93.0078985409479 0.0 - - - - - - - 723.8571428571429 98 7 FBXO32 F-box protein 32 559 71 C20140610_SFK040_01 C20140610_SFK040_01 TB458261.[MT7]-LLELIAK[MT7].2y6_1.heavy 544.37 / 830.547 47638.0 41.414398193359375 50 20 10 10 10 6.3276082944359135 15.80375954812713 0.0 3 0.9944732726122967 16.593122764527312 47638.0 35.21305441954179 0.0 - - - - - - - 256.0 95 9 FBXO32 F-box protein 32 561 72 C20140610_SFK040_01 C20140610_SFK040_01 TB562708.[MT7]-GQLDWK[MT7].2y4_1.heavy 517.797 / 705.405 11709.0 28.031700134277344 48 20 10 10 8 9.137052148631662 10.944448863080606 0.0 4 0.9941537640412196 16.132898087787144 11709.0 13.435603108419697 1.0 - - - - - - - 814.25 23 8 FBXO32 F-box protein 32 563 72 C20140610_SFK040_01 C20140610_SFK040_01 TB562708.[MT7]-GQLDWK[MT7].2y5_1.heavy 517.797 / 833.464 4453.0 28.031700134277344 48 20 10 10 8 9.137052148631662 10.944448863080606 0.0 4 0.9941537640412196 16.132898087787144 4453.0 9.79737427513825 2.0 - - - - - - - 366.55555555555554 9 9 FBXO32 F-box protein 32 565 72 C20140610_SFK040_01 C20140610_SFK040_01 TB562708.[MT7]-GQLDWK[MT7].2b4_1.heavy 517.797 / 558.3 80065.0 28.031700134277344 48 20 10 10 8 9.137052148631662 10.944448863080606 0.0 4 0.9941537640412196 16.132898087787144 80065.0 58.30021664656566 0.0 - - - - - - - 2202.5714285714284 160 7 FBXO32 F-box protein 32 567 72 C20140610_SFK040_01 C20140610_SFK040_01 TB562708.[MT7]-GQLDWK[MT7].2y3_1.heavy 517.797 / 592.321 16326.0 28.031700134277344 48 20 10 10 8 9.137052148631662 10.944448863080606 0.0 4 0.9941537640412196 16.132898087787144 16326.0 23.212896159732196 1.0 - - - - - - - 843.0 47 9 FBXO32 F-box protein 32 569 73 C20140610_SFK040_01 C20140610_SFK040_01 TB458162.[MT7]-VVVPGIR.2y5_2.heavy 442.296 / 271.177 15569.0 30.976200103759766 45 20 10 5 10 26.34626441909422 3.7956045080731027 0.04119873046875 3 0.9972089316927306 23.35479573537254 15569.0 11.026439698381884 1.0 - - - - - - - 1177.4285714285713 31 7 PCNX pecanex homolog (Drosophila) 571 73 C20140610_SFK040_01 C20140610_SFK040_01 TB458162.[MT7]-VVVPGIR.2y5_1.heavy 442.296 / 541.346 135767.0 30.976200103759766 45 20 10 5 10 26.34626441909422 3.7956045080731027 0.04119873046875 3 0.9972089316927306 23.35479573537254 135767.0 61.83950478323136 0.0 - - - - - - - 1755.3333333333333 271 3 PCNX pecanex homolog (Drosophila) 573 73 C20140610_SFK040_01 C20140610_SFK040_01 TB458162.[MT7]-VVVPGIR.2y6_1.heavy 442.296 / 640.414 442903.0 30.976200103759766 45 20 10 5 10 26.34626441909422 3.7956045080731027 0.04119873046875 3 0.9972089316927306 23.35479573537254 442903.0 289.37674450437873 0.0 - - - - - - - 458.0 885 1 PCNX pecanex homolog (Drosophila) 575 73 C20140610_SFK040_01 C20140610_SFK040_01 TB458162.[MT7]-VVVPGIR.2b5_1.heavy 442.296 / 596.389 66052.0 30.976200103759766 45 20 10 5 10 26.34626441909422 3.7956045080731027 0.04119873046875 3 0.9972089316927306 23.35479573537254 66052.0 36.27953491955164 1.0 - - - - - - - 343.0 132 1 PCNX pecanex homolog (Drosophila) 577 74 C20140610_SFK040_01 C20140610_SFK040_01 TB458268.[MT7]-FSLLSEVR.2y5_1.heavy 547.82 / 603.346 87185.0 39.1702995300293 50 20 10 10 10 9.64256462683496 10.370684965045823 0.0 3 0.9957546298533618 18.93436845910258 87185.0 76.14698896750531 0.0 - - - - - - - 423.5 174 4 DFNB31 deafness, autosomal recessive 31 579 74 C20140610_SFK040_01 C20140610_SFK040_01 TB458268.[MT7]-FSLLSEVR.2b4_1.heavy 547.82 / 605.378 73502.0 39.1702995300293 50 20 10 10 10 9.64256462683496 10.370684965045823 0.0 3 0.9957546298533618 18.93436845910258 73502.0 102.50934011883038 0.0 - - - - - - - 795.8571428571429 147 7 DFNB31 deafness, autosomal recessive 31 581 74 C20140610_SFK040_01 C20140610_SFK040_01 TB458268.[MT7]-FSLLSEVR.2y6_1.heavy 547.82 / 716.43 48194.0 39.1702995300293 50 20 10 10 10 9.64256462683496 10.370684965045823 0.0 3 0.9957546298533618 18.93436845910258 48194.0 89.9336259505723 0.0 - - - - - - - 743.8571428571429 96 7 DFNB31 deafness, autosomal recessive 31 583 74 C20140610_SFK040_01 C20140610_SFK040_01 TB458268.[MT7]-FSLLSEVR.2y7_1.heavy 547.82 / 803.462 272815.0 39.1702995300293 50 20 10 10 10 9.64256462683496 10.370684965045823 0.0 3 0.9957546298533618 18.93436845910258 272815.0 292.502927639973 0.0 - - - - - - - 363.0 545 3 DFNB31 deafness, autosomal recessive 31 585 75 C20140610_SFK040_01 C20140610_SFK040_01 TB562700.[MT7]-YLNQTSR.2b3_1.heavy 513.278 / 535.3 10900.0 21.449649810791016 46 20 10 6 10 5.702316620047729 17.536732290246448 0.0364990234375 3 0.9953294516857017 18.051332155376272 10900.0 14.218787973127869 0.0 - - - - - - - 791.0 21 10 FDFT1 farnesyl-diphosphate farnesyltransferase 1 587 75 C20140610_SFK040_01 C20140610_SFK040_01 TB562700.[MT7]-YLNQTSR.2y5_1.heavy 513.278 / 605.3 30440.0 21.449649810791016 46 20 10 6 10 5.702316620047729 17.536732290246448 0.0364990234375 3 0.9953294516857017 18.051332155376272 30440.0 32.400920455409896 0.0 - - - - - - - 854.5714285714286 60 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 589 75 C20140610_SFK040_01 C20140610_SFK040_01 TB562700.[MT7]-YLNQTSR.2b4_1.heavy 513.278 / 663.358 7909.0 21.449649810791016 46 20 10 6 10 5.702316620047729 17.536732290246448 0.0364990234375 3 0.9953294516857017 18.051332155376272 7909.0 16.574435200905487 0.0 - - - - - - - 802.6153846153846 15 13 FDFT1 farnesyl-diphosphate farnesyltransferase 1 591 75 C20140610_SFK040_01 C20140610_SFK040_01 TB562700.[MT7]-YLNQTSR.2y6_1.heavy 513.278 / 718.384 57823.0 21.449649810791016 46 20 10 6 10 5.702316620047729 17.536732290246448 0.0364990234375 3 0.9953294516857017 18.051332155376272 57823.0 132.3936540131918 0.0 - - - - - - - 611.7 115 10 FDFT1 farnesyl-diphosphate farnesyltransferase 1 593 76 C20140610_SFK040_01 C20140610_SFK040_01 TB562608.[MT7]-GTQSLK[MT7].2y4_1.heavy 461.284 / 619.39 21482.0 17.451900482177734 50 20 10 10 10 5.44693105215826 18.35896196269578 0.0 3 0.9903347811197161 12.543135260065792 21482.0 15.066297412985715 0.0 - - - - - - - 2371.6 42 10 AK5 adenylate kinase 5 595 76 C20140610_SFK040_01 C20140610_SFK040_01 TB562608.[MT7]-GTQSLK[MT7].2y5_1.heavy 461.284 / 720.437 26509.0 17.451900482177734 50 20 10 10 10 5.44693105215826 18.35896196269578 0.0 3 0.9903347811197161 12.543135260065792 26509.0 149.91593561779837 0.0 - - - - - - - 773.2727272727273 53 11 AK5 adenylate kinase 5 597 76 C20140610_SFK040_01 C20140610_SFK040_01 TB562608.[MT7]-GTQSLK[MT7].2b4_1.heavy 461.284 / 518.269 19291.0 17.451900482177734 50 20 10 10 10 5.44693105215826 18.35896196269578 0.0 3 0.9903347811197161 12.543135260065792 19291.0 24.754175996560164 0.0 - - - - - - - 783.875 38 8 AK5 adenylate kinase 5 599 76 C20140610_SFK040_01 C20140610_SFK040_01 TB562608.[MT7]-GTQSLK[MT7].2y3_1.heavy 461.284 / 491.331 50998.0 17.451900482177734 50 20 10 10 10 5.44693105215826 18.35896196269578 0.0 3 0.9903347811197161 12.543135260065792 50998.0 118.5206103263277 0.0 - - - - - - - 1221.4285714285713 101 7 AK5 adenylate kinase 5 601 77 C20140610_SFK040_01 C20140610_SFK040_01 TB458502.[MT7]-SFAAVIQALDGEMR.3y7_1.heavy 551.291 / 791.372 24694.0 50.65869903564453 47 17 10 10 10 4.3771053825827035 22.846148598093652 0.0 3 0.9731830694049818 7.519387940066915 24694.0 231.39192592592593 0.0 - - - - - - - 138.0 49 12 FDFT1 farnesyl-diphosphate farnesyltransferase 1 603 77 C20140610_SFK040_01 C20140610_SFK040_01 TB458502.[MT7]-SFAAVIQALDGEMR.3y6_1.heavy 551.291 / 720.334 20836.0 50.65869903564453 47 17 10 10 10 4.3771053825827035 22.846148598093652 0.0 3 0.9731830694049818 7.519387940066915 20836.0 100.51804892141757 0.0 - - - - - - - 170.46666666666667 41 15 FDFT1 farnesyl-diphosphate farnesyltransferase 1 605 77 C20140610_SFK040_01 C20140610_SFK040_01 TB458502.[MT7]-SFAAVIQALDGEMR.3b4_1.heavy 551.291 / 521.284 91204.0 50.65869903564453 47 17 10 10 10 4.3771053825827035 22.846148598093652 0.0 3 0.9731830694049818 7.519387940066915 91204.0 305.4542756875411 0.0 - - - - - - - 767.2857142857143 182 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 607 77 C20140610_SFK040_01 C20140610_SFK040_01 TB458502.[MT7]-SFAAVIQALDGEMR.3b5_1.heavy 551.291 / 620.352 78911.0 50.65869903564453 47 17 10 10 10 4.3771053825827035 22.846148598093652 0.0 3 0.9731830694049818 7.519387940066915 78911.0 -15.901460957178841 0.0 - - - - - - - 272.22222222222223 157 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 609 78 C20140610_SFK040_01 C20140610_SFK040_01 TB563219.[MT7]-LDFSTAILDSR.2b3_1.heavy 691.376 / 520.289 10750.0 41.26777458190918 46 20 10 6 10 16.406679927420623 6.095078373100286 0.03910064697265625 3 0.9987185451149261 34.47182854117622 10750.0 10.601287693745004 1.0 - - - - - - - 773.25 21 8 FBXO32 F-box protein 32 611 78 C20140610_SFK040_01 C20140610_SFK040_01 TB563219.[MT7]-LDFSTAILDSR.2y8_1.heavy 691.376 / 862.463 17342.0 41.26777458190918 46 20 10 6 10 16.406679927420623 6.095078373100286 0.03910064697265625 3 0.9987185451149261 34.47182854117622 17342.0 25.785425558312653 0.0 - - - - - - - 697.125 34 8 FBXO32 F-box protein 32 613 78 C20140610_SFK040_01 C20140610_SFK040_01 TB563219.[MT7]-LDFSTAILDSR.2y9_1.heavy 691.376 / 1009.53 24846.0 41.26777458190918 46 20 10 6 10 16.406679927420623 6.095078373100286 0.03910064697265625 3 0.9987185451149261 34.47182854117622 24846.0 16.641897465336044 0.0 - - - - - - - 1130.142857142857 49 7 FBXO32 F-box protein 32 615 78 C20140610_SFK040_01 C20140610_SFK040_01 TB563219.[MT7]-LDFSTAILDSR.2y10_1.heavy 691.376 / 1124.56 22108.0 41.26777458190918 46 20 10 6 10 16.406679927420623 6.095078373100286 0.03910064697265625 3 0.9987185451149261 34.47182854117622 22108.0 13.351618361787846 1.0 - - - - - - - 329.5 44 4 FBXO32 F-box protein 32 617 79 C20140610_SFK040_01 C20140610_SFK040_01 TB563215.[MT7]-VAIGGQSDESDR.2y4_1.heavy 689.34 / 506.22 24098.0 21.617700576782227 46 16 10 10 10 2.6948582209222436 31.799597911064453 0.0 3 0.9664811356342765 6.721978349535834 24098.0 63.13212223704267 0.0 - - - - - - - 310.45454545454544 48 11 ALDH3B1 aldehyde dehydrogenase 3 family, member B1 619 79 C20140610_SFK040_01 C20140610_SFK040_01 TB563215.[MT7]-VAIGGQSDESDR.2y9_1.heavy 689.34 / 950.381 79597.0 21.617700576782227 46 16 10 10 10 2.6948582209222436 31.799597911064453 0.0 3 0.9664811356342765 6.721978349535834 79597.0 119.69900436283538 0.0 - - - - - - - 682.5714285714286 159 7 ALDH3B1 aldehyde dehydrogenase 3 family, member B1 621 79 C20140610_SFK040_01 C20140610_SFK040_01 TB563215.[MT7]-VAIGGQSDESDR.2y10_1.heavy 689.34 / 1063.47 47513.0 21.617700576782227 46 16 10 10 10 2.6948582209222436 31.799597911064453 0.0 3 0.9664811356342765 6.721978349535834 47513.0 163.34472594072594 0.0 - - - - - - - 227.55555555555554 95 9 ALDH3B1 aldehyde dehydrogenase 3 family, member B1 623 79 C20140610_SFK040_01 C20140610_SFK040_01 TB563215.[MT7]-VAIGGQSDESDR.2y11_1.heavy 689.34 / 1134.5 61712.0 21.617700576782227 46 16 10 10 10 2.6948582209222436 31.799597911064453 0.0 3 0.9664811356342765 6.721978349535834 61712.0 169.8826679484265 0.0 - - - - - - - 314.2 123 5 ALDH3B1 aldehyde dehydrogenase 3 family, member B1 625 80 C20140610_SFK040_01 C20140610_SFK040_01 TB458406.[MT7]-LIDFLEC[CAM]GK[MT7].2y8_1.heavy 691.883 / 1125.57 37291.0 43.03645133972168 39 13 10 6 10 4.09601270185985 20.063626414727217 0.03620147705078125 3 0.9098350669574233 4.078730752421469 37291.0 49.007341068009445 0.0 - - - - - - - 647.4545454545455 74 11 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 627 80 C20140610_SFK040_01 C20140610_SFK040_01 TB458406.[MT7]-LIDFLEC[CAM]GK[MT7].2y3_1.heavy 691.883 / 508.267 31701.0 43.03645133972168 39 13 10 6 10 4.09601270185985 20.063626414727217 0.03620147705078125 3 0.9098350669574233 4.078730752421469 31701.0 38.166224313438484 0.0 - - - - - - - 1263.5 63 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 629 80 C20140610_SFK040_01 C20140610_SFK040_01 TB458406.[MT7]-LIDFLEC[CAM]GK[MT7].2y6_1.heavy 691.883 / 897.462 49466.0 43.03645133972168 39 13 10 6 10 4.09601270185985 20.063626414727217 0.03620147705078125 3 0.9098350669574233 4.078730752421469 49466.0 122.20978677839703 0.0 - - - - - - - 723.2222222222222 98 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 631 80 C20140610_SFK040_01 C20140610_SFK040_01 TB458406.[MT7]-LIDFLEC[CAM]GK[MT7].2y7_1.heavy 691.883 / 1012.49 64398.0 43.03645133972168 39 13 10 6 10 4.09601270185985 20.063626414727217 0.03620147705078125 3 0.9098350669574233 4.078730752421469 64398.0 143.00860964539476 0.0 - - - - - - - 645.5714285714286 128 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 633 81 C20140610_SFK040_01 C20140610_SFK040_01 TB562715.[MT7]-ESQFLK[MT7].2y5_1.heavy 520.305 / 766.458 37916.0 25.921949863433838 44 20 10 6 8 34.505550460825276 2.8980844723382013 0.03299903869628906 4 0.9989415220319171 37.93002625861121 37916.0 64.30550669777028 1.0 - - - - - - - 743.0 75 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 635 81 C20140610_SFK040_01 C20140610_SFK040_01 TB562715.[MT7]-ESQFLK[MT7].2b4_1.heavy 520.305 / 636.311 19885.0 25.921949863433838 44 20 10 6 8 34.505550460825276 2.8980844723382013 0.03299903869628906 4 0.9989415220319171 37.93002625861121 19885.0 37.63668696616534 1.0 - - - - - - - 1221.7142857142858 55 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 637 81 C20140610_SFK040_01 C20140610_SFK040_01 TB562715.[MT7]-ESQFLK[MT7].2y3_1.heavy 520.305 / 551.367 25515.0 25.921949863433838 44 20 10 6 8 34.505550460825276 2.8980844723382013 0.03299903869628906 4 0.9989415220319171 37.93002625861121 25515.0 21.137363570875188 1.0 - - - - - - - 1354.1666666666667 51 12 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 639 81 C20140610_SFK040_01 C20140610_SFK040_01 TB562715.[MT7]-ESQFLK[MT7].2b5_1.heavy 520.305 / 749.395 8838.0 25.921949863433838 44 20 10 6 8 34.505550460825276 2.8980844723382013 0.03299903869628906 4 0.9989415220319171 37.93002625861121 8838.0 9.475769528037613 0.0 - - - - - - - 726.9 17 10 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 641 82 C20140610_SFK040_01 C20140610_SFK040_01 TB458409.[MT7]-SAAEPVASTPASR.2y12_1.heavy 694.369 / 1156.6 5611.0 19.38385009765625 39 13 10 6 10 2.8930408991710728 34.56570559671398 0.03820037841796875 3 0.9262457537748988 4.516091740721715 5611.0 1.8908171861836565 1.0 - - - - - - - 148.5 11 12 CSNK1E casein kinase 1, epsilon 643 82 C20140610_SFK040_01 C20140610_SFK040_01 TB458409.[MT7]-SAAEPVASTPASR.2b4_1.heavy 694.369 / 503.258 60640.0 19.38385009765625 39 13 10 6 10 2.8930408991710728 34.56570559671398 0.03820037841796875 3 0.9262457537748988 4.516091740721715 60640.0 281.4998683297097 0.0 - - - - - - - 235.28571428571428 121 14 CSNK1E casein kinase 1, epsilon 645 82 C20140610_SFK040_01 C20140610_SFK040_01 TB458409.[MT7]-SAAEPVASTPASR.2y9_1.heavy 694.369 / 885.479 60964.0 19.38385009765625 39 13 10 6 10 2.8930408991710728 34.56570559671398 0.03820037841796875 3 0.9262457537748988 4.516091740721715 60964.0 276.5242457378013 0.0 - - - - - - - 279.8181818181818 121 11 CSNK1E casein kinase 1, epsilon 647 82 C20140610_SFK040_01 C20140610_SFK040_01 TB458409.[MT7]-SAAEPVASTPASR.2y10_1.heavy 694.369 / 1014.52 12193.0 19.38385009765625 39 13 10 6 10 2.8930408991710728 34.56570559671398 0.03820037841796875 3 0.9262457537748988 4.516091740721715 12193.0 70.7495061728395 0.0 - - - - - - - 184.5 24 12 CSNK1E casein kinase 1, epsilon 649 83 C20140610_SFK040_01 C20140610_SFK040_01 TB458508.[MT7]-YEIVSTLGEGTFGR.3y7_1.heavy 558.294 / 723.342 138464.0 39.42340087890625 48 18 10 10 10 3.02640346049806 27.779183052401617 0.0 3 0.9800829026988719 8.730233847497725 138464.0 372.93777088910804 0.0 - - - - - - - 261.6666666666667 276 6 CLK2 CDC-like kinase 2 651 83 C20140610_SFK040_01 C20140610_SFK040_01 TB458508.[MT7]-YEIVSTLGEGTFGR.3b4_1.heavy 558.294 / 649.368 49175.0 39.42340087890625 48 18 10 10 10 3.02640346049806 27.779183052401617 0.0 3 0.9800829026988719 8.730233847497725 49175.0 77.81140754369827 0.0 - - - - - - - 800.625 98 8 CLK2 CDC-like kinase 2 653 83 C20140610_SFK040_01 C20140610_SFK040_01 TB458508.[MT7]-YEIVSTLGEGTFGR.3b3_1.heavy 558.294 / 550.299 107775.0 39.42340087890625 48 18 10 10 10 3.02640346049806 27.779183052401617 0.0 3 0.9800829026988719 8.730233847497725 107775.0 150.424269243327 0.0 - - - - - - - 483.0 215 2 CLK2 CDC-like kinase 2 655 83 C20140610_SFK040_01 C20140610_SFK040_01 TB458508.[MT7]-YEIVSTLGEGTFGR.3y5_1.heavy 558.294 / 537.278 88805.0 39.42340087890625 48 18 10 10 10 3.02640346049806 27.779183052401617 0.0 3 0.9800829026988719 8.730233847497725 88805.0 54.14939024390244 0.0 - - - - - - - 2209.4285714285716 177 7 CLK2 CDC-like kinase 2 657 84 C20140610_SFK040_01 C20140610_SFK040_01 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 1665640.0 35.116233825683594 23 -3 10 6 10 null 0.0 0.039699554443359375 3 0.0 0.0 1665640.0 119.89776530703469 0.0 - - - - - - - 2990.0 3331 1 659 84 C20140610_SFK040_01 C20140610_SFK040_01 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 323091.0 35.116233825683594 23 -3 10 6 10 null 0.0 0.039699554443359375 3 0.0 0.0 323091.0 272.37851663247716 0.0 - - - - - - - 748.0 646 1 661 84 C20140610_SFK040_01 C20140610_SFK040_01 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 518959.0 35.116233825683594 23 -3 10 6 10 null 0.0 0.039699554443359375 3 0.0 0.0 518959.0 221.82940725441588 0.0 - - - - - - - 1371.0 1037 1 663 85 C20140610_SFK040_01 C20140610_SFK040_01 TB562714.[MT7]-LLDYLTR.2y4_1.heavy 519.309 / 552.314 94113.0 40.63159942626953 50 20 10 10 10 19.57552199726866 5.108420608857983 0.0 3 0.9957915730944279 19.0173522063266 94113.0 336.12058106082094 0.0 - - - - - - - 635.2857142857143 188 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 665 85 C20140610_SFK040_01 C20140610_SFK040_01 TB562714.[MT7]-LLDYLTR.2y5_1.heavy 519.309 / 667.341 29223.0 40.63159942626953 50 20 10 10 10 19.57552199726866 5.108420608857983 0.0 3 0.9957915730944279 19.0173522063266 29223.0 68.34489483778557 0.0 - - - - - - - 222.0 58 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 667 85 C20140610_SFK040_01 C20140610_SFK040_01 TB562714.[MT7]-LLDYLTR.2b4_1.heavy 519.309 / 649.368 16334.0 40.63159942626953 50 20 10 10 10 19.57552199726866 5.108420608857983 0.0 3 0.9957915730944279 19.0173522063266 16334.0 42.962622253592265 0.0 - - - - - - - 252.27272727272728 32 11 RGL1 ral guanine nucleotide dissociation stimulator-like 1 669 85 C20140610_SFK040_01 C20140610_SFK040_01 TB562714.[MT7]-LLDYLTR.2y6_1.heavy 519.309 / 780.425 58224.0 40.63159942626953 50 20 10 10 10 19.57552199726866 5.108420608857983 0.0 3 0.9957915730944279 19.0173522063266 58224.0 152.62654213903943 0.0 - - - - - - - 210.9 116 10 RGL1 ral guanine nucleotide dissociation stimulator-like 1 671 86 C20140610_SFK040_01 C20140610_SFK040_01 TB562524.[MT7]-LATDLR.2y4_1.heavy 416.754 / 504.278 22756.0 25.680299758911133 43 17 10 10 6 5.0646731648427 19.74461070739316 0.0 6 0.9757136765119718 7.903120263871277 22756.0 20.60829127803855 2.0 - - - - - - - 1818.8 315 10 SPAG5 sperm associated antigen 5 673 86 C20140610_SFK040_01 C20140610_SFK040_01 TB562524.[MT7]-LATDLR.2b3_1.heavy 416.754 / 430.278 38521.0 25.680299758911133 43 17 10 10 6 5.0646731648427 19.74461070739316 0.0 6 0.9757136765119718 7.903120263871277 38521.0 13.732441673810316 4.0 - - - - - - - 1926.0 96 1 SPAG5 sperm associated antigen 5 675 86 C20140610_SFK040_01 C20140610_SFK040_01 TB562524.[MT7]-LATDLR.2y5_1.heavy 416.754 / 575.315 181976.0 25.680299758911133 43 17 10 10 6 5.0646731648427 19.74461070739316 0.0 6 0.9757136765119718 7.903120263871277 181976.0 69.78609468362188 0.0 - - - - - - - 1364.25 363 8 SPAG5 sperm associated antigen 5 677 86 C20140610_SFK040_01 C20140610_SFK040_01 TB562524.[MT7]-LATDLR.2b4_1.heavy 416.754 / 545.305 965589.0 25.680299758911133 43 17 10 10 6 5.0646731648427 19.74461070739316 0.0 6 0.9757136765119718 7.903120263871277 965589.0 473.0503005139225 0.0 - - - - - - - 927.0 1931 1 SPAG5 sperm associated antigen 5 679 87 C20140610_SFK040_01 C20140610_SFK040_01 TB563596.[MT7]-QIIVDPLSFSEER.2y8_1.heavy 838.952 / 964.473 93830.0 41.79059982299805 46 16 10 10 10 4.271841517616249 23.409108129976108 0.0 3 0.962652012001329 6.366016269603293 93830.0 146.89469885923927 0.0 - - - - - - - 781.2857142857143 187 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 681 87 C20140610_SFK040_01 C20140610_SFK040_01 TB563596.[MT7]-QIIVDPLSFSEER.2y9_1.heavy 838.952 / 1079.5 23575.0 41.79059982299805 46 16 10 10 10 4.271841517616249 23.409108129976108 0.0 3 0.962652012001329 6.366016269603293 23575.0 31.58459595959596 0.0 - - - - - - - 716.7 47 10 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 683 87 C20140610_SFK040_01 C20140610_SFK040_01 TB563596.[MT7]-QIIVDPLSFSEER.2y10_1.heavy 838.952 / 1178.57 19049.0 41.79059982299805 46 16 10 10 10 4.271841517616249 23.409108129976108 0.0 3 0.962652012001329 6.366016269603293 19049.0 65.81786607601438 0.0 - - - - - - - 695.375 38 8 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 685 87 C20140610_SFK040_01 C20140610_SFK040_01 TB563596.[MT7]-QIIVDPLSFSEER.2b5_1.heavy 838.952 / 713.431 33854.0 41.79059982299805 46 16 10 10 10 4.271841517616249 23.409108129976108 0.0 3 0.962652012001329 6.366016269603293 33854.0 58.62122290989048 0.0 - - - - - - - 714.0 67 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 687 88 C20140610_SFK040_01 C20140610_SFK040_01 TB563590.[MT7]-EVNDTLLVNELK[MT7].3b6_1.heavy 558.989 / 816.422 110698.0 37.856300354003906 42 12 10 10 10 0.9081219528168135 63.14196757901119 0.0 3 0.8995582540628945 3.8610131513588692 110698.0 247.04575680251264 0.0 - - - - - - - 749.0 221 7 POSTN periostin, osteoblast specific factor 689 88 C20140610_SFK040_01 C20140610_SFK040_01 TB563590.[MT7]-EVNDTLLVNELK[MT7].3b4_1.heavy 558.989 / 602.29 75130.0 37.856300354003906 42 12 10 10 10 0.9081219528168135 63.14196757901119 0.0 3 0.8995582540628945 3.8610131513588692 75130.0 61.92032967032967 0.0 - - - - - - - 1800.5714285714287 150 7 POSTN periostin, osteoblast specific factor 691 88 C20140610_SFK040_01 C20140610_SFK040_01 TB563590.[MT7]-EVNDTLLVNELK[MT7].3y4_1.heavy 558.989 / 647.385 163114.0 37.856300354003906 42 12 10 10 10 0.9081219528168135 63.14196757901119 0.0 3 0.8995582540628945 3.8610131513588692 163114.0 119.82020898112873 0.0 - - - - - - - 250.0 326 1 POSTN periostin, osteoblast specific factor 693 88 C20140610_SFK040_01 C20140610_SFK040_01 TB563590.[MT7]-EVNDTLLVNELK[MT7].3y5_1.heavy 558.989 / 746.453 61277.0 37.856300354003906 42 12 10 10 10 0.9081219528168135 63.14196757901119 0.0 3 0.8995582540628945 3.8610131513588692 61277.0 97.65576190860372 0.0 - - - - - - - 748.7142857142857 122 7 POSTN periostin, osteoblast specific factor 695 89 C20140610_SFK040_01 C20140610_SFK040_01 TB458512.[MT7]-QIIVDPLSFSEER.3y6_1.heavy 559.637 / 754.337 52697.0 41.799875259399414 46 20 10 6 10 6.636151984915314 15.068973740702555 0.03710174560546875 3 0.9926812102074781 14.417086393669695 52697.0 86.15638637177649 0.0 - - - - - - - 760.2857142857143 105 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 697 89 C20140610_SFK040_01 C20140610_SFK040_01 TB458512.[MT7]-QIIVDPLSFSEER.3b5_1.heavy 559.637 / 713.431 50690.0 41.799875259399414 46 20 10 6 10 6.636151984915314 15.068973740702555 0.03710174560546875 3 0.9926812102074781 14.417086393669695 50690.0 40.37770773638968 0.0 - - - - - - - 2156.285714285714 101 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 699 89 C20140610_SFK040_01 C20140610_SFK040_01 TB458512.[MT7]-QIIVDPLSFSEER.3y4_1.heavy 559.637 / 520.236 21463.0 41.799875259399414 46 20 10 6 10 6.636151984915314 15.068973740702555 0.03710174560546875 3 0.9926812102074781 14.417086393669695 21463.0 18.769166641682478 0.0 - - - - - - - 1202.0 42 9 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 701 89 C20140610_SFK040_01 C20140610_SFK040_01 TB458512.[MT7]-QIIVDPLSFSEER.3y5_1.heavy 559.637 / 667.305 18758.0 41.799875259399414 46 20 10 6 10 6.636151984915314 15.068973740702555 0.03710174560546875 3 0.9926812102074781 14.417086393669695 18758.0 34.60577781757402 0.0 - - - - - - - 708.625 37 8 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 703 90 C20140610_SFK040_01 C20140610_SFK040_01 TB562522.[MT7]-LLEQEG.2b4_1.heavy 416.73 / 628.379 62229.0 28.404150009155273 38 18 4 6 10 9.028813290231607 11.075652667243803 0.038299560546875 3 0.9813743891574507 9.028814084281594 62229.0 62.26832231238402 1.0 - - - - - - - 259.25 359 4 EXOSC2 exosome component 2 705 90 C20140610_SFK040_01 C20140610_SFK040_01 TB562522.[MT7]-LLEQEG.2b3_1.heavy 416.73 / 500.32 97060.0 28.404150009155273 38 18 4 6 10 9.028813290231607 11.075652667243803 0.038299560546875 3 0.9813743891574507 9.028814084281594 97060.0 105.73817362903465 0.0 - - - - - - - 259.0 194 1 EXOSC2 exosome component 2 707 91 C20140610_SFK040_01 C20140610_SFK040_01 TB562523.[MT7]-TLAVER.2y4_1.heavy 416.754 / 474.267 96144.0 21.773500442504883 46 16 10 10 10 3.5549613692491833 28.129700892114123 0.0 3 0.9629784234588111 6.394194930216984 96144.0 32.87095691087983 1.0 - - - - - - - 2755.0 192 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 709 91 C20140610_SFK040_01 C20140610_SFK040_01 TB562523.[MT7]-TLAVER.2b3_1.heavy 416.754 / 430.278 120437.0 21.773500442504883 46 16 10 10 10 3.5549613692491833 28.129700892114123 0.0 3 0.9629784234588111 6.394194930216984 120437.0 36.682385982371315 0.0 - - - - - - - 2264.5 240 2 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 711 91 C20140610_SFK040_01 C20140610_SFK040_01 TB562523.[MT7]-TLAVER.2y5_1.heavy 416.754 / 587.351 231541.0 21.773500442504883 46 16 10 10 10 3.5549613692491833 28.129700892114123 0.0 3 0.9629784234588111 6.394194930216984 231541.0 261.19124192223444 0.0 - - - - - - - 1745.0 463 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 713 91 C20140610_SFK040_01 C20140610_SFK040_01 TB562523.[MT7]-TLAVER.2b4_1.heavy 416.754 / 529.347 92506.0 21.773500442504883 46 16 10 10 10 3.5549613692491833 28.129700892114123 0.0 3 0.9629784234588111 6.394194930216984 92506.0 65.45600045367432 0.0 - - - - - - - 480.0 185 1 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 715 92 C20140610_SFK040_01 C20140610_SFK040_01 TB563391.[MT7]-GDGPIC[CAM]LVLAPTR.3y7_1.heavy 504.949 / 769.493 6433.0 39.5306510925293 45 20 10 5 10 7.165977949727286 13.954829431732438 0.04290008544921875 3 0.9906514103118443 12.754117161829187 6433.0 11.422852473278647 0.0 - - - - - - - 208.375 12 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 717 92 C20140610_SFK040_01 C20140610_SFK040_01 TB563391.[MT7]-GDGPIC[CAM]LVLAPTR.3b6_1.heavy 504.949 / 744.347 9650.0 39.5306510925293 45 20 10 5 10 7.165977949727286 13.954829431732438 0.04290008544921875 3 0.9906514103118443 12.754117161829187 9650.0 19.530619133913024 0.0 - - - - - - - 208.375 19 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 719 92 C20140610_SFK040_01 C20140610_SFK040_01 TB563391.[MT7]-GDGPIC[CAM]LVLAPTR.3b5_1.heavy 504.949 / 584.316 23231.0 39.5306510925293 45 20 10 5 10 7.165977949727286 13.954829431732438 0.04290008544921875 3 0.9906514103118443 12.754117161829187 23231.0 53.40447864551556 0.0 - - - - - - - 289.2857142857143 46 7 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 721 92 C20140610_SFK040_01 C20140610_SFK040_01 TB563391.[MT7]-GDGPIC[CAM]LVLAPTR.3y5_1.heavy 504.949 / 557.341 35382.0 39.5306510925293 45 20 10 5 10 7.165977949727286 13.954829431732438 0.04290008544921875 3 0.9906514103118443 12.754117161829187 35382.0 38.049922108457636 0.0 - - - - - - - 357.0 70 4 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 723 93 C20140610_SFK040_01 C20140610_SFK040_01 TB562727.[MT7]-EYAQVFR.2b3_1.heavy 528.783 / 508.252 11621.0 29.572599411010742 48 18 10 10 10 6.3626681666948075 15.716676931770063 0.0 3 0.9809324327166243 8.92323278161968 11621.0 5.425162723041986 3.0 - - - - - - - 2331.0 39 3 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 725 93 C20140610_SFK040_01 C20140610_SFK040_01 TB562727.[MT7]-EYAQVFR.2y5_1.heavy 528.783 / 620.352 20583.0 29.572599411010742 48 18 10 10 10 6.3626681666948075 15.716676931770063 0.0 3 0.9809324327166243 8.92323278161968 20583.0 7.438511341422596 0.0 - - - - - - - 196.5 41 2 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 727 93 C20140610_SFK040_01 C20140610_SFK040_01 TB562727.[MT7]-EYAQVFR.2b4_1.heavy 528.783 / 636.311 22257.0 29.572599411010742 48 18 10 10 10 6.3626681666948075 15.716676931770063 0.0 3 0.9809324327166243 8.92323278161968 22257.0 20.39261649598916 0.0 - - - - - - - 320.0 44 4 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 729 93 C20140610_SFK040_01 C20140610_SFK040_01 TB562727.[MT7]-EYAQVFR.2y6_1.heavy 528.783 / 783.415 40082.0 29.572599411010742 48 18 10 10 10 6.3626681666948075 15.716676931770063 0.0 3 0.9809324327166243 8.92323278161968 40082.0 162.31434018755917 0.0 - - - - - - - 251.55555555555554 80 9 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 731 94 C20140610_SFK040_01 C20140610_SFK040_01 TB458149.[MT7]-LSLLIR.2y4_1.heavy 429.798 / 514.371 59566.0 38.801300048828125 48 18 10 10 10 2.5867133523455017 30.145393461323696 0.0 3 0.9824643667213879 9.306040892555242 59566.0 89.53485832471561 0.0 - - - - - - - 332.25 119 4 FES feline sarcoma oncogene 733 94 C20140610_SFK040_01 C20140610_SFK040_01 TB458149.[MT7]-LSLLIR.2b3_1.heavy 429.798 / 458.31 180994.0 38.801300048828125 48 18 10 10 10 2.5867133523455017 30.145393461323696 0.0 3 0.9824643667213879 9.306040892555242 180994.0 379.56799116997786 0.0 - - - - - - - 338.2 361 5 FES feline sarcoma oncogene 735 94 C20140610_SFK040_01 C20140610_SFK040_01 TB458149.[MT7]-LSLLIR.2y5_1.heavy 429.798 / 601.403 330694.0 38.801300048828125 48 18 10 10 10 2.5867133523455017 30.145393461323696 0.0 3 0.9824643667213879 9.306040892555242 330694.0 1187.008321573243 0.0 - - - - - - - 221.5 661 6 FES feline sarcoma oncogene 737 94 C20140610_SFK040_01 C20140610_SFK040_01 TB458149.[MT7]-LSLLIR.2b4_1.heavy 429.798 / 571.394 181236.0 38.801300048828125 48 18 10 10 10 2.5867133523455017 30.145393461323696 0.0 3 0.9824643667213879 9.306040892555242 181236.0 106.92644208666043 1.0 - - - - - - - 241.75 387 4 FES feline sarcoma oncogene 739 95 C20140610_SFK040_01 C20140610_SFK040_01 TB458281.[MT7]-TIQQENPR.2y4_1.heavy 565.308 / 515.257 N/A 17.53233273824056 46 20 10 6 10 5.876754150831437 17.016195919281753 0.030500411987304688 3 0.9945610026391654 16.726531981851128 3110.0 2.1089187595513685 1.0 - - - - - - - 733.5 6 14 TRIOBP TRIO and F-actin binding protein 741 95 C20140610_SFK040_01 C20140610_SFK040_01 TB458281.[MT7]-TIQQENPR.2y5_1.heavy 565.308 / 643.316 4346.0 17.53233273824056 46 20 10 6 10 5.876754150831437 17.016195919281753 0.030500411987304688 3 0.9945610026391654 16.726531981851128 4346.0 17.609114044357185 0.0 - - - - - - - 210.73684210526315 8 19 TRIOBP TRIO and F-actin binding protein 743 95 C20140610_SFK040_01 C20140610_SFK040_01 TB458281.[MT7]-TIQQENPR.2b5_1.heavy 565.308 / 744.401 1875.0 17.53233273824056 46 20 10 6 10 5.876754150831437 17.016195919281753 0.030500411987304688 3 0.9945610026391654 16.726531981851128 1875.0 9.195974970054934 0.0 - - - - - - - 191.83333333333334 3 24 TRIOBP TRIO and F-actin binding protein 745 95 C20140610_SFK040_01 C20140610_SFK040_01 TB458281.[MT7]-TIQQENPR.2y7_1.heavy 565.308 / 884.458 8095.0 17.53233273824056 46 20 10 6 10 5.876754150831437 17.016195919281753 0.030500411987304688 3 0.9945610026391654 16.726531981851128 8095.0 117.6565096507353 0.0 - - - - - - - 132.2 16 20 TRIOBP TRIO and F-actin binding protein 747 96 C20140610_SFK040_01 C20140610_SFK040_01 TB562722.[MT7]-TTVSQESR.2y5_1.heavy 526.279 / 606.284 18752.0 14.784500122070312 47 17 10 10 10 2.9580743483933967 33.80577640122956 0.0 3 0.9758979704104102 7.933400887031572 18752.0 66.3144812262891 0.0 - - - - - - - 157.14285714285714 37 21 SPAG5 sperm associated antigen 5 749 96 C20140610_SFK040_01 C20140610_SFK040_01 TB562722.[MT7]-TTVSQESR.2b6_1.heavy 526.279 / 790.406 10466.0 14.784500122070312 47 17 10 10 10 2.9580743483933967 33.80577640122956 0.0 3 0.9758979704104102 7.933400887031572 10466.0 126.38487878787879 0.0 - - - - - - - 76.0 20 14 SPAG5 sperm associated antigen 5 751 96 C20140610_SFK040_01 C20140610_SFK040_01 TB562722.[MT7]-TTVSQESR.2y6_1.heavy 526.279 / 705.353 8940.0 14.784500122070312 47 17 10 10 10 2.9580743483933967 33.80577640122956 0.0 3 0.9758979704104102 7.933400887031572 8940.0 76.94371884346958 0.0 - - - - - - - 107.85714285714286 17 21 SPAG5 sperm associated antigen 5 753 96 C20140610_SFK040_01 C20140610_SFK040_01 TB562722.[MT7]-TTVSQESR.2y7_1.heavy 526.279 / 806.4 24830.0 14.784500122070312 47 17 10 10 10 2.9580743483933967 33.80577640122956 0.0 3 0.9758979704104102 7.933400887031572 24830.0 101.12092391304347 0.0 - - - - - - - 124.94736842105263 49 19 SPAG5 sperm associated antigen 5 755 97 C20140610_SFK040_01 C20140610_SFK040_01 TB562812.[MT7]-SSTSQISLR.2y8_1.heavy 561.815 / 891.489 28117.0 23.65180015563965 47 17 10 10 10 3.0781714516602525 27.638983282590658 0.0 3 0.9731679335553177 7.517257238219533 28117.0 53.38593655064664 0.0 - - - - - - - 267.9375 56 16 PCNX pecanex homolog (Drosophila) 757 97 C20140610_SFK040_01 C20140610_SFK040_01 TB562812.[MT7]-SSTSQISLR.2y6_1.heavy 561.815 / 703.41 10895.0 23.65180015563965 47 17 10 10 10 3.0781714516602525 27.638983282590658 0.0 3 0.9731679335553177 7.517257238219533 10895.0 9.443309775789345 0.0 - - - - - - - 761.5 21 12 PCNX pecanex homolog (Drosophila) 759 97 C20140610_SFK040_01 C20140610_SFK040_01 TB562812.[MT7]-SSTSQISLR.2b5_1.heavy 561.815 / 635.312 9911.0 23.65180015563965 47 17 10 10 10 3.0781714516602525 27.638983282590658 0.0 3 0.9731679335553177 7.517257238219533 9911.0 16.347380336351875 0.0 - - - - - - - 808.375 19 8 PCNX pecanex homolog (Drosophila) 761 97 C20140610_SFK040_01 C20140610_SFK040_01 TB562812.[MT7]-SSTSQISLR.2y7_1.heavy 561.815 / 804.457 8365.0 23.65180015563965 47 17 10 10 10 3.0781714516602525 27.638983282590658 0.0 3 0.9731679335553177 7.517257238219533 8365.0 11.961349349664824 0.0 - - - - - - - 765.4444444444445 16 9 PCNX pecanex homolog (Drosophila) 763 98 C20140610_SFK040_01 C20140610_SFK040_01 TB458518.[MT7]-FYGDDPQSSPNLGR.2y5_1.heavy 848.906 / 556.32 21593.0 28.538299560546875 47 17 10 10 10 3.9731987903285932 25.168637482578553 0.0 3 0.9735379781829422 7.569871117194645 21593.0 54.08067918992496 0.0 - - - - - - - 218.11111111111111 43 9 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 765 98 C20140610_SFK040_01 C20140610_SFK040_01 TB458518.[MT7]-FYGDDPQSSPNLGR.2y9_1.heavy 848.906 / 955.496 185715.0 28.538299560546875 47 17 10 10 10 3.9731987903285932 25.168637482578553 0.0 3 0.9735379781829422 7.569871117194645 185715.0 629.221118485232 0.0 - - - - - - - 221.7 371 10 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 767 98 C20140610_SFK040_01 C20140610_SFK040_01 TB458518.[MT7]-FYGDDPQSSPNLGR.2b5_1.heavy 848.906 / 742.316 112999.0 28.538299560546875 47 17 10 10 10 3.9731987903285932 25.168637482578553 0.0 3 0.9735379781829422 7.569871117194645 112999.0 228.12147987098902 0.0 - - - - - - - 246.44444444444446 225 9 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 769 98 C20140610_SFK040_01 C20140610_SFK040_01 TB458518.[MT7]-FYGDDPQSSPNLGR.2y7_1.heavy 848.906 / 730.384 7767.0 28.538299560546875 47 17 10 10 10 3.9731987903285932 25.168637482578553 0.0 3 0.9735379781829422 7.569871117194645 7767.0 16.050947108345536 0.0 - - - - - - - 725.375 15 8 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 771 99 C20140610_SFK040_01 C20140610_SFK040_01 TB563100.[MT7]-WNLDELPK[MT7].2b3_1.heavy 651.868 / 558.316 N/A 36.963401794433594 47 17 10 10 10 3.181379235083236 31.432907745556356 0.0 3 0.9776767061880735 8.244645717383534 15029.0 2.6352029912463237 3.0 - - - - - - - 764.0 31 1 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 773 99 C20140610_SFK040_01 C20140610_SFK040_01 TB563100.[MT7]-WNLDELPK[MT7].2b5_1.heavy 651.868 / 802.385 16175.0 36.963401794433594 47 17 10 10 10 3.181379235083236 31.432907745556356 0.0 3 0.9776767061880735 8.244645717383534 16175.0 20.32061898460552 0.0 - - - - - - - 691.5714285714286 32 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 775 99 C20140610_SFK040_01 C20140610_SFK040_01 TB563100.[MT7]-WNLDELPK[MT7].2b4_1.heavy 651.868 / 673.343 19486.0 36.963401794433594 47 17 10 10 10 3.181379235083236 31.432907745556356 0.0 3 0.9776767061880735 8.244645717383534 19486.0 21.77723627022328 0.0 - - - - - - - 382.0 38 2 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 777 99 C20140610_SFK040_01 C20140610_SFK040_01 TB563100.[MT7]-WNLDELPK[MT7].2y7_1.heavy 651.868 / 972.548 12609.0 36.963401794433594 47 17 10 10 10 3.181379235083236 31.432907745556356 0.0 3 0.9776767061880735 8.244645717383534 12609.0 21.706251422717962 0.0 - - - - - - - 673.1428571428571 25 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 779 100 C20140610_SFK040_01 C20140610_SFK040_01 TB562725.[MT7]-GYSSLLK[MT7].2y4_1.heavy 528.321 / 604.415 5051.0 30.083599090576172 32 16 0 10 6 4.140449555120739 24.151966753543483 0.0 5 0.9629486886904263 6.3916125941687545 5051.0 8.390795802475598 3.0 - - - - - - - 1251.7142857142858 11 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 781 100 C20140610_SFK040_01 C20140610_SFK040_01 TB562725.[MT7]-GYSSLLK[MT7].2y5_1.heavy 528.321 / 691.447 11442.0 30.083599090576172 32 16 0 10 6 4.140449555120739 24.151966753543483 0.0 5 0.9629486886904263 6.3916125941687545 11442.0 12.45006782801047 1.0 - - - - - - - 329.6 95 5 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 783 100 C20140610_SFK040_01 C20140610_SFK040_01 TB562725.[MT7]-GYSSLLK[MT7].2b4_1.heavy 528.321 / 539.258 8143.0 30.083599090576172 32 16 0 10 6 4.140449555120739 24.151966753543483 0.0 5 0.9629486886904263 6.3916125941687545 8143.0 11.58460765405707 0.0 - - - - - - - 1764.875 16 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 785 100 C20140610_SFK040_01 C20140610_SFK040_01 TB562725.[MT7]-GYSSLLK[MT7].2y6_1.heavy 528.321 / 854.51 3299.0 30.083599090576172 32 16 0 10 6 4.140449555120739 24.151966753543483 0.0 5 0.9629486886904263 6.3916125941687545 3299.0 8.352854959858547 2.0 - - - - - - - 670.125 7 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 787 101 C20140610_SFK040_01 C20140610_SFK040_01 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 1083390.0 22.538299560546875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1083390.0 584.4765577706439 0.0 - - - - - - - 835.9230769230769 2166 13 789 101 C20140610_SFK040_01 C20140610_SFK040_01 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 1531490.0 22.538299560546875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1531490.0 1369.6759784330052 0.0 - - - - - - - 259.27777777777777 3062 18 791 101 C20140610_SFK040_01 C20140610_SFK040_01 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 4663760.0 22.538299560546875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 4663760.0 7314.994566495451 0.0 - - - - - - - 284.0769230769231 9327 13 793 102 C20140610_SFK040_01 C20140610_SFK040_01 TB563598.[MT7]-TRYIGEVGDIVVGR.3b9_2.heavy 559.985 / 568.297 143792.0 34.087799072265625 45 15 10 10 10 2.803954478845286 28.428031300751563 0.0 3 0.9586937876204977 6.051294785273929 143792.0 116.81594804969278 0.0 - - - - - - - 363.0 287 4 EXOSC2 exosome component 2 795 102 C20140610_SFK040_01 C20140610_SFK040_01 TB563598.[MT7]-TRYIGEVGDIVVGR.3y7_1.heavy 559.985 / 715.41 155653.0 34.087799072265625 45 15 10 10 10 2.803954478845286 28.428031300751563 0.0 3 0.9586937876204977 6.051294785273929 155653.0 131.14644745090226 0.0 - - - - - - - 968.0 311 1 EXOSC2 exosome component 2 797 102 C20140610_SFK040_01 C20140610_SFK040_01 TB563598.[MT7]-TRYIGEVGDIVVGR.3b6_1.heavy 559.985 / 864.47 79400.0 34.087799072265625 45 15 10 10 10 2.803954478845286 28.428031300751563 0.0 3 0.9586937876204977 6.051294785273929 79400.0 130.9271940181031 0.0 - - - - - - - 242.0 158 6 EXOSC2 exosome component 2 799 102 C20140610_SFK040_01 C20140610_SFK040_01 TB563598.[MT7]-TRYIGEVGDIVVGR.3y5_1.heavy 559.985 / 543.361 112685.0 34.087799072265625 45 15 10 10 10 2.803954478845286 28.428031300751563 0.0 3 0.9586937876204977 6.051294785273929 112685.0 50.481029527373884 0.0 - - - - - - - 968.0 225 1 EXOSC2 exosome component 2 801 103 C20140610_SFK040_01 C20140610_SFK040_01 TB562721.[MT7]-LEELEK[MT7].2y4_1.heavy 524.81 / 662.384 11626.0 27.798900604248047 50 20 10 10 10 10.315246287442356 9.69438801686574 0.0 3 0.9962527804405613 20.154502852175778 11626.0 4.73195692078812 0.0 - - - - - - - 824.3333333333334 23 3 GTPBP4;CCDC87;SPG11 GTP binding protein 4;coiled-coil domain containing 87;spastic paraplegia 11 (autosomal recessive) 803 103 C20140610_SFK040_01 C20140610_SFK040_01 TB562721.[MT7]-LEELEK[MT7].2b3_1.heavy 524.81 / 516.279 N/A 27.798900604248047 50 20 10 10 10 10.315246287442356 9.69438801686574 0.0 3 0.9962527804405613 20.154502852175778 16326.0 2.063157894736842 2.0 - - - - - - - 2721.0 34 2 GTPBP4;CCDC87;SPG11 GTP binding protein 4;coiled-coil domain containing 87;spastic paraplegia 11 (autosomal recessive) 805 103 C20140610_SFK040_01 C20140610_SFK040_01 TB562721.[MT7]-LEELEK[MT7].2y5_1.heavy 524.81 / 791.427 15007.0 27.798900604248047 50 20 10 10 10 10.315246287442356 9.69438801686574 0.0 3 0.9962527804405613 20.154502852175778 15007.0 12.566032566708266 0.0 - - - - - - - 379.2 30 5 GTPBP4;CCDC87;SPG11 GTP binding protein 4;coiled-coil domain containing 87;spastic paraplegia 11 (autosomal recessive) 807 103 C20140610_SFK040_01 C20140610_SFK040_01 TB562721.[MT7]-LEELEK[MT7].2y3_1.heavy 524.81 / 533.341 12533.0 27.798900604248047 50 20 10 10 10 10.315246287442356 9.69438801686574 0.0 3 0.9962527804405613 20.154502852175778 12533.0 4.833418106650696 0.0 - - - - - - - 989.0 25 1 GTPBP4;CCDC87;SPG11 GTP binding protein 4;coiled-coil domain containing 87;spastic paraplegia 11 (autosomal recessive) 809 104 C20140610_SFK040_01 C20140610_SFK040_01 TB458520.[MT7]-GNLVYIIDFGLAK[MT7].3b6_1.heavy 571.006 / 804.474 14833.0 48.55002498626709 41 15 10 6 10 2.067013308676562 41.147404300951735 0.034099578857421875 3 0.9556675745313504 5.8396118004000455 14833.0 37.53739052494831 0.0 - - - - - - - 189.94117647058823 29 17 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 811 104 C20140610_SFK040_01 C20140610_SFK040_01 TB458520.[MT7]-GNLVYIIDFGLAK[MT7].3b4_1.heavy 571.006 / 528.326 47495.0 48.55002498626709 41 15 10 6 10 2.067013308676562 41.147404300951735 0.034099578857421875 3 0.9556675745313504 5.8396118004000455 47495.0 88.6363354966615 0.0 - - - - - - - 719.5 94 8 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 813 104 C20140610_SFK040_01 C20140610_SFK040_01 TB458520.[MT7]-GNLVYIIDFGLAK[MT7].3b5_1.heavy 571.006 / 691.39 36592.0 48.55002498626709 41 15 10 6 10 2.067013308676562 41.147404300951735 0.034099578857421875 3 0.9556675745313504 5.8396118004000455 36592.0 228.24064628527228 0.0 - - - - - - - 304.1666666666667 73 12 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 815 104 C20140610_SFK040_01 C20140610_SFK040_01 TB458520.[MT7]-GNLVYIIDFGLAK[MT7].3y4_1.heavy 571.006 / 532.357 40897.0 48.55002498626709 41 15 10 6 10 2.067013308676562 41.147404300951735 0.034099578857421875 3 0.9556675745313504 5.8396118004000455 40897.0 85.06427431561649 0.0 - - - - - - - 661.8571428571429 81 7 CSNK1D;CSNK1E casein kinase 1, delta;casein kinase 1, epsilon 817 105 C20140610_SFK040_01 C20140610_SFK040_01 TB458563.[MT7]-RFSTFLSLLEAADLK[MT7].4b8_1.heavy 500.542 / 1096.63 N/A 49.2468007405599 36 10 10 6 10 1.4016763554358154 65.34929475740572 0.03150177001953125 3 0.8434618150734254 3.0776337458373684 93.0 0.0 1.0 - - - - - - - 0.0 0 0 POSTN periostin, osteoblast specific factor 819 105 C20140610_SFK040_01 C20140610_SFK040_01 TB458563.[MT7]-RFSTFLSLLEAADLK[MT7].4b5_1.heavy 500.542 / 783.427 10389.0 49.2468007405599 36 10 10 6 10 1.4016763554358154 65.34929475740572 0.03150177001953125 3 0.8434618150734254 3.0776337458373684 10389.0 85.5452299202943 0.0 - - - - - - - 145.2941176470588 20 17 POSTN periostin, osteoblast specific factor 821 105 C20140610_SFK040_01 C20140610_SFK040_01 TB458563.[MT7]-RFSTFLSLLEAADLK[MT7].4b7_1.heavy 500.542 / 983.543 7873.0 49.2468007405599 36 10 10 6 10 1.4016763554358154 65.34929475740572 0.03150177001953125 3 0.8434618150734254 3.0776337458373684 7873.0 86.16157987711213 0.0 - - - - - - - 82.61538461538461 15 13 POSTN periostin, osteoblast specific factor 823 105 C20140610_SFK040_01 C20140610_SFK040_01 TB458563.[MT7]-RFSTFLSLLEAADLK[MT7].4y3_1.heavy 500.542 / 519.326 45422.0 49.2468007405599 36 10 10 6 10 1.4016763554358154 65.34929475740572 0.03150177001953125 3 0.8434618150734254 3.0776337458373684 45422.0 137.84649532131127 0.0 - - - - - - - 217.44444444444446 90 18 POSTN periostin, osteoblast specific factor 825 106 C20140610_SFK040_01 C20140610_SFK040_01 TB562532.[MT7]-AVLMIR.2y4_1.heavy 423.771 / 532.328 13050.0 31.87147569656372 41 17 10 6 8 3.5212588834847387 22.878975383261306 0.03949928283691406 4 0.9712073354464797 7.2556087363639055 13050.0 24.667186525265123 1.0 - - - - - - - 811.6363636363636 27 11 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 827 106 C20140610_SFK040_01 C20140610_SFK040_01 TB562532.[MT7]-AVLMIR.2b3_1.heavy 423.771 / 428.299 18430.0 31.87147569656372 41 17 10 6 8 3.5212588834847387 22.878975383261306 0.03949928283691406 4 0.9712073354464797 7.2556087363639055 18430.0 16.45211151028459 1.0 - - - - - - - 1308.2857142857142 36 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 829 106 C20140610_SFK040_01 C20140610_SFK040_01 TB562532.[MT7]-AVLMIR.2y5_1.heavy 423.771 / 631.396 21063.0 31.87147569656372 41 17 10 6 8 3.5212588834847387 22.878975383261306 0.03949928283691406 4 0.9712073354464797 7.2556087363639055 21063.0 56.10668122270742 0.0 - - - - - - - 735.8571428571429 42 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 831 106 C20140610_SFK040_01 C20140610_SFK040_01 TB562532.[MT7]-AVLMIR.2b4_1.heavy 423.771 / 559.339 13050.0 31.87147569656372 41 17 10 6 8 3.5212588834847387 22.878975383261306 0.03949928283691406 4 0.9712073354464797 7.2556087363639055 13050.0 9.410837916531868 1.0 - - - - - - - 381.3333333333333 34 3 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 833 107 C20140610_SFK040_01 C20140610_SFK040_01 TB562539.[MT7]-YVLGVR.2b3_1.heavy 425.767 / 520.325 28500.0 29.87649917602539 48 18 10 10 10 4.6502254165571415 21.504333885396115 0.0 3 0.989156760269191 11.84103398438199 28500.0 9.601078427414068 1.0 - - - - - - - 202.0 368 1 FES feline sarcoma oncogene 835 107 C20140610_SFK040_01 C20140610_SFK040_01 TB562539.[MT7]-YVLGVR.2y4_1.heavy 425.767 / 444.293 90453.0 29.87649917602539 48 18 10 10 10 4.6502254165571415 21.504333885396115 0.0 3 0.989156760269191 11.84103398438199 90453.0 40.43444450854547 0.0 - - - - - - - 1314.0 180 1 FES feline sarcoma oncogene 837 107 C20140610_SFK040_01 C20140610_SFK040_01 TB562539.[MT7]-YVLGVR.2y5_1.heavy 425.767 / 543.361 169688.0 29.87649917602539 48 18 10 10 10 4.6502254165571415 21.504333885396115 0.0 3 0.989156760269191 11.84103398438199 169688.0 188.56444915997977 0.0 - - - - - - - 404.0 339 1 FES feline sarcoma oncogene 839 107 C20140610_SFK040_01 C20140610_SFK040_01 TB562539.[MT7]-YVLGVR.2b4_1.heavy 425.767 / 577.347 89948.0 29.87649917602539 48 18 10 10 10 4.6502254165571415 21.504333885396115 0.0 3 0.989156760269191 11.84103398438199 89948.0 69.59248465675324 0.0 - - - - - - - 404.0 179 1 FES feline sarcoma oncogene 841 108 C20140610_SFK040_01 C20140610_SFK040_01 TB458272.[MT7]-VLLEEQAR.2y4_1.heavy 551.323 / 503.257 88889.0 27.87529945373535 50 20 10 10 10 4.654075929189106 21.486542446122773 0.0 3 0.9905708094271313 12.699403369448145 88889.0 52.232950326324385 0.0 - - - - - - - 1710.6666666666667 177 3 DFNB31 deafness, autosomal recessive 31 843 108 C20140610_SFK040_01 C20140610_SFK040_01 TB458272.[MT7]-VLLEEQAR.2y5_1.heavy 551.323 / 632.3 149076.0 27.87529945373535 50 20 10 10 10 4.654075929189106 21.486542446122773 0.0 3 0.9905708094271313 12.699403369448145 149076.0 103.5277746026049 0.0 - - - - - - - 870.0 298 3 DFNB31 deafness, autosomal recessive 31 845 108 C20140610_SFK040_01 C20140610_SFK040_01 TB458272.[MT7]-VLLEEQAR.2y6_1.heavy 551.323 / 745.384 158469.0 27.87529945373535 50 20 10 10 10 4.654075929189106 21.486542446122773 0.0 3 0.9905708094271313 12.699403369448145 158469.0 77.43236565858535 0.0 - - - - - - - 1392.0 316 1 DFNB31 deafness, autosomal recessive 31 847 108 C20140610_SFK040_01 C20140610_SFK040_01 TB458272.[MT7]-VLLEEQAR.2y7_1.heavy 551.323 / 858.468 311894.0 27.87529945373535 50 20 10 10 10 4.654075929189106 21.486542446122773 0.0 3 0.9905708094271313 12.699403369448145 311894.0 449.5537208810498 0.0 - - - - - - - 348.0 623 2 DFNB31 deafness, autosomal recessive 31 849 109 C20140610_SFK040_01 C20140610_SFK040_01 TB562737.[MT7]-GMTSEEK[MT7].2b3_1.heavy 535.276 / 434.219 13002.0 18.464500427246094 46 20 8 10 8 3.3951779632119683 29.453537070379713 0.0 4 0.9904047356061475 12.588848875453701 13002.0 11.081810548040831 0.0 - - - - - - - 758.8571428571429 26 14 POSTN periostin, osteoblast specific factor 851 109 C20140610_SFK040_01 C20140610_SFK040_01 TB562737.[MT7]-GMTSEEK[MT7].2y4_1.heavy 535.276 / 636.332 27654.0 18.464500427246094 46 20 8 10 8 3.3951779632119683 29.453537070379713 0.0 4 0.9904047356061475 12.588848875453701 27654.0 129.80797636974398 0.0 - - - - - - - 294.25 55 16 POSTN periostin, osteoblast specific factor 853 109 C20140610_SFK040_01 C20140610_SFK040_01 TB562737.[MT7]-GMTSEEK[MT7].2y5_1.heavy 535.276 / 737.38 71996.0 18.464500427246094 46 20 8 10 8 3.3951779632119683 29.453537070379713 0.0 4 0.9904047356061475 12.588848875453701 71996.0 74.18302879870681 1.0 - - - - - - - 715.75 182 8 POSTN periostin, osteoblast specific factor 855 110 C20140610_SFK040_01 C20140610_SFK040_01 TB562736.[MT7]-ELGGC[CAM]DK[MT7].2y4_1.heavy 533.776 / 623.294 11215.0 18.481550216674805 43 17 10 6 10 2.9619873724373167 33.76111624598638 0.034099578857421875 3 0.9775364966885278 8.218778487843187 11215.0 39.74393417527746 0.0 - - - - - - - 248.94736842105263 22 19 AK5 adenylate kinase 5 857 110 C20140610_SFK040_01 C20140610_SFK040_01 TB562736.[MT7]-ELGGC[CAM]DK[MT7].2y5_1.heavy 533.776 / 680.315 34716.0 18.481550216674805 43 17 10 6 10 2.9619873724373167 33.76111624598638 0.034099578857421875 3 0.9775364966885278 8.218778487843187 34716.0 154.5444727973038 0.0 - - - - - - - 234.6875 69 16 AK5 adenylate kinase 5 859 110 C20140610_SFK040_01 C20140610_SFK040_01 TB562736.[MT7]-ELGGC[CAM]DK[MT7].2b6_1.heavy 533.776 / 776.336 27403.0 18.481550216674805 43 17 10 6 10 2.9619873724373167 33.76111624598638 0.034099578857421875 3 0.9775364966885278 8.218778487843187 27403.0 101.45880322411074 0.0 - - - - - - - 254.28571428571428 54 14 AK5 adenylate kinase 5 861 110 C20140610_SFK040_01 C20140610_SFK040_01 TB562736.[MT7]-ELGGC[CAM]DK[MT7].2y6_1.heavy 533.776 / 793.399 39885.0 18.481550216674805 43 17 10 6 10 2.9619873724373167 33.76111624598638 0.034099578857421875 3 0.9775364966885278 8.218778487843187 39885.0 329.7552265542676 0.0 - - - - - - - 597.0 79 8 AK5 adenylate kinase 5 863 111 C20140610_SFK040_01 C20140610_SFK040_01 TB562530.[MT7]-VLAQLR.2b3_1.heavy 422.28 / 428.299 83390.0 29.07550048828125 48 20 10 10 8 11.265032369454223 8.877027310738644 0.0 4 0.9920689424718875 13.848711464737047 83390.0 55.65894670475209 0.0 - - - - - - - 746.0 166 1 MYO3B;CABIN1;SEZ6L2;CP110 myosin IIIB;calcineurin binding protein 1;seizure related 6 homolog (mouse)-like 2;CP110 protein 865 111 C20140610_SFK040_01 C20140610_SFK040_01 TB562530.[MT7]-VLAQLR.2y4_1.heavy 422.28 / 487.299 179372.0 29.07550048828125 48 20 10 10 8 11.265032369454223 8.877027310738644 0.0 4 0.9920689424718875 13.848711464737047 179372.0 120.02485367670214 1.0 - - - - - - - 1399.0 358 1 MYO3B;CABIN1;SEZ6L2;CP110 myosin IIIB;calcineurin binding protein 1;seizure related 6 homolog (mouse)-like 2;CP110 protein 867 111 C20140610_SFK040_01 C20140610_SFK040_01 TB562530.[MT7]-VLAQLR.2y5_1.heavy 422.28 / 600.383 643250.0 29.07550048828125 48 20 10 10 8 11.265032369454223 8.877027310738644 0.0 4 0.9920689424718875 13.848711464737047 643250.0 287.3913555212539 1.0 - - - - - - - 699.5 1286 2 MYO3B;CABIN1;SEZ6L2;CP110 myosin IIIB;calcineurin binding protein 1;seizure related 6 homolog (mouse)-like 2;CP110 protein 869 111 C20140610_SFK040_01 C20140610_SFK040_01 TB562530.[MT7]-VLAQLR.2b4_1.heavy 422.28 / 556.357 125551.0 29.07550048828125 48 20 10 10 8 11.265032369454223 8.877027310738644 0.0 4 0.9920689424718875 13.848711464737047 125551.0 81.23179317202103 2.0 - - - - - - - 187.0 312 1 MYO3B;CABIN1;SEZ6L2;CP110 myosin IIIB;calcineurin binding protein 1;seizure related 6 homolog (mouse)-like 2;CP110 protein 871 112 C20140610_SFK040_01 C20140610_SFK040_01 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 869097.0 32.24093373616537 23 -3 10 6 10 null 0.0 0.039798736572265625 3 0.0 0.0 869097.0 1422.8551846335972 0.0 - - - - - - - 381.25 1738 4 873 112 C20140610_SFK040_01 C20140610_SFK040_01 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 755293.0 32.24093373616537 23 -3 10 6 10 null 0.0 0.039798736572265625 3 0.0 0.0 755293.0 589.6707613289342 0.0 - - - - - - - 469.0 1510 2 875 112 C20140610_SFK040_01 C20140610_SFK040_01 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 1726170.0 32.24093373616537 23 -3 10 6 10 null 0.0 0.039798736572265625 3 0.0 0.0 1726170.0 983.470811229417 0.0 - - - - - - - 587.0 3452 1 877 113 C20140610_SFK040_01 C20140610_SFK040_01 TB562733.[MT7]-FLHDNK[MT7].2b3_1.heavy 531.303 / 542.321 2068.0 21.39349937438965 34 12 4 10 8 3.6817657366997443 27.16088071633744 0.0 4 0.8897282542794004 3.6817657366997443 2068.0 5.032884650317893 2.0 - - - - - - - 741.1111111111111 14 9 CLK2 CDC-like kinase 2 879 113 C20140610_SFK040_01 C20140610_SFK040_01 TB562733.[MT7]-FLHDNK[MT7].2y5_1.heavy 531.303 / 770.428 2068.0 21.39349937438965 34 12 4 10 8 3.6817657366997443 27.16088071633744 0.0 4 0.8897282542794004 3.6817657366997443 2068.0 9.743642564977112 2.0 - - - - - - - 226.75 4 20 CLK2 CDC-like kinase 2 881 113 C20140610_SFK040_01 C20140610_SFK040_01 TB562733.[MT7]-FLHDNK[MT7].2y3_1.heavy 531.303 / 520.285 N/A 21.39349937438965 34 12 4 10 8 3.6817657366997443 27.16088071633744 0.0 4 0.8897282542794004 3.6817657366997443 3736.0 3.173389497100837 3.0 - - - - - - - 1734.5714285714287 7 7 CLK2 CDC-like kinase 2 883 114 C20140610_SFK040_01 C20140610_SFK040_01 TB562904.[MT7]-IVAEC[CAM]NAVR.2y8_1.heavy 588.32 / 918.446 57098.0 24.097000122070312 50 20 10 10 10 9.890376840099625 10.110838203308814 0.0 3 0.9944925504666878 16.62216480123771 57098.0 93.6757158334623 0.0 - - - - - - - 704.5384615384615 114 13 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 885 114 C20140610_SFK040_01 C20140610_SFK040_01 TB562904.[MT7]-IVAEC[CAM]NAVR.2y5_1.heavy 588.32 / 619.298 11292.0 24.097000122070312 50 20 10 10 10 9.890376840099625 10.110838203308814 0.0 3 0.9944925504666878 16.62216480123771 11292.0 25.44676056338028 0.0 - - - - - - - 775.0833333333334 22 12 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 887 114 C20140610_SFK040_01 C20140610_SFK040_01 TB562904.[MT7]-IVAEC[CAM]NAVR.2y6_1.heavy 588.32 / 748.341 12286.0 24.097000122070312 50 20 10 10 10 9.890376840099625 10.110838203308814 0.0 3 0.9944925504666878 16.62216480123771 12286.0 37.20408450704225 0.0 - - - - - - - 659.2857142857143 24 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 889 114 C20140610_SFK040_01 C20140610_SFK040_01 TB562904.[MT7]-IVAEC[CAM]NAVR.2y7_1.heavy 588.32 / 819.378 28478.0 24.097000122070312 50 20 10 10 10 9.890376840099625 10.110838203308814 0.0 3 0.9944925504666878 16.62216480123771 28478.0 97.11599647887324 0.0 - - - - - - - 312.4 56 20 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 891 115 C20140610_SFK040_01 C20140610_SFK040_01 TB562731.[MT7]-AVIDLNNR.2y4_1.heavy 529.807 / 516.289 146049.0 36.963401794433594 50 20 10 10 10 6.941321950791808 14.406477715472171 0.0 3 0.9956770853970404 18.763656158020503 146049.0 128.01758672137262 0.0 - - - - - - - 766.0 292 3 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 893 115 C20140610_SFK040_01 C20140610_SFK040_01 TB562731.[MT7]-AVIDLNNR.2y5_1.heavy 529.807 / 631.316 64088.0 36.963401794433594 50 20 10 10 10 6.941321950791808 14.406477715472171 0.0 3 0.9956770853970404 18.763656158020503 64088.0 70.85712173060469 0.0 - - - - - - - 255.5 128 2 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 895 115 C20140610_SFK040_01 C20140610_SFK040_01 TB562731.[MT7]-AVIDLNNR.2b4_1.heavy 529.807 / 543.326 141708.0 36.963401794433594 50 20 10 10 10 6.941321950791808 14.406477715472171 0.0 3 0.9956770853970404 18.763656158020503 141708.0 100.17573126955709 0.0 - - - - - - - 128.0 283 1 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 897 115 C20140610_SFK040_01 C20140610_SFK040_01 TB562731.[MT7]-AVIDLNNR.2y6_1.heavy 529.807 / 744.4 47108.0 36.963401794433594 50 20 10 10 10 6.941321950791808 14.406477715472171 0.0 3 0.9956770853970404 18.763656158020503 47108.0 106.64306888147439 0.0 - - - - - - - 255.2 94 5 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 899 116 C20140610_SFK040_01 C20140610_SFK040_01 TB458428.[MT7]-EAAAALVEEETR.2y8_1.heavy 716.874 / 946.484 149983.0 30.95560073852539 46 16 10 10 10 10.431945331105673 9.585939805668161 0.0 3 0.9652406195619609 6.600248364392408 149983.0 223.54760042283297 0.0 - - - - - - - 751.0 299 7 BCAS2 breast carcinoma amplified sequence 2 901 116 C20140610_SFK040_01 C20140610_SFK040_01 TB458428.[MT7]-EAAAALVEEETR.2y9_1.heavy 716.874 / 1017.52 172895.0 30.95560073852539 46 16 10 10 10 10.431945331105673 9.585939805668161 0.0 3 0.9652406195619609 6.600248364392408 172895.0 323.561425967026 0.0 - - - - - - - 796.0 345 7 BCAS2 breast carcinoma amplified sequence 2 903 116 C20140610_SFK040_01 C20140610_SFK040_01 TB458428.[MT7]-EAAAALVEEETR.2b5_1.heavy 716.874 / 558.3 182775.0 30.95560073852539 46 16 10 10 10 10.431945331105673 9.585939805668161 0.0 3 0.9652406195619609 6.600248364392408 182775.0 214.93583243626244 0.0 - - - - - - - 210.0 365 1 BCAS2 breast carcinoma amplified sequence 2 905 116 C20140610_SFK040_01 C20140610_SFK040_01 TB458428.[MT7]-EAAAALVEEETR.2y11_1.heavy 716.874 / 1159.6 138526.0 30.95560073852539 46 16 10 10 10 10.431945331105673 9.585939805668161 0.0 3 0.9652406195619609 6.600248364392408 138526.0 202.64459597126546 0.0 - - - - - - - 1366.0 277 7 BCAS2 breast carcinoma amplified sequence 2 907 117 C20140610_SFK040_01 C20140610_SFK040_01 TB458225.[MT7]-DRGFGAPR.2y5_1.heavy 510.279 / 547.299 565.0 18.823925018310547 31 17 2 6 6 5.272637916733558 18.965838652154368 0.03530120849609375 5 0.9777848546116179 8.264764864135294 565.0 0.6861488032655081 35.0 - - - - - - - 225.23076923076923 16 13 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 909 117 C20140610_SFK040_01 C20140610_SFK040_01 TB458225.[MT7]-DRGFGAPR.2b6_1.heavy 510.279 / 748.386 2570.0 18.823925018310547 31 17 2 6 6 5.272637916733558 18.965838652154368 0.03530120849609375 5 0.9777848546116179 8.264764864135294 2570.0 9.980582524271846 0.0 - - - - - - - 138.23076923076923 5 13 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 911 117 C20140610_SFK040_01 C20140610_SFK040_01 TB458225.[MT7]-DRGFGAPR.2y6_1.heavy 510.279 / 604.32 3393.0 18.823925018310547 31 17 2 6 6 5.272637916733558 18.965838652154368 0.03530120849609375 5 0.9777848546116179 8.264764864135294 3393.0 1.840542452830189 1.0 - - - - - - - 248.33333333333334 6 12 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 913 117 C20140610_SFK040_01 C20140610_SFK040_01 TB458225.[MT7]-DRGFGAPR.2b5_1.heavy 510.279 / 677.349 925.0 18.823925018310547 31 17 2 6 6 5.272637916733558 18.965838652154368 0.03530120849609375 5 0.9777848546116179 8.264764864135294 925.0 1.1460176991150441 10.0 - - - - - - - 166.91666666666666 2 12 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 915 118 C20140610_SFK040_01 C20140610_SFK040_01 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 1148100.0 26.43549919128418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1148100.0 929.8800153755577 0.0 - - - - - - - 10965.0 2296 1 917 118 C20140610_SFK040_01 C20140610_SFK040_01 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 1253790.0 26.43549919128418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1253790.0 1258.4257645569055 0.0 - - - - - - - 16484.0 2507 1 919 118 C20140610_SFK040_01 C20140610_SFK040_01 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 1825700.0 26.43549919128418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1825700.0 2579.733181740705 0.0 - - - - - - - 18471.0 3651 1 921 119 C20140610_SFK040_01 C20140610_SFK040_01 TB562976.[MT7]-TIVFVETK[MT7].3y3_1.heavy 408.92 / 521.305 124319.0 32.93960189819336 50 20 10 10 10 10.053391663071734 9.946891889960028 0.0 3 0.9983195290205905 30.101353521625246 124319.0 226.57875469267165 0.0 - - - - - - - 303.42857142857144 248 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 923 119 C20140610_SFK040_01 C20140610_SFK040_01 TB562976.[MT7]-TIVFVETK[MT7].3b4_1.heavy 408.92 / 605.378 112985.0 32.93960189819336 50 20 10 10 10 10.053391663071734 9.946891889960028 0.0 3 0.9983195290205905 30.101353521625246 112985.0 226.20937499999997 0.0 - - - - - - - 354.0 225 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 925 119 C20140610_SFK040_01 C20140610_SFK040_01 TB562976.[MT7]-TIVFVETK[MT7].3y4_1.heavy 408.92 / 620.374 21723.0 32.93960189819336 50 20 10 10 10 10.053391663071734 9.946891889960028 0.0 3 0.9983195290205905 30.101353521625246 21723.0 28.241216023254026 1.0 - - - - - - - 177.0 68 6 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 927 119 C20140610_SFK040_01 C20140610_SFK040_01 TB562976.[MT7]-TIVFVETK[MT7].3b3_1.heavy 408.92 / 458.31 277091.0 32.93960189819336 50 20 10 10 10 10.053391663071734 9.946891889960028 0.0 3 0.9983195290205905 30.101353521625246 277091.0 227.6622673896906 0.0 - - - - - - - 236.0 554 1 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 929 120 C20140610_SFK040_01 C20140610_SFK040_01 TB324478.[MT7]-FRPSLEER.3y6_1.heavy 393.22 / 730.373 54874.0 24.598499298095703 45 15 10 10 10 2.923967421207687 34.20010745492403 0.0 3 0.9511943277551924 5.563458634619295 54874.0 411.4569516655689 0.0 - - - - - - - 261.3333333333333 109 15 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 931 120 C20140610_SFK040_01 C20140610_SFK040_01 TB324478.[MT7]-FRPSLEER.3y4_1.heavy 393.22 / 546.288 52095.0 24.598499298095703 45 15 10 10 10 2.923967421207687 34.20010745492403 0.0 3 0.9511943277551924 5.563458634619295 52095.0 46.707181033708615 0.0 - - - - - - - 1240.1 104 10 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 933 120 C20140610_SFK040_01 C20140610_SFK040_01 TB324478.[MT7]-FRPSLEER.3b4_2.heavy 393.22 / 316.685 17674.0 24.598499298095703 45 15 10 10 10 2.923967421207687 34.20010745492403 0.0 3 0.9511943277551924 5.563458634619295 17674.0 12.192588949309304 2.0 - - - - - - - 1761.2857142857142 61 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 935 120 C20140610_SFK040_01 C20140610_SFK040_01 TB324478.[MT7]-FRPSLEER.3y5_1.heavy 393.22 / 633.32 44968.0 24.598499298095703 45 15 10 10 10 2.923967421207687 34.20010745492403 0.0 3 0.9511943277551924 5.563458634619295 44968.0 98.92751931319738 0.0 - - - - - - - 773.5714285714286 89 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 937 121 C20140610_SFK040_01 C20140610_SFK040_01 TB324694.[MT7]-RFSTFLSLLEAADLK[MT7].3b5_1.heavy 667.054 / 783.427 15645.0 49.24942588806152 39 13 10 6 10 1.290425719174649 44.71271570037141 0.03150177001953125 3 0.9037085570465301 3.9447584251769974 15645.0 37.86232876712329 0.0 - - - - - - - 239.85 31 20 POSTN periostin, osteoblast specific factor 939 121 C20140610_SFK040_01 C20140610_SFK040_01 TB324694.[MT7]-RFSTFLSLLEAADLK[MT7].3y4_1.heavy 667.054 / 590.363 57866.0 49.24942588806152 39 13 10 6 10 1.290425719174649 44.71271570037141 0.03150177001953125 3 0.9037085570465301 3.9447584251769974 57866.0 101.1986975674788 0.0 - - - - - - - 690.1818181818181 115 11 POSTN periostin, osteoblast specific factor 941 121 C20140610_SFK040_01 C20140610_SFK040_01 TB324694.[MT7]-RFSTFLSLLEAADLK[MT7].3y5_1.heavy 667.054 / 661.4 63123.0 49.24942588806152 39 13 10 6 10 1.290425719174649 44.71271570037141 0.03150177001953125 3 0.9037085570465301 3.9447584251769974 63123.0 87.86403603528628 0.0 - - - - - - - 741.3076923076923 126 13 POSTN periostin, osteoblast specific factor 943 121 C20140610_SFK040_01 C20140610_SFK040_01 TB324694.[MT7]-RFSTFLSLLEAADLK[MT7].3b7_1.heavy 667.054 / 983.543 28662.0 49.24942588806152 39 13 10 6 10 1.290425719174649 44.71271570037141 0.03150177001953125 3 0.9037085570465301 3.9447584251769974 28662.0 122.81696659111066 0.0 - - - - - - - 272.14285714285717 57 21 POSTN periostin, osteoblast specific factor 945 122 C20140610_SFK040_01 C20140610_SFK040_01 TB563066.[MT7]-FANLDSSVK[MT7].3b4_1.heavy 423.574 / 590.342 34621.0 29.48270034790039 48 18 10 10 10 4.768988365727752 20.968807707447596 0.0 3 0.9882284041235052 11.363647330725634 34621.0 41.54775851532729 0.0 - - - - - - - 224.5 69 4 RGL1 ral guanine nucleotide dissociation stimulator-like 1 947 122 C20140610_SFK040_01 C20140610_SFK040_01 TB563066.[MT7]-FANLDSSVK[MT7].3b5_1.heavy 423.574 / 705.369 19954.0 29.48270034790039 48 18 10 10 10 4.768988365727752 20.968807707447596 0.0 3 0.9882284041235052 11.363647330725634 19954.0 28.583386348168034 0.0 - - - - - - - 386.625 39 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 949 122 C20140610_SFK040_01 C20140610_SFK040_01 TB563066.[MT7]-FANLDSSVK[MT7].3y4_1.heavy 423.574 / 564.347 51582.0 29.48270034790039 48 18 10 10 10 4.768988365727752 20.968807707447596 0.0 3 0.9882284041235052 11.363647330725634 51582.0 35.430573459657495 0.0 - - - - - - - 365.6666666666667 103 3 RGL1 ral guanine nucleotide dissociation stimulator-like 1 951 122 C20140610_SFK040_01 C20140610_SFK040_01 TB563066.[MT7]-FANLDSSVK[MT7].3y5_1.heavy 423.574 / 679.374 10676.0 29.48270034790039 48 18 10 10 10 4.768988365727752 20.968807707447596 0.0 3 0.9882284041235052 11.363647330725634 10676.0 53.17571195903513 0.0 - - - - - - - 268.6923076923077 21 13 RGL1 ral guanine nucleotide dissociation stimulator-like 1 953 123 C20140610_SFK040_01 C20140610_SFK040_01 TB458327.[MT7]-TIVFVETK[MT7].2y4_1.heavy 612.876 / 620.374 49179.0 32.93960189819336 48 18 10 10 10 3.7999408040965617 22.791244534842452 0.0 3 0.9846612847936526 9.952018701283649 49179.0 50.71264864864865 0.0 - - - - - - - 826.5 98 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 955 123 C20140610_SFK040_01 C20140610_SFK040_01 TB458327.[MT7]-TIVFVETK[MT7].2y5_1.heavy 612.876 / 767.442 53988.0 32.93960189819336 48 18 10 10 10 3.7999408040965617 22.791244534842452 0.0 3 0.9846612847936526 9.952018701283649 53988.0 74.93069765362272 0.0 - - - - - - - 1202.2857142857142 107 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 957 123 C20140610_SFK040_01 C20140610_SFK040_01 TB458327.[MT7]-TIVFVETK[MT7].2y3_1.heavy 612.876 / 521.305 39078.0 32.93960189819336 48 18 10 10 10 3.7999408040965617 22.791244534842452 0.0 3 0.9846612847936526 9.952018701283649 39078.0 44.533733866978466 0.0 - - - - - - - 922.0 78 3 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 959 123 C20140610_SFK040_01 C20140610_SFK040_01 TB458327.[MT7]-TIVFVETK[MT7].2y6_1.heavy 612.876 / 866.51 30421.0 32.93960189819336 48 18 10 10 10 3.7999408040965617 22.791244534842452 0.0 3 0.9846612847936526 9.952018701283649 30421.0 168.7580931780366 0.0 - - - - - - - 738.4285714285714 60 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 961 124 C20140610_SFK040_01 C20140610_SFK040_01 TB563068.[MT7]-NEEENTHPR.3b4_1.heavy 423.87 / 646.28 20949.0 13.304400444030762 48 18 10 10 10 5.22619417978905 19.13438279555782 0.0 3 0.982363604952285 9.279340353191913 20949.0 129.9962508986341 0.0 - - - - - - - 185.9 41 20 FES feline sarcoma oncogene 963 124 C20140610_SFK040_01 C20140610_SFK040_01 TB563068.[MT7]-NEEENTHPR.3b5_1.heavy 423.87 / 760.323 9648.0 13.304400444030762 48 18 10 10 10 5.22619417978905 19.13438279555782 0.0 3 0.982363604952285 9.279340353191913 9648.0 99.25988897700239 0.0 - - - - - - - 91.10526315789474 19 19 FES feline sarcoma oncogene 965 124 C20140610_SFK040_01 C20140610_SFK040_01 TB563068.[MT7]-NEEENTHPR.3y4_1.heavy 423.87 / 510.278 17428.0 13.304400444030762 48 18 10 10 10 5.22619417978905 19.13438279555782 0.0 3 0.982363604952285 9.279340353191913 17428.0 36.301868941641935 0.0 - - - - - - - 728.6923076923077 34 13 FES feline sarcoma oncogene 967 124 C20140610_SFK040_01 C20140610_SFK040_01 TB563068.[MT7]-NEEENTHPR.3b3_1.heavy 423.87 / 517.237 34545.0 13.304400444030762 48 18 10 10 10 5.22619417978905 19.13438279555782 0.0 3 0.982363604952285 9.279340353191913 34545.0 80.2366655077042 0.0 - - - - - - - 686.5 69 14 FES feline sarcoma oncogene 969 125 C20140610_SFK040_01 C20140610_SFK040_01 TB563126.[MT7]-C[CAM]VVSTILGGK[MT7].2b3_1.heavy 661.391 / 503.277 23720.0 35.80400085449219 42 20 4 10 8 6.3266561255115965 15.80613803186808 0.0 4 0.9904103779193636 12.592557767350183 23720.0 10.820479491942603 0.0 - - - - - - - 1199.0 47 2 RGL1 ral guanine nucleotide dissociation stimulator-like 1 971 125 C20140610_SFK040_01 C20140610_SFK040_01 TB563126.[MT7]-C[CAM]VVSTILGGK[MT7].2y8_1.heavy 661.391 / 918.574 16150.0 35.80400085449219 42 20 4 10 8 6.3266561255115965 15.80613803186808 0.0 4 0.9904103779193636 12.592557767350183 16150.0 20.62994675369289 0.0 - - - - - - - 725.5 32 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 973 125 C20140610_SFK040_01 C20140610_SFK040_01 TB563126.[MT7]-C[CAM]VVSTILGGK[MT7].2y6_1.heavy 661.391 / 732.474 6687.0 35.80400085449219 42 20 4 10 8 6.3266561255115965 15.80613803186808 0.0 4 0.9904103779193636 12.592557767350183 6687.0 3.7711048777875584 1.0 - - - - - - - 189.0 18 2 RGL1 ral guanine nucleotide dissociation stimulator-like 1 975 125 C20140610_SFK040_01 C20140610_SFK040_01 TB563126.[MT7]-C[CAM]VVSTILGGK[MT7].2y7_1.heavy 661.391 / 819.506 19304.0 35.80400085449219 42 20 4 10 8 6.3266561255115965 15.80613803186808 0.0 4 0.9904103779193636 12.592557767350183 19304.0 15.767524768303423 2.0 - - - - - - - 1151.375 91 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 977 126 C20140610_SFK040_01 C20140610_SFK040_01 TB563571.[MT7]-IAEQVASFQEEK[MT7].3b6_1.heavy 556.301 / 756.437 12630.0 32.13650131225586 47 17 10 10 10 2.4956477567045794 32.68629088756256 0.0 3 0.9717059497328464 7.319568172273974 12630.0 14.467126406940885 1.0 - - - - - - - 331.5 27 6 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 979 126 C20140610_SFK040_01 C20140610_SFK040_01 TB563571.[MT7]-IAEQVASFQEEK[MT7].3y3_1.heavy 556.301 / 549.3 46544.0 32.13650131225586 47 17 10 10 10 2.4956477567045794 32.68629088756256 0.0 3 0.9717059497328464 7.319568172273974 46544.0 14.417360482183565 0.0 - - - - - - - 468.0 93 1 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 981 126 C20140610_SFK040_01 C20140610_SFK040_01 TB563571.[MT7]-IAEQVASFQEEK[MT7].3b4_1.heavy 556.301 / 586.332 79288.0 32.13650131225586 47 17 10 10 10 2.4956477567045794 32.68629088756256 0.0 3 0.9717059497328464 7.319568172273974 79288.0 31.440451132513342 0.0 - - - - - - - 585.0 158 2 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 983 126 C20140610_SFK040_01 C20140610_SFK040_01 TB563571.[MT7]-IAEQVASFQEEK[MT7].3b5_1.heavy 556.301 / 685.4 31341.0 32.13650131225586 47 17 10 10 10 2.4956477567045794 32.68629088756256 0.0 3 0.9717059497328464 7.319568172273974 31341.0 26.883735397865227 0.0 - - - - - - - 304.2 62 5 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 985 127 C20140610_SFK040_01 C20140610_SFK040_01 TB458425.[MT7]-SHISGIFRPK[MT7].3y3_1.heavy 477.289 / 544.369 74442.0 28.110700607299805 50 20 10 10 10 20.46401364306777 4.8866269219809295 0.0 2 0.9963652077607951 20.464019380860353 74442.0 42.54069186416898 0.0 - - - - - - - 172.0 148 1 FES feline sarcoma oncogene 987 127 C20140610_SFK040_01 C20140610_SFK040_01 TB458425.[MT7]-SHISGIFRPK[MT7].3y4_1.heavy 477.289 / 691.437 83190.0 28.110700607299805 50 20 10 10 10 20.46401364306777 4.8866269219809295 0.0 2 0.9963652077607951 20.464019380860353 83190.0 119.98338954143726 0.0 - - - - - - - 710.7142857142857 166 7 FES feline sarcoma oncogene 989 128 C20140610_SFK040_01 C20140610_SFK040_01 TB562556.[MT7]-ALHPER.2b3_1.heavy 433.752 / 466.289 12628.0 15.799099922180176 50 20 10 10 10 9.316590001310336 10.733540918505103 0.0 3 0.9958094221767839 19.057838216319002 12628.0 18.5441715197754 0.0 - - - - - - - 311.0769230769231 25 13 FAM134C family with sequence similarity 134, member C 991 128 C20140610_SFK040_01 C20140610_SFK040_01 TB562556.[MT7]-ALHPER.2y4_1.heavy 433.752 / 538.273 15970.0 15.799099922180176 50 20 10 10 10 9.316590001310336 10.733540918505103 0.0 3 0.9958094221767839 19.057838216319002 15970.0 38.63851057134284 0.0 - - - - - - - 707.2 31 10 FAM134C family with sequence similarity 134, member C 993 128 C20140610_SFK040_01 C20140610_SFK040_01 TB562556.[MT7]-ALHPER.2y5_1.heavy 433.752 / 651.357 15829.0 15.799099922180176 50 20 10 10 10 9.316590001310336 10.733540918505103 0.0 3 0.9958094221767839 19.057838216319002 15829.0 40.69525173725145 0.0 - - - - - - - 648.2857142857143 31 7 FAM134C family with sequence similarity 134, member C 995 128 C20140610_SFK040_01 C20140610_SFK040_01 TB562556.[MT7]-ALHPER.2y3_1.heavy 433.752 / 401.214 N/A 15.799099922180176 50 20 10 10 10 9.316590001310336 10.733540918505103 0.0 3 0.9958094221767839 19.057838216319002 23357.0 16.761489213240466 0.0 - - - - - - - 1809.142857142857 46 7 FAM134C family with sequence similarity 134, member C 997 129 C20140610_SFK040_01 C20140610_SFK040_01 TB563573.[MT7]-GVLSAFNFGTVPSNN.2b8_1.heavy 834.429 / 980.532 6959.0 45.961774826049805 39 16 10 3 10 3.2687658228962966 30.592586137417086 0.07850265502929688 3 0.9607342024074642 6.207600211932476 6959.0 10.290709659434793 0.0 - - - - - - - 696.6666666666666 13 9 IPO8 importin 8 999 129 C20140610_SFK040_01 C20140610_SFK040_01 TB563573.[MT7]-GVLSAFNFGTVPSNN.2b7_1.heavy 834.429 / 833.464 7899.0 45.961774826049805 39 16 10 3 10 3.2687658228962966 30.592586137417086 0.07850265502929688 3 0.9607342024074642 6.207600211932476 7899.0 9.539620779236808 1.0 - - - - - - - 320.3333333333333 15 9 IPO8 importin 8 1001 129 C20140610_SFK040_01 C20140610_SFK040_01 TB563573.[MT7]-GVLSAFNFGTVPSNN.2b5_1.heavy 834.429 / 572.352 7084.0 45.961774826049805 39 16 10 3 10 3.2687658228962966 30.592586137417086 0.07850265502929688 3 0.9607342024074642 6.207600211932476 7084.0 10.626417846647072 0.0 - - - - - - - 1230.25 14 8 IPO8 importin 8 1003 129 C20140610_SFK040_01 C20140610_SFK040_01 TB563573.[MT7]-GVLSAFNFGTVPSNN.2b4_1.heavy 834.429 / 501.315 4263.0 45.961774826049805 39 16 10 3 10 3.2687658228962966 30.592586137417086 0.07850265502929688 3 0.9607342024074642 6.207600211932476 4263.0 4.030163941637028 0.0 - - - - - - - 684.0 8 11 IPO8 importin 8 1005 130 C20140610_SFK040_01 C20140610_SFK040_01 TB562820.[MT7]-LLQLVEDR.2y5_1.heavy 565.339 / 631.341 74152.0 39.37969970703125 50 20 10 10 10 129.0460816284487 0.7749169811131609 0.0 3 0.9990203587079312 39.42696685510085 74152.0 111.53441322314049 0.0 - - - - - - - 345.7142857142857 148 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1007 130 C20140610_SFK040_01 C20140610_SFK040_01 TB562820.[MT7]-LLQLVEDR.2b4_1.heavy 565.339 / 612.42 62055.0 39.37969970703125 50 20 10 10 10 129.0460816284487 0.7749169811131609 0.0 3 0.9990203587079312 39.42696685510085 62055.0 72.04104815190959 0.0 - - - - - - - 756.25 124 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1009 130 C20140610_SFK040_01 C20140610_SFK040_01 TB562820.[MT7]-LLQLVEDR.2y6_1.heavy 565.339 / 759.399 78627.0 39.37969970703125 50 20 10 10 10 129.0460816284487 0.7749169811131609 0.0 3 0.9990203587079312 39.42696685510085 78627.0 99.76513191107694 0.0 - - - - - - - 295.77777777777777 157 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1011 130 C20140610_SFK040_01 C20140610_SFK040_01 TB562820.[MT7]-LLQLVEDR.2y7_1.heavy 565.339 / 872.484 186166.0 39.37969970703125 50 20 10 10 10 129.0460816284487 0.7749169811131609 0.0 3 0.9990203587079312 39.42696685510085 186166.0 234.14655741097084 0.0 - - - - - - - 342.8333333333333 372 6 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1013 131 C20140610_SFK040_01 C20140610_SFK040_01 TB562824.[MT7]-ITEVQQK[MT7].2y4_1.heavy 567.342 / 646.4 23684.0 21.146849632263184 44 18 10 6 10 6.076473370823533 16.456914051521167 0.03790092468261719 3 0.9888220487319129 11.662076573003889 23684.0 77.83744265648326 0.0 - - - - - - - 232.53333333333333 47 15 EXOSC2 exosome component 2 1015 131 C20140610_SFK040_01 C20140610_SFK040_01 TB562824.[MT7]-ITEVQQK[MT7].2b4_1.heavy 567.342 / 587.352 26316.0 21.146849632263184 44 18 10 6 10 6.076473370823533 16.456914051521167 0.03790092468261719 3 0.9888220487319129 11.662076573003889 26316.0 64.68854203062378 0.0 - - - - - - - 650.4444444444445 52 9 EXOSC2 exosome component 2 1017 131 C20140610_SFK040_01 C20140610_SFK040_01 TB562824.[MT7]-ITEVQQK[MT7].2y3_1.heavy 567.342 / 547.332 27303.0 21.146849632263184 44 18 10 6 10 6.076473370823533 16.456914051521167 0.03790092468261719 3 0.9888220487319129 11.662076573003889 27303.0 43.996562001679195 0.0 - - - - - - - 1644.857142857143 54 7 EXOSC2 exosome component 2 1019 131 C20140610_SFK040_01 C20140610_SFK040_01 TB562824.[MT7]-ITEVQQK[MT7].2y6_1.heavy 567.342 / 876.491 67500.0 21.146849632263184 44 18 10 6 10 6.076473370823533 16.456914051521167 0.03790092468261719 3 0.9888220487319129 11.662076573003889 67500.0 165.2473360916246 0.0 - - - - - - - 258.57142857142856 135 14 EXOSC2 exosome component 2 1021 132 C20140610_SFK040_01 C20140610_SFK040_01 TB563801.[MT7]-LMQIPDEEGIVIDGFPR.2b3_1.heavy 1037.04 / 517.292 106266.0 45.34120178222656 41 11 10 10 10 1.6468777881358787 60.720959818877176 0.0 3 0.8510796242757922 3.1574915889714106 106266.0 138.19981311950184 0.0 - - - - - - - 674.6666666666666 212 9 AK5 adenylate kinase 5 1023 132 C20140610_SFK040_01 C20140610_SFK040_01 TB563801.[MT7]-LMQIPDEEGIVIDGFPR.2y9_1.heavy 1037.04 / 973.547 11434.0 45.34120178222656 41 11 10 10 10 1.6468777881358787 60.720959818877176 0.0 3 0.8510796242757922 3.1574915889714106 11434.0 27.253173327274954 0.0 - - - - - - - 272.77777777777777 22 18 AK5 adenylate kinase 5 1025 132 C20140610_SFK040_01 C20140610_SFK040_01 TB563801.[MT7]-LMQIPDEEGIVIDGFPR.2b4_1.heavy 1037.04 / 630.377 94186.0 45.34120178222656 41 11 10 10 10 1.6468777881358787 60.720959818877176 0.0 3 0.8510796242757922 3.1574915889714106 94186.0 117.17386803150663 0.0 - - - - - - - 371.375 188 8 AK5 adenylate kinase 5 1027 132 C20140610_SFK040_01 C20140610_SFK040_01 TB563801.[MT7]-LMQIPDEEGIVIDGFPR.2y11_1.heavy 1037.04 / 1231.63 6654.0 45.34120178222656 41 11 10 10 10 1.6468777881358787 60.720959818877176 0.0 3 0.8510796242757922 3.1574915889714106 6654.0 18.20634296818611 0.0 - - - - - - - 681.7777777777778 13 9 AK5 adenylate kinase 5 1029 133 C20140610_SFK040_01 C20140610_SFK040_01 TB562822.[MT7]-LNQALC[CAM]LR.2b3_1.heavy 566.325 / 500.295 18210.0 32.21440124511719 50 20 10 10 10 4.2821214749560434 17.89340299993258 0.0 3 0.9901489109764121 12.424046821805705 18210.0 11.834331651427181 0.0 - - - - - - - 759.0 36 2 SPAG5 sperm associated antigen 5 1031 133 C20140610_SFK040_01 C20140610_SFK040_01 TB562822.[MT7]-LNQALC[CAM]LR.2y5_1.heavy 566.325 / 632.355 26031.0 32.21440124511719 50 20 10 10 10 4.2821214749560434 17.89340299993258 0.0 3 0.9901489109764121 12.424046821805705 26031.0 28.943763855683546 0.0 - - - - - - - 1152.875 52 8 SPAG5 sperm associated antigen 5 1033 133 C20140610_SFK040_01 C20140610_SFK040_01 TB562822.[MT7]-LNQALC[CAM]LR.2b4_1.heavy 566.325 / 571.332 17509.0 32.21440124511719 50 20 10 10 10 4.2821214749560434 17.89340299993258 0.0 3 0.9901489109764121 12.424046821805705 17509.0 8.000114340935493 0.0 - - - - - - - 350.0 35 1 SPAG5 sperm associated antigen 5 1035 133 C20140610_SFK040_01 C20140610_SFK040_01 TB562822.[MT7]-LNQALC[CAM]LR.2y7_1.heavy 566.325 / 874.456 61633.0 32.21440124511719 50 20 10 10 10 4.2821214749560434 17.89340299993258 0.0 3 0.9901489109764121 12.424046821805705 61633.0 94.59411723768736 0.0 - - - - - - - 717.0 123 7 SPAG5 sperm associated antigen 5 1037 134 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 544563.0 37.7692985534668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 544563.0 211.19461513429442 0.0 - - - - - - - 371.0 1089 1 1039 134 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 1511140.0 37.7692985534668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1511140.0 338.91541557384977 0.0 - - - - - - - 679.5 3022 2 1041 134 C20140610_SFK040_01 C20140610_SFK040_01 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 1239550.0 37.7692985534668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1239550.0 183.5706361316949 0.0 - - - - - - - 865.0 2479 1 1043 135 C20140610_SFK040_01 C20140610_SFK040_01 TB562828.[MT7]-AQNC[CAM]QESR.2y5_1.heavy 568.765 / 679.283 N/A N/A - - - - - - - - - 0.0 - - - - - - - CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1045 135 C20140610_SFK040_01 C20140610_SFK040_01 TB562828.[MT7]-AQNC[CAM]QESR.2b4_1.heavy 568.765 / 618.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1047 135 C20140610_SFK040_01 C20140610_SFK040_01 TB562828.[MT7]-AQNC[CAM]QESR.2y6_1.heavy 568.765 / 793.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1049 135 C20140610_SFK040_01 C20140610_SFK040_01 TB562828.[MT7]-AQNC[CAM]QESR.2y7_1.heavy 568.765 / 921.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1051 136 C20140610_SFK040_01 C20140610_SFK040_01 TB563805.[MT7]-LMQIPDEEGIVIDGFPR.3y7_1.heavy 691.698 / 803.441 93346.0 45.34120178222656 43 13 10 10 10 1.7799481229702756 44.33531964273917 0.0 3 0.9288375714843171 4.598617207233038 93346.0 94.58297870371965 0.0 - - - - - - - 788.1 186 10 AK5 adenylate kinase 5 1053 136 C20140610_SFK040_01 C20140610_SFK040_01 TB563805.[MT7]-LMQIPDEEGIVIDGFPR.3y6_1.heavy 691.698 / 704.373 106460.0 45.34120178222656 43 13 10 10 10 1.7799481229702756 44.33531964273917 0.0 3 0.9288375714843171 4.598617207233038 106460.0 103.43606348490165 0.0 - - - - - - - 807.5 212 8 AK5 adenylate kinase 5 1055 136 C20140610_SFK040_01 C20140610_SFK040_01 TB563805.[MT7]-LMQIPDEEGIVIDGFPR.3b4_1.heavy 691.698 / 630.377 204328.0 45.34120178222656 43 13 10 10 10 1.7799481229702756 44.33531964273917 0.0 3 0.9288375714843171 4.598617207233038 204328.0 103.3237564499484 0.0 - - - - - - - 1245.857142857143 408 7 AK5 adenylate kinase 5 1057 136 C20140610_SFK040_01 C20140610_SFK040_01 TB563805.[MT7]-LMQIPDEEGIVIDGFPR.3b3_1.heavy 691.698 / 517.292 125969.0 45.34120178222656 43 13 10 10 10 1.7799481229702756 44.33531964273917 0.0 3 0.9288375714843171 4.598617207233038 125969.0 71.43118240638391 0.0 - - - - - - - 785.8333333333334 251 6 AK5 adenylate kinase 5 1059 137 C20140610_SFK040_01 C20140610_SFK040_01 TB563253.[MT7]-EQNSLSLLEAR.2y8_1.heavy 702.384 / 888.515 6049.0 34.26430130004883 46 18 10 10 8 5.306411453245636 18.845127423889373 0.0 4 0.9879238898617978 11.219172286251338 6049.0 4.88161187875475 1.0 - - - - - - - 801.625 12 8 SFRS18 splicing factor, arginine/serine-rich 18 1061 137 C20140610_SFK040_01 C20140610_SFK040_01 TB563253.[MT7]-EQNSLSLLEAR.2y9_1.heavy 702.384 / 1002.56 11251.0 34.26430130004883 46 18 10 10 8 5.306411453245636 18.845127423889373 0.0 4 0.9879238898617978 11.219172286251338 11251.0 23.24586776859504 0.0 - - - - - - - 795.1428571428571 22 7 SFRS18 splicing factor, arginine/serine-rich 18 1063 137 C20140610_SFK040_01 C20140610_SFK040_01 TB563253.[MT7]-EQNSLSLLEAR.2y6_1.heavy 702.384 / 688.399 7017.0 34.26430130004883 46 18 10 10 8 5.306411453245636 18.845127423889373 0.0 4 0.9879238898617978 11.219172286251338 7017.0 1.4609493605257873 4.0 - - - - - - - 2264.0 18 7 SFRS18 splicing factor, arginine/serine-rich 18 1065 137 C20140610_SFK040_01 C20140610_SFK040_01 TB563253.[MT7]-EQNSLSLLEAR.2y10_1.heavy 702.384 / 1130.62 13186.0 34.26430130004883 46 18 10 10 8 5.306411453245636 18.845127423889373 0.0 4 0.9879238898617978 11.219172286251338 13186.0 24.540650423956208 0.0 - - - - - - - 701.8 26 10 SFRS18 splicing factor, arginine/serine-rich 18 1067 138 C20140610_SFK040_01 C20140610_SFK040_01 TB563702.[MT7]-EIPVTVYK[MT7]PIIK[MT7].4y4_1.heavy 458.796 / 614.436 156803.0 34.770198822021484 44 14 10 10 10 2.6634003502225982 37.5459889053639 0.0 3 0.9444556836313909 5.212085741974118 156803.0 80.55022127726016 0.0 - - - - - - - 124.0 313 1 POSTN periostin, osteoblast specific factor 1069 138 C20140610_SFK040_01 C20140610_SFK040_01 TB563702.[MT7]-EIPVTVYK[MT7]PIIK[MT7].4y8_2.heavy 458.796 / 625.41 82992.0 34.770198822021484 44 14 10 10 10 2.6634003502225982 37.5459889053639 0.0 3 0.9444556836313909 5.212085741974118 82992.0 263.2541935483871 0.0 - - - - - - - 744.0 165 8 POSTN periostin, osteoblast specific factor 1071 138 C20140610_SFK040_01 C20140610_SFK040_01 TB563702.[MT7]-EIPVTVYK[MT7]PIIK[MT7].4b4_1.heavy 458.796 / 583.357 65500.0 34.770198822021484 44 14 10 10 10 2.6634003502225982 37.5459889053639 0.0 3 0.9444556836313909 5.212085741974118 65500.0 104.97208792854133 0.0 - - - - - - - 730.2222222222222 131 9 POSTN periostin, osteoblast specific factor 1073 138 C20140610_SFK040_01 C20140610_SFK040_01 TB563702.[MT7]-EIPVTVYK[MT7]PIIK[MT7].4y6_2.heavy 458.796 / 525.352 119091.0 34.770198822021484 44 14 10 10 10 2.6634003502225982 37.5459889053639 0.0 3 0.9444556836313909 5.212085741974118 119091.0 54.65452052085432 1.0 - - - - - - - 1276.142857142857 244 7 POSTN periostin, osteoblast specific factor 1075 139 C20140610_SFK040_01 C20140610_SFK040_01 TB563251.[MT7]-AVLLVQIDDK[MT7].2y5_1.heavy 701.431 / 762.411 27066.0 37.41960144042969 47 17 10 10 10 4.239417715764801 23.588145048348878 0.0 3 0.9722996564896806 7.397962970067041 27066.0 20.77257004987104 0.0 - - - - - - - 250.5 54 2 PCNX pecanex homolog (Drosophila) 1077 139 C20140610_SFK040_01 C20140610_SFK040_01 TB563251.[MT7]-AVLLVQIDDK[MT7].2b4_1.heavy 701.431 / 541.383 61149.0 37.41960144042969 47 17 10 10 10 4.239417715764801 23.588145048348878 0.0 3 0.9722996564896806 7.397962970067041 61149.0 26.19687408530154 0.0 - - - - - - - 1665.142857142857 122 7 PCNX pecanex homolog (Drosophila) 1079 139 C20140610_SFK040_01 C20140610_SFK040_01 TB563251.[MT7]-AVLLVQIDDK[MT7].2y3_1.heavy 701.431 / 521.269 25813.0 37.41960144042969 47 17 10 10 10 4.239417715764801 23.588145048348878 0.0 3 0.9722996564896806 7.397962970067041 25813.0 17.632823943661972 0.0 - - - - - - - 736.125 51 8 PCNX pecanex homolog (Drosophila) 1081 139 C20140610_SFK040_01 C20140610_SFK040_01 TB563251.[MT7]-AVLLVQIDDK[MT7].2y6_1.heavy 701.431 / 861.48 43732.0 37.41960144042969 47 17 10 10 10 4.239417715764801 23.588145048348878 0.0 3 0.9722996564896806 7.397962970067041 43732.0 31.405773179829403 0.0 - - - - - - - 564.0 87 2 PCNX pecanex homolog (Drosophila) 1083 140 C20140610_SFK040_01 C20140610_SFK040_01 TB324681.[MT7]-TIVQLENEIYQIK[MT7].2y4_1.heavy 940.043 / 695.421 29446.0 44.909223556518555 41 15 10 6 10 1.5365492350020076 41.56115356129777 0.03189849853515625 3 0.9515456242866128 5.583756317359913 29446.0 117.74131716019687 0.0 - - - - - - - 323.6666666666667 58 12 BCAS2 breast carcinoma amplified sequence 2 1085 140 C20140610_SFK040_01 C20140610_SFK040_01 TB324681.[MT7]-TIVQLENEIYQIK[MT7].2y5_1.heavy 940.043 / 808.505 11578.0 44.909223556518555 41 15 10 6 10 1.5365492350020076 41.56115356129777 0.03189849853515625 3 0.9515456242866128 5.583756317359913 11578.0 23.370874097834804 0.0 - - - - - - - 661.5555555555555 23 9 BCAS2 breast carcinoma amplified sequence 2 1087 140 C20140610_SFK040_01 C20140610_SFK040_01 TB324681.[MT7]-TIVQLENEIYQIK[MT7].2b4_1.heavy 940.043 / 586.368 57219.0 44.909223556518555 41 15 10 6 10 1.5365492350020076 41.56115356129777 0.03189849853515625 3 0.9515456242866128 5.583756317359913 57219.0 144.37974314765694 0.0 - - - - - - - 736.0 114 8 BCAS2 breast carcinoma amplified sequence 2 1089 140 C20140610_SFK040_01 C20140610_SFK040_01 TB324681.[MT7]-TIVQLENEIYQIK[MT7].2y7_1.heavy 940.043 / 1051.59 30450.0 44.909223556518555 41 15 10 6 10 1.5365492350020076 41.56115356129777 0.03189849853515625 3 0.9515456242866128 5.583756317359913 30450.0 82.9383706449651 0.0 - - - - - - - 635.5 60 10 BCAS2 breast carcinoma amplified sequence 2 1091 141 C20140610_SFK040_01 C20140610_SFK040_01 TB458314.[MT7]-SPGQNWVK[MT7].2y4_1.heavy 602.34 / 690.406 7270.0 25.263599395751953 41 13 10 10 8 2.3916042254243 41.812938335254344 0.0 4 0.9096036140624539 4.073424499947069 7270.0 16.261976683476156 0.0 - - - - - - - 752.2222222222222 14 9 FBXO32 F-box protein 32 1093 141 C20140610_SFK040_01 C20140610_SFK040_01 TB458314.[MT7]-SPGQNWVK[MT7].2y3_1.heavy 602.34 / 576.363 N/A 25.263599395751953 41 13 10 10 8 2.3916042254243 41.812938335254344 0.0 4 0.9096036140624539 4.073424499947069 30434.0 24.05985920049192 0.0 - - - - - - - 1283.0 60 3 FBXO32 F-box protein 32 1095 141 C20140610_SFK040_01 C20140610_SFK040_01 TB458314.[MT7]-SPGQNWVK[MT7].2y6_1.heavy 602.34 / 875.486 7270.0 25.263599395751953 41 13 10 10 8 2.3916042254243 41.812938335254344 0.0 4 0.9096036140624539 4.073424499947069 7270.0 26.56801995078967 1.0 - - - - - - - 245.0 19 16 FBXO32 F-box protein 32 1097 141 C20140610_SFK040_01 C20140610_SFK040_01 TB458314.[MT7]-SPGQNWVK[MT7].2y7_1.heavy 602.34 / 972.538 85744.0 25.263599395751953 41 13 10 10 8 2.3916042254243 41.812938335254344 0.0 4 0.9096036140624539 4.073424499947069 85744.0 144.65716701323606 0.0 - - - - - - - 671.8571428571429 171 7 FBXO32 F-box protein 32 1099 142 C20140610_SFK040_01 C20140610_SFK040_01 TB563685.[MT7]-LGQGVLVQVSPSLVK[MT7].3b6_1.heavy 604.711 / 712.447 82656.0 39.08689880371094 47 17 10 10 10 3.313288596249802 30.18149403380876 0.0 3 0.9788645410987803 8.474003318933294 82656.0 88.82658454211136 0.0 - - - - - - - 1308.0 165 7 EXOSC2 exosome component 2 1101 142 C20140610_SFK040_01 C20140610_SFK040_01 TB563685.[MT7]-LGQGVLVQVSPSLVK[MT7].3b4_1.heavy 604.711 / 500.295 33776.0 39.08689880371094 47 17 10 10 10 3.313288596249802 30.18149403380876 0.0 3 0.9788645410987803 8.474003318933294 33776.0 28.39698097491446 0.0 - - - - - - - 1189.0 67 7 EXOSC2 exosome component 2 1103 142 C20140610_SFK040_01 C20140610_SFK040_01 TB563685.[MT7]-LGQGVLVQVSPSLVK[MT7].3b5_1.heavy 604.711 / 599.363 88246.0 39.08689880371094 47 17 10 10 10 3.313288596249802 30.18149403380876 0.0 3 0.9788645410987803 8.474003318933294 88246.0 49.696387823216796 0.0 - - - - - - - 357.0 176 1 EXOSC2 exosome component 2 1105 142 C20140610_SFK040_01 C20140610_SFK040_01 TB563685.[MT7]-LGQGVLVQVSPSLVK[MT7].3b7_1.heavy 604.711 / 811.516 32587.0 39.08689880371094 47 17 10 10 10 3.313288596249802 30.18149403380876 0.0 3 0.9788645410987803 8.474003318933294 32587.0 61.13695728758793 0.0 - - - - - - - 238.0 65 10 EXOSC2 exosome component 2 1107 143 C20140610_SFK040_01 C20140610_SFK040_01 TB563053.[MT7]-GTISPQDLER.2y8_1.heavy 630.339 / 957.5 27434.0 27.836599349975586 50 20 10 10 10 10.204687272016699 9.799418378475947 0.0 3 0.9960165978778848 19.547491143483256 27434.0 47.80524066354005 0.0 - - - - - - - 587.625 54 8 DFNB31 deafness, autosomal recessive 31 1109 143 C20140610_SFK040_01 C20140610_SFK040_01 TB563053.[MT7]-GTISPQDLER.2b4_1.heavy 630.339 / 503.295 35724.0 27.836599349975586 50 20 10 10 10 10.204687272016699 9.799418378475947 0.0 3 0.9960165978778848 19.547491143483256 35724.0 33.62279893197865 0.0 - - - - - - - 427.0 71 1 DFNB31 deafness, autosomal recessive 31 1111 143 C20140610_SFK040_01 C20140610_SFK040_01 TB563053.[MT7]-GTISPQDLER.2y6_1.heavy 630.339 / 757.384 50766.0 27.836599349975586 50 20 10 10 10 10.204687272016699 9.799418378475947 0.0 3 0.9960165978778848 19.547491143483256 50766.0 101.72709072681704 0.0 - - - - - - - 227.66666666666666 101 3 DFNB31 deafness, autosomal recessive 31 1113 143 C20140610_SFK040_01 C20140610_SFK040_01 TB563053.[MT7]-GTISPQDLER.2y7_1.heavy 630.339 / 844.416 58202.0 27.836599349975586 50 20 10 10 10 10.204687272016699 9.799418378475947 0.0 3 0.9960165978778848 19.547491143483256 58202.0 92.61199619954724 0.0 - - - - - - - 427.0 116 2 DFNB31 deafness, autosomal recessive 31 1115 144 C20140610_SFK040_01 C20140610_SFK040_01 TB563306.[MT7]-TTYLVLDEADR.2b3_1.heavy 720.379 / 510.268 41722.0 34.5182991027832 47 17 10 10 10 12.430604925169712 8.044660786983762 0.0 3 0.9798783676477795 8.685600251394632 41722.0 61.01871936560586 0.0 - - - - - - - 364.0 83 2 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1117 144 C20140610_SFK040_01 C20140610_SFK040_01 TB563306.[MT7]-TTYLVLDEADR.2y8_1.heavy 720.379 / 930.489 37720.0 34.5182991027832 47 17 10 10 10 12.430604925169712 8.044660786983762 0.0 3 0.9798783676477795 8.685600251394632 37720.0 123.02733014923828 0.0 - - - - - - - 714.2222222222222 75 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1119 144 C20140610_SFK040_01 C20140610_SFK040_01 TB563306.[MT7]-TTYLVLDEADR.2y10_1.heavy 720.379 / 1194.6 24378.0 34.5182991027832 47 17 10 10 10 12.430604925169712 8.044660786983762 0.0 3 0.9798783676477795 8.685600251394632 24378.0 33.26235465772268 0.0 - - - - - - - 866.1428571428571 48 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1121 144 C20140610_SFK040_01 C20140610_SFK040_01 TB563306.[MT7]-TTYLVLDEADR.2y7_1.heavy 720.379 / 817.405 46088.0 34.5182991027832 47 17 10 10 10 12.430604925169712 8.044660786983762 0.0 3 0.9798783676477795 8.685600251394632 46088.0 83.51351948394117 0.0 - - - - - - - 303.25 92 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1123 145 C20140610_SFK040_01 C20140610_SFK040_01 TB563118.[MT7]-GVEIC[CAM]IATPGR.2y5_1.heavy 658.859 / 501.278 23135.0 32.24425029754639 43 17 10 6 10 7.767198516277754 12.874654843754737 0.039798736572265625 3 0.9774978862671813 8.21169769275135 23135.0 14.655488158560516 0.0 - - - - - - - 763.5 46 2 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1125 145 C20140610_SFK040_01 C20140610_SFK040_01 TB563118.[MT7]-GVEIC[CAM]IATPGR.2y9_1.heavy 658.859 / 1016.52 37345.0 32.24425029754639 43 17 10 6 10 7.767198516277754 12.874654843754737 0.039798736572265625 3 0.9774978862671813 8.21169769275135 37345.0 54.762730070621686 0.0 - - - - - - - 293.3333333333333 74 6 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1127 145 C20140610_SFK040_01 C20140610_SFK040_01 TB563118.[MT7]-GVEIC[CAM]IATPGR.2b5_1.heavy 658.859 / 703.357 18555.0 32.24425029754639 43 17 10 6 10 7.767198516277754 12.874654843754737 0.039798736572265625 3 0.9774978862671813 8.21169769275135 18555.0 19.327729180989714 0.0 - - - - - - - 274.0 37 3 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1129 145 C20140610_SFK040_01 C20140610_SFK040_01 TB563118.[MT7]-GVEIC[CAM]IATPGR.2y7_1.heavy 658.859 / 774.393 55783.0 32.24425029754639 43 17 10 6 10 7.767198516277754 12.874654843754737 0.039798736572265625 3 0.9774978862671813 8.21169769275135 55783.0 76.73519529430035 0.0 - - - - - - - 372.0 111 6 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1131 146 C20140610_SFK040_01 C20140610_SFK040_01 TB458245.[MT7]-RLLQGDTPVRK[MT7].3b6_1.heavy 524.326 / 827.486 63956.0 22.235200881958008 38 20 2 10 6 11.229551421207642 8.905075211743931 0.0 5 0.9983279827643189 30.177375293222415 63956.0 166.33615810276677 0.0 - - - - - - - 219.54545454545453 127 11 POSTN periostin, osteoblast specific factor 1133 146 C20140610_SFK040_01 C20140610_SFK040_01 TB458245.[MT7]-RLLQGDTPVRK[MT7].3b3_1.heavy 524.326 / 527.379 2898.0 22.235200881958008 38 20 2 10 6 11.229551421207642 8.905075211743931 0.0 5 0.9983279827643189 30.177375293222415 2898.0 2.9924999999999997 1.0 - - - - - - - 659.3333333333334 6 9 POSTN periostin, osteoblast specific factor 1135 146 C20140610_SFK040_01 C20140610_SFK040_01 TB458245.[MT7]-RLLQGDTPVRK[MT7].3y4_1.heavy 524.326 / 643.437 3381.0 22.235200881958008 38 20 2 10 6 11.229551421207642 8.905075211743931 0.0 5 0.9983279827643189 30.177375293222415 3381.0 5.710384615384616 1.0 - - - - - - - 747.5 332 12 POSTN periostin, osteoblast specific factor 1137 146 C20140610_SFK040_01 C20140610_SFK040_01 TB458245.[MT7]-RLLQGDTPVRK[MT7].3y5_1.heavy 524.326 / 744.485 3726.0 22.235200881958008 38 20 2 10 6 11.229551421207642 8.905075211743931 0.0 5 0.9983279827643189 30.177375293222415 3726.0 5.241176470588235 2.0 - - - - - - - 630.8571428571429 25 7 POSTN periostin, osteoblast specific factor 1139 147 C20140610_SFK040_01 C20140610_SFK040_01 TB563140.[MT7]-LSDPANWLK[MT7].2y8_1.heavy 666.382 / 1074.57 N/A 38.93596522013346 31 16 4 5 6 2.026103083647334 39.88729962827442 0.0410003662109375 5 0.9641661460111544 6.499951774667555 12594.0 6.616639964032758 1.0 - - - - - - - 367.0 155 2 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1141 147 C20140610_SFK040_01 C20140610_SFK040_01 TB563140.[MT7]-LSDPANWLK[MT7].2y3_1.heavy 666.382 / 590.378 5502.0 38.93596522013346 31 16 4 5 6 2.026103083647334 39.88729962827442 0.0410003662109375 5 0.9641661460111544 6.499951774667555 5502.0 4.836873054157157 7.0 - - - - - - - 2305.5714285714284 60 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1143 147 C20140610_SFK040_01 C20140610_SFK040_01 TB563140.[MT7]-LSDPANWLK[MT7].2b6_1.heavy 666.382 / 742.385 4279.0 38.93596522013346 31 16 4 5 6 2.026103083647334 39.88729962827442 0.0410003662109375 5 0.9641661460111544 6.499951774667555 4279.0 4.817200636219041 0.0 - - - - - - - 1249.888888888889 8 9 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1145 147 C20140610_SFK040_01 C20140610_SFK040_01 TB563140.[MT7]-LSDPANWLK[MT7].2y6_1.heavy 666.382 / 872.511 46707.0 38.93596522013346 31 16 4 5 6 2.026103083647334 39.88729962827442 0.0410003662109375 5 0.9641661460111544 6.499951774667555 46707.0 98.06479353248093 0.0 - - - - - - - 786.0 93 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1147 148 C20140610_SFK040_01 C20140610_SFK040_01 TB458449.[MT7]-AQNLLEQFQK[MT7].2y5_1.heavy 753.93 / 823.443 22192.0 36.69380187988281 46 16 10 10 10 3.1219177568875596 32.03159333053553 0.0 3 0.9680772887978423 6.888907323113308 22192.0 48.69717868338558 0.0 - - - - - - - 685.625 44 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1149 148 C20140610_SFK040_01 C20140610_SFK040_01 TB458449.[MT7]-AQNLLEQFQK[MT7].2b4_1.heavy 753.93 / 571.332 36476.0 36.69380187988281 46 16 10 10 10 3.1219177568875596 32.03159333053553 0.0 3 0.9680772887978423 6.888907323113308 36476.0 4.712023805308391 1.0 - - - - - - - 765.375 76 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1151 148 C20140610_SFK040_01 C20140610_SFK040_01 TB458449.[MT7]-AQNLLEQFQK[MT7].2y3_1.heavy 753.93 / 566.342 17090.0 36.69380187988281 46 16 10 10 10 3.1219177568875596 32.03159333053553 0.0 3 0.9680772887978423 6.888907323113308 17090.0 20.07718276212777 0.0 - - - - - - - 291.7142857142857 34 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1153 148 C20140610_SFK040_01 C20140610_SFK040_01 TB458449.[MT7]-AQNLLEQFQK[MT7].2y6_1.heavy 753.93 / 936.527 27293.0 36.69380187988281 46 16 10 10 10 3.1219177568875596 32.03159333053553 0.0 3 0.9680772887978423 6.888907323113308 27293.0 34.41276009488414 0.0 - - - - - - - 619.4285714285714 54 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1155 149 C20140610_SFK040_01 C20140610_SFK040_01 TB563142.[MT7]-ALK[MT7]PEVDK[MT7].3y3_1.heavy 444.613 / 505.31 57628.0 21.656600952148438 48 18 10 10 10 4.293234247999677 23.292463029845727 0.0 3 0.9852310394110277 10.14265011841999 57628.0 27.053937872217684 0.0 - - - - - - - 1324.8 115 5 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1157 149 C20140610_SFK040_01 C20140610_SFK040_01 TB563142.[MT7]-ALK[MT7]PEVDK[MT7].3y7_2.heavy 444.613 / 558.847 31816.0 21.656600952148438 48 18 10 10 10 4.293234247999677 23.292463029845727 0.0 3 0.9852310394110277 10.14265011841999 31816.0 30.55960987899378 0.0 - - - - - - - 1232.142857142857 63 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1159 149 C20140610_SFK040_01 C20140610_SFK040_01 TB563142.[MT7]-ALK[MT7]PEVDK[MT7].3y4_1.heavy 444.613 / 634.353 17392.0 21.656600952148438 48 18 10 10 10 4.293234247999677 23.292463029845727 0.0 3 0.9852310394110277 10.14265011841999 17392.0 28.27573392790784 0.0 - - - - - - - 339.6923076923077 34 13 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1161 149 C20140610_SFK040_01 C20140610_SFK040_01 TB563142.[MT7]-ALK[MT7]PEVDK[MT7].3y5_1.heavy 444.613 / 731.406 112150.0 21.656600952148438 48 18 10 10 10 4.293234247999677 23.292463029845727 0.0 3 0.9852310394110277 10.14265011841999 112150.0 284.43840579710144 0.0 - - - - - - - 286.61538461538464 224 13 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1163 150 C20140610_SFK040_01 C20140610_SFK040_01 TB563819.[MT7]-FIEGGDGHLFEDEEIK[MT7].3y7_1.heavy 708.356 / 1053.52 49693.0 36.05179977416992 41 11 10 10 10 1.4156381797027244 55.832205370317155 0.0 3 0.8780194770333659 3.4970377448878374 49693.0 37.66882321102972 0.0 - - - - - - - 1671.7777777777778 99 9 POSTN periostin, osteoblast specific factor 1165 150 C20140610_SFK040_01 C20140610_SFK040_01 TB563819.[MT7]-FIEGGDGHLFEDEEIK[MT7].3b6_1.heavy 708.356 / 763.374 15426.0 36.05179977416992 41 11 10 10 10 1.4156381797027244 55.832205370317155 0.0 3 0.8780194770333659 3.4970377448878374 15426.0 16.838252876407275 0.0 - - - - - - - 1102.142857142857 30 7 POSTN periostin, osteoblast specific factor 1167 150 C20140610_SFK040_01 C20140610_SFK040_01 TB563819.[MT7]-FIEGGDGHLFEDEEIK[MT7].3b3_1.heavy 708.356 / 534.304 14668.0 36.05179977416992 41 11 10 10 10 1.4156381797027244 55.832205370317155 0.0 3 0.8780194770333659 3.4970377448878374 14668.0 18.93150349191677 1.0 - - - - - - - 657.6 38 5 POSTN periostin, osteoblast specific factor 1169 150 C20140610_SFK040_01 C20140610_SFK040_01 TB563819.[MT7]-FIEGGDGHLFEDEEIK[MT7].3b7_1.heavy 708.356 / 820.396 28956.0 36.05179977416992 41 11 10 10 10 1.4156381797027244 55.832205370317155 0.0 3 0.8780194770333659 3.4970377448878374 28956.0 30.94129906306919 0.0 - - - - - - - 1169.625 57 8 POSTN periostin, osteoblast specific factor 1171 151 C20140610_SFK040_01 C20140610_SFK040_01 TB562952.[MT7]-GNFGEVFSGR.2y8_1.heavy 607.308 / 898.442 11031.0 33.215999603271484 44 14 10 10 10 1.7031351542381188 46.581773428440094 0.0 3 0.9329761615567503 4.7401455709050495 11031.0 16.74406245555578 0.0 - - - - - - - 682.125 22 8 FES feline sarcoma oncogene 1173 151 C20140610_SFK040_01 C20140610_SFK040_01 TB562952.[MT7]-GNFGEVFSGR.2y5_1.heavy 607.308 / 565.309 11979.0 33.215999603271484 44 14 10 10 10 1.7031351542381188 46.581773428440094 0.0 3 0.9329761615567503 4.7401455709050495 11979.0 3.9550159058734926 1.0 - - - - - - - 2253.5714285714284 27 7 FES feline sarcoma oncogene 1175 151 C20140610_SFK040_01 C20140610_SFK040_01 TB562952.[MT7]-GNFGEVFSGR.2b5_1.heavy 607.308 / 649.306 14233.0 33.215999603271484 44 14 10 10 10 1.7031351542381188 46.581773428440094 0.0 3 0.9329761615567503 4.7401455709050495 14233.0 23.21131669353917 0.0 - - - - - - - 403.0 28 5 FES feline sarcoma oncogene 1177 151 C20140610_SFK040_01 C20140610_SFK040_01 TB562952.[MT7]-GNFGEVFSGR.2y7_1.heavy 607.308 / 751.373 24552.0 33.215999603271484 44 14 10 10 10 1.7031351542381188 46.581773428440094 0.0 3 0.9329761615567503 4.7401455709050495 24552.0 30.730502840311384 1.0 - - - - - - - 800.625 49 8 FES feline sarcoma oncogene 1179 152 C20140610_SFK040_01 C20140610_SFK040_01 TB563815.[MT7]-VYNENLVHMIEHAQK[MT7].4b4_1.heavy 529.033 / 650.327 33943.0 35.183998107910156 50 20 10 10 10 10.990680059059931 9.098618052990009 0.0 3 0.9955235737456631 18.438878909520962 33943.0 36.4813696369637 0.0 - - - - - - - 332.6666666666667 67 6 BCAS2 breast carcinoma amplified sequence 2 1181 152 C20140610_SFK040_01 C20140610_SFK040_01 TB563815.[MT7]-VYNENLVHMIEHAQK[MT7].4b5_1.heavy 529.033 / 764.37 52662.0 35.183998107910156 50 20 10 10 10 10.990680059059931 9.098618052990009 0.0 3 0.9955235737456631 18.438878909520962 52662.0 179.25557897343347 0.0 - - - - - - - 332.6666666666667 105 12 BCAS2 breast carcinoma amplified sequence 2 1183 152 C20140610_SFK040_01 C20140610_SFK040_01 TB563815.[MT7]-VYNENLVHMIEHAQK[MT7].4b6_1.heavy 529.033 / 877.454 18344.0 35.183998107910156 50 20 10 10 10 10.990680059059931 9.098618052990009 0.0 3 0.9955235737456631 18.438878909520962 18344.0 70.59656240406102 0.0 - - - - - - - 316.0 36 15 BCAS2 breast carcinoma amplified sequence 2 1185 152 C20140610_SFK040_01 C20140610_SFK040_01 TB563815.[MT7]-VYNENLVHMIEHAQK[MT7].4b3_1.heavy 529.033 / 521.284 29451.0 35.183998107910156 50 20 10 10 10 10.990680059059931 9.098618052990009 0.0 3 0.9955235737456631 18.438878909520962 29451.0 28.283995857922534 0.0 - - - - - - - 1337.2857142857142 58 7 BCAS2 breast carcinoma amplified sequence 2 1187 153 C20140610_SFK040_01 C20140610_SFK040_01 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 892724.0 40.63159942626953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 892724.0 192.42012888987955 0.0 - - - - - - - 942.0 1785 1 1189 153 C20140610_SFK040_01 C20140610_SFK040_01 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 1285770.0 40.63159942626953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1285770.0 188.40522683870745 0.0 - - - - - - - 1309.0 2571 2 1191 153 C20140610_SFK040_01 C20140610_SFK040_01 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 1778620.0 40.63159942626953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1778620.0 232.37512494413704 0.0 - - - - - - - 890.0 3557 2 1193 154 C20140610_SFK040_01 C20140610_SFK040_01 TB563817.[MT7]-FIEGGDGHLFEDEEIK[MT7].4b7_1.heavy 531.519 / 820.396 10364.0 36.072750091552734 39 14 10 5 10 1.8739039123392476 42.65449503426787 0.041900634765625 3 0.939790370302422 5.004098755939492 10364.0 14.551630069238378 1.0 - - - - - - - 668.1428571428571 20 7 POSTN periostin, osteoblast specific factor 1195 154 C20140610_SFK040_01 C20140610_SFK040_01 TB563817.[MT7]-FIEGGDGHLFEDEEIK[MT7].4b5_1.heavy 531.519 / 648.347 4171.0 36.072750091552734 39 14 10 5 10 1.8739039123392476 42.65449503426787 0.041900634765625 3 0.939790370302422 5.004098755939492 4171.0 5.224060646011865 4.0 - - - - - - - 316.0 10 4 POSTN periostin, osteoblast specific factor 1197 154 C20140610_SFK040_01 C20140610_SFK040_01 TB563817.[MT7]-FIEGGDGHLFEDEEIK[MT7].4b6_1.heavy 531.519 / 763.374 7836.0 36.072750091552734 39 14 10 5 10 1.8739039123392476 42.65449503426787 0.041900634765625 3 0.939790370302422 5.004098755939492 7836.0 11.528344348250213 0.0 - - - - - - - 726.875 15 8 POSTN periostin, osteoblast specific factor 1199 154 C20140610_SFK040_01 C20140610_SFK040_01 TB563817.[MT7]-FIEGGDGHLFEDEEIK[MT7].4b3_1.heavy 531.519 / 534.304 11628.0 36.072750091552734 39 14 10 5 10 1.8739039123392476 42.65449503426787 0.041900634765625 3 0.939790370302422 5.004098755939492 11628.0 12.029935942366228 2.0 - - - - - - - 758.5 23 4 POSTN periostin, osteoblast specific factor 1201 155 C20140610_SFK040_01 C20140610_SFK040_01 TB563245.[MT7]-ANSMGLFLQK[MT7].3y3_1.heavy 466.267 / 532.357 23126.0 36.782501220703125 48 18 10 10 10 4.39245100731713 22.766332472101745 0.0 3 0.9822812884175447 9.257696637163745 23126.0 15.237188911283528 0.0 - - - - - - - 255.83333333333334 46 6 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1203 155 C20140610_SFK040_01 C20140610_SFK040_01 TB563245.[MT7]-ANSMGLFLQK[MT7].3b6_1.heavy 466.267 / 718.367 19420.0 36.782501220703125 48 18 10 10 10 4.39245100731713 22.766332472101745 0.0 3 0.9822812884175447 9.257696637163745 19420.0 102.46953736545989 0.0 - - - - - - - 255.7 38 10 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1205 155 C20140610_SFK040_01 C20140610_SFK040_01 TB563245.[MT7]-ANSMGLFLQK[MT7].3b5_1.heavy 466.267 / 605.283 43824.0 36.782501220703125 48 18 10 10 10 4.39245100731713 22.766332472101745 0.0 3 0.9822812884175447 9.257696637163745 43824.0 69.1445904826541 0.0 - - - - - - - 693.5714285714286 87 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1207 155 C20140610_SFK040_01 C20140610_SFK040_01 TB563245.[MT7]-ANSMGLFLQK[MT7].3y4_1.heavy 466.267 / 679.426 8560.0 36.782501220703125 48 18 10 10 10 4.39245100731713 22.766332472101745 0.0 3 0.9822812884175447 9.257696637163745 8560.0 95.96562499999999 0.0 - - - - - - - 204.8 17 5 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1209 156 C20140610_SFK040_01 C20140610_SFK040_01 TB458301.[MT7]-FIQWFQR.2y4_1.heavy 584.823 / 636.325 53749.0 42.19110107421875 50 20 10 10 10 10.67784477503963 9.365185775481445 0.0 3 0.9953900550739591 18.169690121082134 53749.0 89.86778148288849 0.0 - - - - - - - 691.0 107 11 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1211 156 C20140610_SFK040_01 C20140610_SFK040_01 TB458301.[MT7]-FIQWFQR.2b3_1.heavy 584.823 / 533.32 54643.0 42.19110107421875 50 20 10 10 10 10.67784477503963 9.365185775481445 0.0 3 0.9953900550739591 18.169690121082134 54643.0 72.24244626207641 0.0 - - - - - - - 335.25 109 4 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1213 156 C20140610_SFK040_01 C20140610_SFK040_01 TB458301.[MT7]-FIQWFQR.2y5_1.heavy 584.823 / 764.384 60545.0 42.19110107421875 50 20 10 10 10 10.67784477503963 9.365185775481445 0.0 3 0.9953900550739591 18.169690121082134 60545.0 200.51011606447284 0.0 - - - - - - - 281.07142857142856 121 14 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1215 156 C20140610_SFK040_01 C20140610_SFK040_01 TB458301.[MT7]-FIQWFQR.2y6_1.heavy 584.823 / 877.468 111700.0 42.19110107421875 50 20 10 10 10 10.67784477503963 9.365185775481445 0.0 3 0.9953900550739591 18.169690121082134 111700.0 365.039781414913 0.0 - - - - - - - 626.1428571428571 223 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1217 157 C20140610_SFK040_01 C20140610_SFK040_01 TB458440.[MT7]-DILGGPISLGNIR.2y8_1.heavy 734.934 / 869.52 81501.0 41.55644989013672 46 20 10 6 10 10.092441320044092 9.908405392597627 0.0373992919921875 3 0.9901328907194802 12.413940238849616 81501.0 211.78125032715852 0.0 - - - - - - - 684.75 163 8 PCNX pecanex homolog (Drosophila) 1219 157 C20140610_SFK040_01 C20140610_SFK040_01 TB458440.[MT7]-DILGGPISLGNIR.2y12_1.heavy 734.934 / 1209.73 39518.0 41.55644989013672 46 20 10 6 10 10.092441320044092 9.908405392597627 0.0373992919921875 3 0.9901328907194802 12.413940238849616 39518.0 69.12501510019521 0.0 - - - - - - - 689.5555555555555 79 9 PCNX pecanex homolog (Drosophila) 1221 157 C20140610_SFK040_01 C20140610_SFK040_01 TB458440.[MT7]-DILGGPISLGNIR.2y10_1.heavy 734.934 / 983.563 388887.0 41.55644989013672 46 20 10 6 10 10.092441320044092 9.908405392597627 0.0373992919921875 3 0.9901328907194802 12.413940238849616 388887.0 504.3972350617699 0.0 - - - - - - - 182.66666666666666 777 3 PCNX pecanex homolog (Drosophila) 1223 157 C20140610_SFK040_01 C20140610_SFK040_01 TB458440.[MT7]-DILGGPISLGNIR.2y11_1.heavy 734.934 / 1096.65 182077.0 41.55644989013672 46 20 10 6 10 10.092441320044092 9.908405392597627 0.0373992919921875 3 0.9901328907194802 12.413940238849616 182077.0 231.12424314961305 0.0 - - - - - - - 1264.5714285714287 364 7 PCNX pecanex homolog (Drosophila) 1225 158 C20140610_SFK040_01 C20140610_SFK040_01 TB563417.[MT7]-NFYQEHPDLAR.3b4_1.heavy 511.924 / 697.343 45153.0 26.573200225830078 42 16 10 6 10 4.383297653313543 22.813873916229547 0.037200927734375 3 0.9677693816552384 6.855744620497176 45153.0 75.2230946444098 0.0 - - - - - - - 756.0 90 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1227 158 C20140610_SFK040_01 C20140610_SFK040_01 TB563417.[MT7]-NFYQEHPDLAR.3b5_1.heavy 511.924 / 826.385 37323.0 26.573200225830078 42 16 10 6 10 4.383297653313543 22.813873916229547 0.037200927734375 3 0.9677693816552384 6.855744620497176 37323.0 131.6846953125 0.0 - - - - - - - 667.75 74 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1229 158 C20140610_SFK040_01 C20140610_SFK040_01 TB563417.[MT7]-NFYQEHPDLAR.3b3_1.heavy 511.924 / 569.284 44128.0 26.573200225830078 42 16 10 6 10 4.383297653313543 22.813873916229547 0.037200927734375 3 0.9677693816552384 6.855744620497176 44128.0 60.92203741007194 0.0 - - - - - - - 1234.875 88 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1231 158 C20140610_SFK040_01 C20140610_SFK040_01 TB563417.[MT7]-NFYQEHPDLAR.3y5_1.heavy 511.924 / 571.32 237327.0 26.573200225830078 42 16 10 6 10 4.383297653313543 22.813873916229547 0.037200927734375 3 0.9677693816552384 6.855744620497176 237327.0 101.46898189950167 0.0 - - - - - - - 1189.25 474 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1233 159 C20140610_SFK040_01 C20140610_SFK040_01 TB563693.[MT7]-VLEQVSAQLEEC[CAM]K[MT7].3y3_1.heavy 607.66 / 580.288 80324.0 37.68450164794922 47 17 10 10 10 4.064482011590028 24.603381123313156 0.0 3 0.979170188128754 8.536167816376535 80324.0 24.238097334703053 1.0 - - - - - - - 708.0 163 3 SPAG5 sperm associated antigen 5 1235 159 C20140610_SFK040_01 C20140610_SFK040_01 TB563693.[MT7]-VLEQVSAQLEEC[CAM]K[MT7].3b4_1.heavy 607.66 / 614.363 178888.0 37.68450164794922 47 17 10 10 10 4.064482011590028 24.603381123313156 0.0 3 0.979170188128754 8.536167816376535 178888.0 163.17438819722952 0.0 - - - - - - - 750.0 357 2 SPAG5 sperm associated antigen 5 1237 159 C20140610_SFK040_01 C20140610_SFK040_01 TB563693.[MT7]-VLEQVSAQLEEC[CAM]K[MT7].3y4_1.heavy 607.66 / 709.331 124422.0 37.68450164794922 47 17 10 10 10 4.064482011590028 24.603381123313156 0.0 3 0.979170188128754 8.536167816376535 124422.0 126.77641921397378 0.0 - - - - - - - 714.0 248 7 SPAG5 sperm associated antigen 5 1239 159 C20140610_SFK040_01 C20140610_SFK040_01 TB563693.[MT7]-VLEQVSAQLEEC[CAM]K[MT7].3y5_1.heavy 607.66 / 822.415 74703.0 37.68450164794922 47 17 10 10 10 4.064482011590028 24.603381123313156 0.0 3 0.979170188128754 8.536167816376535 74703.0 137.27493438633937 0.0 - - - - - - - 687.375 149 8 SPAG5 sperm associated antigen 5 1241 160 C20140610_SFK040_01 C20140610_SFK040_01 TB563415.[MT7]-LDDIVQHIYK[MT7].3b6_1.heavy 511.296 / 828.458 14337.0 36.43429946899414 45 15 10 10 10 2.3432844186695267 33.90523259811063 0.0 3 0.9596514146451749 6.123179991491042 14337.0 69.63859488654589 0.0 - - - - - - - 197.55555555555554 28 9 SPAG5 sperm associated antigen 5 1243 160 C20140610_SFK040_01 C20140610_SFK040_01 TB563415.[MT7]-LDDIVQHIYK[MT7].3y3_1.heavy 511.296 / 567.362 40218.0 36.43429946899414 45 15 10 10 10 2.3432844186695267 33.90523259811063 0.0 3 0.9596514146451749 6.123179991491042 40218.0 33.353608412150564 0.0 - - - - - - - 381.0 80 3 SPAG5 sperm associated antigen 5 1245 160 C20140610_SFK040_01 C20140610_SFK040_01 TB563415.[MT7]-LDDIVQHIYK[MT7].3b4_1.heavy 511.296 / 601.331 38950.0 36.43429946899414 45 15 10 10 10 2.3432844186695267 33.90523259811063 0.0 3 0.9596514146451749 6.123179991491042 38950.0 49.028653653653656 0.0 - - - - - - - 169.33333333333334 77 3 SPAG5 sperm associated antigen 5 1247 160 C20140610_SFK040_01 C20140610_SFK040_01 TB563415.[MT7]-LDDIVQHIYK[MT7].3b5_1.heavy 511.296 / 700.4 18777.0 36.43429946899414 45 15 10 10 10 2.3432844186695267 33.90523259811063 0.0 3 0.9596514146451749 6.123179991491042 18777.0 37.63608114765012 0.0 - - - - - - - 684.8 37 10 SPAG5 sperm associated antigen 5 1249 161 C20140610_SFK040_01 C20140610_SFK040_01 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 440505.0 35.64070129394531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 440505.0 414.46626000000003 0.0 - - - - - - - 281.25 881 8 1251 161 C20140610_SFK040_01 C20140610_SFK040_01 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 86001.0 35.64070129394531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 86001.0 103.52882285714286 0.0 - - - - - - - 1152.7777777777778 172 9 1253 161 C20140610_SFK040_01 C20140610_SFK040_01 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 64626.0 35.64070129394531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 64626.0 47.63185265720081 0.0 - - - - - - - 1142.857142857143 129 7 1255 162 C20140610_SFK040_01 C20140610_SFK040_01 TB562575.[MT7]-ALLGC[CAM]GR.2b3_1.heavy 445.754 / 442.315 110712.0 24.365400314331055 50 20 10 10 10 14.854657873718875 6.7318951974600365 0.0 3 0.995631946847303 18.66638421038635 110712.0 44.44026407485144 0.0 - - - - - - - 568.0 221 1 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 1257 162 C20140610_SFK040_01 C20140610_SFK040_01 TB562575.[MT7]-ALLGC[CAM]GR.2y4_1.heavy 445.754 / 449.193 236622.0 24.365400314331055 50 20 10 10 10 14.854657873718875 6.7318951974600365 0.0 3 0.995631946847303 18.66638421038635 236622.0 243.31583580823417 0.0 - - - - - - - 834.25 473 4 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 1259 162 C20140610_SFK040_01 C20140610_SFK040_01 TB562575.[MT7]-ALLGC[CAM]GR.2y5_1.heavy 445.754 / 562.277 248765.0 24.365400314331055 50 20 10 10 10 14.854657873718875 6.7318951974600365 0.0 3 0.995631946847303 18.66638421038635 248765.0 315.97295774647887 0.0 - - - - - - - 1286.875 497 8 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 1261 162 C20140610_SFK040_01 C20140610_SFK040_01 TB562575.[MT7]-ALLGC[CAM]GR.2y6_1.heavy 445.754 / 675.361 341582.0 24.365400314331055 50 20 10 10 10 14.854657873718875 6.7318951974600365 0.0 3 0.995631946847303 18.66638421038635 341582.0 185.93132676472584 0.0 - - - - - - - 307.6666666666667 683 3 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 1263 163 C20140610_SFK040_01 C20140610_SFK040_01 TB563569.[MT7]-RAQNLLEQFQK[MT7].3y3_1.heavy 554.989 / 566.342 64078.0 32.97949981689453 43 13 10 10 10 1.5133794296833192 42.364409364248175 0.0 3 0.928219615059414 4.578537549334806 64078.0 94.53465480410026 0.0 - - - - - - - 770.0 128 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1265 163 C20140610_SFK040_01 C20140610_SFK040_01 TB563569.[MT7]-RAQNLLEQFQK[MT7].3b4_1.heavy 554.989 / 614.349 55076.0 32.97949981689453 43 13 10 10 10 1.5133794296833192 42.364409364248175 0.0 3 0.928219615059414 4.578537549334806 55076.0 40.557842401500935 0.0 - - - - - - - 474.0 110 1 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1267 163 C20140610_SFK040_01 C20140610_SFK040_01 TB563569.[MT7]-RAQNLLEQFQK[MT7].3b5_1.heavy 554.989 / 727.433 28782.0 32.97949981689453 43 13 10 10 10 1.5133794296833192 42.364409364248175 0.0 3 0.928219615059414 4.578537549334806 28782.0 39.75164572959635 0.0 - - - - - - - 355.22222222222223 57 9 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1269 163 C20140610_SFK040_01 C20140610_SFK040_01 TB563569.[MT7]-RAQNLLEQFQK[MT7].3y5_1.heavy 554.989 / 823.443 29018.0 32.97949981689453 43 13 10 10 10 1.5133794296833192 42.364409364248175 0.0 3 0.928219615059414 4.578537549334806 29018.0 72.05603978300181 0.0 - - - - - - - 372.2857142857143 58 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1271 164 C20140610_SFK040_01 C20140610_SFK040_01 TB562844.[MT7]-NLPSSIQSR.2y8_1.heavy 573.323 / 887.495 52045.0 23.972400665283203 50 20 10 10 10 4.980903322765802 20.076679573951633 0.0 3 0.9967481641106897 21.63616584470839 52045.0 109.73243332019445 0.0 - - - - - - - 728.2857142857143 104 7 PCNX pecanex homolog (Drosophila) 1273 164 C20140610_SFK040_01 C20140610_SFK040_01 TB562844.[MT7]-NLPSSIQSR.2b6_1.heavy 573.323 / 756.437 8285.0 23.972400665283203 50 20 10 10 10 4.980903322765802 20.076679573951633 0.0 3 0.9967481641106897 21.63616584470839 8285.0 12.39677743894623 1.0 - - - - - - - 719.8333333333334 189 12 PCNX pecanex homolog (Drosophila) 1275 164 C20140610_SFK040_01 C20140610_SFK040_01 TB562844.[MT7]-NLPSSIQSR.2y6_1.heavy 573.323 / 677.358 14587.0 23.972400665283203 50 20 10 10 10 4.980903322765802 20.076679573951633 0.0 3 0.9967481641106897 21.63616584470839 14587.0 17.33448496178132 0.0 - - - - - - - 699.125 29 8 PCNX pecanex homolog (Drosophila) 1277 164 C20140610_SFK040_01 C20140610_SFK040_01 TB562844.[MT7]-NLPSSIQSR.2y7_1.heavy 573.323 / 774.41 172915.0 23.972400665283203 50 20 10 10 10 4.980903322765802 20.076679573951633 0.0 3 0.9967481641106897 21.63616584470839 172915.0 427.48088142834507 0.0 - - - - - - - 647.1428571428571 345 7 PCNX pecanex homolog (Drosophila) 1279 165 C20140610_SFK040_01 C20140610_SFK040_01 TB563130.[MT7]-DYLEDQQGGR.2y8_1.heavy 662.816 / 902.433 14913.0 23.487600326538086 48 18 10 10 10 6.289226683263651 15.9002060247107 0.0 3 0.9880429401472144 11.274998064174673 14913.0 46.735897435897435 0.0 - - - - - - - 251.375 29 16 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1281 165 C20140610_SFK040_01 C20140610_SFK040_01 TB563130.[MT7]-DYLEDQQGGR.2y9_1.heavy 662.816 / 1065.5 40855.0 23.487600326538086 48 18 10 10 10 6.289226683263651 15.9002060247107 0.0 3 0.9880429401472144 11.274998064174673 40855.0 189.71735715773397 0.0 - - - - - - - 291.26666666666665 81 15 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1283 165 C20140610_SFK040_01 C20140610_SFK040_01 TB563130.[MT7]-DYLEDQQGGR.2y6_1.heavy 662.816 / 660.306 20532.0 23.487600326538086 48 18 10 10 10 6.289226683263651 15.9002060247107 0.0 3 0.9880429401472144 11.274998064174673 20532.0 100.43543449346043 0.0 - - - - - - - 259.0 41 15 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1285 165 C20140610_SFK040_01 C20140610_SFK040_01 TB563130.[MT7]-DYLEDQQGGR.2y7_1.heavy 662.816 / 789.349 20948.0 23.487600326538086 48 18 10 10 10 6.289226683263651 15.9002060247107 0.0 3 0.9880429401472144 11.274998064174673 20948.0 97.58837573515147 0.0 - - - - - - - 281.3333333333333 41 18 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1287 166 C20140610_SFK040_01 C20140610_SFK040_01 TB562842.[MT7]-NILEENLR.2y4_1.heavy 572.826 / 531.289 17767.0 32.820499420166016 50 20 10 10 10 11.947776607026999 8.36975809718318 0.0 3 0.9974106120756023 24.247672241708443 17767.0 15.425701535664402 0.0 - - - - - - - 2314.0 35 9 SPAG5 sperm associated antigen 5 1289 166 C20140610_SFK040_01 C20140610_SFK040_01 TB562842.[MT7]-NILEENLR.2y5_1.heavy 572.826 / 660.331 22708.0 32.820499420166016 50 20 10 10 10 11.947776607026999 8.36975809718318 0.0 3 0.9974106120756023 24.247672241708443 22708.0 24.223347337161158 0.0 - - - - - - - 392.3333333333333 45 3 SPAG5 sperm associated antigen 5 1291 166 C20140610_SFK040_01 C20140610_SFK040_01 TB562842.[MT7]-NILEENLR.2y6_1.heavy 572.826 / 773.415 33533.0 32.820499420166016 50 20 10 10 10 11.947776607026999 8.36975809718318 0.0 3 0.9974106120756023 24.247672241708443 33533.0 17.853047464966103 1.0 - - - - - - - 274.3333333333333 68 3 SPAG5 sperm associated antigen 5 1293 166 C20140610_SFK040_01 C20140610_SFK040_01 TB562842.[MT7]-NILEENLR.2y7_1.heavy 572.826 / 886.499 34357.0 32.820499420166016 50 20 10 10 10 11.947776607026999 8.36975809718318 0.0 3 0.9974106120756023 24.247672241708443 34357.0 56.63747906643144 0.0 - - - - - - - 732.0 68 9 SPAG5 sperm associated antigen 5 1295 167 C20140610_SFK040_01 C20140610_SFK040_01 TB562563.[MT7]-NLTGTAR.2y5_1.heavy 438.755 / 505.273 118896.0 17.333900451660156 50 20 10 10 10 12.096584523751096 8.266796284823583 0.0 3 0.9939404409836162 15.846097112857164 118896.0 123.87478206521263 0.0 - - - - - - - 1243.4285714285713 237 7 CSNK1A1;CSNK1D;CSNK1E casein kinase 1, alpha 1;casein kinase 1, delta;casein kinase 1, epsilon 1297 167 C20140610_SFK040_01 C20140610_SFK040_01 TB562563.[MT7]-NLTGTAR.2b4_1.heavy 438.755 / 530.305 21614.0 17.333900451660156 50 20 10 10 10 12.096584523751096 8.266796284823583 0.0 3 0.9939404409836162 15.846097112857164 21614.0 13.645753596461681 0.0 - - - - - - - 1801.5714285714287 43 7 CSNK1A1;CSNK1D;CSNK1E casein kinase 1, alpha 1;casein kinase 1, delta;casein kinase 1, epsilon 1299 167 C20140610_SFK040_01 C20140610_SFK040_01 TB562563.[MT7]-NLTGTAR.2y6_1.heavy 438.755 / 618.357 165478.0 17.333900451660156 50 20 10 10 10 12.096584523751096 8.266796284823583 0.0 3 0.9939404409836162 15.846097112857164 165478.0 187.92656806498292 0.0 - - - - - - - 806.875 330 8 CSNK1A1;CSNK1D;CSNK1E casein kinase 1, alpha 1;casein kinase 1, delta;casein kinase 1, epsilon 1301 167 C20140610_SFK040_01 C20140610_SFK040_01 TB562563.[MT7]-NLTGTAR.2b5_1.heavy 438.755 / 631.353 25817.0 17.333900451660156 50 20 10 10 10 12.096584523751096 8.266796284823583 0.0 3 0.9939404409836162 15.846097112857164 25817.0 20.39089618766609 0.0 - - - - - - - 1340.4285714285713 51 7 CSNK1A1;CSNK1D;CSNK1E casein kinase 1, alpha 1;casein kinase 1, delta;casein kinase 1, epsilon 1303 168 C20140610_SFK040_01 C20140610_SFK040_01 TB562561.[MT7]-IVTIQR.2b3_1.heavy 437.286 / 458.31 70519.0 25.847700119018555 47 17 10 10 10 40.62074336136764 2.4617964056045567 0.0 3 0.9794656511202309 8.597574049120723 70519.0 30.19943754163429 0.0 - - - - - - - 2330.285714285714 141 7 DFNB31 deafness, autosomal recessive 31 1305 168 C20140610_SFK040_01 C20140610_SFK040_01 TB562561.[MT7]-IVTIQR.2y4_1.heavy 437.286 / 517.309 137620.0 25.847700119018555 47 17 10 10 10 40.62074336136764 2.4617964056045567 0.0 3 0.9794656511202309 8.597574049120723 137620.0 44.81217455609316 0.0 - - - - - - - 2190.5 275 4 DFNB31 deafness, autosomal recessive 31 1307 168 C20140610_SFK040_01 C20140610_SFK040_01 TB562561.[MT7]-IVTIQR.2y5_1.heavy 437.286 / 616.378 405166.0 25.847700119018555 47 17 10 10 10 40.62074336136764 2.4617964056045567 0.0 3 0.9794656511202309 8.597574049120723 405166.0 152.47113633921856 0.0 - - - - - - - 997.0 810 1 DFNB31 deafness, autosomal recessive 31 1309 168 C20140610_SFK040_01 C20140610_SFK040_01 TB562561.[MT7]-IVTIQR.2b4_2.heavy 437.286 / 286.2 41955.0 25.847700119018555 47 17 10 10 10 40.62074336136764 2.4617964056045567 0.0 3 0.9794656511202309 8.597574049120723 41955.0 26.96081094916235 0.0 - - - - - - - 1736.25 83 8 DFNB31 deafness, autosomal recessive 31 1311 169 C20140610_SFK040_01 C20140610_SFK040_01 TB563567.[MT7]-HFIIQSLDNLYR.3y7_1.heavy 554.974 / 880.452 25778.0 40.19309997558594 45 20 10 5 10 9.583683432691732 10.434401418026951 0.04199981689453125 3 0.9951503559208168 17.714616948692278 25778.0 94.80938666450477 0.0 - - - - - - - 305.25 51 12 FES feline sarcoma oncogene 1313 169 C20140610_SFK040_01 C20140610_SFK040_01 TB563567.[MT7]-HFIIQSLDNLYR.3y4_1.heavy 554.974 / 565.309 27445.0 40.19309997558594 45 20 10 5 10 9.583683432691732 10.434401418026951 0.04199981689453125 3 0.9951503559208168 17.714616948692278 27445.0 33.183801126168476 0.0 - - - - - - - 277.5 54 8 FES feline sarcoma oncogene 1315 169 C20140610_SFK040_01 C20140610_SFK040_01 TB563567.[MT7]-HFIIQSLDNLYR.3b3_1.heavy 554.974 / 542.321 47001.0 40.19309997558594 45 20 10 5 10 9.583683432691732 10.434401418026951 0.04199981689453125 3 0.9951503559208168 17.714616948692278 47001.0 64.13608526737896 0.0 - - - - - - - 847.375 94 8 FES feline sarcoma oncogene 1317 169 C20140610_SFK040_01 C20140610_SFK040_01 TB563567.[MT7]-HFIIQSLDNLYR.3y5_1.heavy 554.974 / 680.336 34779.0 40.19309997558594 45 20 10 5 10 9.583683432691732 10.434401418026951 0.04199981689453125 3 0.9951503559208168 17.714616948692278 34779.0 134.6960381981982 0.0 - - - - - - - 255.3 69 10 FES feline sarcoma oncogene 1319 170 C20140610_SFK040_01 C20140610_SFK040_01 TB324483.[MT7]-ALPQTR.2y4_1.heavy 415.254 / 501.278 297138.0 18.94747543334961 44 20 10 6 8 18.767199951738395 5.328445386480633 0.03530120849609375 4 0.9991850981108992 43.22949983481528 297138.0 116.07675360064202 0.0 - - - - - - - 862.5 594 2 DFNB31 deafness, autosomal recessive 31 1321 170 C20140610_SFK040_01 C20140610_SFK040_01 TB324483.[MT7]-ALPQTR.2y5_1.heavy 415.254 / 614.362 179139.0 18.94747543334961 44 20 10 6 8 18.767199951738395 5.328445386480633 0.03530120849609375 4 0.9991850981108992 43.22949983481528 179139.0 153.4798965312471 2.0 - - - - - - - 1279.2857142857142 425 7 DFNB31 deafness, autosomal recessive 31 1323 170 C20140610_SFK040_01 C20140610_SFK040_01 TB324483.[MT7]-ALPQTR.2b4_1.heavy 415.254 / 554.342 39500.0 18.94747543334961 44 20 10 6 8 18.767199951738395 5.328445386480633 0.03530120849609375 4 0.9991850981108992 43.22949983481528 39500.0 65.63851243096526 0.0 - - - - - - - 1223.888888888889 79 9 DFNB31 deafness, autosomal recessive 31 1325 170 C20140610_SFK040_01 C20140610_SFK040_01 TB324483.[MT7]-ALPQTR.2b5_1.heavy 415.254 / 655.39 15299.0 18.94747543334961 44 20 10 6 8 18.767199951738395 5.328445386480633 0.03530120849609375 4 0.9991850981108992 43.22949983481528 15299.0 24.531536392090118 2.0 - - - - - - - 739.1428571428571 37 7 DFNB31 deafness, autosomal recessive 31 1327 171 C20140610_SFK040_01 C20140610_SFK040_01 TB563829.[MT7]-VQIVDPSQILEGINLSK[MT7].3y6_1.heavy 714.419 / 775.479 60789.0 46.81930160522461 48 18 10 10 10 4.9617033407194935 20.154369000525342 0.0 3 0.9810378780370783 8.948087899162951 60789.0 126.11896643453437 0.0 - - - - - - - 748.8333333333334 121 12 PCNX pecanex homolog (Drosophila) 1329 171 C20140610_SFK040_01 C20140610_SFK040_01 TB563829.[MT7]-VQIVDPSQILEGINLSK[MT7].3b4_1.heavy 714.419 / 584.389 68942.0 46.81930160522461 48 18 10 10 10 4.9617033407194935 20.154369000525342 0.0 3 0.9810378780370783 8.948087899162951 68942.0 119.28486219676182 0.0 - - - - - - - 1192.5 137 8 PCNX pecanex homolog (Drosophila) 1331 171 C20140610_SFK040_01 C20140610_SFK040_01 TB563829.[MT7]-VQIVDPSQILEGINLSK[MT7].3b5_1.heavy 714.419 / 699.416 138827.0 46.81930160522461 48 18 10 10 10 4.9617033407194935 20.154369000525342 0.0 3 0.9810378780370783 8.948087899162951 138827.0 150.2006506169528 0.0 - - - - - - - 703.8125 277 16 PCNX pecanex homolog (Drosophila) 1333 171 C20140610_SFK040_01 C20140610_SFK040_01 TB563829.[MT7]-VQIVDPSQILEGINLSK[MT7].3y4_1.heavy 714.419 / 605.374 64172.0 46.81930160522461 48 18 10 10 10 4.9617033407194935 20.154369000525342 0.0 3 0.9810378780370783 8.948087899162951 64172.0 87.13765296784402 0.0 - - - - - - - 1227.25 128 8 PCNX pecanex homolog (Drosophila) 1335 172 C20140610_SFK040_01 C20140610_SFK040_01 TB563233.[MT7]-SFPLSSEHAK[MT7].3y6_1.heavy 464.257 / 802.417 5609.0 24.52365016937256 39 12 10 7 10 1.6003775910956801 62.48525382783956 0.029500961303710938 3 0.8846273989824783 3.597860473934636 5609.0 4.303619047619049 1.0 - - - - - - - 275.6470588235294 11 17 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1337 172 C20140610_SFK040_01 C20140610_SFK040_01 TB563233.[MT7]-SFPLSSEHAK[MT7].3y3_1.heavy 464.257 / 499.311 35500.0 24.52365016937256 39 12 10 7 10 1.6003775910956801 62.48525382783956 0.029500961303710938 3 0.8846273989824783 3.597860473934636 35500.0 22.094736842105263 0.0 - - - - - - - 1734.4285714285713 71 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1339 172 C20140610_SFK040_01 C20140610_SFK040_01 TB563233.[MT7]-SFPLSSEHAK[MT7].3b4_1.heavy 464.257 / 589.347 15478.0 24.52365016937256 39 12 10 7 10 1.6003775910956801 62.48525382783956 0.029500961303710938 3 0.8846273989824783 3.597860473934636 15478.0 11.129800569800569 0.0 - - - - - - - 1815.5714285714287 30 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1341 172 C20140610_SFK040_01 C20140610_SFK040_01 TB563233.[MT7]-SFPLSSEHAK[MT7].3b7_1.heavy 464.257 / 892.453 2059.0 24.52365016937256 39 12 10 7 10 1.6003775910956801 62.48525382783956 0.029500961303710938 3 0.8846273989824783 3.597860473934636 2059.0 13.533333333333331 0.0 - - - - - - - 203.53333333333333 4 15 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1343 173 C20140610_SFK040_01 C20140610_SFK040_01 TB563827.[MT7]-VQIVDPSQILEGINLSK[MT7].2y4_1.heavy 1071.12 / 605.374 7273.0 46.849751472473145 38 13 10 5 10 3.4539947430826263 28.951983844292666 0.040599822998046875 3 0.9218635661768796 4.385976704148679 7273.0 16.893303283471788 0.0 - - - - - - - 208.57142857142858 14 14 PCNX pecanex homolog (Drosophila) 1345 173 C20140610_SFK040_01 C20140610_SFK040_01 TB563827.[MT7]-VQIVDPSQILEGINLSK[MT7].2y9_1.heavy 1071.12 / 1130.69 2865.0 46.849751472473145 38 13 10 5 10 3.4539947430826263 28.951983844292666 0.040599822998046875 3 0.9218635661768796 4.385976704148679 2865.0 10.34266070761181 1.0 - - - - - - - 191.3684210526316 5 19 PCNX pecanex homolog (Drosophila) 1347 173 C20140610_SFK040_01 C20140610_SFK040_01 TB563827.[MT7]-VQIVDPSQILEGINLSK[MT7].2b5_1.heavy 1071.12 / 699.416 31242.0 46.849751472473145 38 13 10 5 10 3.4539947430826263 28.951983844292666 0.040599822998046875 3 0.9218635661768796 4.385976704148679 31242.0 135.037248150061 0.0 - - - - - - - 220.42857142857142 62 7 PCNX pecanex homolog (Drosophila) 1349 173 C20140610_SFK040_01 C20140610_SFK040_01 TB563827.[MT7]-VQIVDPSQILEGINLSK[MT7].2y7_1.heavy 1071.12 / 904.522 2810.0 46.849751472473145 38 13 10 5 10 3.4539947430826263 28.951983844292666 0.040599822998046875 3 0.9218635661768796 4.385976704148679 2810.0 8.091326721606217 1.0 - - - - - - - 158.7058823529412 5 17 PCNX pecanex homolog (Drosophila) 1351 174 C20140610_SFK040_01 C20140610_SFK040_01 TB562942.[MT7]-NQALEQSK[MT7].2y4_1.heavy 603.34 / 635.348 15248.0 18.016700744628906 47 17 10 10 10 2.86338868722666 27.91286820238492 0.0 3 0.9758030852947376 7.917767531175989 15248.0 81.26272615326323 0.0 - - - - - - - 156.88235294117646 30 17 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1353 174 C20140610_SFK040_01 C20140610_SFK040_01 TB562942.[MT7]-NQALEQSK[MT7].2y5_1.heavy 603.34 / 748.432 9783.0 18.016700744628906 47 17 10 10 10 2.86338868722666 27.91286820238492 0.0 3 0.9758030852947376 7.917767531175989 9783.0 35.20006619425709 0.0 - - - - - - - 170.05 19 20 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1355 174 C20140610_SFK040_01 C20140610_SFK040_01 TB562942.[MT7]-NQALEQSK[MT7].2y3_1.heavy 603.34 / 506.306 9553.0 18.016700744628906 47 17 10 10 10 2.86338868722666 27.91286820238492 0.0 3 0.9758030852947376 7.917767531175989 9553.0 23.516820637796414 0.0 - - - - - - - 725.0 19 14 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1357 174 C20140610_SFK040_01 C20140610_SFK040_01 TB562942.[MT7]-NQALEQSK[MT7].2y6_1.heavy 603.34 / 819.469 9507.0 18.016700744628906 47 17 10 10 10 2.86338868722666 27.91286820238492 0.0 3 0.9758030852947376 7.917767531175989 9507.0 282.1098913043478 0.0 - - - - - - - 154.1764705882353 19 17 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1359 175 C20140610_SFK040_01 C20140610_SFK040_01 TB563421.[MT7]-ISQLEQDLASMR.2y8_1.heavy 767.904 / 949.441 25076.0 42.61050033569336 47 17 10 10 10 4.328806159626839 23.101057500024538 0.0 3 0.9787121434128756 8.443508483272534 25076.0 42.799860230082786 0.0 - - - - - - - 742.5 50 8 SPAG5 sperm associated antigen 5 1361 175 C20140610_SFK040_01 C20140610_SFK040_01 TB563421.[MT7]-ISQLEQDLASMR.2y5_1.heavy 767.904 / 577.313 37221.0 42.61050033569336 47 17 10 10 10 4.328806159626839 23.101057500024538 0.0 3 0.9787121434128756 8.443508483272534 37221.0 37.759514270773124 0.0 - - - - - - - 825.1111111111111 74 9 SPAG5 sperm associated antigen 5 1363 175 C20140610_SFK040_01 C20140610_SFK040_01 TB563421.[MT7]-ISQLEQDLASMR.2y9_1.heavy 767.904 / 1062.52 24465.0 42.61050033569336 47 17 10 10 10 4.328806159626839 23.101057500024538 0.0 3 0.9787121434128756 8.443508483272534 24465.0 30.507220220709407 0.0 - - - - - - - 300.8888888888889 48 9 SPAG5 sperm associated antigen 5 1365 175 C20140610_SFK040_01 C20140610_SFK040_01 TB563421.[MT7]-ISQLEQDLASMR.2y7_1.heavy 767.904 / 820.398 15116.0 42.61050033569336 47 17 10 10 10 4.328806159626839 23.101057500024538 0.0 3 0.9787121434128756 8.443508483272534 15116.0 34.3738690237043 0.0 - - - - - - - 716.5 30 10 SPAG5 sperm associated antigen 5 1367 176 C20140610_SFK040_01 C20140610_SFK040_01 TB563231.[MT7]-SAAEPVASTPASR.3y7_1.heavy 463.248 / 689.358 48814.0 19.38385009765625 46 20 10 6 10 5.390004271380283 18.552860993260737 0.03820037841796875 3 0.9930443258907103 14.789064426030366 48814.0 189.88745417515275 0.0 - - - - - - - 671.0 97 7 CSNK1E casein kinase 1, epsilon 1369 176 C20140610_SFK040_01 C20140610_SFK040_01 TB563231.[MT7]-SAAEPVASTPASR.3y6_1.heavy 463.248 / 618.321 41497.0 19.38385009765625 46 20 10 6 10 5.390004271380283 18.552860993260737 0.03820037841796875 3 0.9930443258907103 14.789064426030366 41497.0 76.54265836994475 0.0 - - - - - - - 824.5 82 10 CSNK1E casein kinase 1, epsilon 1371 176 C20140610_SFK040_01 C20140610_SFK040_01 TB563231.[MT7]-SAAEPVASTPASR.3b4_1.heavy 463.248 / 503.258 184826.0 19.38385009765625 46 20 10 6 10 5.390004271380283 18.552860993260737 0.03820037841796875 3 0.9930443258907103 14.789064426030366 184826.0 245.41913919413918 0.0 - - - - - - - 1177.7142857142858 369 7 CSNK1E casein kinase 1, epsilon 1373 176 C20140610_SFK040_01 C20140610_SFK040_01 TB563231.[MT7]-SAAEPVASTPASR.3b5_1.heavy 463.248 / 600.311 24461.0 19.38385009765625 46 20 10 6 10 5.390004271380283 18.552860993260737 0.03820037841796875 3 0.9930443258907103 14.789064426030366 24461.0 21.25249790950303 0.0 - - - - - - - 673.4444444444445 48 9 CSNK1E casein kinase 1, epsilon 1375 177 C20140610_SFK040_01 C20140610_SFK040_01 TB562567.[MT7]-LDFSVR.2b3_1.heavy 440.754 / 520.289 30377.0 32.97949981689453 48 18 10 10 10 5.873341193042736 17.02608391258709 0.0 3 0.984214823003684 9.809902629170043 30377.0 70.01493863527742 0.0 - - - - - - - 691.75 60 8 FAM134C family with sequence similarity 134, member C 1377 177 C20140610_SFK040_01 C20140610_SFK040_01 TB562567.[MT7]-LDFSVR.2y4_1.heavy 440.754 / 508.288 198042.0 32.97949981689453 48 18 10 10 10 5.873341193042736 17.02608391258709 0.0 3 0.984214823003684 9.809902629170043 198042.0 317.63453041265944 0.0 - - - - - - - 756.8571428571429 396 7 FAM134C family with sequence similarity 134, member C 1379 177 C20140610_SFK040_01 C20140610_SFK040_01 TB562567.[MT7]-LDFSVR.2y5_1.heavy 440.754 / 623.315 165781.0 32.97949981689453 48 18 10 10 10 5.873341193042736 17.02608391258709 0.0 3 0.984214823003684 9.809902629170043 165781.0 168.0110914098812 0.0 - - - - - - - 765.375 331 8 FAM134C family with sequence similarity 134, member C 1381 177 C20140610_SFK040_01 C20140610_SFK040_01 TB562567.[MT7]-LDFSVR.2b4_1.heavy 440.754 / 607.321 56516.0 32.97949981689453 48 18 10 10 10 5.873341193042736 17.02608391258709 0.0 3 0.984214823003684 9.809902629170043 56516.0 107.75316574910471 0.0 - - - - - - - 353.125 113 8 FAM134C family with sequence similarity 134, member C 1383 178 C20140610_SFK040_01 C20140610_SFK040_01 TB563138.[MT7]-ILVDQVTGVSR.2y8_1.heavy 665.894 / 861.443 80516.0 33.42449951171875 46 16 10 10 10 6.062165999183007 16.495754160060432 0.0 3 0.9620259769294288 6.312989540200646 80516.0 100.51161530299694 0.0 - - - - - - - 1254.625 161 8 ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1385 178 C20140610_SFK040_01 C20140610_SFK040_01 TB563138.[MT7]-ILVDQVTGVSR.2y9_1.heavy 665.894 / 960.511 86011.0 33.42449951171875 46 16 10 10 10 6.062165999183007 16.495754160060432 0.0 3 0.9620259769294288 6.312989540200646 86011.0 147.62106417463858 0.0 - - - - - - - 791.5 172 8 ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1387 178 C20140610_SFK040_01 C20140610_SFK040_01 TB563138.[MT7]-ILVDQVTGVSR.2y10_1.heavy 665.894 / 1073.59 170111.0 33.42449951171875 46 16 10 10 10 6.062165999183007 16.495754160060432 0.0 3 0.9620259769294288 6.312989540200646 170111.0 190.04831841898846 0.0 - - - - - - - 785.0 340 7 ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1389 178 C20140610_SFK040_01 C20140610_SFK040_01 TB563138.[MT7]-ILVDQVTGVSR.2y7_1.heavy 665.894 / 746.416 75140.0 33.42449951171875 46 16 10 10 10 6.062165999183007 16.495754160060432 0.0 3 0.9620259769294288 6.312989540200646 75140.0 139.7934081259604 0.0 - - - - - - - 250.6 150 10 ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1391 179 C20140610_SFK040_01 C20140610_SFK040_01 TB563734.[MT7]-RLTLGEALQHPFFAR.4y4_1.heavy 475.772 / 540.293 75424.0 38.672000885009766 43 13 10 10 10 1.5679752217735572 51.269518453343636 0.0 3 0.9242028755726223 4.454037601592608 75424.0 114.21247715514593 0.0 - - - - - - - 290.75 150 8 CLK2 CDC-like kinase 2 1393 179 C20140610_SFK040_01 C20140610_SFK040_01 TB563734.[MT7]-RLTLGEALQHPFFAR.4y5_1.heavy 475.772 / 637.346 187213.0 38.672000885009766 43 13 10 10 10 1.5679752217735572 51.269518453343636 0.0 3 0.9242028755726223 4.454037601592608 187213.0 579.9862574048057 0.0 - - - - - - - 318.3 374 10 CLK2 CDC-like kinase 2 1395 179 C20140610_SFK040_01 C20140610_SFK040_01 TB563734.[MT7]-RLTLGEALQHPFFAR.4b7_1.heavy 475.772 / 885.527 21917.0 38.672000885009766 43 13 10 10 10 1.5679752217735572 51.269518453343636 0.0 3 0.9242028755726223 4.454037601592608 21917.0 175.33599999999998 0.0 - - - - - - - 293.8 43 5 CLK2 CDC-like kinase 2 1397 179 C20140610_SFK040_01 C20140610_SFK040_01 TB563734.[MT7]-RLTLGEALQHPFFAR.4b6_1.heavy 475.772 / 814.49 32080.0 38.672000885009766 43 13 10 10 10 1.5679752217735572 51.269518453343636 0.0 3 0.9242028755726223 4.454037601592608 32080.0 122.30466551743314 0.0 - - - - - - - 269.2 64 10 CLK2 CDC-like kinase 2 1399 180 C20140610_SFK040_01 C20140610_SFK040_01 TB563838.[MT7]-LFSASEFEDPLVGEDTER.3y7_1.heavy 729.019 / 805.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - FDFT1 farnesyl-diphosphate farnesyltransferase 1 1401 180 C20140610_SFK040_01 C20140610_SFK040_01 TB563838.[MT7]-LFSASEFEDPLVGEDTER.3b6_1.heavy 729.019 / 779.406 N/A N/A - - - - - - - - - 0.0 - - - - - - - FDFT1 farnesyl-diphosphate farnesyltransferase 1 1403 180 C20140610_SFK040_01 C20140610_SFK040_01 TB563838.[MT7]-LFSASEFEDPLVGEDTER.3y6_1.heavy 729.019 / 706.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - FDFT1 farnesyl-diphosphate farnesyltransferase 1 1405 180 C20140610_SFK040_01 C20140610_SFK040_01 TB563838.[MT7]-LFSASEFEDPLVGEDTER.3y9_1.heavy 729.019 / 1015.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - FDFT1 farnesyl-diphosphate farnesyltransferase 1 1407 181 C20140610_SFK040_01 C20140610_SFK040_01 TB563732.[MT7]-AEVAELLVHSGDFLVR.3y7_1.heavy 633.687 / 793.42 256112.0 45.305301666259766 47 17 10 10 10 4.241528344124451 23.57640734348135 0.0 3 0.979118102984874 8.525478115162713 256112.0 369.37121010923113 0.0 - - - - - - - 702.0 512 10 FES feline sarcoma oncogene 1409 181 C20140610_SFK040_01 C20140610_SFK040_01 TB563732.[MT7]-AEVAELLVHSGDFLVR.3b6_1.heavy 633.687 / 757.421 289571.0 45.305301666259766 47 17 10 10 10 4.241528344124451 23.57640734348135 0.0 3 0.979118102984874 8.525478115162713 289571.0 458.2136667734519 0.0 - - - - - - - 720.4166666666666 579 12 FES feline sarcoma oncogene 1411 181 C20140610_SFK040_01 C20140610_SFK040_01 TB563732.[MT7]-AEVAELLVHSGDFLVR.3b5_1.heavy 633.687 / 644.337 327578.0 45.305301666259766 47 17 10 10 10 4.241528344124451 23.57640734348135 0.0 3 0.979118102984874 8.525478115162713 327578.0 551.0831536751259 0.0 - - - - - - - 1291.888888888889 655 9 FES feline sarcoma oncogene 1413 181 C20140610_SFK040_01 C20140610_SFK040_01 TB563732.[MT7]-AEVAELLVHSGDFLVR.3y8_1.heavy 633.687 / 930.479 213816.0 45.305301666259766 47 17 10 10 10 4.241528344124451 23.57640734348135 0.0 3 0.979118102984874 8.525478115162713 213816.0 500.0004923076923 0.0 - - - - - - - 682.5 427 8 FES feline sarcoma oncogene 1415 182 C20140610_SFK040_01 C20140610_SFK040_01 TB563161.[MT7]-RIEAEEAIK[MT7].3b6_1.heavy 449.601 / 872.459 16365.0 23.218599319458008 40 10 10 10 10 1.120042510459243 59.921878769519935 0.0 3 0.8227627305907016 2.887029190618902 16365.0 168.16523942136612 0.0 - - - - - - - 183.72727272727272 32 11 ELAVL2;ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1417 182 C20140610_SFK040_01 C20140610_SFK040_01 TB563161.[MT7]-RIEAEEAIK[MT7].3y3_1.heavy 449.601 / 475.336 142066.0 23.218599319458008 40 10 10 10 10 1.120042510459243 59.921878769519935 0.0 3 0.8227627305907016 2.887029190618902 142066.0 10.986654339379111 0.0 - - - - - - - 1219.0 284 2 ELAVL2;ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1419 182 C20140610_SFK040_01 C20140610_SFK040_01 TB563161.[MT7]-RIEAEEAIK[MT7].3b5_1.heavy 449.601 / 743.417 45336.0 23.218599319458008 40 10 10 10 10 1.120042510459243 59.921878769519935 0.0 3 0.8227627305907016 2.887029190618902 45336.0 119.67834767594684 0.0 - - - - - - - 795.7142857142857 90 7 ELAVL2;ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1421 182 C20140610_SFK040_01 C20140610_SFK040_01 TB563161.[MT7]-RIEAEEAIK[MT7].3b3_1.heavy 449.601 / 543.337 41227.0 23.218599319458008 40 10 10 10 10 1.120042510459243 59.921878769519935 0.0 3 0.8227627305907016 2.887029190618902 41227.0 26.280922350781637 0.0 - - - - - - - 2220.777777777778 82 9 ELAVL2;ELAVL3;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1423 183 C20140610_SFK040_01 C20140610_SFK040_01 TB562596.[MT7]-TTQGSK[MT7].2y4_1.heavy 455.266 / 563.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - POSTN periostin, osteoblast specific factor 1425 183 C20140610_SFK040_01 C20140610_SFK040_01 TB562596.[MT7]-TTQGSK[MT7].2y5_1.heavy 455.266 / 664.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - POSTN periostin, osteoblast specific factor 1427 183 C20140610_SFK040_01 C20140610_SFK040_01 TB562596.[MT7]-TTQGSK[MT7].2b4_1.heavy 455.266 / 532.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - POSTN periostin, osteoblast specific factor 1429 183 C20140610_SFK040_01 C20140610_SFK040_01 TB562596.[MT7]-TTQGSK[MT7].2b5_1.heavy 455.266 / 619.317 N/A N/A - - - - - - - - - 0.0 - - - - - - - POSTN periostin, osteoblast specific factor 1431 184 C20140610_SFK040_01 C20140610_SFK040_01 TB563832.[MT7]-EEEAGGFIANLEPVSLADR.3y7_1.heavy 721.035 / 757.42 22764.0 42.78282451629639 44 18 10 6 10 3.2956659506078907 24.102156251818776 0.037097930908203125 3 0.9845727651915189 9.923352271917471 22764.0 10.190121440399011 0.0 - - - - - - - 417.0 45 1 EXOSC2 exosome component 2 1433 184 C20140610_SFK040_01 C20140610_SFK040_01 TB563832.[MT7]-EEEAGGFIANLEPVSLADR.3b6_1.heavy 721.035 / 717.317 12424.0 42.78282451629639 44 18 10 6 10 3.2956659506078907 24.102156251818776 0.037097930908203125 3 0.9845727651915189 9.923352271917471 12424.0 8.759381795912596 0.0 - - - - - - - 1198.75 24 8 EXOSC2 exosome component 2 1435 184 C20140610_SFK040_01 C20140610_SFK040_01 TB563832.[MT7]-EEEAGGFIANLEPVSLADR.3y8_1.heavy 721.035 / 886.463 8172.0 42.78282451629639 44 18 10 6 10 3.2956659506078907 24.102156251818776 0.037097930908203125 3 0.9845727651915189 9.923352271917471 8172.0 16.018087774294674 0.0 - - - - - - - 742.0 16 10 EXOSC2 exosome component 2 1437 184 C20140610_SFK040_01 C20140610_SFK040_01 TB563832.[MT7]-EEEAGGFIANLEPVSLADR.3b7_1.heavy 721.035 / 864.386 16427.0 42.78282451629639 44 18 10 6 10 3.2956659506078907 24.102156251818776 0.037097930908203125 3 0.9845727651915189 9.923352271917471 16427.0 19.004797669934835 1.0 - - - - - - - 334.0 32 2 EXOSC2 exosome component 2 1439 185 C20140610_SFK040_01 C20140610_SFK040_01 TB563163.[MT7]-NC[CAM]IISLVTQR.2b3_1.heavy 674.38 / 532.267 34452.0 38.20650100708008 46 16 10 10 10 1.875768138642122 37.73268381592213 0.0 3 0.9677039944117278 6.848763188163692 34452.0 14.572560145698635 1.0 - - - - - - - 373.0 69 1 EXOSC2 exosome component 2 1441 185 C20140610_SFK040_01 C20140610_SFK040_01 TB563163.[MT7]-NC[CAM]IISLVTQR.2y9_1.heavy 674.38 / 1089.61 52610.0 38.20650100708008 46 16 10 10 10 1.875768138642122 37.73268381592213 0.0 3 0.9677039944117278 6.848763188163692 52610.0 43.89824217457481 0.0 - - - - - - - 373.0 105 3 EXOSC2 exosome component 2 1443 185 C20140610_SFK040_01 C20140610_SFK040_01 TB563163.[MT7]-NC[CAM]IISLVTQR.2y6_1.heavy 674.38 / 703.41 39676.0 38.20650100708008 46 16 10 10 10 1.875768138642122 37.73268381592213 0.0 3 0.9677039944117278 6.848763188163692 39676.0 36.57403465345106 0.0 - - - - - - - 373.0 79 2 EXOSC2 exosome component 2 1445 185 C20140610_SFK040_01 C20140610_SFK040_01 TB563163.[MT7]-NC[CAM]IISLVTQR.2y7_1.heavy 674.38 / 816.494 39924.0 38.20650100708008 46 16 10 10 10 1.875768138642122 37.73268381592213 0.0 3 0.9677039944117278 6.848763188163692 39924.0 57.7268378721603 0.0 - - - - - - - 414.3333333333333 79 3 EXOSC2 exosome component 2 1447 186 C20140610_SFK040_01 C20140610_SFK040_01 TB562876.[MT7]-GLDVEDVK[MT7].2y4_1.heavy 581.832 / 634.353 13084.0 28.448832829793293 46 20 10 6 10 7.4944719467102345 13.343168232672603 0.038299560546875 3 0.9968232347185654 21.890453956738085 13084.0 4.505066404328578 0.0 - - - - - - - 1713.0 26 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1449 186 C20140610_SFK040_01 C20140610_SFK040_01 TB562876.[MT7]-GLDVEDVK[MT7].2y5_1.heavy 581.832 / 733.421 25284.0 28.448832829793293 46 20 10 6 10 7.4944719467102345 13.343168232672603 0.038299560546875 3 0.9968232347185654 21.890453956738085 25284.0 29.947493121864376 0.0 - - - - - - - 773.375 50 8 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1451 186 C20140610_SFK040_01 C20140610_SFK040_01 TB562876.[MT7]-GLDVEDVK[MT7].2b4_1.heavy 581.832 / 529.31 N/A 28.448832829793293 46 20 10 6 10 7.4944719467102345 13.343168232672603 0.038299560546875 3 0.9968232347185654 21.890453956738085 12730.0 5.415052660779308 3.0 - - - - - - - 1635.5 25 2 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1453 186 C20140610_SFK040_01 C20140610_SFK040_01 TB562876.[MT7]-GLDVEDVK[MT7].2b6_1.heavy 581.832 / 773.38 44733.0 28.448832829793293 46 20 10 6 10 7.4944719467102345 13.343168232672603 0.038299560546875 3 0.9968232347185654 21.890453956738085 44733.0 51.40925386367908 0.0 - - - - - - - 1168.888888888889 89 9 DDX17;DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17;DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1455 187 C20140610_SFK040_01 C20140610_SFK040_01 TB562592.[MT7]-DSAQAK[MT7].2y4_1.heavy 454.258 / 561.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - FES feline sarcoma oncogene 1457 187 C20140610_SFK040_01 C20140610_SFK040_01 TB562592.[MT7]-DSAQAK[MT7].2y5_1.heavy 454.258 / 648.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - FES feline sarcoma oncogene 1459 187 C20140610_SFK040_01 C20140610_SFK040_01 TB562592.[MT7]-DSAQAK[MT7].2b4_1.heavy 454.258 / 546.264 N/A N/A - - - - - - - - - 0.0 - - - - - - - FES feline sarcoma oncogene 1461 187 C20140610_SFK040_01 C20140610_SFK040_01 TB562592.[MT7]-DSAQAK[MT7].2b5_1.heavy 454.258 / 617.301 N/A N/A - - - - - - - - - 0.0 - - - - - - - FES feline sarcoma oncogene 1463 188 C20140610_SFK040_01 C20140610_SFK040_01 TB563836.[MT7]-DLVSLGQAAPDLHVLSEDR.3y6_1.heavy 727.054 / 718.373 76584.0 39.50920104980469 48 18 10 10 10 3.71201556720839 21.771841586585037 0.0 3 0.9833698601497479 9.556760684495176 76584.0 29.1953854791211 0.0 - - - - - - - 937.0 153 1 FBXO32 F-box protein 32 1465 188 C20140610_SFK040_01 C20140610_SFK040_01 TB563836.[MT7]-DLVSLGQAAPDLHVLSEDR.3b4_1.heavy 727.054 / 559.321 67450.0 39.50920104980469 48 18 10 10 10 3.71201556720839 21.771841586585037 0.0 3 0.9833698601497479 9.556760684495176 67450.0 38.17910421477105 0.0 - - - - - - - 703.0 134 3 FBXO32 F-box protein 32 1467 188 C20140610_SFK040_01 C20140610_SFK040_01 TB563836.[MT7]-DLVSLGQAAPDLHVLSEDR.3y5_1.heavy 727.054 / 619.305 99184.0 39.50920104980469 48 18 10 10 10 3.71201556720839 21.771841586585037 0.0 3 0.9833698601497479 9.556760684495176 99184.0 88.7781762574506 0.0 - - - - - - - 351.0 198 1 FBXO32 F-box protein 32 1469 188 C20140610_SFK040_01 C20140610_SFK040_01 TB563836.[MT7]-DLVSLGQAAPDLHVLSEDR.3y10_1.heavy 727.054 / 1180.6 100589.0 39.50920104980469 48 18 10 10 10 3.71201556720839 21.771841586585037 0.0 3 0.9833698601497479 9.556760684495176 100589.0 60.87150062584464 0.0 - - - - - - - 234.0 201 2 FBXO32 F-box protein 32 1471 189 C20140610_SFK040_01 C20140610_SFK040_01 TB563537.[MT7]-DVHEGQPLLNVK[MT7].3b6_1.heavy 546.314 / 810.386 62168.0 27.972350120544434 34 18 2 6 8 3.93212934738941 25.43151335201912 0.03949928283691406 4 0.9801652954320069 8.748408121406605 62168.0 140.215760871202 0.0 - - - - - - - 721.4 124 10 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1473 189 C20140610_SFK040_01 C20140610_SFK040_01 TB563537.[MT7]-DVHEGQPLLNVK[MT7].3y3_1.heavy 546.314 / 504.326 138934.0 27.972350120544434 34 18 2 6 8 3.93212934738941 25.43151335201912 0.03949928283691406 4 0.9801652954320069 8.748408121406605 138934.0 86.81465765343415 1.0 - - - - - - - 1230.6666666666667 916 3 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1475 189 C20140610_SFK040_01 C20140610_SFK040_01 TB563537.[MT7]-DVHEGQPLLNVK[MT7].3b5_1.heavy 546.314 / 682.328 28852.0 27.972350120544434 34 18 2 6 8 3.93212934738941 25.43151335201912 0.03949928283691406 4 0.9801652954320069 8.748408121406605 28852.0 32.75142068207233 0.0 - - - - - - - 1152.857142857143 57 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1477 189 C20140610_SFK040_01 C20140610_SFK040_01 TB563537.[MT7]-DVHEGQPLLNVK[MT7].3y4_1.heavy 546.314 / 617.41 133438.0 27.972350120544434 34 18 2 6 8 3.93212934738941 25.43151335201912 0.03949928283691406 4 0.9801652954320069 8.748408121406605 133438.0 85.92737031774801 0.0 - - - - - - - 1214.2857142857142 266 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1479 190 C20140610_SFK040_01 C20140610_SFK040_01 TB458363.[MT7]-ELQGLLEFLS.2b4_1.heavy 646.865 / 572.316 520.0 54.74409866333008 33 3 10 10 10 0.4986735507595551 99.94388206267527 0.0 3 0.5180901650940135 1.7008026408620565 520.0 -0.1290951810967772 15.0 - - - - - - - 0.0 1 0 SPAG5 sperm associated antigen 5 1481 190 C20140610_SFK040_01 C20140610_SFK040_01 TB458363.[MT7]-ELQGLLEFLS.2b6_1.heavy 646.865 / 798.484 8852.0 54.74409866333008 33 3 10 10 10 0.4986735507595551 99.94388206267527 0.0 3 0.5180901650940135 1.7008026408620565 8852.0 50.215151995770555 0.0 - - - - - - - 71.82142857142857 17 56 SPAG5 sperm associated antigen 5 1483 190 C20140610_SFK040_01 C20140610_SFK040_01 TB458363.[MT7]-ELQGLLEFLS.2b7_1.heavy 646.865 / 927.527 43101.0 54.74409866333008 33 3 10 10 10 0.4986735507595551 99.94388206267527 0.0 3 0.5180901650940135 1.7008026408620565 43101.0 -4.845531197301854 0.0 - - - - - - - 66.85964912280701 86 57 SPAG5 sperm associated antigen 5 1485 190 C20140610_SFK040_01 C20140610_SFK040_01 TB458363.[MT7]-ELQGLLEFLS.2b5_1.heavy 646.865 / 685.4 6846.0 54.74409866333008 33 3 10 10 10 0.4986735507595551 99.94388206267527 0.0 3 0.5180901650940135 1.7008026408620565 6846.0 -1.0875297855440824 0.0 - - - - - - - 93.56140350877193 13 57 SPAG5 sperm associated antigen 5 1487 191 C20140610_SFK040_01 C20140610_SFK040_01 TB458362.[MT7]-FLIYAQDK[MT7].2b3_1.heavy 643.373 / 518.346 59557.0 35.39350128173828 44 14 10 10 10 1.1718567588622582 52.20478773841387 0.0 3 0.9372192587218157 4.899484925285944 59557.0 48.66444186265224 0.0 - - - - - - - 757.0 119 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1489 191 C20140610_SFK040_01 C20140610_SFK040_01 TB458362.[MT7]-FLIYAQDK[MT7].2y4_1.heavy 643.373 / 605.338 32176.0 35.39350128173828 44 14 10 10 10 1.1718567588622582 52.20478773841387 0.0 3 0.9372192587218157 4.899484925285944 32176.0 20.883917937863323 0.0 - - - - - - - 757.0 64 2 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1491 191 C20140610_SFK040_01 C20140610_SFK040_01 TB458362.[MT7]-FLIYAQDK[MT7].2y5_1.heavy 643.373 / 768.401 59305.0 35.39350128173828 44 14 10 10 10 1.1718567588622582 52.20478773841387 0.0 3 0.9372192587218157 4.899484925285944 59305.0 39.693350946719505 0.0 - - - - - - - 1730.5714285714287 118 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1493 191 C20140610_SFK040_01 C20140610_SFK040_01 TB458362.[MT7]-FLIYAQDK[MT7].2y6_1.heavy 643.373 / 881.485 24479.0 35.39350128173828 44 14 10 10 10 1.1718567588622582 52.20478773841387 0.0 3 0.9372192587218157 4.899484925285944 24479.0 53.363183554089815 0.0 - - - - - - - 673.0 48 12 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1495 192 C20140610_SFK040_01 C20140610_SFK040_01 TB458469.[MT7]-ESAEVEEIVFPR.2b4_1.heavy 774.905 / 561.264 30187.0 38.388976097106934 39 16 10 5 8 3.637609519484807 22.380280539549204 0.041500091552734375 4 0.9614145507192404 6.2624482509743595 30187.0 17.3474772381822 1.0 - - - - - - - 313.5 60 2 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1497 192 C20140610_SFK040_01 C20140610_SFK040_01 TB458469.[MT7]-ESAEVEEIVFPR.2y6_1.heavy 774.905 / 760.435 5887.0 38.388976097106934 39 16 10 5 8 3.637609519484807 22.380280539549204 0.041500091552734375 4 0.9614145507192404 6.2624482509743595 5887.0 1.9026213120002775 3.0 - - - - - - - 251.0 21 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1499 192 C20140610_SFK040_01 C20140610_SFK040_01 TB458469.[MT7]-ESAEVEEIVFPR.2b7_1.heavy 774.905 / 918.417 10647.0 38.388976097106934 39 16 10 5 8 3.637609519484807 22.380280539549204 0.041500091552734375 4 0.9614145507192404 6.2624482509743595 10647.0 5.861883623757806 1.0 - - - - - - - 250.75 27 4 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1501 192 C20140610_SFK040_01 C20140610_SFK040_01 TB458469.[MT7]-ESAEVEEIVFPR.2y7_1.heavy 774.905 / 889.478 14530.0 38.388976097106934 39 16 10 5 8 3.637609519484807 22.380280539549204 0.041500091552734375 4 0.9614145507192404 6.2624482509743595 14530.0 9.463314106009754 1.0 - - - - - - - 125.0 31 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1503 193 C20140610_SFK040_01 C20140610_SFK040_01 TB458369.[MT7]-AK[MT7]PVDVDK[MT7].3y6_1.heavy 435.27 / 816.458 15120.0 19.429899215698242 42 12 10 10 10 1.077229827035861 67.1402243661905 0.0 3 0.8988810482555094 3.8478370681816627 15120.0 73.89656055454986 0.0 - - - - - - - 184.78947368421052 30 19 PCNX pecanex homolog (Drosophila) 1505 193 C20140610_SFK040_01 C20140610_SFK040_01 TB458369.[MT7]-AK[MT7]PVDVDK[MT7].3y3_1.heavy 435.27 / 505.31 81456.0 19.429899215698242 42 12 10 10 10 1.077229827035861 67.1402243661905 0.0 3 0.8988810482555094 3.8478370681816627 81456.0 106.47843137254901 0.0 - - - - - - - 1224.4 162 10 PCNX pecanex homolog (Drosophila) 1507 193 C20140610_SFK040_01 C20140610_SFK040_01 TB458369.[MT7]-AK[MT7]PVDVDK[MT7].3y4_1.heavy 435.27 / 620.337 41420.0 19.429899215698242 42 12 10 10 10 1.077229827035861 67.1402243661905 0.0 3 0.8988810482555094 3.8478370681816627 41420.0 78.30780817919633 0.0 - - - - - - - 692.1818181818181 82 11 PCNX pecanex homolog (Drosophila) 1509 193 C20140610_SFK040_01 C20140610_SFK040_01 TB458369.[MT7]-AK[MT7]PVDVDK[MT7].3y5_1.heavy 435.27 / 719.406 11659.0 19.429899215698242 42 12 10 10 10 1.077229827035861 67.1402243661905 0.0 3 0.8988810482555094 3.8478370681816627 11659.0 49.620206059820404 0.0 - - - - - - - 263.22222222222223 23 18 PCNX pecanex homolog (Drosophila) 1511 194 C20140610_SFK040_01 C20140610_SFK040_01 TB563437.[MT7]-HLTPVTLELGGK[MT7].3b6_1.heavy 518.315 / 793.469 26824.0 32.86050033569336 47 17 10 10 10 4.584185787878793 17.187320422137997 0.0 3 0.9783554775192184 8.373401132338879 26824.0 76.63002909520993 0.0 - - - - - - - 377.6363636363636 53 11 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 1513 194 C20140610_SFK040_01 C20140610_SFK040_01 TB563437.[MT7]-HLTPVTLELGGK[MT7].3b5_1.heavy 518.315 / 692.421 49732.0 32.86050033569336 47 17 10 10 10 4.584185787878793 17.187320422137997 0.0 3 0.9783554775192184 8.373401132338879 49732.0 41.416798998368336 0.0 - - - - - - - 712.0 99 9 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 1515 194 C20140610_SFK040_01 C20140610_SFK040_01 TB563437.[MT7]-HLTPVTLELGGK[MT7].3b8_1.heavy 518.315 / 1035.6 10801.0 32.86050033569336 47 17 10 10 10 4.584185787878793 17.187320422137997 0.0 3 0.9783554775192184 8.373401132338879 10801.0 85.67881856540085 0.0 - - - - - - - 197.77777777777777 21 9 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 1517 194 C20140610_SFK040_01 C20140610_SFK040_01 TB563437.[MT7]-HLTPVTLELGGK[MT7].3y5_1.heavy 518.315 / 647.385 54717.0 32.86050033569336 47 17 10 10 10 4.584185787878793 17.187320422137997 0.0 3 0.9783554775192184 8.373401132338879 54717.0 61.290887963385714 0.0 - - - - - - - 356.0 109 2 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 1519 195 C20140610_SFK040_01 C20140610_SFK040_01 TB563025.[MT7]-LLQEEVTK[MT7].2y4_1.heavy 624.376 / 620.374 27827.0 29.205699920654297 42 14 10 10 8 3.7397643347217637 26.739652836290265 0.0 4 0.9488493704642453 5.433354810645305 27827.0 15.581608758119458 0.0 - - - - - - - 2228.4285714285716 55 7 POSTN periostin, osteoblast specific factor 1521 195 C20140610_SFK040_01 C20140610_SFK040_01 TB563025.[MT7]-LLQEEVTK[MT7].2y5_1.heavy 624.376 / 749.416 26094.0 29.205699920654297 42 14 10 10 8 3.7397643347217637 26.739652836290265 0.0 4 0.9488493704642453 5.433354810645305 26094.0 29.597541651294687 0.0 - - - - - - - 715.4285714285714 52 7 POSTN periostin, osteoblast specific factor 1523 195 C20140610_SFK040_01 C20140610_SFK040_01 TB563025.[MT7]-LLQEEVTK[MT7].2y6_1.heavy 624.376 / 877.475 28405.0 29.205699920654297 42 14 10 10 8 3.7397643347217637 26.739652836290265 0.0 4 0.9488493704642453 5.433354810645305 28405.0 54.387788544415315 1.0 - - - - - - - 784.1428571428571 60 7 POSTN periostin, osteoblast specific factor 1525 195 C20140610_SFK040_01 C20140610_SFK040_01 TB563025.[MT7]-LLQEEVTK[MT7].2y7_1.heavy 624.376 / 990.559 61624.0 29.205699920654297 42 14 10 10 8 3.7397643347217637 26.739652836290265 0.0 4 0.9488493704642453 5.433354810645305 61624.0 57.32393083217106 0.0 - - - - - - - 417.0 123 3 POSTN periostin, osteoblast specific factor 1527 196 C20140610_SFK040_01 C20140610_SFK040_01 TB562693.[MT7]-WQVAVK[MT7].2b3_1.heavy 509.818 / 558.316 27636.0 29.527700424194336 38 20 0 10 8 8.94410986054494 11.18054245298674 0.0 4 0.9959996232777324 19.505946972918412 27636.0 13.38392595555397 0.0 - - - - - - - 924.3333333333334 55 3 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1529 196 C20140610_SFK040_01 C20140610_SFK040_01 TB562693.[MT7]-WQVAVK[MT7].2y4_1.heavy 509.818 / 560.389 55668.0 29.527700424194336 38 20 0 10 8 8.94410986054494 11.18054245298674 0.0 4 0.9959996232777324 19.505946972918412 55668.0 57.56147532320975 1.0 - - - - - - - 330.0 451 3 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1531 196 C20140610_SFK040_01 C20140610_SFK040_01 TB562693.[MT7]-WQVAVK[MT7].2y5_1.heavy 509.818 / 688.447 42791.0 29.527700424194336 38 20 0 10 8 8.94410986054494 11.18054245298674 0.0 4 0.9959996232777324 19.505946972918412 42791.0 22.341280891054645 0.0 - - - - - - - 806.2857142857143 85 7 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1533 196 C20140610_SFK040_01 C20140610_SFK040_01 TB562693.[MT7]-WQVAVK[MT7].2b4_1.heavy 509.818 / 629.353 25952.0 29.527700424194336 38 20 0 10 8 8.94410986054494 11.18054245298674 0.0 4 0.9959996232777324 19.505946972918412 25952.0 27.36385866517106 0.0 - - - - - - - 1696.375 51 8 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1535 197 C20140610_SFK040_01 C20140610_SFK040_01 TB324657.[MT7]-SFAAVIQALDGEMR.2y9_1.heavy 826.433 / 1032.51 38929.0 50.65869903564453 42 12 10 10 10 1.3067707764624696 50.934895275457066 0.0 3 0.8974773317798448 3.8209400249101866 38929.0 81.17482062780269 0.0 - - - - - - - 776.875 77 8 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1537 197 C20140610_SFK040_01 C20140610_SFK040_01 TB324657.[MT7]-SFAAVIQALDGEMR.2b4_1.heavy 826.433 / 521.284 45299.0 50.65869903564453 42 12 10 10 10 1.3067707764624696 50.934895275457066 0.0 3 0.8974773317798448 3.8209400249101866 45299.0 99.0013626675057 0.0 - - - - - - - 659.4285714285714 90 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1539 197 C20140610_SFK040_01 C20140610_SFK040_01 TB324657.[MT7]-SFAAVIQALDGEMR.2y10_1.heavy 826.433 / 1131.58 16525.0 50.65869903564453 42 12 10 10 10 1.3067707764624696 50.934895275457066 0.0 3 0.8974773317798448 3.8209400249101866 16525.0 38.917111027793396 0.0 - - - - - - - 665.8181818181819 33 11 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1541 197 C20140610_SFK040_01 C20140610_SFK040_01 TB324657.[MT7]-SFAAVIQALDGEMR.2b5_1.heavy 826.433 / 620.352 49053.0 50.65869903564453 42 12 10 10 10 1.3067707764624696 50.934895275457066 0.0 3 0.8974773317798448 3.8209400249101866 49053.0 112.83189465745812 0.0 - - - - - - - 666.7777777777778 98 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1543 198 C20140610_SFK040_01 C20140610_SFK040_01 TB563433.[MT7]-ESAEVEEIVFPR.3b4_1.heavy 516.939 / 561.264 73970.0 38.324724197387695 40 17 10 5 8 3.0049644971036082 26.410353706853137 0.04309844970703125 4 0.9728822528749848 7.477376116025447 73970.0 87.6127523846293 0.0 - - - - - - - 1285.0 147 3 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1545 198 C20140610_SFK040_01 C20140610_SFK040_01 TB563433.[MT7]-ESAEVEEIVFPR.3b5_1.heavy 516.939 / 660.332 27972.0 38.324724197387695 40 17 10 5 8 3.0049644971036082 26.410353706853137 0.04309844970703125 4 0.9728822528749848 7.477376116025447 27972.0 0.7763062716652016 1.0 - - - - - - - 249.0 64 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1547 198 C20140610_SFK040_01 C20140610_SFK040_01 TB563433.[MT7]-ESAEVEEIVFPR.3y4_1.heavy 516.939 / 518.308 79564.0 38.324724197387695 40 17 10 5 8 3.0049644971036082 26.410353706853137 0.04309844970703125 4 0.9728822528749848 7.477376116025447 79564.0 49.500030922453846 0.0 - - - - - - - 1368.0 159 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1549 198 C20140610_SFK040_01 C20140610_SFK040_01 TB563433.[MT7]-ESAEVEEIVFPR.3y5_1.heavy 516.939 / 631.393 26604.0 38.324724197387695 40 17 10 5 8 3.0049644971036082 26.410353706853137 0.04309844970703125 4 0.9728822528749848 7.477376116025447 26604.0 18.612982102813625 0.0 - - - - - - - 414.3333333333333 53 3 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1551 199 C20140610_SFK040_01 C20140610_SFK040_01 TB563021.[MT7]-LEINVLEK[MT7].3y3_1.heavy 415.927 / 533.341 82125.0 37.009498596191406 50 20 10 10 10 7.539160128823639 13.264076938448493 0.0 3 0.9917388247575616 13.568817978401816 82125.0 63.82734442539841 1.0 - - - - - - - 275.8333333333333 193 6 CLK2 CDC-like kinase 2 1553 199 C20140610_SFK040_01 C20140610_SFK040_01 TB563021.[MT7]-LEINVLEK[MT7].3b4_1.heavy 415.927 / 614.363 144515.0 37.009498596191406 50 20 10 10 10 7.539160128823639 13.264076938448493 0.0 3 0.9917388247575616 13.568817978401816 144515.0 427.03769240535405 0.0 - - - - - - - 276.0 289 6 CLK2 CDC-like kinase 2 1555 199 C20140610_SFK040_01 C20140610_SFK040_01 TB563021.[MT7]-LEINVLEK[MT7].3b5_1.heavy 415.927 / 713.431 32468.0 37.009498596191406 50 20 10 10 10 7.539160128823639 13.264076938448493 0.0 3 0.9917388247575616 13.568817978401816 32468.0 44.853449152481275 0.0 - - - - - - - 181.71428571428572 64 7 CLK2 CDC-like kinase 2 1557 199 C20140610_SFK040_01 C20140610_SFK040_01 TB563021.[MT7]-LEINVLEK[MT7].3b3_1.heavy 415.927 / 500.32 76650.0 37.009498596191406 50 20 10 10 10 7.539160128823639 13.264076938448493 0.0 3 0.9917388247575616 13.568817978401816 76650.0 84.16187142686691 0.0 - - - - - - - 255.0 153 3 CLK2 CDC-like kinase 2 1559 200 C20140610_SFK040_01 C20140610_SFK040_01 TB562688.[MT7]-WSLIAK[MT7].2y4_1.heavy 503.32 / 588.42 40296.0 34.94160079956055 50 20 10 10 10 27.764388277217403 3.6017361161188237 0.0 3 0.999232546394527 44.54598078656403 40296.0 31.346922997319503 0.0 - - - - - - - 1180.3333333333333 80 3 AK5;MYBL1 adenylate kinase 5;v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1561 200 C20140610_SFK040_01 C20140610_SFK040_01 TB562688.[MT7]-WSLIAK[MT7].2b3_1.heavy 503.32 / 531.305 53728.0 34.94160079956055 50 20 10 10 10 27.764388277217403 3.6017361161188237 0.0 3 0.999232546394527 44.54598078656403 53728.0 55.972726374014364 0.0 - - - - - - - 1343.0 107 8 AK5;MYBL1 adenylate kinase 5;v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1563 200 C20140610_SFK040_01 C20140610_SFK040_01 TB562688.[MT7]-WSLIAK[MT7].2y5_1.heavy 503.32 / 675.452 126506.0 34.94160079956055 50 20 10 10 10 27.764388277217403 3.6017361161188237 0.0 3 0.999232546394527 44.54598078656403 126506.0 161.27386971552576 0.0 - - - - - - - 746.5555555555555 253 9 AK5;MYBL1 adenylate kinase 5;v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1565 200 C20140610_SFK040_01 C20140610_SFK040_01 TB562688.[MT7]-WSLIAK[MT7].2b4_1.heavy 503.32 / 644.389 26986.0 34.94160079956055 50 20 10 10 10 27.764388277217403 3.6017361161188237 0.0 3 0.999232546394527 44.54598078656403 26986.0 63.354321046148016 0.0 - - - - - - - 341.6 53 5 AK5;MYBL1 adenylate kinase 5;v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1567 201 C20140610_SFK040_01 C20140610_SFK040_01 TB562869.[MT7]-VVEDGILK[MT7].2y4_1.heavy 580.86 / 574.404 69011.0 30.041400909423828 43 15 8 10 10 5.614671115622631 17.810482206473928 0.0 3 0.9523029773457663 5.628273915369918 69011.0 29.06172369391786 0.0 - - - - - - - 1955.0 138 3 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1569 201 C20140610_SFK040_01 C20140610_SFK040_01 TB562869.[MT7]-VVEDGILK[MT7].2y6_1.heavy 580.86 / 818.474 29217.0 30.041400909423828 43 15 8 10 10 5.614671115622631 17.810482206473928 0.0 3 0.9523029773457663 5.628273915369918 29217.0 58.60307009409726 0.0 - - - - - - - 643.2857142857143 58 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1571 201 C20140610_SFK040_01 C20140610_SFK040_01 TB562869.[MT7]-VVEDGILK[MT7].2b5_1.heavy 580.86 / 644.337 12671.0 30.041400909423828 43 15 8 10 10 5.614671115622631 17.810482206473928 0.0 3 0.9523029773457663 5.628273915369918 12671.0 20.23840277777778 2.0 - - - - - - - 335.0 196 5 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1573 201 C20140610_SFK040_01 C20140610_SFK040_01 TB562869.[MT7]-VVEDGILK[MT7].2y7_1.heavy 580.86 / 917.542 55502.0 30.041400909423828 43 15 8 10 10 5.614671115622631 17.810482206473928 0.0 3 0.9523029773457663 5.628273915369918 55502.0 73.83133322901617 0.0 - - - - - - - 1279.888888888889 111 9 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1575 202 C20140610_SFK040_01 C20140610_SFK040_01 TB563019.[MT7]-LIASVAGSVER.2y8_1.heavy 623.368 / 804.421 153306.0 34.17689895629883 47 17 10 10 10 3.818422508253541 20.687666377927307 0.0 3 0.9766223863593084 8.055872195344847 153306.0 115.76506742791892 0.0 - - - - - - - 302.5 306 2 EXOSC2 exosome component 2 1577 202 C20140610_SFK040_01 C20140610_SFK040_01 TB563019.[MT7]-LIASVAGSVER.2y9_1.heavy 623.368 / 875.458 224994.0 34.17689895629883 47 17 10 10 10 3.818422508253541 20.687666377927307 0.0 3 0.9766223863593084 8.055872195344847 224994.0 219.94907206905543 0.0 - - - - - - - 338.8 449 5 EXOSC2 exosome component 2 1579 202 C20140610_SFK040_01 C20140610_SFK040_01 TB563019.[MT7]-LIASVAGSVER.2y6_1.heavy 623.368 / 618.321 153185.0 34.17689895629883 47 17 10 10 10 3.818422508253541 20.687666377927307 0.0 3 0.9766223863593084 8.055872195344847 153185.0 104.79924736586462 0.0 - - - - - - - 1332.0 306 1 EXOSC2 exosome component 2 1581 202 C20140610_SFK040_01 C20140610_SFK040_01 TB563019.[MT7]-LIASVAGSVER.2y10_1.heavy 623.368 / 988.542 322233.0 34.17689895629883 47 17 10 10 10 3.818422508253541 20.687666377927307 0.0 3 0.9766223863593084 8.055872195344847 322233.0 508.4923697172271 0.0 - - - - - - - 443.6666666666667 644 3 EXOSC2 exosome component 2 1583 203 C20140610_SFK040_01 C20140610_SFK040_01 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 1021500.0 44.33130137125651 23 -3 10 6 10 null 0.0 0.03749847412109375 3 0.0 0.0 1021500.0 1177.1602907157694 0.0 - - - - - - - 412.0 2043 1 1585 203 C20140610_SFK040_01 C20140610_SFK040_01 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 1715510.0 44.33130137125651 23 -3 10 6 10 null 0.0 0.03749847412109375 3 0.0 0.0 1715510.0 648.7502545386574 0.0 - - - - - - - 1167.0 3431 2 1587 203 C20140610_SFK040_01 C20140610_SFK040_01 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 1598200.0 44.33130137125651 23 -3 10 6 10 null 0.0 0.03749847412109375 3 0.0 0.0 1598200.0 1169.9205331070457 0.0 - - - - - - - 961.0 3196 1 1589 204 C20140610_SFK040_01 C20140610_SFK040_01 TB563296.[MT7]-EAAAALVEEETR.3y6_1.heavy 478.252 / 762.363 82142.0 30.95560073852539 50 20 10 10 10 7.347108431055683 13.610796810525814 0.0 3 0.9924261238099005 14.17192286570315 82142.0 130.85812150002215 0.0 - - - - - - - 800.375 164 8 BCAS2 breast carcinoma amplified sequence 2 1591 204 C20140610_SFK040_01 C20140610_SFK040_01 TB563296.[MT7]-EAAAALVEEETR.3b4_1.heavy 478.252 / 487.263 329451.0 30.95560073852539 50 20 10 10 10 7.347108431055683 13.610796810525814 0.0 3 0.9924261238099005 14.17192286570315 329451.0 116.78369907610764 0.0 - - - - - - - 1214.0 658 1 BCAS2 breast carcinoma amplified sequence 2 1593 204 C20140610_SFK040_01 C20140610_SFK040_01 TB563296.[MT7]-EAAAALVEEETR.3b5_1.heavy 478.252 / 558.3 445487.0 30.95560073852539 50 20 10 10 10 7.347108431055683 13.610796810525814 0.0 3 0.9924261238099005 14.17192286570315 445487.0 237.8144152554959 0.0 - - - - - - - 1214.0 890 1 BCAS2 breast carcinoma amplified sequence 2 1595 204 C20140610_SFK040_01 C20140610_SFK040_01 TB563296.[MT7]-EAAAALVEEETR.3y5_1.heavy 478.252 / 663.294 282308.0 30.95560073852539 50 20 10 10 10 7.347108431055683 13.610796810525814 0.0 3 0.9924261238099005 14.17192286570315 282308.0 220.58184937834113 0.0 - - - - - - - 386.5 564 2 BCAS2 breast carcinoma amplified sequence 2 1597 205 C20140610_SFK040_01 C20140610_SFK040_01 TB563017.[MT7]-THSQDIEK[MT7].3y3_1.heavy 415.894 / 533.341 113857.0 16.24679946899414 38 8 10 10 10 1.4819252343657683 62.58721803394192 0.0 3 0.7921782413713848 2.6588348041863936 113857.0 96.39074855970105 0.0 - - - - - - - 1237.6666666666667 227 9 FES feline sarcoma oncogene 1599 205 C20140610_SFK040_01 C20140610_SFK040_01 TB563017.[MT7]-THSQDIEK[MT7].3b5_1.heavy 415.894 / 713.333 51841.0 16.24679946899414 38 8 10 10 10 1.4819252343657683 62.58721803394192 0.0 3 0.7921782413713848 2.6588348041863936 51841.0 86.05807858000911 0.0 - - - - - - - 269.35 103 20 FES feline sarcoma oncogene 1601 205 C20140610_SFK040_01 C20140610_SFK040_01 TB563017.[MT7]-THSQDIEK[MT7].3b5_2.heavy 415.894 / 357.17 369051.0 16.24679946899414 38 8 10 10 10 1.4819252343657683 62.58721803394192 0.0 3 0.7921782413713848 2.6588348041863936 369051.0 81.34099399332402 0.0 - - - - - - - 2729.0 738 2 FES feline sarcoma oncogene 1603 205 C20140610_SFK040_01 C20140610_SFK040_01 TB563017.[MT7]-THSQDIEK[MT7].3y4_1.heavy 415.894 / 648.369 84446.0 16.24679946899414 38 8 10 10 10 1.4819252343657683 62.58721803394192 0.0 3 0.7921782413713848 2.6588348041863936 84446.0 130.90733050762339 0.0 - - - - - - - 673.125 168 8 FES feline sarcoma oncogene 1605 206 C20140610_SFK040_01 C20140610_SFK040_01 TB563744.[MT7]-ELAQQVQQVAAEYC[CAM]R.3y6_1.heavy 646.327 / 769.33 156744.0 37.856300354003906 48 18 10 10 10 3.3816242329642656 24.608454313664758 0.0 3 0.9819421439915039 9.170089341292622 156744.0 270.5533689839572 0.0 - - - - - - - 349.2 313 5 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1607 206 C20140610_SFK040_01 C20140610_SFK040_01 TB563744.[MT7]-ELAQQVQQVAAEYC[CAM]R.3b4_1.heavy 646.327 / 586.332 92276.0 37.856300354003906 48 18 10 10 10 3.3816242329642656 24.608454313664758 0.0 3 0.9819421439915039 9.170089341292622 92276.0 48.44978138387587 0.0 - - - - - - - 748.0 184 1 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1609 206 C20140610_SFK040_01 C20140610_SFK040_01 TB563744.[MT7]-ELAQQVQQVAAEYC[CAM]R.3b5_1.heavy 646.327 / 714.39 115844.0 37.856300354003906 48 18 10 10 10 3.3816242329642656 24.608454313664758 0.0 3 0.9819421439915039 9.170089341292622 115844.0 82.85853933946805 0.0 - - - - - - - 374.0 231 1 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1611 206 C20140610_SFK040_01 C20140610_SFK040_01 TB563744.[MT7]-ELAQQVQQVAAEYC[CAM]R.3y5_1.heavy 646.327 / 698.293 67711.0 37.856300354003906 48 18 10 10 10 3.3816242329642656 24.608454313664758 0.0 3 0.9819421439915039 9.170089341292622 67711.0 83.26755208864913 0.0 - - - - - - - 324.2 135 5 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1613 207 C20140610_SFK040_01 C20140610_SFK040_01 TB562689.[MT7]-EEDAEK[MT7].2y4_1.heavy 504.758 / 606.321 456.0 14.101200103759766 37 13 10 6 8 0.894642910334325 71.91420488504609 0.03240013122558594 4 0.910586238007321 4.096092930081592 456.0 4.109916823777309 6.0 - - - - - - - 0.0 1 0 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 1615 207 C20140610_SFK040_01 C20140610_SFK040_01 TB562689.[MT7]-EEDAEK[MT7].2b3_1.heavy 504.758 / 518.221 2282.0 14.101200103759766 37 13 10 6 8 0.894642910334325 71.91420488504609 0.03240013122558594 4 0.910586238007321 4.096092930081592 2282.0 12.0116462305935 0.0 - - - - - - - 770.0909090909091 4 11 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 1617 207 C20140610_SFK040_01 C20140610_SFK040_01 TB562689.[MT7]-EEDAEK[MT7].2y5_1.heavy 504.758 / 735.364 609.0 14.101200103759766 37 13 10 6 8 0.894642910334325 71.91420488504609 0.03240013122558594 4 0.910586238007321 4.096092930081592 609.0 1.6818154782488415 2.0 - - - - - - - 0.0 1 0 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 1619 207 C20140610_SFK040_01 C20140610_SFK040_01 TB562689.[MT7]-EEDAEK[MT7].2b4_1.heavy 504.758 / 589.259 1243.0 14.101200103759766 37 13 10 6 8 0.894642910334325 71.91420488504609 0.03240013122558594 4 0.910586238007321 4.096092930081592 1243.0 4.427224958949097 1.0 - - - - - - - 240.52 2 25 LOC100509022;U2AF1 splicing factor U2AF 35 kDa subunit-like;U2 small nuclear RNA auxiliary factor 1 1621 208 C20140610_SFK040_01 C20140610_SFK040_01 TB563015.[MT7]-EVLELLLDR.2y8_1.heavy 622.373 / 970.593 65827.0 47.40240001678467 43 17 10 6 10 4.401771063285094 22.71812835385601 0.037998199462890625 3 0.9760186780012899 7.953422531784192 65827.0 161.40759181799442 0.0 - - - - - - - 231.375 131 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1623 208 C20140610_SFK040_01 C20140610_SFK040_01 TB563015.[MT7]-EVLELLLDR.2y5_1.heavy 622.373 / 629.398 30327.0 47.40240001678467 43 17 10 6 10 4.401771063285094 22.71812835385601 0.037998199462890625 3 0.9760186780012899 7.953422531784192 30327.0 48.03949934481578 0.0 - - - - - - - 810.5555555555555 60 9 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1625 208 C20140610_SFK040_01 C20140610_SFK040_01 TB563015.[MT7]-EVLELLLDR.2b4_1.heavy 622.373 / 615.347 42034.0 47.40240001678467 43 17 10 6 10 4.401771063285094 22.71812835385601 0.037998199462890625 3 0.9760186780012899 7.953422531784192 42034.0 75.95344989019229 0.0 - - - - - - - 728.25 84 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1627 208 C20140610_SFK040_01 C20140610_SFK040_01 TB563015.[MT7]-EVLELLLDR.2y7_1.heavy 622.373 / 871.525 42034.0 47.40240001678467 43 17 10 6 10 4.401771063285094 22.71812835385601 0.037998199462890625 3 0.9760186780012899 7.953422531784192 42034.0 70.70410476213912 0.0 - - - - - - - 625.875 84 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1629 209 C20140610_SFK040_01 C20140610_SFK040_01 TB563152.[MT7]-DWVLNEFK[MT7].2y4_1.heavy 669.868 / 681.369 34082.0 40.2140998840332 47 17 10 10 10 4.086587874096593 19.558759948436588 0.0 3 0.9728279965175767 7.4698729554856005 34082.0 33.57605937921727 0.0 - - - - - - - 1304.6666666666667 68 9 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1631 209 C20140610_SFK040_01 C20140610_SFK040_01 TB563152.[MT7]-DWVLNEFK[MT7].2b3_1.heavy 669.868 / 545.284 44569.0 40.2140998840332 47 17 10 10 10 4.086587874096593 19.558759948436588 0.0 3 0.9728279965175767 7.4698729554856005 44569.0 41.82975174865268 0.0 - - - - - - - 1809.75 89 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1633 209 C20140610_SFK040_01 C20140610_SFK040_01 TB563152.[MT7]-DWVLNEFK[MT7].2y5_1.heavy 669.868 / 794.453 40009.0 40.2140998840332 47 17 10 10 10 4.086587874096593 19.558759948436588 0.0 3 0.9728279965175767 7.4698729554856005 40009.0 39.404275573549256 0.0 - - - - - - - 1270.2857142857142 80 7 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1635 209 C20140610_SFK040_01 C20140610_SFK040_01 TB563152.[MT7]-DWVLNEFK[MT7].2y7_1.heavy 669.868 / 1079.6 31688.0 40.2140998840332 47 17 10 10 10 4.086587874096593 19.558759948436588 0.0 3 0.9728279965175767 7.4698729554856005 31688.0 80.54364243943192 0.0 - - - - - - - 698.25 63 8 DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 1637 210 C20140610_SFK040_01 C20140610_SFK040_01 TB562584.[MT7]-QPIELLSMK[MT7].3y3_1.heavy 449.603 / 509.287 121163.0 38.420101165771484 47 17 10 10 10 4.021028528223954 24.869259021191017 0.0 3 0.9778463919610878 8.276278449922806 121163.0 57.12979039028946 1.0 - - - - - - - 247.5 242 6 BCAS2 breast carcinoma amplified sequence 2 1639 210 C20140610_SFK040_01 C20140610_SFK040_01 TB562584.[MT7]-QPIELLSMK[MT7].3b4_1.heavy 449.603 / 612.347 73316.0 38.420101165771484 47 17 10 10 10 4.021028528223954 24.869259021191017 0.0 3 0.9778463919610878 8.276278449922806 73316.0 100.98178473628325 0.0 - - - - - - - 278.25 146 4 BCAS2 breast carcinoma amplified sequence 2 1641 210 C20140610_SFK040_01 C20140610_SFK040_01 TB562584.[MT7]-QPIELLSMK[MT7].3b5_1.heavy 449.603 / 725.431 28807.0 38.420101165771484 47 17 10 10 10 4.021028528223954 24.869259021191017 0.0 3 0.9778463919610878 8.276278449922806 28807.0 90.6835950271021 0.0 - - - - - - - 318.14285714285717 57 7 BCAS2 breast carcinoma amplified sequence 2 1643 210 C20140610_SFK040_01 C20140610_SFK040_01 TB562584.[MT7]-QPIELLSMK[MT7].3y4_1.heavy 449.603 / 622.371 16196.0 38.420101165771484 47 17 10 10 10 4.021028528223954 24.869259021191017 0.0 3 0.9778463919610878 8.276278449922806 16196.0 20.94791169614414 0.0 - - - - - - - 293.625 32 8 BCAS2 breast carcinoma amplified sequence 2 1645 211 C20140610_SFK040_01 C20140610_SFK040_01 TB563545.[MT7]-EELVAAVEDVRK[MT7].3y3_1.heavy 549.317 / 546.384 47214.0 33.38240051269531 48 18 10 10 10 26.528678067956005 3.7695055797292074 0.0 3 0.9845416135836846 9.913322620917427 47214.0 36.84414732765278 0.0 - - - - - - - 1280.5714285714287 94 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1647 211 C20140610_SFK040_01 C20140610_SFK040_01 TB563545.[MT7]-EELVAAVEDVRK[MT7].3b4_1.heavy 549.317 / 615.347 65621.0 33.38240051269531 48 18 10 10 10 26.528678067956005 3.7695055797292074 0.0 3 0.9845416135836846 9.913322620917427 65621.0 48.59698744955722 0.0 - - - - - - - 1673.25 131 8 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1649 211 C20140610_SFK040_01 C20140610_SFK040_01 TB563545.[MT7]-EELVAAVEDVRK[MT7].3b5_1.heavy 549.317 / 686.384 62155.0 33.38240051269531 48 18 10 10 10 26.528678067956005 3.7695055797292074 0.0 3 0.9845416135836846 9.913322620917427 62155.0 51.358611290374135 0.0 - - - - - - - 398.3333333333333 124 3 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1651 211 C20140610_SFK040_01 C20140610_SFK040_01 TB563545.[MT7]-EELVAAVEDVRK[MT7].3y8_1.heavy 549.317 / 1031.6 59645.0 33.38240051269531 48 18 10 10 10 26.528678067956005 3.7695055797292074 0.0 3 0.9845416135836846 9.913322620917427 59645.0 399.89838026363327 0.0 - - - - - - - 199.55555555555554 119 9 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1653 212 C20140610_SFK040_01 C20140610_SFK040_01 TB563340.[MT7]-DILGGPISLGNIR.3y6_1.heavy 490.292 / 659.383 236575.0 41.537750244140625 46 20 10 6 10 9.73935732366555 10.267617941998203 0.0373992919921875 3 0.9967188530694411 21.539256608803136 236575.0 413.67235057682865 0.0 - - - - - - - 230.375 473 8 PCNX pecanex homolog (Drosophila) 1655 212 C20140610_SFK040_01 C20140610_SFK040_01 TB563340.[MT7]-DILGGPISLGNIR.3b4_1.heavy 490.292 / 543.326 50535.0 41.537750244140625 46 20 10 6 10 9.73935732366555 10.267617941998203 0.0373992919921875 3 0.9967188530694411 21.539256608803136 50535.0 176.69884020618557 0.0 - - - - - - - 349.2 101 15 PCNX pecanex homolog (Drosophila) 1657 212 C20140610_SFK040_01 C20140610_SFK040_01 TB563340.[MT7]-DILGGPISLGNIR.3b5_1.heavy 490.292 / 600.347 280612.0 41.537750244140625 46 20 10 6 10 9.73935732366555 10.267617941998203 0.0373992919921875 3 0.9967188530694411 21.539256608803136 280612.0 378.36482131942466 0.0 - - - - - - - 763.875 561 8 PCNX pecanex homolog (Drosophila) 1659 212 C20140610_SFK040_01 C20140610_SFK040_01 TB563340.[MT7]-DILGGPISLGNIR.3y5_1.heavy 490.292 / 572.352 88267.0 41.537750244140625 46 20 10 6 10 9.73935732366555 10.267617941998203 0.0373992919921875 3 0.9967188530694411 21.539256608803136 88267.0 153.22479222839019 0.0 - - - - - - - 368.6 176 10 PCNX pecanex homolog (Drosophila) 1661 213 C20140610_SFK040_01 C20140610_SFK040_01 TB562582.[MT7]-AEVIYR.2b3_1.heavy 447.762 / 444.258 85683.0 23.683799743652344 47 17 10 10 10 3.0545238016250527 32.7383273120342 0.0 3 0.9768239564711585 8.090965792058325 85683.0 12.029158401311154 0.0 - - - - - - - 561.0 171 1 PCNX pecanex homolog (Drosophila) 1663 213 C20140610_SFK040_01 C20140610_SFK040_01 TB562582.[MT7]-AEVIYR.2y4_1.heavy 447.762 / 550.335 47368.0 23.683799743652344 47 17 10 10 10 3.0545238016250527 32.7383273120342 0.0 3 0.9768239564711585 8.090965792058325 47368.0 82.32205859065716 0.0 - - - - - - - 1263.2857142857142 94 7 PCNX pecanex homolog (Drosophila) 1665 213 C20140610_SFK040_01 C20140610_SFK040_01 TB562582.[MT7]-AEVIYR.2y5_1.heavy 447.762 / 679.377 72280.0 23.683799743652344 47 17 10 10 10 3.0545238016250527 32.7383273120342 0.0 3 0.9768239564711585 8.090965792058325 72280.0 305.4629045234143 0.0 - - - - - - - 798.25 144 8 PCNX pecanex homolog (Drosophila) 1667 213 C20140610_SFK040_01 C20140610_SFK040_01 TB562582.[MT7]-AEVIYR.2b4_1.heavy 447.762 / 557.341 55368.0 23.683799743652344 47 17 10 10 10 3.0545238016250527 32.7383273120342 0.0 3 0.9768239564711585 8.090965792058325 55368.0 48.21515632461973 0.0 - - - - - - - 386.0 110 2 PCNX pecanex homolog (Drosophila) 1669 214 C20140610_SFK040_01 C20140610_SFK040_01 TB563547.[MT7]-EELVAAVEDVRK[MT7].4y5_1.heavy 412.24 / 790.454 9216.0 33.38240051269531 41 11 10 10 10 1.2440157236039389 69.15943112992163 0.0 3 0.8504182963678529 3.15032018487209 9216.0 106.90302928870292 0.0 - - - - - - - 199.5 18 6 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1671 214 C20140610_SFK040_01 C20140610_SFK040_01 TB563547.[MT7]-EELVAAVEDVRK[MT7].4b4_1.heavy 412.24 / 615.347 61877.0 33.38240051269531 41 11 10 10 10 1.2440157236039389 69.15943112992163 0.0 3 0.8504182963678529 3.15032018487209 61877.0 114.44525239071223 0.0 - - - - - - - 778.0 123 8 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1673 214 C20140610_SFK040_01 C20140610_SFK040_01 TB563547.[MT7]-EELVAAVEDVRK[MT7].4y3_1.heavy 412.24 / 546.384 27887.0 33.38240051269531 41 11 10 10 10 1.2440157236039389 69.15943112992163 0.0 3 0.8504182963678529 3.15032018487209 27887.0 33.08353904779355 0.0 - - - - - - - 757.8333333333334 55 12 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1675 214 C20140610_SFK040_01 C20140610_SFK040_01 TB563547.[MT7]-EELVAAVEDVRK[MT7].4y7_2.heavy 412.24 / 480.783 154513.0 33.38240051269531 41 11 10 10 10 1.2440157236039389 69.15943112992163 0.0 3 0.8504182963678529 3.15032018487209 154513.0 419.36839034434877 0.0 - - - - - - - 666.4285714285714 309 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 1677 215 C20140610_SFK040_01 C20140610_SFK040_01 TB563157.[MT7]-WINIAHEC[CAM]R.3y3_1.heavy 448.232 / 464.192 104015.0 30.703899383544922 50 20 10 10 10 17.05658911058039 5.862836898496248 0.0 3 0.9976431257106112 25.416095013241655 104015.0 117.18108038929384 0.0 - - - - - - - 714.2 208 5 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1679 215 C20140610_SFK040_01 C20140610_SFK040_01 TB563157.[MT7]-WINIAHEC[CAM]R.3y4_1.heavy 448.232 / 601.251 165060.0 30.703899383544922 50 20 10 10 10 17.05658911058039 5.862836898496248 0.0 3 0.9976431257106112 25.416095013241655 165060.0 262.1463496827813 0.0 - - - - - - - 397.0 330 3 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1681 215 C20140610_SFK040_01 C20140610_SFK040_01 TB563157.[MT7]-WINIAHEC[CAM]R.3b3_1.heavy 448.232 / 558.316 210953.0 30.703899383544922 50 20 10 10 10 17.05658911058039 5.862836898496248 0.0 3 0.9976431257106112 25.416095013241655 210953.0 186.30010299641643 0.0 - - - - - - - 324.5 421 2 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1683 215 C20140610_SFK040_01 C20140610_SFK040_01 TB563157.[MT7]-WINIAHEC[CAM]R.3y5_1.heavy 448.232 / 672.288 67972.0 30.703899383544922 50 20 10 10 10 17.05658911058039 5.862836898496248 0.0 3 0.9976431257106112 25.416095013241655 67972.0 106.57986133702595 0.0 - - - - - - - 746.8 135 10 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1685 216 C20140610_SFK040_01 C20140610_SFK040_01 TB562786.[MT7]-SQQALQER.2y5_1.heavy 552.3 / 616.341 18982.0 17.207825183868408 46 20 10 6 10 5.564680197452038 14.33124261922243 0.03370094299316406 3 0.9944121117289897 16.50198062618875 18982.0 87.1675674678041 0.0 - - - - - - - 175.68421052631578 37 19 SPAG5 sperm associated antigen 5 1687 216 C20140610_SFK040_01 C20140610_SFK040_01 TB562786.[MT7]-SQQALQER.2b4_1.heavy 552.3 / 559.296 22237.0 17.207825183868408 46 20 10 6 10 5.564680197452038 14.33124261922243 0.03370094299316406 3 0.9944121117289897 16.50198062618875 22237.0 78.45334277783252 0.0 - - - - - - - 235.69565217391303 44 23 SPAG5 sperm associated antigen 5 1689 216 C20140610_SFK040_01 C20140610_SFK040_01 TB562786.[MT7]-SQQALQER.2y6_1.heavy 552.3 / 744.4 16813.0 17.207825183868408 46 20 10 6 10 5.564680197452038 14.33124261922243 0.03370094299316406 3 0.9944121117289897 16.50198062618875 16813.0 88.77264 0.0 - - - - - - - 202.52380952380952 33 21 SPAG5 sperm associated antigen 5 1691 216 C20140610_SFK040_01 C20140610_SFK040_01 TB562786.[MT7]-SQQALQER.2y7_1.heavy 552.3 / 872.458 28536.0 17.207825183868408 46 20 10 6 10 5.564680197452038 14.33124261922243 0.03370094299316406 3 0.9944121117289897 16.50198062618875 28536.0 134.21342709254222 0.0 - - - - - - - 192.27777777777777 57 18 SPAG5 sperm associated antigen 5 1693 217 C20140610_SFK040_01 C20140610_SFK040_01 TB562865.[MT7]-IITGPEIK[MT7].2y4_1.heavy 579.87 / 630.394 54803.0 30.579099655151367 48 18 10 10 10 2.9941030582052353 23.35713218997207 0.0 3 0.9884521543305306 11.473424604120101 54803.0 27.555039843347416 0.0 - - - - - - - 436.0 109 2 POSTN periostin, osteoblast specific factor 1695 217 C20140610_SFK040_01 C20140610_SFK040_01 TB562865.[MT7]-IITGPEIK[MT7].2y5_1.heavy 579.87 / 687.416 63083.0 30.579099655151367 48 18 10 10 10 2.9941030582052353 23.35713218997207 0.0 3 0.9884521543305306 11.473424604120101 63083.0 120.40545935414563 0.0 - - - - - - - 858.375 126 8 POSTN periostin, osteoblast specific factor 1697 217 C20140610_SFK040_01 C20140610_SFK040_01 TB562865.[MT7]-IITGPEIK[MT7].2y6_1.heavy 579.87 / 788.463 83239.0 30.579099655151367 48 18 10 10 10 2.9941030582052353 23.35713218997207 0.0 3 0.9884521543305306 11.473424604120101 83239.0 43.53143992413413 0.0 - - - - - - - 926.5 166 2 POSTN periostin, osteoblast specific factor 1699 217 C20140610_SFK040_01 C20140610_SFK040_01 TB562865.[MT7]-IITGPEIK[MT7].2y7_1.heavy 579.87 / 901.547 74305.0 30.579099655151367 48 18 10 10 10 2.9941030582052353 23.35713218997207 0.0 3 0.9884521543305306 11.473424604120101 74305.0 90.49593679394826 0.0 - - - - - - - 1229.4285714285713 148 7 POSTN periostin, osteoblast specific factor 1701 218 C20140610_SFK040_01 C20140610_SFK040_01 TB458455.[MT7]-ELEQLFSQYGR.2b3_1.heavy 757.392 / 516.279 36999.0 41.79059982299805 44 14 10 10 10 1.1738796137413312 50.14681699371752 0.0 3 0.935776070020618 4.843527022250232 36999.0 31.859908109966344 0.0 - - - - - - - 1256.4444444444443 73 9 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1703 218 C20140610_SFK040_01 C20140610_SFK040_01 TB458455.[MT7]-ELEQLFSQYGR.2y8_1.heavy 757.392 / 998.505 27377.0 41.79059982299805 44 14 10 10 10 1.1738796137413312 50.14681699371752 0.0 3 0.935776070020618 4.843527022250232 27377.0 36.38104723574451 0.0 - - - - - - - 784.5454545454545 54 11 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1705 218 C20140610_SFK040_01 C20140610_SFK040_01 TB458455.[MT7]-ELEQLFSQYGR.2b4_1.heavy 757.392 / 644.337 N/A 41.79059982299805 44 14 10 10 10 1.1738796137413312 50.14681699371752 0.0 3 0.935776070020618 4.843527022250232 38983.0 16.483648113938546 0.0 - - - - - - - 1885.0 77 1 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1707 218 C20140610_SFK040_01 C20140610_SFK040_01 TB458455.[MT7]-ELEQLFSQYGR.2y10_1.heavy 757.392 / 1240.63 15077.0 41.79059982299805 44 14 10 10 10 1.1738796137413312 50.14681699371752 0.0 3 0.935776070020618 4.843527022250232 15077.0 28.722597809831633 0.0 - - - - - - - 731.5 30 8 ELAVL2;ELAVL4 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B);ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) 1709 219 C20140610_SFK040_01 C20140610_SFK040_01 TB458459.[MT7]-SQLTSLSGIAQK[MT7].3y3_1.heavy 507.634 / 490.311 158915.0 31.6643009185791 47 17 10 10 10 4.907704712071014 20.37612404716191 0.0 3 0.9760778529719242 7.963293056965053 158915.0 51.97735180675263 0.0 - - - - - - - 1372.0 317 1 FBXO32 F-box protein 32 1711 219 C20140610_SFK040_01 C20140610_SFK040_01 TB458459.[MT7]-SQLTSLSGIAQK[MT7].3y6_1.heavy 507.634 / 747.448 14520.0 31.6643009185791 47 17 10 10 10 4.907704712071014 20.37612404716191 0.0 3 0.9760778529719242 7.963293056965053 14520.0 25.82274052478134 0.0 - - - - - - - 718.8571428571429 29 7 FBXO32 F-box protein 32 1713 219 C20140610_SFK040_01 C20140610_SFK040_01 TB458459.[MT7]-SQLTSLSGIAQK[MT7].3b4_1.heavy 507.634 / 574.332 25724.0 31.6643009185791 47 17 10 10 10 4.907704712071014 20.37612404716191 0.0 3 0.9760778529719242 7.963293056965053 25724.0 18.354805655293326 0.0 - - - - - - - 457.0 51 2 FBXO32 F-box protein 32 1715 219 C20140610_SFK040_01 C20140610_SFK040_01 TB458459.[MT7]-SQLTSLSGIAQK[MT7].3b5_1.heavy 507.634 / 661.364 38414.0 31.6643009185791 47 17 10 10 10 4.907704712071014 20.37612404716191 0.0 3 0.9760778529719242 7.963293056965053 38414.0 64.58330417881439 0.0 - - - - - - - 304.6666666666667 76 3 FBXO32 F-box protein 32 1717 220 C20140610_SFK040_01 C20140610_SFK040_01 TB563541.[MT7]-EQYGDTLQLC[CAM]K[MT7].3b6_1.heavy 548.283 / 838.37 25078.0 30.10469913482666 35 10 10 5 10 1.0987699829658581 72.35372475097401 0.04220008850097656 3 0.8362953508384194 3.0076057122152355 25078.0 18.902638527372375 0.0 - - - - - - - 704.875 50 8 FBXO32 F-box protein 32 1719 220 C20140610_SFK040_01 C20140610_SFK040_01 TB563541.[MT7]-EQYGDTLQLC[CAM]K[MT7].3y3_1.heavy 548.283 / 564.33 64890.0 30.10469913482666 35 10 10 5 10 1.0987699829658581 72.35372475097401 0.04220008850097656 3 0.8362953508384194 3.0076057122152355 64890.0 87.20300049413666 0.0 - - - - - - - 701.4285714285714 129 7 FBXO32 F-box protein 32 1721 220 C20140610_SFK040_01 C20140610_SFK040_01 TB563541.[MT7]-EQYGDTLQLC[CAM]K[MT7].3b5_1.heavy 548.283 / 737.322 31661.0 30.10469913482666 35 10 10 5 10 1.0987699829658581 72.35372475097401 0.04220008850097656 3 0.8362953508384194 3.0076057122152355 31661.0 51.50593301435407 0.0 - - - - - - - 744.375 63 8 FBXO32 F-box protein 32 1723 220 C20140610_SFK040_01 C20140610_SFK040_01 TB563541.[MT7]-EQYGDTLQLC[CAM]K[MT7].3b3_1.heavy 548.283 / 565.274 23720.0 30.10469913482666 35 10 10 5 10 1.0987699829658581 72.35372475097401 0.04220008850097656 3 0.8362953508384194 3.0076057122152355 23720.0 22.228079202798305 0.0 - - - - - - - 1223.857142857143 47 7 FBXO32 F-box protein 32 1725 221 C20140610_SFK040_01 C20140610_SFK040_01 TB563740.[MT7]-TNIIRDYLEDQQGGR.3y7_1.heavy 641.333 / 789.349 39335.0 35.47650146484375 46 16 10 10 10 2.335029488856427 34.83012314856212 0.0 3 0.9654947789326449 6.6246540145573825 39335.0 79.38976035300871 0.0 - - - - - - - 350.0 78 5 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1727 221 C20140610_SFK040_01 C20140610_SFK040_01 TB563740.[MT7]-TNIIRDYLEDQQGGR.3y6_1.heavy 641.333 / 660.306 51448.0 35.47650146484375 46 16 10 10 10 2.335029488856427 34.83012314856212 0.0 3 0.9654947789326449 6.6246540145573825 51448.0 48.65041274820008 0.0 - - - - - - - 1266.7142857142858 102 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1729 221 C20140610_SFK040_01 C20140610_SFK040_01 TB563740.[MT7]-TNIIRDYLEDQQGGR.3b10_2.heavy 641.333 / 689.36 74799.0 35.47650146484375 46 16 10 10 10 2.335029488856427 34.83012314856212 0.0 3 0.9654947789326449 6.6246540145573825 74799.0 110.01295139539239 0.0 - - - - - - - 312.5 149 4 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1731 221 C20140610_SFK040_01 C20140610_SFK040_01 TB563740.[MT7]-TNIIRDYLEDQQGGR.3y5_1.heavy 641.333 / 545.279 114135.0 35.47650146484375 46 16 10 10 10 2.335029488856427 34.83012314856212 0.0 3 0.9654947789326449 6.6246540145573825 114135.0 67.76291995812315 0.0 - - - - - - - 1855.142857142857 228 7 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1733 222 C20140610_SFK040_01 C20140610_SFK040_01 TB458357.[MT7]-TLLSIPEVVR.2y8_1.heavy 635.896 / 912.551 25945.0 41.13650131225586 47 17 10 10 10 5.988950685382744 16.697415833473197 0.0 3 0.9781426050372944 8.332377454348832 25945.0 62.98927800269905 0.0 - - - - - - - 320.625 51 8 SPAG5 sperm associated antigen 5 1735 222 C20140610_SFK040_01 C20140610_SFK040_01 TB458357.[MT7]-TLLSIPEVVR.2y5_1.heavy 635.896 / 599.351 46852.0 41.13650131225586 47 17 10 10 10 5.988950685382744 16.697415833473197 0.0 3 0.9781426050372944 8.332377454348832 46852.0 53.462924965157576 0.0 - - - - - - - 1151.875 93 8 SPAG5 sperm associated antigen 5 1737 222 C20140610_SFK040_01 C20140610_SFK040_01 TB458357.[MT7]-TLLSIPEVVR.2y9_1.heavy 635.896 / 1025.64 36588.0 41.13650131225586 47 17 10 10 10 5.988950685382744 16.697415833473197 0.0 3 0.9781426050372944 8.332377454348832 36588.0 74.94121052631579 0.0 - - - - - - - 771.875 73 8 SPAG5 sperm associated antigen 5 1739 222 C20140610_SFK040_01 C20140610_SFK040_01 TB458357.[MT7]-TLLSIPEVVR.2y7_1.heavy 635.896 / 799.467 40010.0 41.13650131225586 47 17 10 10 10 5.988950685382744 16.697415833473197 0.0 3 0.9781426050372944 8.332377454348832 40010.0 61.099485984101364 0.0 - - - - - - - 781.1111111111111 80 9 SPAG5 sperm associated antigen 5 1741 223 C20140610_SFK040_01 C20140610_SFK040_01 TB563445.[MT7]-VSVVEDGGLSWLR.3y7_1.heavy 520.955 / 788.441 4013.0 42.63436762491862 36 18 4 6 8 2.932278994913589 34.103166913333524 0.035800933837890625 4 0.9845223763234926 9.90714405925224 4013.0 12.416025930257184 1.0 - - - - - - - 232.6 8 15 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1743 223 C20140610_SFK040_01 C20140610_SFK040_01 TB563445.[MT7]-VSVVEDGGLSWLR.3b4_1.heavy 520.955 / 529.347 13523.0 42.63436762491862 36 18 4 6 8 2.932278994913589 34.103166913333524 0.035800933837890625 4 0.9845223763234926 9.90714405925224 13523.0 29.866287904836092 0.0 - - - - - - - 846.4 27 10 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1745 223 C20140610_SFK040_01 C20140610_SFK040_01 TB563445.[MT7]-VSVVEDGGLSWLR.3y4_1.heavy 520.955 / 561.314 25127.0 42.63436762491862 36 18 4 6 8 2.932278994913589 34.103166913333524 0.035800933837890625 4 0.9845223763234926 9.90714405925224 25127.0 61.130275952049 0.0 - - - - - - - 1246.2857142857142 50 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1747 223 C20140610_SFK040_01 C20140610_SFK040_01 TB563445.[MT7]-VSVVEDGGLSWLR.3y5_1.heavy 520.955 / 674.398 N/A 42.63436762491862 36 18 4 6 8 2.932278994913589 34.103166913333524 0.035800933837890625 4 0.9845223763234926 9.90714405925224 3839.0 20.153050397877983 4.0 - - - - - - - 724.0 86 10 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1749 224 C20140610_SFK040_01 C20140610_SFK040_01 TB562684.[MT7]-NAIASILR.2y5_1.heavy 501.315 / 559.356 36922.0 36.18069839477539 46 18 10 10 8 4.682714358861954 21.35513557660244 0.0 4 0.9811252882393279 8.968849385518103 36922.0 41.055181198743114 0.0 - - - - - - - 794.7142857142857 73 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1751 224 C20140610_SFK040_01 C20140610_SFK040_01 TB562684.[MT7]-NAIASILR.2b4_1.heavy 501.315 / 514.311 14668.0 36.18069839477539 46 18 10 10 8 4.682714358861954 21.35513557660244 0.0 4 0.9811252882393279 8.968849385518103 14668.0 13.919309849029474 0.0 - - - - - - - 379.0 29 4 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1753 224 C20140610_SFK040_01 C20140610_SFK040_01 TB562684.[MT7]-NAIASILR.2y6_1.heavy 501.315 / 672.44 16059.0 36.18069839477539 46 18 10 10 8 4.682714358861954 21.35513557660244 0.0 4 0.9811252882393279 8.968849385518103 16059.0 18.314153745229643 1.0 - - - - - - - 273.8333333333333 40 6 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1755 224 C20140610_SFK040_01 C20140610_SFK040_01 TB562684.[MT7]-NAIASILR.2y7_1.heavy 501.315 / 743.477 31864.0 36.18069839477539 46 18 10 10 8 4.682714358861954 21.35513557660244 0.0 4 0.9811252882393279 8.968849385518103 31864.0 69.47947299077734 0.0 - - - - - - - 275.72727272727275 63 11 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1757 225 C20140610_SFK040_01 C20140610_SFK040_01 TB458451.[MT7]-NAVC[CAM]IFYLVLR.2y8_1.heavy 756.43 / 1083.6 10888.0 51.21653366088867 41 15 10 6 10 2.007760435436582 42.1069915090051 0.03440093994140625 3 0.953725452114033 5.714814711164334 10888.0 51.52418987032053 0.0 - - - - - - - 279.9375 21 16 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1759 225 C20140610_SFK040_01 C20140610_SFK040_01 TB458451.[MT7]-NAVC[CAM]IFYLVLR.2y5_1.heavy 756.43 / 663.419 N/A 51.21653366088867 41 15 10 6 10 2.007760435436582 42.1069915090051 0.03440093994140625 3 0.953725452114033 5.714814711164334 3538.0 0.6357592093441151 23.0 - - - - - - - 2270.3333333333335 7 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1761 225 C20140610_SFK040_01 C20140610_SFK040_01 TB458451.[MT7]-NAVC[CAM]IFYLVLR.2b4_1.heavy 756.43 / 589.288 2165.0 51.21653366088867 41 15 10 6 10 2.007760435436582 42.1069915090051 0.03440093994140625 3 0.953725452114033 5.714814711164334 2165.0 7.239962444880478 2.0 - - - - - - - 264.75 4 16 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1763 225 C20140610_SFK040_01 C20140610_SFK040_01 TB458451.[MT7]-NAVC[CAM]IFYLVLR.2y6_1.heavy 756.43 / 810.487 3660.0 51.21653366088867 41 15 10 6 10 2.007760435436582 42.1069915090051 0.03440093994140625 3 0.953725452114033 5.714814711164334 3660.0 14.761991910350773 0.0 - - - - - - - 281.85 7 20 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1765 226 C20140610_SFK040_01 C20140610_SFK040_01 TB562682.[MT7]-TLPAWIR.2y4_1.heavy 500.807 / 545.319 14703.0 37.17099952697754 45 20 10 5 10 6.078940703099873 16.450234487236628 0.046199798583984375 3 0.9931379191441253 14.889694741363686 14703.0 30.557492113564667 0.0 - - - - - - - 612.8333333333334 29 6 SFRS18 splicing factor, arginine/serine-rich 18 1767 226 C20140610_SFK040_01 C20140610_SFK040_01 TB562682.[MT7]-TLPAWIR.2y5_1.heavy 500.807 / 642.372 250719.0 37.17099952697754 45 20 10 5 10 6.078940703099873 16.450234487236628 0.046199798583984375 3 0.9931379191441253 14.889694741363686 250719.0 276.1196968812495 0.0 - - - - - - - 211.33333333333334 501 3 SFRS18 splicing factor, arginine/serine-rich 18 1769 226 C20140610_SFK040_01 C20140610_SFK040_01 TB562682.[MT7]-TLPAWIR.2b4_1.heavy 500.807 / 527.331 43730.0 37.17099952697754 45 20 10 5 10 6.078940703099873 16.450234487236628 0.046199798583984375 3 0.9931379191441253 14.889694741363686 43730.0 64.01313257810625 0.0 - - - - - - - 253.5 87 2 SFRS18 splicing factor, arginine/serine-rich 18 1771 226 C20140610_SFK040_01 C20140610_SFK040_01 TB562682.[MT7]-TLPAWIR.2y6_1.heavy 500.807 / 755.456 81249.0 37.17099952697754 45 20 10 5 10 6.078940703099873 16.450234487236628 0.046199798583984375 3 0.9931379191441253 14.889694741363686 81249.0 154.4308627600212 0.0 - - - - - - - 724.2857142857143 162 7 SFRS18 splicing factor, arginine/serine-rich 18 1773 227 C20140610_SFK040_01 C20140610_SFK040_01 TB562679.[MT7]-ILGPIPSR.2y5_1.heavy 498.82 / 569.341 23836.0 31.6643009185791 50 20 10 10 10 8.481971695406372 11.789711589600984 0.0 3 0.994568987860492 16.738835142548826 23836.0 25.57151641908181 0.0 - - - - - - - 456.0 47 1 CLK2 CDC-like kinase 2 1775 227 C20140610_SFK040_01 C20140610_SFK040_01 TB562679.[MT7]-ILGPIPSR.2y6_1.heavy 498.82 / 626.362 54742.0 31.6643009185791 50 20 10 10 10 8.481971695406372 11.789711589600984 0.0 3 0.994568987860492 16.738835142548826 54742.0 23.27255998116096 0.0 - - - - - - - 798.0 109 1 CLK2 CDC-like kinase 2 1777 227 C20140610_SFK040_01 C20140610_SFK040_01 TB562679.[MT7]-ILGPIPSR.2b5_1.heavy 498.82 / 638.436 11633.0 31.6643009185791 50 20 10 10 10 8.481971695406372 11.789711589600984 0.0 3 0.994568987860492 16.738835142548826 11633.0 5.559925113226199 0.0 - - - - - - - 798.0 23 1 CLK2 CDC-like kinase 2 1779 227 C20140610_SFK040_01 C20140610_SFK040_01 TB562679.[MT7]-ILGPIPSR.2y7_1.heavy 498.82 / 739.446 64550.0 31.6643009185791 50 20 10 10 10 8.481971695406372 11.789711589600984 0.0 3 0.994568987860492 16.738835142548826 64550.0 112.79263157894738 0.0 - - - - - - - 342.0 129 2 CLK2 CDC-like kinase 2 1781 228 C20140610_SFK040_01 C20140610_SFK040_01 TB563007.[MT7]-AQLQILANMDSQLK[MT7].3b4_1.heavy 621.02 / 585.348 78153.0 41.45349884033203 50 20 10 10 10 5.306028318479183 18.84648818245698 0.0 3 0.9907845174663081 12.846039268070971 78153.0 60.97028417519566 0.0 - - - - - - - 195.0 156 1 SPAG5 sperm associated antigen 5 1783 228 C20140610_SFK040_01 C20140610_SFK040_01 TB563007.[MT7]-AQLQILANMDSQLK[MT7].3b5_1.heavy 621.02 / 698.432 55768.0 41.45349884033203 50 20 10 10 10 5.306028318479183 18.84648818245698 0.0 3 0.9907845174663081 12.846039268070971 55768.0 29.374216482290738 0.0 - - - - - - - 227.0 111 3 SPAG5 sperm associated antigen 5 1785 228 C20140610_SFK040_01 C20140610_SFK040_01 TB563007.[MT7]-AQLQILANMDSQLK[MT7].3y4_1.heavy 621.02 / 619.39 31534.0 41.45349884033203 50 20 10 10 10 5.306028318479183 18.84648818245698 0.0 3 0.9907845174663081 12.846039268070971 31534.0 42.2360879359135 0.0 - - - - - - - 194.75 63 4 SPAG5 sperm associated antigen 5 1787 228 C20140610_SFK040_01 C20140610_SFK040_01 TB563007.[MT7]-AQLQILANMDSQLK[MT7].3y5_1.heavy 621.02 / 734.417 29879.0 41.45349884033203 50 20 10 10 10 5.306028318479183 18.84648818245698 0.0 3 0.9907845174663081 12.846039268070971 29879.0 38.12414514237307 0.0 - - - - - - - 766.25 59 8 SPAG5 sperm associated antigen 5 1789 229 C20140610_SFK040_01 C20140610_SFK040_01 TB563454.[MT7]-Y[MT7]IGEVGDIVVGR.3y7_1.heavy 522.303 / 715.41 64098.0 34.1327018737793 44 14 10 10 10 1.4476332959645002 48.15375423850544 0.0 3 0.931792448668866 4.698358646062905 64098.0 55.17745500081764 0.0 - - - - - - - 323.3333333333333 128 6 EXOSC2 exosome component 2 1791 229 C20140610_SFK040_01 C20140610_SFK040_01 TB563454.[MT7]-Y[MT7]IGEVGDIVVGR.3y8_1.heavy 522.303 / 814.478 21810.0 34.1327018737793 44 14 10 10 10 1.4476332959645002 48.15375423850544 0.0 3 0.931792448668866 4.698358646062905 21810.0 113.21776859504132 0.0 - - - - - - - 228.77777777777777 43 9 EXOSC2 exosome component 2 1793 229 C20140610_SFK040_01 C20140610_SFK040_01 TB563454.[MT7]-Y[MT7]IGEVGDIVVGR.3y5_1.heavy 522.303 / 543.361 57312.0 34.1327018737793 44 14 10 10 10 1.4476332959645002 48.15375423850544 0.0 3 0.931792448668866 4.698358646062905 57312.0 66.4406617382501 0.0 - - - - - - - 807.6666666666666 114 3 EXOSC2 exosome component 2 1795 229 C20140610_SFK040_01 C20140610_SFK040_01 TB563454.[MT7]-Y[MT7]IGEVGDIVVGR.3b7_2.heavy 522.303 / 511.773 86271.0 34.1327018737793 44 14 10 10 10 1.4476332959645002 48.15375423850544 0.0 3 0.931792448668866 4.698358646062905 86271.0 140.62228114403655 0.0 - - - - - - - 387.8 172 5 EXOSC2 exosome component 2 1797 230 C20140610_SFK040_01 C20140610_SFK040_01 TB562677.[MT7]-FIGDEK[MT7].2y4_1.heavy 498.784 / 592.306 79430.0 25.510499954223633 47 17 10 10 10 3.122465283667618 32.02597656507519 0.0 3 0.9741979757165272 7.666501493488 79430.0 52.41348014330925 0.0 - - - - - - - 1807.5714285714287 158 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1799 230 C20140610_SFK040_01 C20140610_SFK040_01 TB562677.[MT7]-FIGDEK[MT7].2y5_1.heavy 498.784 / 705.39 76784.0 25.510499954223633 47 17 10 10 10 3.122465283667618 32.02597656507519 0.0 3 0.9741979757165272 7.666501493488 76784.0 103.74097773719359 0.0 - - - - - - - 762.3333333333334 153 12 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1801 230 C20140610_SFK040_01 C20140610_SFK040_01 TB562677.[MT7]-FIGDEK[MT7].2b4_1.heavy 498.784 / 577.31 71136.0 25.510499954223633 47 17 10 10 10 3.122465283667618 32.02597656507519 0.0 3 0.9741979757165272 7.666501493488 71136.0 50.31948425675044 0.0 - - - - - - - 1623.7142857142858 142 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1803 230 C20140610_SFK040_01 C20140610_SFK040_01 TB562677.[MT7]-FIGDEK[MT7].2y3_1.heavy 498.784 / 535.284 16873.0 25.510499954223633 47 17 10 10 10 3.122465283667618 32.02597656507519 0.0 3 0.9741979757165272 7.666501493488 16873.0 9.563052281052281 0.0 - - - - - - - 667.0 33 3 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1805 231 C20140610_SFK040_01 C20140610_SFK040_01 TB458205.[MT7]-NYEIER.2y4_1.heavy 484.252 / 546.288 30086.0 22.020299911499023 50 20 10 10 10 29.357015750619595 3.4063407823695244 0.0 3 0.9952268037890358 17.85602671654125 30086.0 31.96842843741892 0.0 - - - - - - - 1222.5 60 8 BCAS2 breast carcinoma amplified sequence 2 1807 231 C20140610_SFK040_01 C20140610_SFK040_01 TB458205.[MT7]-NYEIER.2b3_1.heavy 484.252 / 551.258 115422.0 22.020299911499023 50 20 10 10 10 29.357015750619595 3.4063407823695244 0.0 3 0.9952268037890358 17.85602671654125 115422.0 127.22290597740368 0.0 - - - - - - - 256.5 230 4 BCAS2 breast carcinoma amplified sequence 2 1809 231 C20140610_SFK040_01 C20140610_SFK040_01 TB458205.[MT7]-NYEIER.2y5_1.heavy 484.252 / 709.352 99422.0 22.020299911499023 50 20 10 10 10 29.357015750619595 3.4063407823695244 0.0 3 0.9952268037890358 17.85602671654125 99422.0 179.12726019971737 0.0 - - - - - - - 350.625 198 8 BCAS2 breast carcinoma amplified sequence 2 1811 231 C20140610_SFK040_01 C20140610_SFK040_01 TB458205.[MT7]-NYEIER.2b4_1.heavy 484.252 / 664.342 42736.0 22.020299911499023 50 20 10 10 10 29.357015750619595 3.4063407823695244 0.0 3 0.9952268037890358 17.85602671654125 42736.0 115.58502051688143 0.0 - - - - - - - 735.0833333333334 85 12 BCAS2 breast carcinoma amplified sequence 2 1813 232 C20140610_SFK040_01 C20140610_SFK040_01 TB563856.[MT7]-AHVLAASVEQATENFLEK[MT7].3y7_1.heavy 749.074 / 1024.54 38845.0 42.61945056915283 43 17 10 6 10 2.2407701624516507 30.468012604962034 0.035800933837890625 3 0.979167483303772 8.535611705739049 38845.0 74.1988722623897 0.0 - - - - - - - 638.8333333333334 77 12 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1815 232 C20140610_SFK040_01 C20140610_SFK040_01 TB563856.[MT7]-AHVLAASVEQATENFLEK[MT7].3b6_1.heavy 749.074 / 707.432 28963.0 42.61945056915283 43 17 10 6 10 2.2407701624516507 30.468012604962034 0.035800933837890625 3 0.979167483303772 8.535611705739049 28963.0 50.99785188550957 0.0 - - - - - - - 776.2222222222222 57 9 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1817 232 C20140610_SFK040_01 C20140610_SFK040_01 TB563856.[MT7]-AHVLAASVEQATENFLEK[MT7].3b4_1.heavy 749.074 / 565.358 36034.0 42.61945056915283 43 17 10 6 10 2.2407701624516507 30.468012604962034 0.035800933837890625 3 0.979167483303772 8.535611705739049 36034.0 42.49463945147831 0.0 - - - - - - - 1117.875 72 8 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1819 232 C20140610_SFK040_01 C20140610_SFK040_01 TB563856.[MT7]-AHVLAASVEQATENFLEK[MT7].3b5_1.heavy 749.074 / 636.395 35352.0 42.61945056915283 43 17 10 6 10 2.2407701624516507 30.468012604962034 0.035800933837890625 3 0.979167483303772 8.535611705739049 35352.0 19.64612379800197 0.0 - - - - - - - 2204.0 70 8 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1821 233 C20140610_SFK040_01 C20140610_SFK040_01 TB458606.[MT7]-AEVQNLGGELVVSGVDSAMSLIQAAK[MT7].4b4_1.heavy 719.393 / 572.316 2450.0 54.72890090942383 46 16 10 10 10 6.438103721014717 15.532523912839181 0.0 3 0.9674662342441861 6.823554730745297 2450.0 -0.8277027027027024 0.0 - - - - - - - 621.4285714285714 4 7 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1823 233 C20140610_SFK040_01 C20140610_SFK040_01 TB458606.[MT7]-AEVQNLGGELVVSGVDSAMSLIQAAK[MT7].4b5_1.heavy 719.393 / 686.359 3925.0 54.72890090942383 46 16 10 10 10 6.438103721014717 15.532523912839181 0.0 3 0.9674662342441861 6.823554730745297 3925.0 -1.5422396856581528 0.0 - - - - - - - 134.5625 7 48 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1825 233 C20140610_SFK040_01 C20140610_SFK040_01 TB458606.[MT7]-AEVQNLGGELVVSGVDSAMSLIQAAK[MT7].4b9_1.heavy 719.393 / 1042.53 6302.0 54.72890090942383 46 16 10 10 10 6.438103721014717 15.532523912839181 0.0 3 0.9674662342441861 6.823554730745297 6302.0 -5.5276457717554015 0.0 - - - - - - - 155.75510204081633 12 49 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1827 233 C20140610_SFK040_01 C20140610_SFK040_01 TB458606.[MT7]-AEVQNLGGELVVSGVDSAMSLIQAAK[MT7].4b6_1.heavy 719.393 / 799.443 1163.0 54.72890090942383 46 16 10 10 10 6.438103721014717 15.532523912839181 0.0 3 0.9674662342441861 6.823554730745297 1163.0 0.0 0.0 - - - - - - - 146.46 2 50 CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 1829 234 C20140610_SFK040_01 C20140610_SFK040_01 TB563517.[MT7]-NLVIAHEGDPAWR.3y7_1.heavy 541.29 / 830.379 122389.0 30.746299743652344 50 20 10 10 10 8.552915410382026 11.691919679062204 0.0 3 0.9968149331121064 21.86189239694592 122389.0 328.61670910786546 0.0 - - - - - - - 670.8888888888889 244 9 PCNX pecanex homolog (Drosophila) 1831 234 C20140610_SFK040_01 C20140610_SFK040_01 TB563517.[MT7]-NLVIAHEGDPAWR.3b4_1.heavy 541.29 / 584.389 180784.0 30.746299743652344 50 20 10 10 10 8.552915410382026 11.691919679062204 0.0 3 0.9968149331121064 21.86189239694592 180784.0 121.62063069376313 0.0 - - - - - - - 659.0 361 1 PCNX pecanex homolog (Drosophila) 1833 234 C20140610_SFK040_01 C20140610_SFK040_01 TB563517.[MT7]-NLVIAHEGDPAWR.3b5_1.heavy 541.29 / 655.426 210091.0 30.746299743652344 50 20 10 10 10 8.552915410382026 11.691919679062204 0.0 3 0.9968149331121064 21.86189239694592 210091.0 192.59965879140287 0.0 - - - - - - - 812.2 420 5 PCNX pecanex homolog (Drosophila) 1835 234 C20140610_SFK040_01 C20140610_SFK040_01 TB563517.[MT7]-NLVIAHEGDPAWR.3y4_1.heavy 541.29 / 529.288 669264.0 30.746299743652344 50 20 10 10 10 8.552915410382026 11.691919679062204 0.0 3 0.9968149331121064 21.86189239694592 669264.0 186.65368233759136 0.0 - - - - - - - 1866.0 1338 2 PCNX pecanex homolog (Drosophila) 1837 235 C20140610_SFK040_01 C20140610_SFK040_01 TB563718.[MT7]-LSLK[MT7]PTLTEESVK[MT7].4y4_1.heavy 470.038 / 606.358 35183.0 32.09629821777344 42 12 10 10 10 1.1058121289180913 52.94780896213263 0.0 3 0.893656489146803 3.75042822561258 35183.0 25.187498156533497 1.0 - - - - - - - 1187.625 79 8 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1839 235 C20140610_SFK040_01 C20140610_SFK040_01 TB563718.[MT7]-LSLK[MT7]PTLTEESVK[MT7].4b7_2.heavy 470.038 / 521.349 74823.0 32.09629821777344 42 12 10 10 10 1.1058121289180913 52.94780896213263 0.0 3 0.893656489146803 3.75042822561258 74823.0 53.67321875115573 0.0 - - - - - - - 469.0 149 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1841 235 C20140610_SFK040_01 C20140610_SFK040_01 TB563718.[MT7]-LSLK[MT7]PTLTEESVK[MT7].4b4_1.heavy 470.038 / 730.506 18764.0 32.09629821777344 42 12 10 10 10 1.1058121289180913 52.94780896213263 0.0 3 0.893656489146803 3.75042822561258 18764.0 65.78672027478405 0.0 - - - - - - - 288.0 37 11 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1843 235 C20140610_SFK040_01 C20140610_SFK040_01 TB563718.[MT7]-LSLK[MT7]PTLTEESVK[MT7].4b9_2.heavy 470.038 / 636.394 58522.0 32.09629821777344 42 12 10 10 10 1.1058121289180913 52.94780896213263 0.0 3 0.893656489146803 3.75042822561258 58522.0 30.469980092202814 0.0 - - - - - - - 117.0 117 1 CDH2 cadherin 2, type 1, N-cadherin (neuronal) 1845 236 C20140610_SFK040_01 C20140610_SFK040_01 TB458609.[MT7]-LEGEGFPSIPLLIDHLLSTQQPLTK[MT7].4y4_1.heavy 759.432 / 602.399 2783.0 51.408498764038086 32 10 10 6 6 1.1384939298526862 56.923630759886535 0.03440093994140625 6 0.831461518737088 2.9628896871714696 2783.0 5.8568445507872795 0.0 - - - - - - - 710.1428571428571 5 21 FES feline sarcoma oncogene 1847 236 C20140610_SFK040_01 C20140610_SFK040_01 TB458609.[MT7]-LEGEGFPSIPLLIDHLLSTQQPLTK[MT7].4b4_1.heavy 759.432 / 573.3 764.0 51.408498764038086 32 10 10 6 6 1.1384939298526862 56.923630759886535 0.03440093994140625 6 0.831461518737088 2.9628896871714696 764.0 0.47233384853168475 20.0 - - - - - - - 0.0 1 0 FES feline sarcoma oncogene 1849 236 C20140610_SFK040_01 C20140610_SFK040_01 TB458609.[MT7]-LEGEGFPSIPLLIDHLLSTQQPLTK[MT7].4b5_1.heavy 759.432 / 630.321 1023.0 51.408498764038086 32 10 10 6 6 1.1384939298526862 56.923630759886535 0.03440093994140625 6 0.831461518737088 2.9628896871714696 1023.0 0.0 10.0 - - - - - - - 698.9375 3 16 FES feline sarcoma oncogene 1851 236 C20140610_SFK040_01 C20140610_SFK040_01 TB458609.[MT7]-LEGEGFPSIPLLIDHLLSTQQPLTK[MT7].4b6_1.heavy 759.432 / 777.39 505.0 51.408498764038086 32 10 10 6 6 1.1384939298526862 56.923630759886535 0.03440093994140625 6 0.831461518737088 2.9628896871714696 505.0 1.584702870072645 11.0 - - - - - - - 0.0 1 0 FES feline sarcoma oncogene 1853 237 C20140610_SFK040_01 C20140610_SFK040_01 TB563852.[MT7]-LEHLGPGEPPPVLLLQDDR.3y7_1.heavy 747.078 / 872.484 40378.0 40.589500427246094 50 20 10 10 10 6.226694268015103 16.05988598375125 0.0 3 0.9915427124167343 13.410354709975133 40378.0 33.37612258026371 0.0 - - - - - - - 420.0 80 1 FES feline sarcoma oncogene 1855 237 C20140610_SFK040_01 C20140610_SFK040_01 TB563852.[MT7]-LEHLGPGEPPPVLLLQDDR.3b3_1.heavy 747.078 / 524.295 97747.0 40.589500427246094 50 20 10 10 10 6.226694268015103 16.05988598375125 0.0 3 0.9915427124167343 13.410354709975133 97747.0 70.21318077075884 0.0 - - - - - - - 420.0 195 1 FES feline sarcoma oncogene 1857 237 C20140610_SFK040_01 C20140610_SFK040_01 TB563852.[MT7]-LEHLGPGEPPPVLLLQDDR.3y10_1.heavy 747.078 / 1165.66 52964.0 40.589500427246094 50 20 10 10 10 6.226694268015103 16.05988598375125 0.0 3 0.9915427124167343 13.410354709975133 52964.0 13.726538798314849 1.0 - - - - - - - 909.0 112 3 FES feline sarcoma oncogene 1859 237 C20140610_SFK040_01 C20140610_SFK040_01 TB563852.[MT7]-LEHLGPGEPPPVLLLQDDR.3y9_1.heavy 747.078 / 1068.6 121450.0 40.589500427246094 50 20 10 10 10 6.226694268015103 16.05988598375125 0.0 3 0.9915427124167343 13.410354709975133 121450.0 58.67396762929549 0.0 - - - - - - - 1206.0 242 2 FES feline sarcoma oncogene 1861 238 C20140610_SFK040_01 C20140610_SFK040_01 TB563513.[MT7]-RYELPAPSSGQK[MT7].3b6_1.heavy 540.97 / 874.49 60829.0 24.4011492729187 41 14 10 7 10 4.309403187750446 23.205069389713117 0.028600692749023438 3 0.9420649915002327 5.102376028749934 60829.0 113.99067971204188 0.0 - - - - - - - 331.3333333333333 121 3 BCAS2 breast carcinoma amplified sequence 2 1863 238 C20140610_SFK040_01 C20140610_SFK040_01 TB563513.[MT7]-RYELPAPSSGQK[MT7].3b4_1.heavy 540.97 / 706.4 49530.0 24.4011492729187 41 14 10 7 10 4.309403187750446 23.205069389713117 0.028600692749023438 3 0.9420649915002327 5.102376028749934 49530.0 49.51299252781854 1.0 - - - - - - - 497.0 99 1 BCAS2 breast carcinoma amplified sequence 2 1865 238 C20140610_SFK040_01 C20140610_SFK040_01 TB563513.[MT7]-RYELPAPSSGQK[MT7].3b3_1.heavy 540.97 / 593.316 25582.0 24.4011492729187 41 14 10 7 10 4.309403187750446 23.205069389713117 0.028600692749023438 3 0.9420649915002327 5.102376028749934 25582.0 19.179554137826003 0.0 - - - - - - - 812.4285714285714 51 7 BCAS2 breast carcinoma amplified sequence 2 1867 238 C20140610_SFK040_01 C20140610_SFK040_01 TB563513.[MT7]-RYELPAPSSGQK[MT7].3y5_1.heavy 540.97 / 650.359 61185.0 24.4011492729187 41 14 10 7 10 4.309403187750446 23.205069389713117 0.028600692749023438 3 0.9420649915002327 5.102376028749934 61185.0 15.744993583868844 0.0 - - - - - - - 402.3333333333333 122 3 BCAS2 breast carcinoma amplified sequence 2 1869 239 C20140610_SFK040_01 C20140610_SFK040_01 TB563185.[MT7]-EFEVIAQIK[MT7].3b4_1.heavy 455.606 / 649.331 170069.0 37.640899658203125 44 14 10 10 10 2.445586549041052 31.473207576972435 0.0 3 0.9476726517147679 5.3713788143776 170069.0 821.1903142857142 0.0 - - - - - - - 270.8333333333333 340 6 RGL1;RALGDS ral guanine nucleotide dissociation stimulator-like 1;ral guanine nucleotide dissociation stimulator 1871 239 C20140610_SFK040_01 C20140610_SFK040_01 TB563185.[MT7]-EFEVIAQIK[MT7].3b5_1.heavy 455.606 / 762.415 17869.0 37.640899658203125 44 14 10 10 10 2.445586549041052 31.473207576972435 0.0 3 0.9476726517147679 5.3713788143776 17869.0 70.52298666666667 0.0 - - - - - - - 238.63636363636363 35 11 RGL1;RALGDS ral guanine nucleotide dissociation stimulator-like 1;ral guanine nucleotide dissociation stimulator 1873 239 C20140610_SFK040_01 C20140610_SFK040_01 TB563185.[MT7]-EFEVIAQIK[MT7].3y4_1.heavy 455.606 / 603.395 59106.0 37.640899658203125 44 14 10 10 10 2.445586549041052 31.473207576972435 0.0 3 0.9476726517147679 5.3713788143776 59106.0 62.88681547229296 0.0 - - - - - - - 250.0 118 3 RGL1;RALGDS ral guanine nucleotide dissociation stimulator-like 1;ral guanine nucleotide dissociation stimulator 1875 239 C20140610_SFK040_01 C20140610_SFK040_01 TB563185.[MT7]-EFEVIAQIK[MT7].3b3_1.heavy 455.606 / 550.263 117212.0 37.640899658203125 44 14 10 10 10 2.445586549041052 31.473207576972435 0.0 3 0.9476726517147679 5.3713788143776 117212.0 145.19207555609879 1.0 - - - - - - - 225.0 310 5 RGL1;RALGDS ral guanine nucleotide dissociation stimulator-like 1;ral guanine nucleotide dissociation stimulator 1877 240 C20140610_SFK040_01 C20140610_SFK040_01 TB458608.[MT7]-GFLQEGDLISAEVQAVFSDGAVSLHTR.3y8_1.heavy 997.516 / 840.469 393.0 52.66867542266846 40 15 10 7 8 2.1497530870047106 36.68303003224254 0.029499053955078125 4 0.95598111786948 5.8605281165899985 393.0 0.10807731594248454 13.0 - - - - - - - 0.0 1 0 EXOSC2 exosome component 2 1879 240 C20140610_SFK040_01 C20140610_SFK040_01 TB458608.[MT7]-GFLQEGDLISAEVQAVFSDGAVSLHTR.3b8_1.heavy 997.516 / 1004.52 678.0 52.66867542266846 40 15 10 7 8 2.1497530870047106 36.68303003224254 0.029499053955078125 4 0.95598111786948 5.8605281165899985 678.0 2.8955544455544455 1.0 - - - - - - - 0.0 1 0 EXOSC2 exosome component 2 1881 240 C20140610_SFK040_01 C20140610_SFK040_01 TB458608.[MT7]-GFLQEGDLISAEVQAVFSDGAVSLHTR.3b7_1.heavy 997.516 / 891.433 1089.0 52.66867542266846 40 15 10 7 8 2.1497530870047106 36.68303003224254 0.029499053955078125 4 0.95598111786948 5.8605281165899985 1089.0 -0.5654093416405412 1.0 - - - - - - - 186.21428571428572 2 28 EXOSC2 exosome component 2 1883 240 C20140610_SFK040_01 C20140610_SFK040_01 TB458608.[MT7]-GFLQEGDLISAEVQAVFSDGAVSLHTR.3y10_1.heavy 997.516 / 1042.53 803.0 52.66867542266846 40 15 10 7 8 2.1497530870047106 36.68303003224254 0.029499053955078125 4 0.95598111786948 5.8605281165899985 803.0 3.612577011494253 4.0 - - - - - - - 0.0 1 0 EXOSC2 exosome component 2 1885 241 C20140610_SFK040_01 C20140610_SFK040_01 TB563280.[MT7]-WDTFVSQEK[MT7].3b4_1.heavy 476.585 / 694.332 23218.0 33.99610137939453 50 20 10 10 10 9.821360819391924 10.181888420447155 0.0 3 0.997602385358809 25.199148625713818 23218.0 37.102818089274145 0.0 - - - - - - - 704.2857142857143 46 7 AK5 adenylate kinase 5 1887 241 C20140610_SFK040_01 C20140610_SFK040_01 TB563280.[MT7]-WDTFVSQEK[MT7].3b5_1.heavy 476.585 / 793.4 5293.0 33.99610137939453 50 20 10 10 10 9.821360819391924 10.181888420447155 0.0 3 0.997602385358809 25.199148625713818 5293.0 17.993922332396814 0.0 - - - - - - - 288.8 10 10 AK5 adenylate kinase 5 1889 241 C20140610_SFK040_01 C20140610_SFK040_01 TB563280.[MT7]-WDTFVSQEK[MT7].3y4_1.heavy 476.585 / 635.348 33082.0 33.99610137939453 50 20 10 10 10 9.821360819391924 10.181888420447155 0.0 3 0.997602385358809 25.199148625713818 33082.0 63.61923076923077 0.0 - - - - - - - 858.8571428571429 66 7 AK5 adenylate kinase 5 1891 241 C20140610_SFK040_01 C20140610_SFK040_01 TB563280.[MT7]-WDTFVSQEK[MT7].3b3_1.heavy 476.585 / 547.263 31759.0 33.99610137939453 50 20 10 10 10 9.821360819391924 10.181888420447155 0.0 3 0.997602385358809 25.199148625713818 31759.0 27.714977870534828 0.0 - - - - - - - 721.5714285714286 63 7 AK5 adenylate kinase 5 1893 242 C20140610_SFK040_01 C20140610_SFK040_01 TB458602.[MT7]-EILQEYLEISSLVQDEVVAIHR.4y9_1.heavy 682.623 / 1066.56 1563.0 51.43429946899414 46 18 10 10 8 4.300741717883585 23.251803191104084 0.0 4 0.9810187219347923 8.943557130829962 1563.0 15.211592558983666 0.0 - - - - - - - 131.59375 3 32 FES feline sarcoma oncogene 1895 242 C20140610_SFK040_01 C20140610_SFK040_01 TB458602.[MT7]-EILQEYLEISSLVQDEVVAIHR.4b4_1.heavy 682.623 / 628.379 N/A 51.43429946899414 46 18 10 10 8 4.300741717883585 23.251803191104084 0.0 4 0.9810187219347923 8.943557130829962 1448.0 3.810526315789474 4.0 - - - - - - - 243.73333333333332 3 30 FES feline sarcoma oncogene 1897 242 C20140610_SFK040_01 C20140610_SFK040_01 TB458602.[MT7]-EILQEYLEISSLVQDEVVAIHR.4b5_1.heavy 682.623 / 757.421 1795.0 51.43429946899414 46 18 10 10 8 4.300741717883585 23.251803191104084 0.0 4 0.9810187219347923 8.943557130829962 1795.0 7.748045649761135 1.0 - - - - - - - 193.14814814814815 3 27 FES feline sarcoma oncogene 1899 242 C20140610_SFK040_01 C20140610_SFK040_01 TB458602.[MT7]-EILQEYLEISSLVQDEVVAIHR.4b6_1.heavy 682.623 / 920.485 869.0 51.43429946899414 46 18 10 10 8 4.300741717883585 23.251803191104084 0.0 4 0.9810187219347923 8.943557130829962 869.0 1.9977011494252874 1.0 - - - - - - - 0.0 1 0 FES feline sarcoma oncogene 1901 243 C20140610_SFK040_01 C20140610_SFK040_01 TB458483.[MT7]-IQPEAEYQGFLR.2y8_1.heavy 797.921 / 983.495 19141.0 36.82780075073242 48 20 10 10 8 7.670720689473177 13.036584702821186 0.0 4 0.9977306077941906 25.901530327421554 19141.0 46.56135662812134 0.0 - - - - - - - 653.75 38 8 FES feline sarcoma oncogene 1903 243 C20140610_SFK040_01 C20140610_SFK040_01 TB458483.[MT7]-IQPEAEYQGFLR.2y9_1.heavy 797.921 / 1112.54 6125.0 36.82780075073242 48 20 10 10 8 7.670720689473177 13.036584702821186 0.0 4 0.9977306077941906 25.901530327421554 6125.0 21.434015813123587 0.0 - - - - - - - 680.5555555555555 12 9 FES feline sarcoma oncogene 1905 243 C20140610_SFK040_01 C20140610_SFK040_01 TB458483.[MT7]-IQPEAEYQGFLR.2y6_1.heavy 797.921 / 783.415 12250.0 36.82780075073242 48 20 10 10 8 7.670720689473177 13.036584702821186 0.0 4 0.9977306077941906 25.901530327421554 12250.0 3.735689574746622 4.0 - - - - - - - 255.0 26 1 FES feline sarcoma oncogene 1907 243 C20140610_SFK040_01 C20140610_SFK040_01 TB458483.[MT7]-IQPEAEYQGFLR.2y10_1.heavy 797.921 / 1209.59 98385.0 36.82780075073242 48 20 10 10 8 7.670720689473177 13.036584702821186 0.0 4 0.9977306077941906 25.901530327421554 98385.0 281.86936334892295 0.0 - - - - - - - 717.75 196 8 FES feline sarcoma oncogene 1909 244 C20140610_SFK040_01 C20140610_SFK040_01 TB458343.[MT7]-LEINVLEK[MT7].2y5_1.heavy 623.386 / 746.453 45074.0 36.9864501953125 39 14 10 5 10 1.3679313548117085 50.91317277466732 0.0460968017578125 3 0.9309963038624173 4.670857932093927 45074.0 15.62408975187282 1.0 - - - - - - - 1193.875 90 8 CLK2 CDC-like kinase 2 1911 244 C20140610_SFK040_01 C20140610_SFK040_01 TB458343.[MT7]-LEINVLEK[MT7].2b4_1.heavy 623.386 / 614.363 62645.0 36.9864501953125 39 14 10 5 10 1.3679313548117085 50.91317277466732 0.0460968017578125 3 0.9309963038624173 4.670857932093927 62645.0 16.50181937172775 0.0 - - - - - - - 2037.0 125 1 CLK2 CDC-like kinase 2 1913 244 C20140610_SFK040_01 C20140610_SFK040_01 TB458343.[MT7]-LEINVLEK[MT7].2y3_1.heavy 623.386 / 533.341 34123.0 36.9864501953125 39 14 10 5 10 1.3679313548117085 50.91317277466732 0.0460968017578125 3 0.9309963038624173 4.670857932093927 34123.0 17.108656441861438 0.0 - - - - - - - 1401.0 68 1 CLK2 CDC-like kinase 2 1915 244 C20140610_SFK040_01 C20140610_SFK040_01 TB458343.[MT7]-LEINVLEK[MT7].2y6_1.heavy 623.386 / 859.537 29030.0 36.9864501953125 39 14 10 5 10 1.3679313548117085 50.91317277466732 0.0460968017578125 3 0.9309963038624173 4.670857932093927 29030.0 9.971501267973462 0.0 - - - - - - - 706.0909090909091 58 11 CLK2 CDC-like kinase 2 1917 245 C20140610_SFK040_01 C20140610_SFK040_01 TB563456.[MT7]-AIVSALQSNSIYR.2y8_1.heavy 783.442 / 980.516 23089.0 35.64070129394531 44 14 10 10 10 2.3607821677713963 35.02142371276068 0.0 3 0.942334962448741 5.114423561928047 23089.0 47.91116988133431 0.0 - - - - - - - 270.2857142857143 46 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1919 245 C20140610_SFK040_01 C20140610_SFK040_01 TB563456.[MT7]-AIVSALQSNSIYR.2y9_1.heavy 783.442 / 1051.55 34192.0 35.64070129394531 44 14 10 10 10 2.3607821677713963 35.02142371276068 0.0 3 0.942334962448741 5.114423561928047 34192.0 37.03488479000355 0.0 - - - - - - - 294.5 68 6 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1921 245 C20140610_SFK040_01 C20140610_SFK040_01 TB563456.[MT7]-AIVSALQSNSIYR.2y10_1.heavy 783.442 / 1138.59 56650.0 35.64070129394531 44 14 10 10 10 2.3607821677713963 35.02142371276068 0.0 3 0.942334962448741 5.114423561928047 56650.0 81.39619434891631 0.0 - - - - - - - 270.57142857142856 113 7 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1923 245 C20140610_SFK040_01 C20140610_SFK040_01 TB563456.[MT7]-AIVSALQSNSIYR.2y11_1.heavy 783.442 / 1237.65 22206.0 35.64070129394531 44 14 10 10 10 2.3607821677713963 35.02142371276068 0.0 3 0.942334962448741 5.114423561928047 22206.0 24.03447116061809 0.0 - - - - - - - 599.5 44 8 RGL1 ral guanine nucleotide dissociation stimulator-like 1 1925 246 C20140610_SFK040_01 C20140610_SFK040_01 TB562673.[MT7]-NVSEEK[MT7].2y4_1.heavy 497.276 / 636.332 14586.0 15.83430004119873 48 20 10 10 8 11.379860143676295 8.78745421626023 0.0 4 0.9981154620199294 28.424425470608323 14586.0 99.7152 0.0 - - - - - - - 214.65 29 20 EXPH5;ASPM exophilin 5;asp (abnormal spindle) homolog, microcephaly associated (Drosophila) 1927 246 C20140610_SFK040_01 C20140610_SFK040_01 TB562673.[MT7]-NVSEEK[MT7].2y5_1.heavy 497.276 / 735.401 8237.0 15.83430004119873 48 20 10 10 8 11.379860143676295 8.78745421626023 0.0 4 0.9981154620199294 28.424425470608323 8237.0 86.41089797996945 1.0 - - - - - - - 1362.857142857143 20 7 EXPH5;ASPM exophilin 5;asp (abnormal spindle) homolog, microcephaly associated (Drosophila) 1929 246 C20140610_SFK040_01 C20140610_SFK040_01 TB562673.[MT7]-NVSEEK[MT7].2y3_1.heavy 497.276 / 549.3 3912.0 15.83430004119873 48 20 10 10 8 11.379860143676295 8.78745421626023 0.0 4 0.9981154620199294 28.424425470608323 3912.0 14.603392491531977 0.0 - - - - - - - 252.8421052631579 7 19 EXPH5;ASPM exophilin 5;asp (abnormal spindle) homolog, microcephaly associated (Drosophila) 1931 246 C20140610_SFK040_01 C20140610_SFK040_01 TB562673.[MT7]-NVSEEK[MT7].2b5_1.heavy 497.276 / 703.338 2471.0 15.83430004119873 48 20 10 10 8 11.379860143676295 8.78745421626023 0.0 4 0.9981154620199294 28.424425470608323 2471.0 12.399879796578826 1.0 - - - - - - - 228.8095238095238 6 21 EXPH5;ASPM exophilin 5;asp (abnormal spindle) homolog, microcephaly associated (Drosophila) 1933 247 C20140610_SFK040_01 C20140610_SFK040_01 TB563000.[MT7]-ELNPYWK[MT7].2y4_1.heavy 619.345 / 737.41 46399.0 32.6963005065918 45 15 10 10 10 2.7401828496576086 36.493915000050166 0.0 3 0.95961163187396 6.120142969886122 46399.0 73.31364898098003 0.0 - - - - - - - 1191.4285714285713 92 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1935 247 C20140610_SFK040_01 C20140610_SFK040_01 TB563000.[MT7]-ELNPYWK[MT7].2b3_1.heavy 619.345 / 501.279 45459.0 32.6963005065918 45 15 10 10 10 2.7401828496576086 36.493915000050166 0.0 3 0.95961163187396 6.120142969886122 45459.0 29.697579936541224 0.0 - - - - - - - 293.5 90 2 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1937 247 C20140610_SFK040_01 C20140610_SFK040_01 TB563000.[MT7]-ELNPYWK[MT7].2y5_1.heavy 619.345 / 851.453 N/A 32.6963005065918 45 15 10 10 10 2.7401828496576086 36.493915000050166 0.0 3 0.95961163187396 6.120142969886122 46399.0 89.78868653815732 0.0 - - - - - - - 719.5 92 8 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1939 247 C20140610_SFK040_01 C20140610_SFK040_01 TB563000.[MT7]-ELNPYWK[MT7].2y3_1.heavy 619.345 / 640.357 9632.0 32.6963005065918 45 15 10 10 10 2.7401828496576086 36.493915000050166 0.0 3 0.95961163187396 6.120142969886122 9632.0 9.110256164576583 0.0 - - - - - - - 1266.3333333333333 19 9 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1941 248 C20140610_SFK040_01 C20140610_SFK040_01 TB562992.[MT7]-NFEDIVAER.2y8_1.heavy 618.821 / 978.489 109931.0 33.29800033569336 46 16 10 10 10 1.8573051553909172 36.202730007097486 0.0 3 0.9649946222568873 6.576879560057881 109931.0 175.81557239057238 0.0 - - - - - - - 747.0 219 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1943 248 C20140610_SFK040_01 C20140610_SFK040_01 TB562992.[MT7]-NFEDIVAER.2y5_1.heavy 618.821 / 587.351 98166.0 33.29800033569336 46 16 10 10 10 1.8573051553909172 36.202730007097486 0.0 3 0.9649946222568873 6.576879560057881 98166.0 31.82911206221426 1.0 - - - - - - - 1402.2 216 5 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1945 248 C20140610_SFK040_01 C20140610_SFK040_01 TB562992.[MT7]-NFEDIVAER.2b4_1.heavy 618.821 / 650.29 101255.0 33.29800033569336 46 16 10 10 10 1.8573051553909172 36.202730007097486 0.0 3 0.9649946222568873 6.576879560057881 101255.0 120.80742966524217 0.0 - - - - - - - 798.0 202 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1947 248 C20140610_SFK040_01 C20140610_SFK040_01 TB562992.[MT7]-NFEDIVAER.2y6_1.heavy 618.821 / 702.378 43141.0 33.29800033569336 46 16 10 10 10 1.8573051553909172 36.202730007097486 0.0 3 0.9649946222568873 6.576879560057881 43141.0 57.48914479058939 0.0 - - - - - - - 257.8333333333333 86 6 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1949 249 C20140610_SFK040_01 C20140610_SFK040_01 TB563274.[MT7]-YIGEVGDIVVGR.2y8_1.heavy 710.899 / 814.478 67344.0 39.00450134277344 45 15 10 10 10 2.0247723830580853 41.15613555205714 0.0 3 0.9548532949878695 5.786310462533964 67344.0 112.20353476283302 0.0 - - - - - - - 820.375 134 8 EXOSC2 exosome component 2 1951 249 C20140610_SFK040_01 C20140610_SFK040_01 TB563274.[MT7]-YIGEVGDIVVGR.2y5_1.heavy 710.899 / 543.361 125571.0 39.00450134277344 45 15 10 10 10 2.0247723830580853 41.15613555205714 0.0 3 0.9548532949878695 5.786310462533964 125571.0 106.47785781683626 0.0 - - - - - - - 1215.875 251 8 EXOSC2 exosome component 2 1953 249 C20140610_SFK040_01 C20140610_SFK040_01 TB563274.[MT7]-YIGEVGDIVVGR.2y10_1.heavy 710.899 / 1000.54 281654.0 39.00450134277344 45 15 10 10 10 2.0247723830580853 41.15613555205714 0.0 3 0.9548532949878695 5.786310462533964 281654.0 301.24548990276736 0.0 - - - - - - - 425.5 563 2 EXOSC2 exosome component 2 1955 249 C20140610_SFK040_01 C20140610_SFK040_01 TB563274.[MT7]-YIGEVGDIVVGR.2y11_1.heavy 710.899 / 1113.63 196684.0 39.00450134277344 45 15 10 10 10 2.0247723830580853 41.15613555205714 0.0 3 0.9548532949878695 5.786310462533964 196684.0 198.7533368403748 0.0 - - - - - - - 340.2 393 5 EXOSC2 exosome component 2 1957 250 C20140610_SFK040_01 C20140610_SFK040_01 TB562984.[MT7]-TRQIISTIR.3b4_1.heavy 411.258 / 643.401 13004.0 25.06559944152832 44 20 10 6 8 5.927177197315554 16.87143756142308 0.03639984130859375 4 0.9958601703159686 19.174373966246446 13004.0 22.14789398979432 1.0 - - - - - - - 682.0909090909091 26 11 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1959 250 C20140610_SFK040_01 C20140610_SFK040_01 TB562984.[MT7]-TRQIISTIR.3b3_1.heavy 411.258 / 530.317 12361.0 25.06559944152832 44 20 10 6 8 5.927177197315554 16.87143756142308 0.03639984130859375 4 0.9958601703159686 19.174373966246446 12361.0 1.57264631043257 1.0 - - - - - - - 1214.6666666666667 26 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1961 250 C20140610_SFK040_01 C20140610_SFK040_01 TB562984.[MT7]-TRQIISTIR.3y4_1.heavy 411.258 / 476.283 118254.0 25.06559944152832 44 20 10 6 8 5.927177197315554 16.87143756142308 0.03639984130859375 4 0.9958601703159686 19.174373966246446 118254.0 60.4572236539667 0.0 - - - - - - - 2232.75 236 8 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1963 250 C20140610_SFK040_01 C20140610_SFK040_01 TB562984.[MT7]-TRQIISTIR.3y5_1.heavy 411.258 / 589.367 46730.0 25.06559944152832 44 20 10 6 8 5.927177197315554 16.87143756142308 0.03639984130859375 4 0.9958601703159686 19.174373966246446 46730.0 53.0891583948864 0.0 - - - - - - - 1183.0 93 9 FDFT1 farnesyl-diphosphate farnesyltransferase 1 1965 251 C20140610_SFK040_01 C20140610_SFK040_01 TB563720.[MT7]-TIVQLENEIYQIK[MT7].3b6_1.heavy 627.031 / 828.495 164398.0 44.917198181152344 46 16 10 10 10 2.6474640262005282 29.573577261989342 0.0 3 0.9630483383991151 6.400278990401487 164398.0 359.18890756302517 0.0 - - - - - - - 646.0 328 8 BCAS2 breast carcinoma amplified sequence 2 1967 251 C20140610_SFK040_01 C20140610_SFK040_01 TB563720.[MT7]-TIVQLENEIYQIK[MT7].3b4_1.heavy 627.031 / 586.368 481359.0 44.917198181152344 46 16 10 10 10 2.6474640262005282 29.573577261989342 0.0 3 0.9630483383991151 6.400278990401487 481359.0 498.74154888162366 0.0 - - - - - - - 1292.0 962 8 BCAS2 breast carcinoma amplified sequence 2 1969 251 C20140610_SFK040_01 C20140610_SFK040_01 TB563720.[MT7]-TIVQLENEIYQIK[MT7].3b5_1.heavy 627.031 / 699.452 229219.0 44.917198181152344 46 16 10 10 10 2.6474640262005282 29.573577261989342 0.0 3 0.9630483383991151 6.400278990401487 229219.0 258.73124483797477 0.0 - - - - - - - 1301.7142857142858 458 7 BCAS2 breast carcinoma amplified sequence 2 1971 251 C20140610_SFK040_01 C20140610_SFK040_01 TB563720.[MT7]-TIVQLENEIYQIK[MT7].3y4_1.heavy 627.031 / 695.421 577959.0 44.917198181152344 46 16 10 10 10 2.6474640262005282 29.573577261989342 0.0 3 0.9630483383991151 6.400278990401487 577959.0 979.6099943438913 0.0 - - - - - - - 1147.5 1155 8 BCAS2 breast carcinoma amplified sequence 2 1973 252 C20140610_SFK040_01 C20140610_SFK040_01 TB563726.[MT7]-MAEY[MT7]LASIFGTEK[MT7].3b4_1.heavy 631.345 / 783.395 22941.0 44.31880187988281 44 16 10 10 8 2.9570310997973652 33.81770317087725 0.0 4 0.9605449528381669 6.192595573264336 22941.0 56.01872093023255 0.0 - - - - - - - 636.375 45 8 U2AF1L4;U2AF1 U2 small nuclear RNA auxiliary factor 1-like 4;U2 small nuclear RNA auxiliary factor 1 1975 252 C20140610_SFK040_01 C20140610_SFK040_01 TB563726.[MT7]-MAEY[MT7]LASIFGTEK[MT7].3b5_1.heavy 631.345 / 896.479 9033.0 44.31880187988281 44 16 10 10 8 2.9570310997973652 33.81770317087725 0.0 4 0.9605449528381669 6.192595573264336 9033.0 81.08693023255813 0.0 - - - - - - - 194.94444444444446 18 18 U2AF1L4;U2AF1 U2 small nuclear RNA auxiliary factor 1-like 4;U2 small nuclear RNA auxiliary factor 1 1977 252 C20140610_SFK040_01 C20140610_SFK040_01 TB563726.[MT7]-MAEY[MT7]LASIFGTEK[MT7].3y4_1.heavy 631.345 / 578.327 20001.0 44.31880187988281 44 16 10 10 8 2.9570310997973652 33.81770317087725 0.0 4 0.9605449528381669 6.192595573264336 20001.0 34.71901322347923 1.0 - - - - - - - 1106.2857142857142 46 7 U2AF1L4;U2AF1 U2 small nuclear RNA auxiliary factor 1-like 4;U2 small nuclear RNA auxiliary factor 1 1979 252 C20140610_SFK040_01 C20140610_SFK040_01 TB563726.[MT7]-MAEY[MT7]LASIFGTEK[MT7].3y5_1.heavy 631.345 / 725.395 22224.0 44.31880187988281 44 16 10 10 8 2.9570310997973652 33.81770317087725 0.0 4 0.9605449528381669 6.192595573264336 22224.0 39.61389048457333 0.0 - - - - - - - 661.7692307692307 44 13 U2AF1L4;U2AF1 U2 small nuclear RNA auxiliary factor 1-like 4;U2 small nuclear RNA auxiliary factor 1 1981 253 C20140610_SFK040_01 C20140610_SFK040_01 TB562664.[MT7]-ESDLVK[MT7].2y4_1.heavy 489.789 / 618.394 9409.0 21.569274425506592 43 17 10 6 10 3.0319007725753857 28.401633413680678 0.03769874572753906 3 0.9784105187517965 8.384106871489184 9409.0 29.85169497418942 0.0 - - - - - - - 296.125 18 8 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1983 253 C20140610_SFK040_01 C20140610_SFK040_01 TB562664.[MT7]-ESDLVK[MT7].2y5_1.heavy 489.789 / 705.426 37705.0 21.569274425506592 43 17 10 6 10 3.0319007725753857 28.401633413680678 0.03769874572753906 3 0.9784105187517965 8.384106871489184 37705.0 52.413553431798434 0.0 - - - - - - - 710.9 75 10 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1985 253 C20140610_SFK040_01 C20140610_SFK040_01 TB562664.[MT7]-ESDLVK[MT7].2b4_1.heavy 489.789 / 589.295 23557.0 21.569274425506592 43 17 10 6 10 3.0319007725753857 28.401633413680678 0.03769874572753906 3 0.9784105187517965 8.384106871489184 23557.0 18.81754786161985 0.0 - - - - - - - 1294.5 47 8 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1987 253 C20140610_SFK040_01 C20140610_SFK040_01 TB562664.[MT7]-ESDLVK[MT7].2y3_1.heavy 489.789 / 503.367 51785.0 21.569274425506592 43 17 10 6 10 3.0319007725753857 28.401633413680678 0.03769874572753906 3 0.9784105187517965 8.384106871489184 51785.0 79.93087027914613 0.0 - - - - - - - 1167.5 103 8 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1989 254 C20140610_SFK040_01 C20140610_SFK040_01 TB563724.[MT7]-ENLFNSLNYDVAAK[MT7].3b4_1.heavy 629.335 / 648.347 49554.0 39.81890106201172 44 14 10 10 10 1.2636351364132938 47.458366453712365 0.0 3 0.9399542646045078 5.010993410066069 49554.0 54.7251506915585 0.0 - - - - - - - 1705.375 99 8 FBXO32 F-box protein 32 1991 254 C20140610_SFK040_01 C20140610_SFK040_01 TB563724.[MT7]-ENLFNSLNYDVAAK[MT7].3b5_1.heavy 629.335 / 762.39 28566.0 39.81890106201172 44 14 10 10 10 1.2636351364132938 47.458366453712365 0.0 3 0.9399542646045078 5.010993410066069 28566.0 20.64385250444394 0.0 - - - - - - - 777.4444444444445 57 9 FBXO32 F-box protein 32 1993 254 C20140610_SFK040_01 C20140610_SFK040_01 TB563724.[MT7]-ENLFNSLNYDVAAK[MT7].3y4_1.heavy 629.335 / 532.357 65528.0 39.81890106201172 44 14 10 10 10 1.2636351364132938 47.458366453712365 0.0 3 0.9399542646045078 5.010993410066069 65528.0 31.870467744154656 0.0 - - - - - - - 758.0 131 2 FBXO32 F-box protein 32 1995 254 C20140610_SFK040_01 C20140610_SFK040_01 TB563724.[MT7]-ENLFNSLNYDVAAK[MT7].3b3_1.heavy 629.335 / 501.279 58299.0 39.81890106201172 44 14 10 10 10 1.2636351364132938 47.458366453712365 0.0 3 0.9399542646045078 5.010993410066069 58299.0 27.333115267105036 0.0 - - - - - - - 350.0 116 1 FBXO32 F-box protein 32 1997 255 C20140610_SFK040_01 C20140610_SFK040_01 TB562663.[MT7]-SLESQGGR.2y5_1.heavy 489.26 / 504.253 20412.0 16.45319938659668 48 18 10 10 10 3.5895556297197135 27.858601541664473 0.0 3 0.983083615961696 9.475332740011973 20412.0 65.7409981238274 0.0 - - - - - - - 305.4 40 15 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 1999 255 C20140610_SFK040_01 C20140610_SFK040_01 TB562663.[MT7]-SLESQGGR.2y6_1.heavy 489.26 / 633.295 15197.0 16.45319938659668 48 18 10 10 10 3.5895556297197135 27.858601541664473 0.0 3 0.983083615961696 9.475332740011973 15197.0 25.470743290960453 0.0 - - - - - - - 699.4444444444445 30 9 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2001 255 C20140610_SFK040_01 C20140610_SFK040_01 TB562663.[MT7]-SLESQGGR.2b7_1.heavy 489.26 / 803.402 2421.0 16.45319938659668 48 18 10 10 10 3.5895556297197135 27.858601541664473 0.0 3 0.983083615961696 9.475332740011973 2421.0 7.311350357218647 0.0 - - - - - - - 232.33333333333334 4 21 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2003 255 C20140610_SFK040_01 C20140610_SFK040_01 TB562663.[MT7]-SLESQGGR.2b5_1.heavy 489.26 / 689.359 1788.0 16.45319938659668 48 18 10 10 10 3.5895556297197135 27.858601541664473 0.0 3 0.983083615961696 9.475332740011973 1788.0 5.509156010230179 0.0 - - - - - - - 271.23809523809524 3 21 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2005 256 C20140610_SFK040_01 C20140610_SFK040_01 TB563177.[MT7]-LLPALQSTITR.2y8_1.heavy 678.92 / 889.51 66494.0 39.9286003112793 45 20 10 5 10 6.658143222681444 15.019202299425283 0.044403076171875 3 0.9970696506803883 22.792741369129182 66494.0 145.95075164721626 0.0 - - - - - - - 395.5 132 4 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 2007 256 C20140610_SFK040_01 C20140610_SFK040_01 TB563177.[MT7]-LLPALQSTITR.2y9_1.heavy 678.92 / 986.563 1245770.0 39.9286003112793 45 20 10 5 10 6.658143222681444 15.019202299425283 0.044403076171875 3 0.9970696506803883 22.792741369129182 1245770.0 1458.7220300241904 0.0 - - - - - - - 452.0 2491 1 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 2009 256 C20140610_SFK040_01 C20140610_SFK040_01 TB563177.[MT7]-LLPALQSTITR.2y10_1.heavy 678.92 / 1099.65 288706.0 39.9286003112793 45 20 10 5 10 6.658143222681444 15.019202299425283 0.044403076171875 3 0.9970696506803883 22.792741369129182 288706.0 171.31089627646685 0.0 - - - - - - - 339.0 577 1 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 2011 256 C20140610_SFK040_01 C20140610_SFK040_01 TB563177.[MT7]-LLPALQSTITR.2y7_1.heavy 678.92 / 818.473 45234.0 39.9286003112793 45 20 10 5 10 6.658143222681444 15.019202299425283 0.044403076171875 3 0.9970696506803883 22.792741369129182 45234.0 91.62290495526162 0.0 - - - - - - - 263.6666666666667 90 3 ALDH3B1;ALDH3B2 aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2 2013 257 C20140610_SFK040_01 C20140610_SFK040_01 TB563173.[MT7]-HIQDLNWQR.3y3_1.heavy 451.91 / 489.257 169697.0 27.725000381469727 48 18 10 10 10 3.6044536111945744 18.71803926425662 0.0 3 0.9878990629381216 11.207634162029972 169697.0 37.41234668408865 0.0 - - - - - - - 1693.0 339 1 BCAS2 breast carcinoma amplified sequence 2 2015 257 C20140610_SFK040_01 C20140610_SFK040_01 TB563173.[MT7]-HIQDLNWQR.3b4_1.heavy 451.91 / 638.338 164779.0 27.725000381469727 48 18 10 10 10 3.6044536111945744 18.71803926425662 0.0 3 0.9878990629381216 11.207634162029972 164779.0 196.8476307868383 0.0 - - - - - - - 705.375 329 8 BCAS2 breast carcinoma amplified sequence 2 2017 257 C20140610_SFK040_01 C20140610_SFK040_01 TB563173.[MT7]-HIQDLNWQR.3y4_1.heavy 451.91 / 603.3 216696.0 27.725000381469727 48 18 10 10 10 3.6044536111945744 18.71803926425662 0.0 3 0.9878990629381216 11.207634162029972 216696.0 147.58282756078407 0.0 - - - - - - - 1280.7777777777778 433 9 BCAS2 breast carcinoma amplified sequence 2 2019 257 C20140610_SFK040_01 C20140610_SFK040_01 TB563173.[MT7]-HIQDLNWQR.3y5_1.heavy 451.91 / 716.384 25313.0 27.725000381469727 48 18 10 10 10 3.6044536111945744 18.71803926425662 0.0 3 0.9878990629381216 11.207634162029972 25313.0 31.957637870483566 0.0 - - - - - - - 315.8333333333333 50 12 BCAS2 breast carcinoma amplified sequence 2 2021 258 C20140610_SFK040_01 C20140610_SFK040_01 TB563326.[MT7]-GFEPGVTNILK[MT7].3y3_1.heavy 488.288 / 517.383 60063.0 36.69380187988281 48 20 10 10 8 3.056789741257655 24.839454546135954 0.0 4 0.9900202199715894 12.343548915742646 60063.0 50.524125575211634 1.0 - - - - - - - 638.0 212 2 POSTN periostin, osteoblast specific factor 2023 258 C20140610_SFK040_01 C20140610_SFK040_01 TB563326.[MT7]-GFEPGVTNILK[MT7].3b6_1.heavy 488.288 / 731.385 37874.0 36.69380187988281 48 20 10 10 8 3.056789741257655 24.839454546135954 0.0 4 0.9900202199715894 12.343548915742646 37874.0 85.87248758169935 0.0 - - - - - - - 276.5 75 6 POSTN periostin, osteoblast specific factor 2025 258 C20140610_SFK040_01 C20140610_SFK040_01 TB563326.[MT7]-GFEPGVTNILK[MT7].3b4_1.heavy 488.288 / 575.295 17088.0 36.69380187988281 48 20 10 10 8 3.056789741257655 24.839454546135954 0.0 4 0.9900202199715894 12.343548915742646 17088.0 19.784425770308122 0.0 - - - - - - - 255.5 34 2 POSTN periostin, osteoblast specific factor 2027 258 C20140610_SFK040_01 C20140610_SFK040_01 TB563326.[MT7]-GFEPGVTNILK[MT7].3b5_1.heavy 488.288 / 632.316 150604.0 36.69380187988281 48 20 10 10 8 3.056789741257655 24.839454546135954 0.0 4 0.9900202199715894 12.343548915742646 150604.0 234.59677100588334 0.0 - - - - - - - 383.0 301 2 POSTN periostin, osteoblast specific factor 2029 259 C20140610_SFK040_01 C20140610_SFK040_01 TB562661.[MT7]-TDLDVIR.2y5_1.heavy 488.283 / 615.382 38968.0 28.99209976196289 48 20 10 10 8 4.267054666800773 23.43536884540902 0.0 4 0.9924005776497198 14.148052496613502 38968.0 34.831114205394215 0.0 - - - - - - - 649.3333333333334 77 3 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 2031 259 C20140610_SFK040_01 C20140610_SFK040_01 TB562661.[MT7]-TDLDVIR.2b4_1.heavy 488.283 / 589.295 82019.0 28.99209976196289 48 20 10 10 8 4.267054666800773 23.43536884540902 0.0 4 0.9924005776497198 14.148052496613502 82019.0 56.90365259091055 1.0 - - - - - - - 186.0 164 1 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 2033 259 C20140610_SFK040_01 C20140610_SFK040_01 TB562661.[MT7]-TDLDVIR.2y6_1.heavy 488.283 / 730.409 22917.0 28.99209976196289 48 20 10 10 8 4.267054666800773 23.43536884540902 0.0 4 0.9924005776497198 14.148052496613502 22917.0 19.17123418340116 2.0 - - - - - - - 728.7142857142857 137 7 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 2035 259 C20140610_SFK040_01 C20140610_SFK040_01 TB562661.[MT7]-TDLDVIR.2b5_1.heavy 488.283 / 688.363 30247.0 28.99209976196289 48 20 10 10 8 4.267054666800773 23.43536884540902 0.0 4 0.9924005776497198 14.148052496613502 30247.0 35.761814950157856 1.0 - - - - - - - 1311.857142857143 69 7 FRA10AC1 fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 2037 260 C20140610_SFK040_01 C20140610_SFK040_01 TB458471.[MT7]-VSVVEDGGLSWLR.2y8_1.heavy 780.929 / 903.468 8671.0 42.61957550048828 33 10 10 3 10 1.06305779516616 54.17796752592878 0.07110214233398438 3 0.8499939408642806 3.1457432634880442 8671.0 12.408530367661994 0.0 - - - - - - - 680.4 17 10 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2039 260 C20140610_SFK040_01 C20140610_SFK040_01 TB458471.[MT7]-VSVVEDGGLSWLR.2y5_1.heavy 780.929 / 674.398 1864.0 42.61957550048828 33 10 10 3 10 1.06305779516616 54.17796752592878 0.07110214233398438 3 0.8499939408642806 3.1457432634880442 1864.0 1.1747271460516522 10.0 - - - - - - - 804.6 27 15 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2041 260 C20140610_SFK040_01 C20140610_SFK040_01 TB458471.[MT7]-VSVVEDGGLSWLR.2b6_1.heavy 780.929 / 773.416 8023.0 42.61957550048828 33 10 10 3 10 1.06305779516616 54.17796752592878 0.07110214233398438 3 0.8499939408642806 3.1457432634880442 8023.0 2.8797094915548627 1.0 - - - - - - - 729.0 16 10 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2043 260 C20140610_SFK040_01 C20140610_SFK040_01 TB458471.[MT7]-VSVVEDGGLSWLR.2y7_1.heavy 780.929 / 788.441 15073.0 42.61957550048828 33 10 10 3 10 1.06305779516616 54.17796752592878 0.07110214233398438 3 0.8499939408642806 3.1457432634880442 15073.0 9.839622754982095 0.0 - - - - - - - 342.0 30 9 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2045 261 C20140610_SFK040_01 C20140610_SFK040_01 TB458470.[MT7]-HLTPVTLELGGK[MT7].2y5_1.heavy 776.969 / 647.385 6653.0 32.86050033569336 41 11 10 10 10 1.4358415925790924 57.10117559358649 0.0 3 0.8748582169226584 3.451632287450785 6653.0 17.725071306008807 0.0 - - - - - - - 285.2 13 10 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 2047 261 C20140610_SFK040_01 C20140610_SFK040_01 TB458470.[MT7]-HLTPVTLELGGK[MT7].2y9_1.heavy 776.969 / 1057.64 70331.0 32.86050033569336 41 11 10 10 10 1.4358415925790924 57.10117559358649 0.0 3 0.8748582169226584 3.451632287450785 70331.0 161.4569831730769 0.0 - - - - - - - 330.0 140 9 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 2049 261 C20140610_SFK040_01 C20140610_SFK040_01 TB458470.[MT7]-HLTPVTLELGGK[MT7].2y10_1.heavy 776.969 / 1158.69 15563.0 32.86050033569336 41 11 10 10 10 1.4358415925790924 57.10117559358649 0.0 3 0.8748582169226584 3.451632287450785 15563.0 44.9278817157078 0.0 - - - - - - - 259.27272727272725 31 11 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 2051 261 C20140610_SFK040_01 C20140610_SFK040_01 TB458470.[MT7]-HLTPVTLELGGK[MT7].2y7_1.heavy 776.969 / 861.516 8079.0 32.86050033569336 41 11 10 10 10 1.4358415925790924 57.10117559358649 0.0 3 0.8748582169226584 3.451632287450785 8079.0 34.70702701168993 0.0 - - - - - - - 288.5 16 14 ALDH3A1;ALDH3B1;ALDH3B2;ALDH3A2 aldehyde dehydrogenase 3 family, member A1;aldehyde dehydrogenase 3 family, member B1;aldehyde dehydrogenase 3 family, member B2;aldehyde dehydrogenase 3 family, member A2 2053 262 C20140610_SFK040_01 C20140610_SFK040_01 TB562662.[MT7]-TTLEVLR.2y5_1.heavy 488.301 / 629.398 29539.0 30.329200744628906 48 20 10 10 8 4.838553561655468 20.667333475954308 0.0 4 0.9906704891036467 12.767171914869431 29539.0 30.804620871055295 0.0 - - - - - - - 632.625 59 8 SPAG5 sperm associated antigen 5 2055 262 C20140610_SFK040_01 C20140610_SFK040_01 TB562662.[MT7]-TTLEVLR.2b4_1.heavy 488.301 / 589.331 57496.0 30.329200744628906 48 20 10 10 8 4.838553561655468 20.667333475954308 0.0 4 0.9906704891036467 12.767171914869431 57496.0 16.88053007615318 2.0 - - - - - - - 422.0 159 1 SPAG5 sperm associated antigen 5 2057 262 C20140610_SFK040_01 C20140610_SFK040_01 TB562662.[MT7]-TTLEVLR.2y6_1.heavy 488.301 / 730.446 72265.0 30.329200744628906 48 20 10 10 8 4.838553561655468 20.667333475954308 0.0 4 0.9906704891036467 12.767171914869431 72265.0 205.9821597833446 0.0 - - - - - - - 281.0 144 6 SPAG5 sperm associated antigen 5 2059 262 C20140610_SFK040_01 C20140610_SFK040_01 TB562662.[MT7]-TTLEVLR.2b5_1.heavy 488.301 / 688.4 36291.0 30.329200744628906 48 20 10 10 8 4.838553561655468 20.667333475954308 0.0 4 0.9906704891036467 12.767171914869431 36291.0 115.52027546628406 1.0 - - - - - - - 593.125 72 8 SPAG5 sperm associated antigen 5 2061 263 C20140610_SFK040_01 C20140610_SFK040_01 TB562660.[MT7]-ALLSAVTR.2y5_1.heavy 487.809 / 533.304 178243.0 31.584400177001953 48 18 10 10 10 3.6942557982689532 21.635697424852584 0.0 3 0.9842312473634219 9.815023692807102 178243.0 164.9580642242111 0.0 - - - - - - - 1739.4285714285713 356 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 2063 263 C20140610_SFK040_01 C20140610_SFK040_01 TB562660.[MT7]-ALLSAVTR.2y6_1.heavy 487.809 / 646.388 121309.0 31.584400177001953 48 18 10 10 10 3.6942557982689532 21.635697424852584 0.0 3 0.9842312473634219 9.815023692807102 121309.0 175.42488040316618 0.0 - - - - - - - 1161.3 242 10 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 2065 263 C20140610_SFK040_01 C20140610_SFK040_01 TB562660.[MT7]-ALLSAVTR.2b5_1.heavy 487.809 / 600.384 44420.0 31.584400177001953 48 18 10 10 10 3.6942557982689532 21.635697424852584 0.0 3 0.9842312473634219 9.815023692807102 44420.0 38.086384026035844 0.0 - - - - - - - 789.2 88 5 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 2067 263 C20140610_SFK040_01 C20140610_SFK040_01 TB562660.[MT7]-ALLSAVTR.2y7_1.heavy 487.809 / 759.472 170351.0 31.584400177001953 48 18 10 10 10 3.6942557982689532 21.635697424852584 0.0 3 0.9842312473634219 9.815023692807102 170351.0 145.304983183251 0.0 - - - - - - - 338.14285714285717 340 7 CTNNA1;CTNNA2 catenin (cadherin-associated protein), alpha 1, 102kDa;catenin (cadherin-associated protein), alpha 2 2069 264 C20140610_SFK040_01 C20140610_SFK040_01 TB563661.[MT7]-ELQEVIQQQNEK[MT7].3y3_1.heavy 591.991 / 534.3 61702.0 29.527700424194336 45 15 10 10 10 2.810136166624946 35.58546421617101 0.0 3 0.9598989442073607 6.142177621533552 61702.0 30.71002716967608 0.0 - - - - - - - 1102.0 123 3 SPAG5 sperm associated antigen 5 2071 264 C20140610_SFK040_01 C20140610_SFK040_01 TB563661.[MT7]-ELQEVIQQQNEK[MT7].3b4_1.heavy 591.991 / 644.337 118897.0 29.527700424194336 45 15 10 10 10 2.810136166624946 35.58546421617101 0.0 3 0.9598989442073607 6.142177621533552 118897.0 68.14166987904844 0.0 - - - - - - - 350.5 237 2 SPAG5 sperm associated antigen 5 2073 264 C20140610_SFK040_01 C20140610_SFK040_01 TB563661.[MT7]-ELQEVIQQQNEK[MT7].3b5_1.heavy 591.991 / 743.406 80934.0 29.527700424194336 45 15 10 10 10 2.810136166624946 35.58546421617101 0.0 3 0.9598989442073607 6.142177621533552 80934.0 73.27336308364195 0.0 - - - - - - - 233.66666666666666 161 3 SPAG5 sperm associated antigen 5 2075 264 C20140610_SFK040_01 C20140610_SFK040_01 TB563661.[MT7]-ELQEVIQQQNEK[MT7].3b3_1.heavy 591.991 / 515.295 32654.0 29.527700424194336 45 15 10 10 10 2.810136166624946 35.58546421617101 0.0 3 0.9598989442073607 6.142177621533552 32654.0 25.62027008928571 0.0 - - - - - - - 1817.2857142857142 65 7 SPAG5 sperm associated antigen 5 2077 265 C20140610_SFK040_01 C20140610_SFK040_01 TB458336.[MT7]-ELNPYWK[MT7].3y3_1.heavy 413.232 / 640.357 14965.0 32.6963005065918 50 20 10 10 10 7.9673138543489745 12.551281627422624 0.0 3 0.9996043917539975 62.04622786813906 14965.0 48.793131688889375 0.0 - - - - - - - 342.45454545454544 29 11 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2079 265 C20140610_SFK040_01 C20140610_SFK040_01 TB458336.[MT7]-ELNPYWK[MT7].3b4_1.heavy 413.232 / 598.332 11665.0 32.6963005065918 50 20 10 10 10 7.9673138543489745 12.551281627422624 0.0 3 0.9996043917539975 62.04622786813906 11665.0 31.19365128683134 1.0 - - - - - - - 314.0833333333333 23 12 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2081 265 C20140610_SFK040_01 C20140610_SFK040_01 TB458336.[MT7]-ELNPYWK[MT7].3b5_1.heavy 413.232 / 761.395 2946.0 32.6963005065918 50 20 10 10 10 7.9673138543489745 12.551281627422624 0.0 3 0.9996043917539975 62.04622786813906 2946.0 36.43802542372881 0.0 - - - - - - - 168.42857142857142 5 7 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2083 265 C20140610_SFK040_01 C20140610_SFK040_01 TB458336.[MT7]-ELNPYWK[MT7].3b3_1.heavy 413.232 / 501.279 216931.0 32.6963005065918 50 20 10 10 10 7.9673138543489745 12.551281627422624 0.0 3 0.9996043917539975 62.04622786813906 216931.0 190.20783341893176 0.0 - - - - - - - 353.5 433 2 CWF19L2 CWF19-like 2, cell cycle control (S. pombe) 2085 266 C20140610_SFK040_01 C20140610_SFK040_01 TB458335.[MT7]-NMQLTAGSK[MT7].3y3_1.heavy 413.232 / 435.268 133671.0 22.91784954071045 34 20 2 6 6 6.569923994350658 15.220876236313835 0.03750038146972656 5 0.9947782283226552 17.0712085216829 133671.0 36.829816810390696 1.0 - - - - - - - 765.75 695 4 BCAS2 breast carcinoma amplified sequence 2 2087 266 C20140610_SFK040_01 C20140610_SFK040_01 TB458335.[MT7]-NMQLTAGSK[MT7].3y4_1.heavy 413.232 / 506.306 96981.0 22.91784954071045 34 20 2 6 6 6.569923994350658 15.220876236313835 0.03750038146972656 5 0.9947782283226552 17.0712085216829 96981.0 24.296855378408075 1.0 - - - - - - - 766.0 193 1 BCAS2 breast carcinoma amplified sequence 2 2089 266 C20140610_SFK040_01 C20140610_SFK040_01 TB458335.[MT7]-NMQLTAGSK[MT7].3b3_1.heavy 413.232 / 518.251 113272.0 22.91784954071045 34 20 2 6 6 6.569923994350658 15.220876236313835 0.03750038146972656 5 0.9947782283226552 17.0712085216829 113272.0 36.41042247708371 1.0 - - - - - - - 348.0 391 1 BCAS2 breast carcinoma amplified sequence 2 2091 266 C20140610_SFK040_01 C20140610_SFK040_01 TB458335.[MT7]-NMQLTAGSK[MT7].3y5_1.heavy 413.232 / 607.353 26665.0 22.91784954071045 34 20 2 6 6 6.569923994350658 15.220876236313835 0.03750038146972656 5 0.9947782283226552 17.0712085216829 26665.0 59.347168968597536 0.0 - - - - - - - 711.6666666666666 53 9 BCAS2 breast carcinoma amplified sequence 2